data_1y9o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y9o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.38 141.97 32.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.683 1.593 . . . . 0.0 109.975 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -83.53 111.46 19.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.203 1.001 . . . . 0.0 109.731 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.3 ptm -92.4 102.57 15.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.634 1.174 . . . . 0.0 108.343 173.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -73.46 127.52 32.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.78 105.57 7.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.721 0.772 . . . . 0.0 109.744 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.3 15.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.885 1.674 . . . . 0.0 107.434 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.36 114.05 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.46 153.31 19.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.268 1.427 . . . . 0.0 109.967 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.1 -161.13 13.92 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.507 1.051 . . . . 0.0 111.66 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tp -83.0 26.21 0.63 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.058 0.543 . . . . 0.0 111.532 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.1 -10.68 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 113.098 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -57.6 151.97 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.632 1.173 . . . . 0.0 110.009 166.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.61 -62.48 4.6 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.84 165.1 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.246 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.41 48.14 3.57 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.934 0.778 . . . . 0.0 112.465 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.01 -60.87 2.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.593 1.157 . . . . 0.0 108.921 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -61.54 -25.58 67.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 112.071 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.24 -48.96 48.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 0.0 109.474 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.29 -46.67 82.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.432 0.693 . . . . 0.0 111.167 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -55.67 -36.85 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.893 0.477 . . . . 0.0 110.635 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -57.34 11.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.852 -1.07 . . . . 0.0 110.928 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -44.15 -55.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.612 1.096 . . . . 0.0 111.638 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.4 -47.41 67.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.385 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.76 -50.86 54.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.8 -47.49 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.573 1.549 . . . . 0.0 109.018 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.58 -39.61 70.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.253 0.621 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -94.39 -0.62 54.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.514 1.525 . . . . 0.0 113.236 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.45 62.2 4.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.952 0.796 . . . . 0.0 111.735 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 mm -115.42 141.77 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 126.285 1.834 . . . . 0.0 107.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -104.06 167.56 9.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.805 1.242 . . . . 0.0 108.485 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.07 -146.92 16.58 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 118.158 0.435 . . . . 0.0 113.123 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -170.76 139.99 1.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 109.357 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.35 88.93 2.91 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.439 1.095 . . . . 0.0 108.58 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.04 77.9 4.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -164.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -72.82 74.0 1.12 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.662 1.585 . . . . 0.0 111.302 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.36 124.0 76.07 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 165.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.46 76.81 3.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.803 2.335 . . . . 0.0 110.749 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -151.14 26.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.613 1.165 . . . . 0.0 111.983 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.59 -48.64 3.71 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.611 0.624 . . . . 0.0 112.353 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 p -91.31 91.28 8.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.781 1.232 . . . . 0.0 110.873 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.51 126.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 124.111 0.964 . . . . 0.0 109.904 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 141.53 29.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.234 0.614 . . . . 0.0 109.506 175.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.69 137.15 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -118.52 61.03 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.423 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.85 156.2 39.42 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.622 1.169 . . . . 0.0 110.167 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.18 112.21 6.6 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.933 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.07 156.82 23.13 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.583 0.628 . . . . 0.0 114.012 -172.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -71.99 -92.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.047 1.739 . . . . 0.0 110.28 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.57 -80.41 0.09 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.429 1.492 . . . . 0.0 107.397 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.66 -52.21 56.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.283 0.633 . . . . 0.0 109.795 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.79 68.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.993 0.517 . . . . 0.0 111.808 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.2 tp -64.95 -66.4 0.55 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -46.38 -42.61 15.25 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.451 1.501 . . . . 0.0 112.941 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -57.41 -62.67 1.61 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.292 0.951 . . . . 0.0 110.17 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -57.37 -35.73 70.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.205 0.602 . . . . 0.0 112.219 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.64 -63.25 1.17 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.982 0.913 . . . . 0.0 110.515 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.31 -37.24 55.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.088 1.355 . . . . 0.0 111.618 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.42 -59.81 3.18 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.433 1.093 . . . . 0.0 111.12 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.33 -61.87 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.139 0.427 . . . . 0.0 111.239 -163.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -48.42 64.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 113.104 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -58.41 -51.97 67.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.262 0.625 . . . . 0.0 110.966 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.8 86.22 0.45 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.03 1.3 . . . . 0.0 109.857 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 163.71 30.91 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.287 2.658 . . . . 0.0 111.226 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.72 165.36 31.18 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.941 2.427 . . . . 0.0 111.188 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.37 43.2 0.72 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.889 0.876 . . . . 0.0 111.096 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.93 25.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.976 1.31 . . . . 0.0 109.327 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -76.53 80.52 3.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.561 1.144 . . . . 0.0 109.574 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.54 119.89 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.052 0.941 . . . . 0.0 108.673 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.56 -50.03 6.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.442 1.097 . . . . 0.0 110.387 -168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -166.09 71.59 0.14 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.413 0.625 . . . . 0.0 111.633 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -65.67 94.35 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.433 0.693 . . . . 0.0 111.122 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.94 83.72 1.88 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.093 1.357 . . . . 0.0 108.01 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -77.66 163.43 26.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.849 0.356 . . . . 0.0 110.676 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.2 m -139.08 110.18 6.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 109.665 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 120.75 10.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 m -127.69 -152.3 0.51 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.811 1.245 . . . . 0.0 109.106 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 155.99 49.15 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.481 1.112 . . . . 0.0 109.198 170.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -81.23 124.11 29.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.012 0.925 . . . . 0.0 110.658 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -73.63 -46.78 44.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 164.5 32.51 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.88 134.04 34.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.582 1.153 . . . . 0.0 109.257 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -74.21 145.88 43.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.583 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.55 87.28 0.9 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.997 0.919 . . . . 0.0 110.104 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 66.44 -160.46 0.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.477 1.111 . . . . 0.0 109.601 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.73 113.39 9.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.211 1.004 . . . . 0.0 109.283 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.93 164.56 20.51 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.638 0.775 . . . . 0.0 110.868 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.97 143.51 38.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.373 1.069 . . . . 0.0 110.408 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.018 -1.468 . . . . 0.0 111.108 168.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.315 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 173.51 9.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.148 1.379 . . . . 0.0 110.839 -167.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -100.21 127.36 46.49 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.085 0.554 . . . . 0.0 111.257 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.47 158.38 31.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 153.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.06 97.26 2.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.85 116.06 29.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.87 0.868 . . . . 0.0 110.944 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.67 107.86 19.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 108.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.92 107.74 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.1 147.88 22.96 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.103 0.961 . . . . 0.0 110.278 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.97 -161.75 27.14 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.244 0.926 . . . . 0.0 110.967 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tp -82.23 20.14 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.268 0.627 . . . . 0.0 110.648 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.26 -14.66 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.106 1.362 . . . . 0.0 112.794 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.37 117.18 7.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.857 0.863 . . . . 0.0 109.653 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.49 48.96 40.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.08 0.848 . . . . 0.0 113.304 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.09 -168.07 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 109.014 166.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.02 79.33 0.2 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.485 1.041 . . . . 0.0 111.013 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -158.42 -174.42 4.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.556 1.542 . . . . 0.0 108.573 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 73.51 -73.57 0.1 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.576 1.951 . . . . 0.0 109.53 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -56.62 -36.96 70.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.283 1.033 . . . . 0.0 110.351 172.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -48.76 -48.14 41.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.274 1.03 . . . . 0.0 111.722 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.16 -37.54 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.158 -0.338 . . . . 0.0 110.422 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.72 -49.29 66.51 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.037 -1.459 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.8 mm -43.93 -53.38 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 120.707 1.594 . . . . 0.0 111.416 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -66.9 -51.68 52.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.6 -44.84 66.25 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.85 -46.33 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 108.635 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -42.03 88.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.318 0.647 . . . . 0.0 111.012 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.3 mt -92.3 -52.53 4.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.058 1.343 . . . . 0.0 111.751 -169.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.14 66.6 0.17 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.167 1.365 . . . . 0.0 112.704 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.79 147.12 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 108.821 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -108.06 174.11 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 108.847 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.86 -150.63 22.44 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 118.619 0.645 . . . . 0.0 112.594 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -164.78 140.87 5.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.72 82.43 1.85 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.396 1.078 . . . . 0.0 110.087 -168.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.38 104.21 16.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 -164.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -78.7 126.11 30.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.3 mt -101.85 93.99 4.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.25 76.89 4.02 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.482 2.788 . . . . 0.0 111.548 -159.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 173.94 -43.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.159 2.584 . . . . 0.0 108.708 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.36 -119.25 4.56 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.737 1.16 . . . . 0.0 111.429 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -129.25 126.04 38.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.57 1.548 . . . . 0.0 109.425 -168.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.27 122.06 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.7 0.8 . . . . 0.0 110.158 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.21 140.19 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.796 0.839 . . . . 0.0 109.646 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.5 t -127.05 134.06 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.178 0.991 . . . . 0.0 108.554 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.1 74.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.71 0.804 . . . . 0.0 110.821 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.89 150.12 37.63 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -117.67 96.63 5.47 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.197 0.599 . . . . 0.0 110.951 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.25 174.52 17.39 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.932 0.777 . . . . 0.0 112.437 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.74 -98.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 108.668 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -152.14 -73.75 0.14 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.291 1.436 . . . . 0.0 108.211 -174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.68 -45.46 48.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.611 1.164 . . . . 0.0 109.338 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.6 57.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.86 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.5 tp -53.78 -56.75 14.68 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.449 0.568 . . . . 0.0 109.56 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.1 p -47.52 -36.38 10.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.888 1.275 . . . . 0.0 112.862 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -64.3 -36.4 84.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.43 1.092 . . . . 0.0 111.444 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.6 -50.15 12.0 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.646 0.778 . . . . 0.0 109.044 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -52.8 25.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.354 0.662 . . . . 0.0 111.168 -171.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.06 -35.68 77.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.281 1.433 . . . . 0.0 113.159 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -48.57 14.48 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.89 1.276 . . . . 0.0 110.73 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.46 -56.42 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 119.02 -0.514 . . . . 0.0 110.616 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.2 -54.28 38.38 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.236 0.471 . . . . 0.0 110.517 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 47.61 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.451 1.1 . . . . 0.0 109.641 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.47 66.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.55 161.3 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.512 2.808 . . . . 0.0 111.311 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.13 170.16 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.954 3.103 . . . . 0.0 111.802 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.24 48.12 1.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.092 0.957 . . . . 0.0 111.027 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -149.37 167.49 26.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.713 1.205 . . . . 0.0 110.162 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.79 89.49 1.37 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.12 86.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 109.967 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -41.54 -60.76 1.22 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.799 1.64 . . . . 0.0 111.344 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.71 140.22 3.87 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.676 0.39 . . . . 0.0 110.473 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.27 97.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 166.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.53 82.48 6.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -76.61 156.44 32.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -141.89 108.91 5.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.805 1.242 . . . . 0.0 108.764 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -69.09 127.5 33.35 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -134.83 -173.56 3.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.086 0.954 . . . . 0.0 110.398 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 141.83 38.35 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.094 0.957 . . . . 0.0 108.616 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.19 56.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -54.18 20.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 170.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.15 -176.05 34.78 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.03 119.1 28.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.278 1.031 . . . . 0.0 109.318 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -70.04 135.37 49.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.44 91.92 1.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.531 0.733 . . . . 0.0 109.979 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 67.92 -161.32 0.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.423 1.089 . . . . 0.0 109.683 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.0 89.94 3.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.635 1.174 . . . . 0.0 108.982 -175.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.53 159.75 16.46 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -115.36 144.23 44.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.306 0.643 . . . . 0.0 110.955 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.027 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.569 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.18 167.1 16.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.116 0.966 . . . . 0.0 112.157 -161.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -100.27 130.76 46.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.4 ttp -66.44 166.23 12.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.196 0.998 . . . . 0.0 108.795 158.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.42 86.78 1.55 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 163.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.35 105.19 17.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.465 0.706 . . . . 0.0 110.953 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 101.02 13.53 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.272 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -90.42 110.86 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -96.15 148.34 22.81 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.969 0.907 . . . . 0.0 109.295 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.41 -157.35 22.27 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.01 1.29 . . . . 0.0 111.316 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -80.46 19.62 0.77 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.517 0.727 . . . . 0.0 111.402 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.62 -23.3 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.151 0.98 . . . . 0.0 111.022 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.77 142.43 50.16 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 109.668 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.13 -65.61 2.85 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.42 169.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.842 0.821 . . . . 0.0 110.953 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.01 -94.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.493 1.044 . . . . 0.0 111.767 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.65 -59.69 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 113.26 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -38.78 -37.78 0.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.762 2.825 . . . . 0.0 113.082 170.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.79 -50.97 25.05 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.536 0.735 . . . . 0.0 109.939 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.96 -39.93 63.32 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 111.48 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.35 -42.29 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 123.44 0.696 . . . . 0.0 110.029 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.4 ' CA ' HE21 ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.42 -54.23 39.98 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 117.715 -1.136 . . . . 0.0 110.143 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.9 mm -41.63 -54.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.877 1.217 . . . . 0.0 113.054 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -73.31 -45.61 54.4 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.554 0.342 . . . . 0.0 110.72 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.64 -51.01 59.11 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.149 0.5 . . . . 0.0 111.741 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -44.6 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 126.219 1.807 . . . . 0.0 109.972 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -53.01 -39.96 63.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.803 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.44 11.7 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.781 1.233 . . . . 0.0 113.47 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.89 64.61 3.67 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 118.841 0.746 . . . . 0.0 112.112 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.5 mm -121.88 138.62 51.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.354 1.462 . . . . 0.0 108.735 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -98.56 173.38 6.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.689 1.196 . . . . 0.0 108.243 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.7 -143.92 11.19 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.499 -0.75 . . . . 0.0 111.7 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -175.26 144.2 0.71 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.551 1.14 . . . . 0.0 109.19 170.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 82.82 1.8 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -95.13 111.78 23.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.353 0.597 . . . . 0.0 110.156 -164.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -91.73 119.69 31.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 108.505 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.04 98.05 4.27 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.52 144.91 91.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.433 2.089 . . . . 0.0 110.812 -169.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.7 t0 55.95 54.73 7.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.475 1.11 . . . . 0.0 109.67 -166.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.27 -134.97 2.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -124.8 161.0 27.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.816 1.646 . . . . 0.0 110.464 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.84 117.83 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.067 0.947 . . . . 0.0 109.629 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -93.19 143.47 26.23 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.618 0.767 . . . . 0.0 110.456 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.25 123.15 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.428 1.091 . . . . 0.0 108.773 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.39 62.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.825 0.85 . . . . 0.0 110.966 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 129.75 38.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.457 0.703 . . . . 0.0 111.042 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -117.62 108.08 15.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.747 1.219 . . . . 0.0 110.503 -165.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 177.32 37.5 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-O 122.216 0.898 . . . . 0.0 114.369 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -69.87 169.65 12.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.128 1.371 . . . . 0.0 108.946 165.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -79.85 -30.25 40.3 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.12 -25.53 68.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.918 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.28 -13.54 18.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.914 0.885 . . . . 0.0 111.825 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.83 -59.79 2.71 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 p -38.57 -45.01 1.02 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.278 1.831 . . . . 0.0 112.912 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.45 -42.02 88.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.854 0.862 . . . . 0.0 112.682 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -74.11 -21.99 59.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.626 1.171 . . . . 0.0 111.551 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.7 -61.24 2.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.471 1.108 . . . . 0.0 110.317 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -53.89 -42.07 68.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 110.299 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -34.37 -47.42 0.3 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.305 2.642 . . . . 0.0 113.556 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.61 -68.25 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.608 0.763 . . . . 0.0 110.728 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -52.13 -44.93 64.75 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.84 -51.96 67.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.299 1.04 . . . . 0.0 111.186 173.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.09 85.3 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.61 160.55 45.59 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.924 2.416 . . . . 0.0 111.262 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.25 160.58 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.274 2.649 . . . . 0.0 110.765 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 48.83 1.33 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.824 0.85 . . . . 0.0 110.957 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.39 169.06 25.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 110.484 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.1 77.73 2.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.189 0.995 . . . . 0.0 109.374 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.08 125.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.953 0.901 . . . . 0.0 109.389 173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.93 -60.34 2.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 108.163 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -156.13 115.47 3.53 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.72 87.01 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 161.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.09 67.42 8.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.458 1.103 . . . . 0.0 108.268 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.2 154.38 31.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.826 -170.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -138.23 117.65 12.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.67 129.93 44.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m -127.21 -161.89 1.12 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.443 1.097 . . . . 0.0 109.24 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.23 141.48 45.79 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.617 0.767 . . . . 0.0 109.026 170.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -54.8 135.1 47.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.567 1.147 . . . . 0.0 112.96 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -73.35 -57.49 3.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 165.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.29 -177.55 40.01 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.43 122.2 16.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.56 0.744 . . . . 0.0 110.417 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -72.98 -26.5 61.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 111.468 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.51 91.31 0.07 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.637 1.575 . . . . 0.0 111.028 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.53 179.72 0.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 110.472 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.88 95.84 2.56 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.68 167.04 13.39 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 p -103.69 152.02 22.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.482 0.713 . . . . 0.0 110.791 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 153.219 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.23 166.57 10.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.262 1.025 . . . . 0.0 109.905 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -99.15 101.56 12.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 110.347 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.3 ttp -70.01 144.77 52.15 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 164.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -124.18 136.35 54.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.993 1.717 . . . . 0.0 106.561 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 107.59 4.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.343 0.592 . . . . 0.0 109.976 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 98.93 8.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.73 101.09 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.31 149.89 26.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.267 0.627 . . . . 0.0 111.265 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.61 -163.53 18.45 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.315 1.436 . . . . 0.0 110.7 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 47.8 1.55 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.02 41.62 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.326 1.05 . . . . 0.0 110.747 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.62 150.43 33.15 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.404 1.082 . . . . 0.0 110.384 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.72 -56.83 4.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.527 0.584 . . . . 0.0 111.871 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -48.38 150.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.803 2.041 . . . . 0.0 111.292 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.82 38.45 2.34 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.825 0.726 . . . . 0.0 113.486 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -67.17 -35.87 80.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.64 0.72 . . . . 0.0 110.016 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -58.22 -31.77 67.67 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.265 1.026 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.72 -48.15 34.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.668 1.187 . . . . 0.0 109.843 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.13 -44.84 79.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.507 0.723 . . . . 0.0 111.579 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.51 -37.5 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.666 0.786 . . . . 0.0 109.969 172.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.37 -57.7 9.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.848 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -43.06 -51.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 119.451 1.023 . . . . 0.0 111.757 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -67.22 -56.6 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.841 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.68 -47.82 20.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.54 -42.88 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 126.224 1.81 . . . . 0.0 110.47 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -62.52 -34.41 76.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.766 0.426 . . . . 0.0 111.799 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.98 -0.19 55.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.855 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.17 5.32 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 118.65 0.659 . . . . 0.0 111.557 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -121.26 141.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.649 1.58 . . . . 0.0 108.311 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -103.43 166.38 10.46 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.26 -145.21 12.25 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.957 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.36 141.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 110.19 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.11 86.68 2.34 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.165 1.386 . . . . 0.0 108.727 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -100.27 90.1 4.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.862 0.865 . . . . 0.0 110.511 -164.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.73 92.76 4.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.557 1.543 . . . . 0.0 109.811 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.7 mt -66.13 106.19 1.03 Allowed Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 125.772 1.629 . . . . 0.0 108.321 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.07 43.24 1.43 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.584 2.189 . . . . 0.0 113.058 -160.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.5 47.77 0.34 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.472 1.509 . . . . 0.0 108.285 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.83 -135.7 3.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -112.6 169.34 8.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.494 1.517 . . . . 0.0 109.656 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.68 135.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 C-N-CA 124.204 1.001 . . . . 0.0 112.011 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -100.48 122.71 43.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.604 1.161 . . . . 0.0 109.183 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.38 145.11 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.639 1.176 . . . . 0.0 108.518 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.23 86.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.072 0.949 . . . . 0.0 109.827 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.42 143.02 26.67 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.028 1.331 . . . . 0.0 111.592 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -126.28 99.12 5.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.272 0.629 . . . . 0.0 110.772 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.54 164.14 30.15 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 121.598 0.554 . . . . 0.0 113.073 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -66.7 167.32 11.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 -35.58 67.28 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.977 -0.452 . . . . 0.0 111.911 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -45.3 -39.91 7.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.791 1.236 . . . . 0.0 112.159 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.08 0.85 21.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.94 1.296 . . . . 0.0 112.586 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -70.29 -59.29 2.96 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.285 0.948 . . . . 0.0 108.829 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -42.63 -45.4 4.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.269 1.428 . . . . 0.0 112.063 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.17 -32.42 64.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.718 1.607 . . . . 0.0 112.885 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.23 -53.88 4.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.07 1.348 . . . . 0.0 109.927 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -53.24 56.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.49 1.116 . . . . 0.0 111.109 -167.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -68.91 -34.6 75.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.636 1.174 . . . . 0.0 111.433 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.43 -42.26 10.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.384 1.474 . . . . 0.0 111.206 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.41 -61.61 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.217 0.607 . . . . 0.0 111.2 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.54 -48.69 80.68 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.09 0.405 . . . . 0.0 111.029 -168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -94.94 38.36 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.927 1.291 . . . . 0.0 110.275 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.3 76.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.99 162.04 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.464 2.776 . . . . 0.0 112.594 -167.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.65 -1.73 5.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.222 3.281 . . . . 0.0 114.525 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.36 28.8 4.67 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 126.163 1.785 . . . . 0.0 110.114 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.35 164.16 32.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.997 1.719 . . . . 0.0 107.995 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.15 80.5 4.57 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.076 0.551 . . . . 0.0 110.945 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.33 126.88 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.164 0.986 . . . . 0.0 109.656 170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -93.65 -53.1 4.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.455 1.102 . . . . 0.0 109.405 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -164.85 76.12 0.29 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.064 0.459 . . . . 0.0 112.165 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.4 p -67.21 89.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.282 0.633 . . . . 0.0 111.013 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.07 85.5 3.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.158 1.383 . . . . 0.0 108.046 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -77.74 170.33 16.76 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.176 0.512 . . . . 0.0 112.212 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -139.7 112.16 7.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.222 1.409 . . . . 0.0 109.843 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -66.26 138.7 57.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 163.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m -161.24 174.07 14.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.083 0.468 . . . . 0.0 109.959 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.29 146.14 27.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.086 0.954 . . . . 0.0 110.604 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.29 127.85 33.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.24 0.616 . . . . 0.0 110.164 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -42.63 18.13 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.01 161.8 34.18 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.22 149.96 21.55 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.602 1.161 . . . . 0.0 110.568 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.15 153.99 33.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.093 165.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -71.87 78.6 0.88 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.213 1.005 . . . . 0.0 109.696 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.68 -162.76 0.19 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.151 1.38 . . . . 0.0 110.296 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.66 116.01 21.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.116 1.366 . . . . 0.0 108.362 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -129.35 166.31 19.76 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.86 123.92 48.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.834 0.853 . . . . 0.0 110.26 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.53 1.532 . . . . 0.0 107.844 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 -179.55 6.43 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.355 1.062 . . . . 0.0 111.415 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -108.96 127.4 54.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.25 0.62 . . . . 0.0 112.386 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 ttp -79.31 146.56 32.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 155.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -127.95 135.44 49.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.444 1.897 . . . . 0.0 106.335 165.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.67 110.52 5.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.394 0.616 . . . . 0.0 111.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -84.3 99.23 10.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.166 1.386 . . . . 0.0 108.084 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.12 107.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -97.32 149.65 21.85 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.439 1.096 . . . . 0.0 110.253 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.5 -158.43 26.03 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.885 1.231 . . . . 0.0 110.962 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.92 22.5 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.515 0.726 . . . . 0.0 110.977 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.84 -17.4 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.118 1.367 . . . . 0.0 111.885 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -67.47 121.04 14.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.062 0.545 . . . . 0.0 111.627 -172.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.48 37.03 93.46 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.462 1.029 . . . . 0.0 112.773 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.14 91.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.0 -139.1 44.45 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.485 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 t80 56.48 -173.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.003 1.721 . . . . 0.0 111.428 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 68.36 -76.04 0.06 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 126.126 1.771 . . . . 0.0 109.243 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -45.85 -42.35 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.303 1.441 . . . . 0.0 111.92 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.66 -53.82 50.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 111.245 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -67.23 -18.83 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 122.074 -0.392 . . . . 0.0 111.344 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -54.83 13.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.266 -1.349 . . . . 0.0 110.713 167.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.7 mm -36.27 -55.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 120.483 1.492 . . . . 0.0 112.886 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -67.62 -51.94 44.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.75 0.42 . . . . 0.0 110.759 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -45.38 -65.98 0.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.575 1.15 . . . . 0.0 111.351 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.41 -47.92 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 111.631 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -53.52 -46.68 70.19 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.06 0.544 . . . . 0.0 110.571 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.9 mt -102.29 37.33 1.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 111.851 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.23 68.43 1.67 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.981 1.277 . . . . 0.0 113.766 167.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.4 mm -117.3 141.45 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.802 1.241 . . . . 0.0 108.978 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -101.81 174.57 5.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 108.481 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.56 -152.44 24.0 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.342 0.974 . . . . 0.0 112.288 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -170.88 142.91 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.451 0.7 . . . . 0.0 110.347 167.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.74 90.2 3.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.295 1.038 . . . . 0.0 111.977 -165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -111.15 104.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.592 0.357 . . . . 0.0 111.823 -160.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -80.17 97.32 6.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.005 0.922 . . . . 0.0 109.42 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -73.73 102.52 0.62 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.04 136.5 48.48 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.891 1.728 . . . . 0.0 110.499 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 55.86 53.35 9.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 110.124 -167.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.47 -131.37 1.25 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.3 t -121.61 150.33 41.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.481 1.112 . . . . 0.0 110.134 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -99.66 94.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.51 137.81 32.23 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.051 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 143.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.04 136.84 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 164.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.91 138.25 31.91 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.083 0.953 . . . . 0.0 108.717 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.15 90.78 3.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -168.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.93 168.62 16.99 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 123.289 0.471 . . . . 0.0 112.199 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -77.07 -100.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.84 1.656 . . . . 0.0 108.942 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -150.92 -57.47 0.16 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.796 1.638 . . . . 0.0 108.188 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -49.89 -45.12 50.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.848 0.859 . . . . 0.0 109.64 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.69 -34.46 67.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.05 0.54 . . . . 0.0 111.372 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.17 -61.02 2.75 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.4 p -43.33 -47.58 6.75 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.682 1.593 . . . . 0.0 112.213 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -56.18 -41.68 75.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.403 1.081 . . . . 0.0 111.666 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.4 -24.65 31.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.711 1.605 . . . . 0.0 111.154 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.53 -60.84 2.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.139 0.976 . . . . 0.0 110.936 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.81 -43.47 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.239 1.016 . . . . 0.0 111.058 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -34.1 -50.99 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.074 2.55 . . . . 0.0 113.259 165.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -69.18 -68.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.682 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -52.49 -41.83 63.73 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.79 -53.81 44.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.723 0.809 . . . . 0.0 110.754 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.09 0.3 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.863 1.22 . . . . 0.0 110.56 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.38 161.54 42.76 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.251 2.634 . . . . 0.0 111.296 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.33 164.71 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.516 2.811 . . . . 0.0 111.793 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.12 50.18 1.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 111.02 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.22 159.34 17.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.599 1.559 . . . . 0.0 107.84 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.18 84.49 3.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.597 0.359 . . . . 0.0 110.437 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.88 127.88 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.765 0.826 . . . . 0.0 109.183 168.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.85 -61.42 1.63 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.729 1.212 . . . . 0.0 108.05 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -146.4 119.94 9.11 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.01 0.524 . . . . 0.0 112.055 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.47 101.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -100.26 79.64 2.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.238 1.415 . . . . 0.0 108.062 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.24 152.34 21.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 m -145.29 139.85 27.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.0 0.92 . . . . 0.0 110.664 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.98 127.34 42.85 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 109.033 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -136.35 -175.86 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.224 1.01 . . . . 0.0 110.639 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.59 152.53 18.45 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.536 0.734 . . . . 0.0 110.57 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.57 133.96 53.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.432 1.093 . . . . 0.0 111.39 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -71.34 -50.37 32.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.07 172.48 35.19 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.12 112.4 20.2 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.958 0.903 . . . . 0.0 109.094 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.67 133.46 54.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.61 97.43 1.71 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.68 -167.41 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.203 1.401 . . . . 0.0 110.539 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 80.54 1.94 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.12 1.368 . . . . 0.0 108.658 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -106.85 160.64 15.35 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 123.255 0.347 . . . . 0.0 110.149 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.18 141.3 47.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.496 0.718 . . . . 0.0 111.559 -165.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.405 1.482 . . . . 0.0 108.306 170.145 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.57 152.16 32.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.293 1.837 . . . . 0.0 108.57 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -97.87 113.94 25.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.277 1.031 . . . . 0.0 110.587 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.0 ptm -86.28 161.7 18.63 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.11 85.56 1.61 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.69 96.19 10.3 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.121 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -80.88 107.2 13.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 t -91.45 90.39 3.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -168.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -65.38 148.28 51.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.13 -164.79 13.14 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.995 0.807 . . . . 0.0 112.157 166.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -90.23 36.92 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.85 0.86 . . . . 0.0 110.218 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.91 -19.39 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 142.32 45.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.011 0.924 . . . . 0.0 111.107 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.0 -43.31 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.839 0.733 . . . . 0.0 112.243 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.21 78.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.939 0.896 . . . . 0.0 109.854 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.5 -121.44 7.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.918 1.247 . . . . 0.0 111.214 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.9 t80 65.35 -56.95 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.092 2.557 . . . . 0.0 114.635 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -32.99 -51.28 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.525 2.73 . . . . 0.0 112.992 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -79.65 -41.73 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.096 0.958 . . . . 0.0 111.183 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -51.25 -41.84 60.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 111.085 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.53 -43.36 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.593 1.157 . . . . 0.0 111.375 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -57.96 10.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.728 0.811 . . . . 0.0 110.589 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.2 mm -47.47 -57.45 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 118.389 0.54 . . . . 0.0 111.3 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -69.94 -39.45 76.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.288 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.79 -61.9 1.93 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.297 0.499 . . . . 0.0 110.918 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.75 -50.62 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.732 1.613 . . . . 0.0 110.39 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -51.3 62.14 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.915 0.886 . . . . 0.0 109.804 -176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.13 4.13 46.58 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.022 1.329 . . . . 0.0 113.387 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.01 58.2 9.38 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.755 0.707 . . . . 0.0 111.454 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.52 142.75 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.784 1.634 . . . . 0.0 107.81 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.53 162.98 13.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.435 1.094 . . . . 0.0 108.58 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -149.68 21.67 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -169.59 143.35 2.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.92 82.88 1.92 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.365 1.066 . . . . 0.0 108.957 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.506 1.146 . . . . 0.0 109.638 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.5 67.35 10.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 127.531 2.332 . . . . 0.0 110.609 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.1 mt -48.79 104.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 126.393 1.877 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.47 32.73 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.115 1.877 . . . . 0.0 113.211 -164.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -147.93 44.83 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.18 1.392 . . . . 0.0 107.604 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.61 -149.86 8.16 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -120.67 151.41 39.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.686 1.194 . . . . 0.0 109.701 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.4 126.96 32.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.89 0.876 . . . . 0.0 111.47 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -92.06 127.48 37.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.68 97.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.48 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.754 0.787 . . . . 0.0 109.732 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.53 156.38 32.94 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.857 1.263 . . . . 0.0 111.38 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -146.57 122.87 10.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.343 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.05 164.92 35.66 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 118.75 0.705 . . . . 0.0 112.773 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.24 162.9 11.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.458 1.103 . . . . 0.0 108.67 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.84 -24.51 44.34 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -166.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.45 -44.08 95.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.655 0.661 . . . . 0.0 109.909 168.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.04 -14.42 59.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.507 0.723 . . . . 0.0 112.439 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.13 -62.96 1.17 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -49.45 -42.46 42.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 112.809 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -61.71 -38.96 89.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.139 0.976 . . . . 0.0 112.047 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -70.61 -55.31 9.09 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -50.95 -53.58 31.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.773 0.429 . . . . 0.0 111.554 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.06 -37.63 83.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.76 0.824 . . . . 0.0 112.246 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.66 -49.07 7.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.917 1.287 . . . . 0.0 110.8 167.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -70.4 -52.63 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.19 0.596 . . . . 0.0 110.296 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -49.94 73.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.453 0.569 . . . . 0.0 111.2 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -69.52 -36.9 76.86 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.367 1.067 . . . . 0.0 111.581 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.99 74.78 0.24 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.234 1.397 . . . . 0.0 110.22 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.77 168.49 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.826 3.017 . . . . 0.0 110.174 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.1 150.02 77.04 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.58 1.52 . . . . 0.0 108.533 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.86 45.56 0.82 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.002 0.521 . . . . 0.0 110.553 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.21 175.64 9.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 109.681 -173.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.27 74.33 3.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.639 0.776 . . . . 0.0 109.92 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 117.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -76.84 -52.28 9.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.505 1.122 . . . . 0.0 108.783 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -179.31 110.38 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.075 1.35 . . . . 0.0 110.211 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -75.74 78.07 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.339 1.056 . . . . 0.0 109.512 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -95.14 89.4 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.38 164.06 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.018 0.437 . . . . 0.0 111.944 -171.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -117.52 125.03 50.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.078 1.351 . . . . 0.0 108.769 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.25 128.75 34.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 m -136.51 179.25 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.633 0.773 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -96.47 146.69 24.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.084 1.354 . . . . 0.0 108.874 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -69.44 135.77 50.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -89.1 -57.35 2.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.018 1.327 . . . . 0.0 108.639 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 27.51 22.52 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.726 1.155 . . . . 0.0 113.536 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.86 -35.34 26.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.408 1.104 . . . . 0.0 112.887 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -83.84 82.27 8.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.08 0.552 . . . . 0.0 111.427 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.23 88.6 0.18 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.917 0.887 . . . . 0.0 109.36 171.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 90.85 145.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 128.507 2.723 . . . . 0.0 110.504 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.92 112.38 24.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.329 1.052 . . . . 0.0 108.829 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.48 165.7 15.95 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.07 0.548 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 p -108.12 146.28 32.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.834 0.854 . . . . 0.0 110.747 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.312 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 168.51 12.35 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.777 0.831 . . . . 0.0 112.267 -169.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -93.44 114.92 27.43 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.05 0.453 . . . . 0.0 111.472 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.8 ptm -93.94 86.27 5.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 122.059 0.933 . . . . 0.0 110.529 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.38 114.83 18.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.32 110.68 16.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.316 1.047 . . . . 0.0 110.323 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 109.16 20.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.046 1.338 . . . . 0.0 107.921 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -96.24 110.12 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.52 154.77 17.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.132 0.973 . . . . 0.0 111.728 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.3 -159.05 21.3 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.735 1.636 . . . . 0.0 110.895 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -86.4 47.97 1.55 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.99 41.72 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 125.192 1.397 . . . . 0.0 110.43 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -108.16 33.93 3.87 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.355 0.662 . . . . 0.0 111.86 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.48 -160.7 26.84 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.785 1.183 . . . . 0.0 110.319 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 70.23 -175.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.965 1.306 . . . . 0.0 109.812 -175.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.99 51.19 2.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.817 0.723 . . . . 0.0 112.616 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.49 178.86 5.82 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.742 2.017 . . . . 0.0 112.075 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 61.65 -74.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.84 2.056 . . . . 0.0 111.061 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.15 -47.2 1.56 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.899 1.679 . . . . 0.0 111.137 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.23 -50.12 67.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.312 0.645 . . . . 0.0 112.127 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.0 -36.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 123.434 0.694 . . . . 0.0 110.341 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.4 -51.85 65.9 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.286 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -44.23 -50.41 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.844 1.656 . . . . 0.0 112.363 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -71.27 -49.64 40.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.854 0.462 . . . . 0.0 110.209 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.63 -48.39 58.06 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.031 0.933 . . . . 0.0 113.132 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.32 -47.16 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.327 1.851 . . . . 0.0 108.36 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.35 -42.87 67.25 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.98 0.355 . . . . 0.0 110.993 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -93.28 6.82 46.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.99 1.316 . . . . 0.0 113.285 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.62 59.83 8.21 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 118.595 0.634 . . . . 0.0 112.244 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -113.45 139.54 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 125.605 1.562 . . . . 0.0 108.399 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -103.46 157.52 16.98 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.671 1.188 . . . . 0.0 108.06 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.97 -158.78 31.58 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 118.569 0.622 . . . . 0.0 113.072 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -170.43 137.98 1.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.591 1.156 . . . . 0.0 108.641 167.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.39 87.51 2.63 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.99 0.916 . . . . 0.0 108.78 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -94.71 115.42 27.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.804 0.842 . . . . 0.0 109.807 -167.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.33 130.38 34.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.542 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -102.55 96.71 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.08 23.6 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.293 2.662 . . . . 0.0 114.43 -161.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.35 42.13 2.05 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.015 1.326 . . . . 0.0 108.303 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.69 -122.22 0.83 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -117.48 164.14 15.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.261 1.824 . . . . 0.0 110.579 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -102.85 124.75 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.595 0.758 . . . . 0.0 110.501 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -98.58 125.52 43.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.757 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -109.06 115.55 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.44 135.1 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 164.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.31 146.4 18.5 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.508 1.123 . . . . 0.0 108.733 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.81 122.63 18.81 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.334 0.654 . . . . 0.0 111.219 -171.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.95 165.3 28.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 121.91 0.728 . . . . 0.0 113.881 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.44 172.68 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.093 160.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.92 -25.54 40.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.06 -52.01 52.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.93 -14.9 62.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.31 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.61 -68.29 0.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -46.34 -43.68 16.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.66 1.184 . . . . 0.0 112.825 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.587 1.155 . . . . 0.0 111.632 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.2 -24.94 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.906 0.482 . . . . 0.0 111.592 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -59.23 2.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 109.862 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.26 -33.53 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.686 0.794 . . . . 0.0 112.207 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.94 -54.57 2.71 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.485 1.514 . . . . 0.0 111.09 170.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.2 mt -74.39 -52.45 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.658 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -54.36 42.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.582 0.628 . . . . 0.0 110.269 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -90.82 41.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.051 1.34 . . . . 0.0 110.201 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.39 73.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.52 163.58 26.58 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.962 3.108 . . . . 0.0 111.639 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.35 -8.78 23.08 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.41 2.74 . . . . 0.0 113.919 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 78.81 25.77 0.5 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.083 2.153 . . . . 0.0 111.084 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.21 169.08 14.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.29 1.836 . . . . 0.0 107.987 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.2 77.99 1.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.689 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.46 122.69 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.749 1.22 . . . . 0.0 110.018 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -82.83 -57.95 3.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.072 1.349 . . . . 0.0 107.898 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.23 136.29 6.54 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.164 0.29 . . . . 0.0 110.841 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 84.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -87.58 75.46 9.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -70.38 160.5 32.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.886 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 m -146.1 80.31 1.57 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 109.489 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.25 137.47 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.481 1.513 . . . . 0.0 112.467 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -144.85 -177.51 5.56 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 0.0 110.871 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 153.12 39.9 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.11 124.67 23.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.748 0.819 . . . . 0.0 111.578 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.18 -49.46 35.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.93 172.5 42.07 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.86 109.98 20.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.68 140.89 58.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.891 0.877 . . . . 0.0 109.935 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.25 91.82 2.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.676 0.79 . . . . 0.0 110.588 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.9 -163.41 0.23 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.43 1.092 . . . . 0.0 109.811 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.1 87.62 2.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.618 0.767 . . . . 0.0 109.638 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -104.25 -175.91 2.93 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.606 0.762 . . . . 0.0 109.079 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -125.17 158.81 33.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.118 -1.42 . . . . 0.0 109.934 159.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.493 0.187 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 164.13 19.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.236 1.014 . . . . 0.0 111.592 -170.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -86.39 118.42 25.82 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.1 ptm -89.58 91.35 8.65 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.279 1.037 . . . . 0.0 108.832 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.28 128.66 35.34 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.32 14.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.097 0.475 . . . . 0.0 111.254 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -100.77 94.56 6.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.005 0.922 . . . . 0.0 109.084 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.83 103.76 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.482 0.713 . . . . 0.0 109.135 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -101.86 143.47 31.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.799 0.84 . . . . 0.0 110.569 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.72 -165.95 33.22 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.49 0.494 . . . . 0.0 112.342 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.65 20.5 0.73 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.706 0.803 . . . . 0.0 110.546 168.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.23 -3.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.97 1.308 . . . . 0.0 112.469 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -82.23 33.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.714 1.605 . . . . 0.0 112.814 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.23 57.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.96 -174.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.218 1.007 . . . . 0.0 108.402 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.86 66.53 0.65 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.188 0.899 . . . . 0.0 111.897 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -133.24 171.51 13.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.703 2.001 . . . . 0.0 107.372 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 80.32 -62.39 0.24 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.639 1.576 . . . . 0.0 107.886 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -54.26 -41.14 68.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.696 0.798 . . . . 0.0 109.478 165.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.79 -55.8 23.21 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.62 -18.57 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.875 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -57.67 -58.8 6.76 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.224 0.92 . . . . 0.0 109.324 165.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.0 mm -46.79 -56.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 123.232 0.613 . . . . 0.0 111.49 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -66.13 -44.3 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.5 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.31 -65.16 0.6 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.214 0.461 . . . . 0.0 110.766 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.93 -45.96 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.978 1.711 . . . . 0.0 111.428 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.93 -43.8 98.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 111.469 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.29 16.72 8.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.777 0.831 . . . . 0.0 112.531 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.74 58.23 15.3 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 124.334 0.969 . . . . 0.0 112.518 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.21 139.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.942 1.297 . . . . 0.0 109.916 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.11 175.13 5.63 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.238 1.415 . . . . 0.0 108.237 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.56 -140.41 11.77 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -170.88 150.67 3.21 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.027 0.413 . . . . 0.0 111.297 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.48 86.5 2.37 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.415 1.486 . . . . 0.0 108.953 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.48 108.95 20.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.24 1.016 . . . . 0.0 108.427 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.15 92.83 9.12 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.16 1.384 . . . . 0.0 109.756 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.88 113.67 32.21 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.59 72.91 5.42 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.357 2.705 . . . . 0.0 112.201 -162.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -165.25 55.93 0.12 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.85 1.66 . . . . 0.0 107.992 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.47 -40.59 1.78 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.48 1.038 . . . . 0.0 114.082 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -90.99 93.22 9.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.404 1.482 . . . . 0.0 110.93 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.37 119.83 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.74 125.79 36.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.746 1.218 . . . . 0.0 109.003 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.77 135.25 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.685 1.194 . . . . 0.0 107.881 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.59 55.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 C-N-CA 124.113 0.965 . . . . 0.0 108.981 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.96 157.54 30.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.249 1.42 . . . . 0.0 110.165 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -143.83 123.03 12.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.545 -172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.88 166.72 39.39 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.467 -1.349 . . . . 0.0 113.748 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -52.43 156.25 1.84 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 0.0 111.352 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.68 -15.05 58.95 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.9 -36.32 82.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.271 0.487 . . . . 0.0 109.942 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.73 -3.53 29.96 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.666 1.186 . . . . 0.0 112.696 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.4 tp -66.9 -61.54 1.89 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.265 0.939 . . . . 0.0 109.364 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -44.7 -41.94 7.2 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.128 1.371 . . . . 0.0 112.878 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.18 -50.31 73.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.627 1.171 . . . . 0.0 111.079 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.19 -30.04 65.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.624 0.37 . . . . 0.0 111.274 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.21 -58.7 3.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.98 -38.81 68.29 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.985 0.914 . . . . 0.0 112.268 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -30.44 -52.08 0.15 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.571 1.948 . . . . 0.0 112.542 164.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.16 -72.36 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 122.752 0.421 . . . . 0.0 110.452 -169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -49.89 45.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.053 0.941 . . . . 0.0 111.869 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -89.18 29.42 1.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.467 1.107 . . . . 0.0 111.954 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.56 68.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.77 164.92 32.62 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.022 3.148 . . . . 0.0 111.546 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -178.51 4.23 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.512 2.808 . . . . 0.0 110.864 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.12 28.81 0.69 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.104 0.961 . . . . 0.0 112.251 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.25 167.0 19.94 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.732 1.213 . . . . 0.0 110.328 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.84 81.99 2.76 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.81 83.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.549 1.54 . . . . 0.0 110.607 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -39.44 -62.37 0.68 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.964 2.106 . . . . 0.0 111.458 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -165.57 129.28 2.24 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 111.702 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.68 99.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.29 80.7 9.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -74.75 142.61 44.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.0 m -148.28 85.26 1.52 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 109.593 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.98 142.4 0.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.567 1.947 . . . . 0.0 111.027 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -159.95 171.85 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.26 143.06 39.17 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.008 0.923 . . . . 0.0 109.773 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.48 145.69 52.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.085 0.469 . . . . 0.0 111.936 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -58.28 2.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.113 1.365 . . . . 0.0 108.332 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.62 167.8 39.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.54 103.05 6.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.427 0.691 . . . . 0.0 110.213 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -77.55 79.24 4.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -44.44 119.5 1.88 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.375 1.87 . . . . 0.0 112.502 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.5 t70 68.1 124.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.874 2.07 . . . . 0.0 111.595 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.35 95.1 3.15 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -118.21 160.09 22.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 0.819 . . . . 0.0 110.794 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.95 145.97 29.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.678 0.791 . . . . 0.0 112.385 -171.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.304 154.128 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 171.58 8.19 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.874 0.869 . . . . 0.0 111.731 -174.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -103.11 107.35 18.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.976 1.311 . . . . 0.0 111.375 -168.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.14 98.2 11.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 109.583 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -74.82 133.86 41.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.17 105.84 5.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.67 99.61 12.61 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.225 1.41 . . . . 0.0 108.37 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.22 116.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.462 1.105 . . . . 0.0 109.065 -170.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -98.97 158.03 15.92 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.688 1.195 . . . . 0.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.11 -162.71 14.76 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 124.631 1.11 . . . . 0.0 111.993 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.23 32.86 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.701 0.8 . . . . 0.0 110.773 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.88 -19.22 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.291 1.036 . . . . 0.0 111.212 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -56.62 133.95 54.12 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.352 1.061 . . . . 0.0 110.15 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.74 10.47 83.26 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.109 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.17 152.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.73 1.212 . . . . 0.0 107.843 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.49 45.9 3.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.769 0.7 . . . . 0.0 112.89 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -57.82 -51.69 68.54 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.676 0.79 . . . . 0.0 109.376 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -56.84 -42.29 79.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.717 0.807 . . . . 0.0 111.692 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.27 -46.08 81.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.274 1.03 . . . . 0.0 110.452 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.99 -45.19 75.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.001 0.364 . . . . 0.0 110.489 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.36 -32.8 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.969 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.54 -55.78 30.22 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.284 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mm -42.01 -57.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.766 1.166 . . . . 0.0 113.325 -172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -68.65 -48.07 64.95 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.393 0.542 . . . . 0.0 110.443 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.39 -65.4 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 111.646 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.45 -49.85 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.218 2.207 . . . . 0.0 111.5 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.87 78.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.846 0.458 . . . . 0.0 111.944 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.5 mt -102.06 23.47 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.71 65.87 3.25 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.454 1.026 . . . . 0.0 113.304 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.92 139.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 125.045 1.338 . . . . 0.0 108.004 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -101.56 167.1 10.35 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.072 1.349 . . . . 0.0 107.808 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.98 -146.52 14.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.338 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -167.45 148.6 5.54 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.576 1.15 . . . . 0.0 109.186 166.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.52 81.44 1.59 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.85 0.86 . . . . 0.0 108.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -86.83 84.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.82 87.64 2.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.724 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 123.05 85.67 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 163.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.52 69.33 7.75 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.65 2.234 . . . . 0.0 111.428 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -159.05 56.04 0.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.216 1.406 . . . . 0.0 108.527 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.82 -55.6 4.75 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.856 0.741 . . . . 0.0 113.545 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 m -94.37 66.3 3.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.424 0.689 . . . . 0.0 112.567 -161.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.67 118.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.047 0.539 . . . . 0.0 110.294 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.48 121.21 32.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.0 110.01 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.14 147.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.93 66.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.58 157.57 37.75 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.249 1.42 . . . . 0.0 110.315 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.12 116.7 11.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.742 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.03 159.84 27.47 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 118.722 0.692 . . . . 0.0 114.566 -170.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.9 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.264 1.826 . . . . 0.0 109.535 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -154.72 -75.84 0.11 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.301 1.441 . . . . 0.0 108.222 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -55.1 -48.59 73.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.0 69.38 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.986 0.515 . . . . 0.0 111.797 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.08 -66.31 0.56 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.4 t -44.98 -46.1 10.94 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.041 1.737 . . . . 0.0 112.77 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.73 -44.05 94.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.395 0.543 . . . . 0.0 111.891 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.29 -23.59 51.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.766 0.826 . . . . 0.0 111.354 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.44 -61.55 1.73 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.226 -0.921 . . . . 0.0 110.857 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.36 -36.91 79.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.875 0.87 . . . . 0.0 111.146 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -36.96 -49.59 0.83 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 165.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.81 -64.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.242 0.617 . . . . 0.0 110.056 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -51.57 62.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.831 0.852 . . . . 0.0 111.476 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -77.63 -33.14 53.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.041 0.936 . . . . 0.0 111.998 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.78 85.94 0.42 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.413 1.006 . . . . 0.0 110.686 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.66 156.23 66.19 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.965 2.443 . . . . 0.0 111.299 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.77 172.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.018 3.145 . . . . 0.0 111.715 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.01 27.76 1.53 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.162 0.985 . . . . 0.0 111.875 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.18 28.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.902 1.281 . . . . 0.0 109.445 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 81.64 3.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.45 122.41 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.56 -56.79 4.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -168.31 142.8 3.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.631 1.173 . . . . 0.0 108.667 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.49 100.24 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.76 75.01 4.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -78.71 160.38 27.5 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -135.46 109.43 8.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.734 1.614 . . . . 0.0 109.591 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 119.55 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -134.42 179.49 6.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.798 1.239 . . . . 0.0 110.461 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -104.82 135.92 45.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.128 0.971 . . . . 0.0 110.03 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -52.17 138.98 24.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.065 2.146 . . . . 0.0 112.746 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -79.33 -48.83 13.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.48 179.5 27.16 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.73 112.79 20.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.69 1.196 . . . . 0.0 107.905 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -70.05 137.79 51.56 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -68.17 90.29 0.33 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.664 0.786 . . . . 0.0 110.212 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 70.18 -164.93 0.16 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.229 1.412 . . . . 0.0 109.713 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.7 96.82 3.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.993 0.917 . . . . 0.0 108.856 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -121.56 163.28 19.15 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.483 0.713 . . . . 0.0 109.836 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.94 148.64 33.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.847 1.259 . . . . 0.0 111.73 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.28 155.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.28 168.26 12.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.788 0.835 . . . . 0.0 111.483 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -96.52 97.33 9.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.824 1.25 . . . . 0.0 109.996 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 ttp -62.93 152.33 36.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -149.92 123.73 9.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.338 1.055 . . . . 0.0 108.75 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.48 117.01 22.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.142 0.977 . . . . 0.0 110.67 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -91.37 92.74 8.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.312 1.445 . . . . 0.0 107.913 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -88.76 112.13 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -172.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.52 149.65 21.96 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.173 0.589 . . . . 0.0 111.417 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.92 -153.87 20.51 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.854 1.216 . . . . 0.0 111.855 166.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.47 14.93 1.41 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.264 1.026 . . . . 0.0 111.662 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.51 21.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.346 1.458 . . . . 0.0 112.914 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -97.89 60.03 1.47 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.94 0.876 . . . . 0.0 110.707 -159.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.31 61.24 0.98 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.392 1.472 . . . . 0.0 111.087 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.27 101.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 108.709 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.54 -62.59 3.81 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.274 0.94 . . . . 0.0 111.123 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -64.14 172.85 2.19 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.364 1.066 . . . . 0.0 110.772 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 76.11 -60.57 0.48 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.601 1.96 . . . . 0.0 109.93 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -74.08 -46.52 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.526 0.73 . . . . 0.0 109.555 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -54.52 -51.18 65.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.518 -0.739 . . . . 0.0 111.116 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.43 -20.84 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.095 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -60.15 4.33 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.572 0.624 . . . . 0.0 109.335 169.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -46.15 -52.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.791 0.836 . . . . 0.0 111.841 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -69.59 -46.97 65.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.436 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.34 -52.44 37.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.411 0.55 . . . . 0.0 112.148 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.8 -40.4 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.459 1.504 . . . . 0.0 110.733 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -41.59 93.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.379 0.536 . . . . 0.0 111.731 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.93 11.04 21.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.817 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.16 56.02 24.53 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.701 0.667 . . . . 0.0 112.164 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.84 139.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.436 1.494 . . . . 0.0 108.791 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -108.94 169.6 8.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.382 1.473 . . . . 0.0 107.634 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.81 -138.76 9.14 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -175.46 141.58 0.53 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 117.69 0.745 . . . . 0.0 111.099 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.6 87.19 2.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.253 1.421 . . . . 0.0 110.165 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -92.68 110.07 21.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.269 0.628 . . . . 0.0 110.222 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.07 96.94 10.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.718 1.607 . . . . 0.0 109.234 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -77.89 110.81 14.33 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.07 79.18 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.442 2.761 . . . . 0.0 112.123 -161.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -142.09 -75.39 0.29 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.263 1.825 . . . . 0.0 106.428 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -168.87 35.93 0.2 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.673 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -137.3 103.82 5.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.257 1.023 . . . . 0.0 109.943 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.56 111.08 32.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -91.73 117.22 29.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.467 1.107 . . . . 0.0 109.576 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.27 104.75 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 110.054 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.3 t -79.86 130.26 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.29 124.67 16.6 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.244 1.018 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -108.58 104.66 14.02 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 109.074 -171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.76 159.63 27.96 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -71.52 -98.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.685 1.194 . . . . 0.0 109.656 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -159.65 -53.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.35 1.06 . . . . 0.0 109.486 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -44.3 -42.48 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.27 1.428 . . . . 0.0 110.385 162.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.51 -29.48 18.92 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.514 1.126 . . . . 0.0 112.248 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.08 -58.33 8.9 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 119.045 0.839 . . . . 0.0 109.89 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 p -43.48 -44.31 5.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.39 1.476 . . . . 0.0 112.866 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.58 -33.38 74.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.952 0.901 . . . . 0.0 112.285 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.62 -53.14 7.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.647 0.779 . . . . 0.0 110.324 169.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -52.9 61.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 110.454 -170.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.16 -36.46 83.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.174 1.389 . . . . 0.0 112.15 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.9 -50.34 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.605 169.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.97 -52.55 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 123.201 0.313 . . . . 0.0 110.592 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -49.48 77.32 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.339 0.518 . . . . 0.0 111.129 -174.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.9 -44.16 81.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.096 1.358 . . . . 0.0 110.914 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.63 82.3 0.3 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.514 1.53 . . . . 0.0 109.649 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.17 164.02 26.87 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.737 2.958 . . . . 0.0 111.412 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.58 148.35 72.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.476 2.117 . . . . 0.0 109.501 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.13 49.72 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.475 0.71 . . . . 0.0 110.874 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.23 167.47 29.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.624 1.17 . . . . 0.0 109.238 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.9 77.45 2.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.697 0.799 . . . . 0.0 110.108 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.63 122.65 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.176 0.99 . . . . 0.0 109.456 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.62 -59.35 2.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -169.94 135.78 1.44 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.372 0.669 . . . . 0.0 110.152 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.59 96.87 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -87.13 71.77 10.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.37 148.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.713 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -151.87 103.01 2.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 146.85 52.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.473 0.709 . . . . 0.0 110.579 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -134.19 -174.1 3.46 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 110.383 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.39 25.58 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.099 1.36 . . . . 0.0 109.047 170.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -76.9 144.42 38.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.004 0.922 . . . . 0.0 111.718 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -83.96 -57.75 3.07 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -152.53 172.18 31.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.72 115.77 21.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.359 1.064 . . . . 0.0 108.733 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -68.63 -38.18 80.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.727 1.211 . . . . 0.0 110.506 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 56.86 62.04 2.4 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.81 1.644 . . . . 0.0 112.412 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 t70 157.2 86.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.099 2.559 . . . . 0.0 108.438 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -73.99 91.59 2.05 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -125.84 154.53 42.53 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 111.292 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 120.79 36.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.985 0.914 . . . . 0.0 109.819 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -173.31 3.37 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.597 1.559 . . . . 0.0 111.759 -168.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -111.99 132.59 54.69 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.067 0.947 . . . . 0.0 111.287 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.0 ttp -82.5 164.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 156.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -158.53 82.99 0.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.607 1.163 . . . . 0.0 108.239 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.59 105.89 17.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.726 0.81 . . . . 0.0 109.714 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.81 9.67 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.36 114.62 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -166.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.13 140.36 38.42 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.295 1.438 . . . . 0.0 110.87 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.17 -156.39 23.34 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.998 1.285 . . . . 0.0 111.355 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.93 15.68 0.84 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.523 0.729 . . . . 0.0 111.777 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -57.71 -30.37 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.896 0.878 . . . . 0.0 109.954 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.78 126.07 28.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 162.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.52 26.52 25.04 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.968 0.794 . . . . 0.0 111.623 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.37 151.66 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.044 1.338 . . . . 0.0 107.898 171.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.09 -69.02 1.4 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.027 0.823 . . . . 0.0 111.687 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 t80 52.79 -116.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 116.942 -1.504 . . . . 0.0 109.717 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 35.92 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.23 2.612 . . . . 0.0 114.423 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -33.03 -47.92 0.19 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.417 1.887 . . . . 0.0 112.254 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.23 -43.68 78.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.41 0.684 . . . . 0.0 111.97 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.24 -36.71 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 C-N-CA 123.53 0.732 . . . . 0.0 109.975 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -46.79 87.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.131 -0.937 . . . . 0.0 109.793 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mm -38.91 -56.47 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -174.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -67.92 -48.19 66.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.418 1.008 . . . . 0.0 111.115 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.06 -64.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.011 0.924 . . . . 0.0 111.603 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.37 -51.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 127.841 2.456 . . . . 0.0 110.621 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -42.28 62.31 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.266 0.626 . . . . 0.0 110.811 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.0 21.58 12.51 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.359 1.464 . . . . 0.0 112.371 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.12 2.93 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.146 0.879 . . . . 0.0 112.863 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 mm -119.39 142.71 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.768 1.227 . . . . 0.0 109.777 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 175.56 5.46 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.386 1.474 . . . . 0.0 108.453 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.47 -148.0 19.61 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -173.87 140.46 0.74 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 117.652 0.726 . . . . 0.0 111.173 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.34 88.03 2.82 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 124.631 1.172 . . . . 0.0 110.322 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.44 107.73 20.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.519 0.728 . . . . 0.0 110.694 -166.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.69 119.6 20.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.767 172.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.37 97.37 1.59 Allowed Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -64.31 138.51 61.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.688 1.592 . . . . 0.0 110.193 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t0 57.49 59.46 3.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.498 1.119 . . . . 0.0 109.434 -164.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.44 -140.16 3.96 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.4 p -124.1 156.46 36.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.76 1.624 . . . . 0.0 109.922 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.84 105.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 123.534 0.733 . . . . 0.0 109.512 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -93.77 134.1 36.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.482 0.713 . . . . 0.0 111.103 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.21 116.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.623 1.169 . . . . 0.0 109.418 -171.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.6 141.82 16.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.84 123.38 17.22 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.899 1.279 . . . . 0.0 108.002 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.83 90.17 3.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.546 0.738 . . . . 0.0 109.214 -162.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 162.86 22.92 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 122.086 0.826 . . . . 0.0 114.672 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.36 163.03 28.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.872 1.269 . . . . 0.0 108.01 163.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.72 -23.58 42.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -64.4 -50.01 69.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -9.83 58.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.936 0.894 . . . . 0.0 112.512 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.92 -60.96 2.01 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 119.325 0.966 . . . . 0.0 109.011 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -44.59 -44.67 9.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.566 1.146 . . . . 0.0 112.803 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -49.9 -51.6 39.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.208 1.003 . . . . 0.0 111.91 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.32 -42.48 45.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.435 1.494 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -55.48 -58.26 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.539 1.136 . . . . 0.0 110.388 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.64 -33.31 68.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.682 1.193 . . . . 0.0 111.394 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -40.08 -48.23 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.241 1.417 . . . . 0.0 111.023 165.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.57 -58.76 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.029 0.532 . . . . 0.0 111.065 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -59.52 -39.19 83.07 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.343 0.519 . . . . 0.0 111.088 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -72.93 -44.43 61.2 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.249 1.42 . . . . 0.0 111.094 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 80.91 0.28 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.069 1.318 . . . . 0.0 110.151 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -62.44 159.42 36.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.923 2.415 . . . . 0.0 111.128 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.56 156.08 54.51 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.26 2.64 . . . . 0.0 110.811 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.48 42.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.74 . . . . 0.0 111.25 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.01 167.62 28.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.73 1.612 . . . . 0.0 109.357 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.23 82.13 4.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.663 0.785 . . . . 0.0 109.015 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.69 127.52 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 109.415 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -90.07 -51.93 5.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.539 1.136 . . . . 0.0 109.517 -174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -163.1 74.6 0.37 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 112.079 -173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.39 88.08 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.657 0.741 . . . . 0.0 110.44 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.28 80.23 3.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.763 1.225 . . . . 0.0 107.791 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.29 162.39 29.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.029 0.443 . . . . 0.0 111.391 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.1 m -140.82 134.89 30.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.14 0.976 . . . . 0.0 109.301 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.71 138.37 31.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 m -137.76 177.84 7.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 111.724 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -82.39 152.2 26.29 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 124.602 1.161 . . . . 0.0 111.058 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 117.48 8.44 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 110.281 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -99.23 -55.59 2.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.969 1.308 . . . . 0.0 108.531 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.43 38.86 37.27 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 123.927 0.775 . . . . 0.0 113.255 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -85.14 -30.55 23.9 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -81.98 131.99 35.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.892 0.769 . . . . 0.0 110.586 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.68 119.44 33.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.183 1.793 . . . . 0.0 107.467 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.4 t70 64.41 171.27 0.19 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.64 1.176 . . . . 0.0 111.385 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.39 87.53 2.68 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.436 1.495 . . . . 0.0 108.357 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -105.74 152.6 22.97 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 111.128 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.15 130.15 55.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.255 1.022 . . . . 0.0 109.986 -168.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.62 1.568 . . . . 0.0 107.786 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 168.4 14.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.437 1.095 . . . . 0.0 111.744 -164.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -97.78 124.79 42.29 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 111.58 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -91.56 153.82 19.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -135.16 98.65 4.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.584 1.554 . . . . 0.0 109.374 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.46 109.67 21.82 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.332 0.653 . . . . 0.0 110.274 177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -92.26 91.22 7.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.304 1.041 . . . . 0.0 108.258 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.11 112.23 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.074 0.55 . . . . 0.0 109.63 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.11 146.4 25.08 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.476 1.511 . . . . 0.0 109.87 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.53 -175.62 20.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.213 0.911 . . . . 0.0 111.59 173.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 tp -82.81 28.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 0.0 110.576 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.22 -28.11 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.019 0.927 . . . . 0.0 110.939 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.74 131.84 14.6 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 109.889 162.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 -55.55 2.43 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.441 -0.644 . . . . 0.0 112.169 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 m -71.78 -178.98 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 117.936 0.868 . . . . 0.0 111.767 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.78 85.9 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.926 1.251 . . . . 0.0 111.497 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -156.48 174.62 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.923 1.289 . . . . 0.0 109.072 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 76.12 -66.31 0.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.115 1.766 . . . . 0.0 109.752 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -53.84 -45.68 70.98 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.8 -42.68 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.088 0.955 . . . . 0.0 111.604 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.88 -32.77 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 110.573 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -56.94 15.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 110.316 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -46.68 -56.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.366 0.666 . . . . 0.0 112.12 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -65.88 -47.85 73.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.033 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.78 -65.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.554 0.741 . . . . 0.0 111.415 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.13 -46.09 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 126.619 1.967 . . . . 0.0 111.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -60.93 -39.5 89.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.162 0.585 . . . . 0.0 111.116 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.85 20.36 7.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.787 0.835 . . . . 0.0 112.834 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.84 53.23 45.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.299 0.952 . . . . 0.0 113.287 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mm -108.94 135.67 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.232 1.413 . . . . 0.0 108.408 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.38 178.63 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.673 1.189 . . . . 0.0 109.126 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.3 -142.43 10.02 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 119.538 1.063 . . . . 0.0 111.917 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -178.64 141.46 0.21 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.507 1.523 . . . . 0.0 110.137 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.42 87.69 2.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.932 0.893 . . . . 0.0 110.672 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -93.78 105.01 17.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.441 0.639 . . . . 0.0 110.994 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.12 96.5 7.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.37 117.61 69.03 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.53 71.69 6.34 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.578 2.852 . . . . 0.0 111.381 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.23 41.24 0.81 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.233 1.413 . . . . 0.0 108.537 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.56 33.64 67.36 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.202 0.906 . . . . 0.0 112.795 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 m -145.78 90.66 2.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.763 0.782 . . . . 0.0 110.035 -173.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -98.65 121.7 49.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.533 0.733 . . . . 0.0 109.092 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.52 143.64 28.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.85 130.21 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.1 141.88 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 158.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.59 122.26 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 109.448 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -124.8 116.53 22.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.222 1.009 . . . . 0.0 111.483 -156.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.31 -171.1 44.09 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.34 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.87 164.0 10.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.384 1.073 . . . . 0.0 110.182 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -81.89 -24.77 35.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -63.39 -52.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.22 -21.38 63.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.4 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.34 -61.44 1.84 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.0 p -47.41 -46.27 26.15 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.904 0.882 . . . . 0.0 112.498 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -51.78 -48.96 63.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.859 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.37 -54.34 21.41 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 110.711 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.9 59.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.219 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.72 -36.56 80.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.642 1.577 . . . . 0.0 112.157 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.71 -43.43 17.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.132 1.373 . . . . 0.0 111.644 171.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.02 -59.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 110.506 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.74 -41.46 97.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.077 0.399 . . . . 0.0 111.7 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.24 -45.97 68.47 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.988 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.38 78.84 0.25 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.742 1.163 . . . . 0.0 110.874 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 157.75 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.023 2.482 . . . . 0.0 110.516 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 165.09 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.388 2.725 . . . . 0.0 111.105 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.77 42.94 0.95 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.611 0.764 . . . . 0.0 111.268 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.48 172.12 14.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.046 0.938 . . . . 0.0 110.061 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.82 86.5 0.51 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.335 1.054 . . . . 0.0 109.644 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.48 80.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.024 1.33 . . . . 0.0 109.334 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -38.74 -65.28 0.37 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.491 2.316 . . . . 0.0 111.342 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -151.56 147.43 26.78 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.389 0.676 . . . . 0.0 109.835 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.45 84.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.81 68.53 10.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -73.77 162.91 28.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -147.47 133.39 19.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.784 0.834 . . . . 0.0 109.202 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.89 135.89 34.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.819 1.248 . . . . 0.0 107.955 170.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 m -129.84 -177.55 4.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.455 1.102 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.05 166.83 13.2 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.836 0.855 . . . . 0.0 111.111 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -55.78 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.596 0.758 . . . . 0.0 110.589 166.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -100.31 -56.7 2.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.337 0.655 . . . . 0.0 110.313 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.24 135.57 3.75 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.42 100.45 9.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.774 1.229 . . . . 0.0 110.648 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -75.95 72.36 2.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.94 68.68 1.82 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.647 1.579 . . . . 0.0 112.993 -165.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 166.51 89.43 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 128.492 2.717 . . . . 0.0 106.056 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.75 83.9 6.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.0 158.81 22.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 123.482 0.489 . . . . 0.0 109.949 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.03 139.4 35.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.251 0.62 . . . . 0.0 110.309 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.161 -1.4 . . . . 0.0 109.333 166.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 -179.44 4.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.227 1.011 . . . . 0.0 111.734 -171.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -106.38 130.8 54.14 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.303 0.641 . . . . 0.0 112.667 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.3 ttp -69.12 156.9 37.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 154.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.05 87.37 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 107.18 19.13 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -85.97 102.49 13.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 t -96.78 121.82 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 122.912 0.485 . . . . 0.0 110.424 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.67 153.13 20.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 -175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.46 -155.51 17.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.463 1.506 . . . . 0.0 110.695 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 16.86 0.82 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.54 0.736 . . . . 0.0 111.563 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.4 -20.59 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.936 0.895 . . . . 0.0 111.57 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.93 138.65 50.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.384 0.673 . . . . 0.0 109.325 167.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.29 -64.23 4.2 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.8 157.6 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.343 1.057 . . . . 0.0 108.715 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.16 -96.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.514 1.054 . . . . 0.0 112.728 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 t80 63.64 -62.06 0.15 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.4 2.28 . . . . 0.0 112.931 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -33.18 -44.59 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.44 2.696 . . . . 0.0 112.879 167.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -69.38 -45.77 68.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.361 0.664 . . . . 0.0 109.869 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -56.25 -46.22 79.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.44 0.696 . . . . 0.0 110.927 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.28 -37.38 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.924 0.49 . . . . 0.0 110.485 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -64.31 -49.98 69.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.261 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mm -45.42 -56.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.661 1.118 . . . . 0.0 111.515 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -64.36 -48.33 75.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.98 -51.06 59.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.63 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.391 1.476 . . . . 0.0 109.269 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -55.23 -38.57 68.65 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.496 0.718 . . . . 0.0 110.883 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.33 2.81 55.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.266 1.426 . . . . 0.0 113.161 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 62.52 4.95 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.883 0.765 . . . . 0.0 111.68 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.97 143.91 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 125.517 1.527 . . . . 0.0 108.597 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -101.84 170.01 8.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.771 1.228 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.13 -143.58 11.07 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.853 0.752 . . . . 0.0 112.344 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -174.15 142.56 0.83 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.568 1.147 . . . . 0.0 108.953 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.74 79.03 1.88 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -93.5 96.34 9.82 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.792 -164.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.78 93.89 9.62 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 126.292 1.837 . . . . 0.0 110.182 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.03 110.62 6.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.58 64.78 8.66 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.208 2.606 . . . . 0.0 111.567 -161.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -167.36 38.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.87 1.668 . . . . 0.0 109.569 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.27 -105.86 0.28 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -121.14 144.53 48.52 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.618 1.567 . . . . 0.0 110.568 -165.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.63 125.21 41.85 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.717 0.807 . . . . 0.0 110.397 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.08 116.32 27.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.0 t -112.81 123.19 68.23 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.062 0 C-N-CA 124.065 0.946 . . . . 0.0 108.682 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 m -118.0 69.3 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.5 0.72 . . . . 0.0 111.406 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.49 128.45 35.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.948 0.899 . . . . 0.0 111.293 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.65 107.6 15.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.588 0.755 . . . . 0.0 111.085 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.99 172.68 34.58 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.634 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -67.42 168.0 11.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.015 1.326 . . . . 0.0 109.026 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.99 -18.56 53.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.935 0.494 . . . . 0.0 112.093 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.71 -29.12 69.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.21 1.004 . . . . 0.0 110.683 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -2.04 15.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.114 1.366 . . . . 0.0 112.073 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.21 -66.31 0.6 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -41.2 -45.43 2.85 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 125.313 1.445 . . . . 0.0 112.129 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -54.17 -52.72 60.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.59 0.756 . . . . 0.0 111.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.12 -24.08 61.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.825 1.65 . . . . 0.0 111.947 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.61 -61.54 1.85 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.991 0.916 . . . . 0.0 111.103 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -47.15 -45.51 22.64 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.584 1.954 . . . . 0.0 111.446 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -29.76 -56.99 0.17 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.022 1.729 . . . . 0.0 112.022 164.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.02 -71.41 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 122.761 0.424 . . . . 0.0 110.876 -167.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -48.49 -44.64 36.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.137 0.975 . . . . 0.0 112.319 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -103.42 53.17 0.76 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.239 1.016 . . . . 0.0 110.57 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.71 153.17 24.65 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.02 114.0 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.775 2.983 . . . . 0.0 110.991 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.75 145.96 47.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.221 1.947 . . . . 0.0 110.838 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.01 -21.37 62.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.46 0.704 . . . . 0.0 111.777 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.1 172.15 10.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.207 1.403 . . . . 0.0 110.828 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.6 73.44 3.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.96 121.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.539 1.136 . . . . 0.0 109.096 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.97 -60.18 2.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.32 152.71 6.14 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 122.905 0.482 . . . . 0.0 110.895 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.26 97.95 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.245 1.018 . . . . 0.0 109.03 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.02 75.73 7.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -80.45 163.05 24.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.532 0.682 . . . . 0.0 112.197 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 123.52 18.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.721 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 123.86 25.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 164.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -128.72 174.31 9.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.945 0.898 . . . . 0.0 110.119 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.64 141.39 28.99 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.56 139.25 58.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.467 1.507 . . . . 0.0 111.393 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.84 -49.32 13.12 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.223 1.009 . . . . 0.0 108.931 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.43 175.56 41.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.39 106.13 17.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.43 134.04 55.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.126 0.97 . . . . 0.0 108.643 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.72 96.68 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.279 0.632 . . . . 0.0 109.61 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 71.22 -170.43 0.15 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.798 1.639 . . . . 0.0 110.668 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.01 92.11 2.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.437 1.095 . . . . 0.0 108.466 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -121.88 164.41 17.58 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.719 0.408 . . . . 0.0 109.959 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -99.01 139.34 34.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.474 0.71 . . . . 0.0 110.508 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.827 -1.559 . . . . 0.0 111.101 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 163.54 13.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.966 0.906 . . . . 0.0 112.309 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -84.62 114.36 21.94 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.495 0.664 . . . . 0.0 110.182 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.0 ptm -88.71 102.31 14.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.743 0.817 . . . . 0.0 110.149 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.62 108.01 18.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.908 1.283 . . . . 0.0 108.372 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.77 108.57 18.03 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.796 1.239 . . . . 0.0 110.382 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.7 116.81 29.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.588 1.955 . . . . 0.0 107.348 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.37 120.97 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.29 150.8 26.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.353 1.061 . . . . 0.0 110.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.65 -154.31 21.24 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.702 1.144 . . . . 0.0 110.743 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.36 17.81 3.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.365 0.602 . . . . 0.0 110.211 166.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.43 -36.89 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.664 1.986 . . . . 0.0 112.14 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -75.26 80.13 2.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.13 -67.04 0.05 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.95 38.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.883 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.73 -93.34 0.12 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.902 1.239 . . . . 0.0 112.499 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.2 t80 70.78 -38.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.511 2.324 . . . . 0.0 114.128 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -42.87 -44.83 4.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.297 1.439 . . . . 0.0 112.531 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -69.37 -48.83 60.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.079 0.552 . . . . 0.0 110.537 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -51.77 -43.37 62.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.494 1.118 . . . . 0.0 111.707 174.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.6 -39.7 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -45.95 79.66 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 117.32 -1.324 . . . . 0.0 112.046 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.3 mm -48.14 -54.58 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.123 1.783 . . . . 0.0 111.922 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -66.75 -47.21 72.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.132 -0.461 . . . . 0.0 109.967 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.59 -52.09 24.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.426 0.69 . . . . 0.0 112.717 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.87 -43.17 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 126.434 1.894 . . . . 0.0 110.099 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -63.61 -34.33 77.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.102 0.561 . . . . 0.0 111.791 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.2 18.67 20.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.252 . . . . 0.0 112.305 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.01 63.82 4.91 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.413 1.006 . . . . 0.0 113.512 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.14 146.51 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.757 1.623 . . . . 0.0 108.659 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.79 166.93 10.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.76 1.224 . . . . 0.0 108.403 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.79 -152.97 24.11 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.786 0.721 . . . . 0.0 112.717 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -166.28 141.09 4.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.225 1.01 . . . . 0.0 109.132 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.89 91.11 3.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.657 1.183 . . . . 0.0 108.962 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -85.94 80.91 8.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -102.91 59.25 0.78 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.456 1.102 . . . . 0.0 108.932 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.4 mt -71.52 108.81 4.36 Favored Pre-proline 0 C--N 1.34 0.188 0 C-N-CA 125.629 1.572 . . . . 0.0 108.43 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -79.71 64.07 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.845 3.03 . . . . 0.0 112.804 -163.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -173.01 54.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.903 2.081 . . . . 0.0 108.095 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 -109.3 0.33 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 m -133.09 160.53 36.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.801 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.34 95.54 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.44 134.47 42.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.595 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.8 t -106.35 133.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.26 78.05 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.19 166.86 16.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.715 1.206 . . . . 0.0 109.818 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.86 109.41 7.44 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 118.866 -0.588 . . . . 0.0 111.965 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.32 149.19 21.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.961 0.8 . . . . 0.0 113.794 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -57.48 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.405 2.282 . . . . 0.0 111.769 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -154.75 -71.16 0.13 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.04 1.736 . . . . 0.0 107.157 -165.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -51.66 -50.65 59.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 164.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.25 62.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.319 1.047 . . . . 0.0 111.949 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -67.07 -66.84 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -48.4 -36.21 14.25 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.956 1.703 . . . . 0.0 113.291 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -63.76 -50.39 69.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.75 0.705 . . . . 0.0 112.542 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.39 -22.85 60.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.707 0.685 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.22 -58.05 4.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.858 -0.526 . . . . 0.0 110.909 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.31 -31.91 73.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.37 0.668 . . . . 0.0 111.614 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -39.28 -54.2 1.85 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.078 1.351 . . . . 0.0 110.364 162.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.83 -53.0 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.032 0.533 . . . . 0.0 111.319 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.51 -38.42 91.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.297 0.499 . . . . 0.0 111.293 -168.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -76.05 -37.94 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.887 0.875 . . . . 0.0 111.482 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.15 74.58 0.24 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.319 0.961 . . . . 0.0 111.21 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.81 164.01 34.44 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.635 2.89 . . . . 0.0 111.688 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.97 128.03 11.18 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.218 2.612 . . . . 0.0 109.293 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.867 0.867 . . . . 0.0 110.058 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.99 74.38 0.43 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.459 0.704 . . . . 0.0 110.093 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 30.02 72.26 0.06 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.503 1.921 . . . . 0.0 110.877 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 90.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -50.72 -55.29 17.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.96 0.904 . . . . 0.0 110.098 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -170.47 140.56 1.81 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 171.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.09 84.37 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 165.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.67 76.25 7.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -71.73 160.12 33.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -150.39 95.56 2.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 141.26 57.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.739 0.816 . . . . 0.0 110.064 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -133.49 177.49 7.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.552 0.741 . . . . 0.0 111.456 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.03 124.02 34.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.051 1.74 . . . . 0.0 108.288 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -55.73 122.14 10.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.935 0.494 . . . . 0.0 112.017 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.65 -47.94 73.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.94 -157.02 10.11 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -89.03 107.45 19.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 109.358 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.75 73.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.05 137.04 8.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.944 1.698 . . . . 0.0 112.644 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 63.12 -165.57 0.24 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.392 1.077 . . . . 0.0 109.063 -173.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.75 82.81 1.22 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.98 162.81 13.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -171.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.11 134.06 55.14 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 111.072 -167.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.183 -1.389 . . . . 0.0 108.468 162.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.527 0.09 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -178.21 3.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.413 1.085 . . . . 0.0 111.393 -174.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -99.91 127.12 46.12 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.887 0.475 . . . . 0.0 110.773 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 ptm -97.9 96.62 8.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.141 0.972 . . . . 0.0 110.266 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -87.81 108.63 19.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.5 1.12 . . . . 0.0 108.587 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.74 109.15 14.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 110.721 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.25 100.37 12.94 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.433 1.093 . . . . 0.0 108.848 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 101.74 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.78 155.51 17.61 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.269 0.627 . . . . 0.0 111.758 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.95 -155.37 21.22 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.352 1.454 . . . . 0.0 111.581 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -81.6 28.99 0.38 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.996 0.918 . . . . 0.0 110.238 173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.2 m -76.13 -6.98 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.336 1.055 . . . . 0.0 112.717 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 164.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 164.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.87 -62.9 4.47 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -171.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -72.83 155.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.56 -83.11 0.33 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 122.949 0.309 . . . . 0.0 112.383 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 47.5 56.3 7.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.594 1.558 . . . . 0.0 111.519 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.97 -41.32 0.53 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.428 1.491 . . . . 0.0 108.729 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -72.39 -48.91 37.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.328 0.651 . . . . 0.0 110.848 171.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.17 -46.37 68.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.136 0.494 . . . . 0.0 111.114 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.19 -35.48 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.246 0.619 . . . . 0.0 110.359 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -47.15 78.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.058 0.943 . . . . 0.0 110.641 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.57 -56.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.62 1.1 . . . . 0.0 110.935 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -70.41 -40.78 73.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.281 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.94 -54.91 11.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.2 0.6 . . . . 0.0 111.634 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.89 -38.81 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.119 1.368 . . . . 0.0 111.349 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -59.44 -37.1 77.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.915 0.486 . . . . 0.0 111.137 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -98.13 19.06 14.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.772 0.829 . . . . 0.0 112.869 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 56.54 22.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.023 0.821 . . . . 0.0 113.204 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -104.49 143.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 125.387 1.475 . . . . 0.0 108.91 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -104.27 171.27 7.43 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.531 1.132 . . . . 0.0 108.549 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.49 -138.72 10.27 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.207 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -166.6 145.9 5.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.508 0.654 . . . . 0.0 112.358 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.58 85.7 2.37 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.907 1.683 . . . . 0.0 108.938 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -95.39 100.84 12.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.012 0.525 . . . . 0.0 110.351 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.64 116.23 8.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 170.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.2 mt -94.13 94.12 1.04 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.57 141.52 95.5 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.387 2.058 . . . . 0.0 111.024 -170.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.49 61.57 2.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.644 1.178 . . . . 0.0 109.634 -166.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.75 -126.67 1.0 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -129.25 149.2 51.15 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.035 1.734 . . . . 0.0 109.303 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.6 99.42 5.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.25 125.34 30.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.84 1.256 . . . . 0.0 108.362 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -112.95 125.3 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.8 77.87 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 161.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.32 162.14 20.18 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.036 1.334 . . . . 0.0 108.845 172.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -138.93 105.15 5.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.069 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.03 166.23 24.96 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 118.708 0.685 . . . . 0.0 112.911 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -67.8 173.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.36 1.064 . . . . 0.0 108.632 161.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.85 -31.19 63.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.2 -20.49 65.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.128 0.571 . . . . 0.0 112.287 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.68 -12.09 18.67 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.938 0.895 . . . . 0.0 111.781 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.94 -70.7 0.24 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 p -43.81 -34.81 1.68 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.028 1.331 . . . . 0.0 113.602 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -68.73 -56.47 8.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.85 0.86 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.45 -22.16 62.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.425 0.69 . . . . 0.0 111.175 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.5 -59.77 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.6 -0.687 . . . . 0.0 110.191 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -61.69 -32.09 72.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.718 0.69 . . . . 0.0 111.85 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -43.54 -51.45 6.79 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.415 1.486 . . . . 0.0 111.952 164.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -67.29 -53.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 C-N-CA 123.246 0.619 . . . . 0.0 110.519 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -41.78 93.76 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.893 0.315 . . . . 0.0 110.63 -172.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -70.39 -42.12 72.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.447 1.499 . . . . 0.0 111.497 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.2 78.08 0.24 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.355 1.455 . . . . 0.0 111.075 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.75 169.39 17.68 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 124.033 3.155 . . . . 0.0 112.126 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.59 162.14 38.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.03 2.486 . . . . 0.0 110.944 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.91 33.74 0.33 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.807 0.843 . . . . 0.0 111.852 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.94 174.16 13.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.398 1.079 . . . . 0.0 109.857 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.26 88.52 0.85 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.07 122.24 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.872 0.869 . . . . 0.0 109.218 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -75.24 -58.04 3.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -166.11 132.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.029 0.531 . . . . 0.0 110.112 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -87.25 86.17 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 162.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.53 75.61 9.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.95 151.57 33.63 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.633 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.6 m -151.18 95.61 2.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 0.0 109.349 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -60.9 152.79 26.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.427 1.491 . . . . 0.0 110.801 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 m -157.91 176.72 12.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.67 144.54 45.79 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -65.49 132.71 49.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.53 1.132 . . . . 0.0 112.401 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -69.23 -51.88 33.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 109.119 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.91 -178.16 36.5 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.61 111.9 23.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.978 1.311 . . . . 0.0 108.524 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -75.46 -17.97 59.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.843 0.857 . . . . 0.0 111.948 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 66.12 94.94 0.06 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.71 1.604 . . . . 0.0 111.181 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 68.85 155.75 0.13 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.393 1.877 . . . . 0.0 110.986 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -101.94 92.06 4.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -110.84 160.45 16.75 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -105.36 142.77 34.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.984 0.514 . . . . 0.0 111.644 -167.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.032 174.259 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.59 144.09 48.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.237 1.415 . . . . 0.0 109.761 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -83.07 108.71 16.55 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.97 0.508 . . . . 0.0 111.131 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.7 ptm -93.41 94.06 8.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.494 0.664 . . . . 0.0 109.74 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.91 133.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.09 104.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -97.1 100.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.107 1.763 . . . . 0.0 109.207 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.55 127.13 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 110.226 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -102.66 155.04 18.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.941 1.297 . . . . 0.0 110.14 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.56 -168.85 19.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.003 1.287 . . . . 0.0 110.65 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -88.8 56.04 3.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.78 3.7 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.384 1.073 . . . . 0.0 112.372 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.89 152.99 25.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.76 -56.15 4.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -69.75 -179.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.593 0.757 . . . . 0.0 110.556 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.71 -97.19 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.269 0.938 . . . . 0.0 112.863 -171.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 64.0 -65.01 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.78 2.032 . . . . 0.0 113.078 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -48.5 -31.32 6.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.185 2.194 . . . . 0.0 113.177 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.29 -46.57 15.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.493 1.517 . . . . 0.0 110.851 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.78 -49.37 77.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.021 0.528 . . . . 0.0 111.341 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.02 -26.99 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.389 172.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.99 -56.07 15.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.905 0.882 . . . . 0.0 110.173 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.5 mm -43.83 -56.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 118.876 0.762 . . . . 0.0 111.029 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -64.62 -49.59 70.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.21 -65.06 0.63 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.515 0.726 . . . . 0.0 112.212 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.61 -50.97 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 126.097 1.759 . . . . 0.0 110.132 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -56.82 -41.39 77.72 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.385 0.674 . . . . 0.0 110.864 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.9 mt -93.93 15.36 16.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.399 1.48 . . . . 0.0 113.144 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.82 48.61 84.43 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.972 0.796 . . . . 0.0 113.123 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.08 143.2 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.394 1.478 . . . . 0.0 107.846 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -104.09 169.36 8.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.425 1.09 . . . . 0.0 108.282 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.82 -150.4 22.28 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 119.162 0.892 . . . . 0.0 112.886 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -170.89 140.76 1.65 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.836 1.254 . . . . 0.0 109.172 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.15 89.86 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.37 1.068 . . . . 0.0 110.288 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.11 98.19 7.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.261 0.624 . . . . 0.0 110.796 -165.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.63 115.03 16.02 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.51 170.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.68 104.51 10.43 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.99 141.68 65.36 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.058 2.505 . . . . 0.0 111.597 -163.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 63.98 60.03 1.05 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.809 1.644 . . . . 0.0 110.426 -171.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -129.49 1.51 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 p -120.87 163.44 18.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.627 1.571 . . . . 0.0 109.835 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -116.92 125.09 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.977 0.911 . . . . 0.0 110.77 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.54 145.46 30.27 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.929 0.492 . . . . 0.0 110.656 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.91 137.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 66.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.5 155.58 29.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.473 1.109 . . . . 0.0 109.94 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -142.86 106.24 4.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.921 -0.562 . . . . 0.0 109.888 -167.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.03 149.78 19.99 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.295 0.498 . . . . 0.0 113.912 -171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -63.06 163.88 9.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.757 0.823 . . . . 0.0 108.856 162.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -78.18 -34.24 49.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.464 0.706 . . . . 0.0 111.11 -171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -69.65 -9.04 52.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.979 0.912 . . . . 0.0 111.632 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.91 4.32 10.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.672 1.189 . . . . 0.0 111.907 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -71.62 -68.56 0.44 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.427 1.012 . . . . 0.0 109.619 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.2 p -44.98 -42.47 8.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.558 1.543 . . . . 0.0 112.957 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -53.42 -48.59 68.61 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.237 1.015 . . . . 0.0 111.05 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.44 -51.97 17.91 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -52.54 -57.06 11.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.467 0.576 . . . . 0.0 111.777 -170.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.48 -40.37 68.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.056 1.343 . . . . 0.0 112.456 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.9 -51.14 7.77 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.214 1.006 . . . . 0.0 110.681 169.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.48 -53.58 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.329 -173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -46.44 71.65 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.071 0.396 . . . . 0.0 111.56 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -71.87 -55.61 7.22 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.862 0.865 . . . . 0.0 110.49 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.32 97.87 2.11 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.295 -1.281 . . . . 0.0 110.561 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.74 145.23 80.53 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.496 2.131 . . . . 0.0 109.07 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -86.93 49.54 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.913 1.742 . . . . 0.0 114.498 -153.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 56.58 37.15 28.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.36 1.064 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.3 161.72 39.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.058 0.943 . . . . 0.0 109.238 -168.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -84.55 75.89 10.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.95 135.59 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.905 1.282 . . . . 0.0 110.817 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.96 -57.57 2.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.018 1.327 . . . . 0.0 108.319 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -166.72 137.76 3.33 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 122.878 0.471 . . . . 0.0 110.996 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.33 96.4 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 121.784 -0.572 . . . . 0.0 110.169 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.97 72.26 9.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.7 161.95 28.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.476 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.5 t -137.9 127.43 24.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.606 0.762 . . . . 0.0 110.037 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.58 131.37 42.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 167.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 m -128.21 -160.06 0.99 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.292 1.037 . . . . 0.0 110.02 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -120.83 152.81 37.93 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.634 1.973 . . . . 0.0 108.967 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -52.21 86.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.919 1.688 . . . . 0.0 111.641 166.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -100.75 -54.8 2.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.727 1.211 . . . . 0.0 110.468 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.56 133.96 5.83 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.1 92.22 8.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.428 1.091 . . . . 0.0 109.809 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -72.13 87.92 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.86 143.39 56.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.635 0.774 . . . . 0.0 110.54 -174.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 64.9 -170.27 0.19 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.845 1.258 . . . . 0.0 109.374 -166.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.41 100.75 2.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.84 158.06 26.38 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 122.965 0.506 . . . . 0.0 111.391 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.67 139.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.686 1.195 . . . . 0.0 110.121 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.94 -178.719 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.255 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 165.38 18.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.926 0.89 . . . . 0.0 111.999 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -97.55 123.81 41.57 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 121.545 0.688 . . . . 0.0 112.092 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.9 ttp -67.9 154.79 40.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 150.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.8 106.94 2.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.39 116.94 28.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.299 1.04 . . . . 0.0 109.547 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 93.73 7.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.7 110.01 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.48 0.312 . . . . 0.0 110.646 -166.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -97.96 145.46 26.45 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.204 1.002 . . . . 0.0 110.823 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.52 -166.37 30.17 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 123.751 0.691 . . . . 0.0 111.973 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.84 15.74 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.523 0.729 . . . . 0.0 110.961 169.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.5 -15.44 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.114 1.366 . . . . 0.0 112.29 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -77.13 29.41 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.369 1.468 . . . . 0.0 113.737 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.82 24.13 0.17 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.153 1.359 . . . . 0.0 112.292 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.97 169.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.227 1.011 . . . . 0.0 108.582 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.87 33.35 2.15 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.663 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.48 45.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.031 1.415 . . . . 0.0 110.594 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -141.13 -45.88 0.39 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.897 2.479 . . . . 0.0 106.526 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -71.26 -44.67 64.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.097 0.959 . . . . 0.0 110.195 169.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.93 -55.62 28.6 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.941 -0.474 . . . . 0.0 111.752 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.21 -34.64 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 122.725 0.41 . . . . 0.0 111.32 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -58.66 -38.57 78.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.404 1.482 . . . . 0.0 112.809 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.45 -57.47 11.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.352 1.433 . . . . 0.0 110.487 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -64.03 -38.98 93.04 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.6 0.636 . . . . 0.0 110.679 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.85 11.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.064 0.545 . . . . 0.0 111.966 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.94 -36.42 77.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.498 0.719 . . . . 0.0 110.861 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -52.41 -43.93 65.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.282 1.033 . . . . 0.0 109.479 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.11 23.07 13.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.05 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.22 63.77 4.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.5 1.048 . . . . 0.0 112.999 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.41 138.12 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.221 1.409 . . . . 0.0 108.304 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -100.89 165.03 11.55 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.326 1.05 . . . . 0.0 108.463 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.41 -139.34 7.09 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -176.4 148.49 0.75 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.581 0.691 . . . . 0.0 110.669 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.46 78.73 1.14 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 109.502 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -90.22 86.32 6.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.946 0.879 . . . . 0.0 109.244 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.5 97.26 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.967 1.307 . . . . 0.0 109.945 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.6 mt -78.63 102.22 0.95 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 125.059 1.344 . . . . 0.0 107.582 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 146.84 79.77 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.501 2.134 . . . . 0.0 111.118 -164.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 55.28 53.35 10.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.476 1.11 . . . . 0.0 109.489 -167.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.3 -132.95 1.63 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -127.37 149.69 49.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.743 1.617 . . . . 0.0 109.94 -169.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.96 115.8 29.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 121.594 0.711 . . . . 0.0 109.419 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.97 103.49 16.0 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.34 1.456 . . . . 0.0 107.079 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.58 132.23 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.316 0.646 . . . . 0.0 109.833 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.56 145.83 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.58 119.39 4.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.359 0.527 . . . . 0.0 110.652 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -109.67 107.44 17.49 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.307 1.443 . . . . 0.0 110.865 -166.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.66 174.94 26.33 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-O 121.826 0.681 . . . . 0.0 113.011 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -72.64 173.25 9.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 160.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.97 -30.02 63.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -64.84 -17.86 64.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.426 0.691 . . . . 0.0 112.598 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.44 -2.98 10.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.411 1.085 . . . . 0.0 112.263 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -68.18 -62.32 1.45 Allowed 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -42.69 -42.84 3.63 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.737 1.615 . . . . 0.0 113.064 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -51.49 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.953 0.501 . . . . 0.0 111.454 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.05 -24.15 63.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.499 1.12 . . . . 0.0 111.639 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.96 -61.79 1.88 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 108.835 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.23 -25.7 65.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.266 1.426 . . . . 0.0 111.766 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -54.23 0.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.185 1.394 . . . . 0.0 110.776 159.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mt -71.21 -56.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.87 -48.76 80.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.454 0.302 . . . . 0.0 110.818 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -68.92 -42.34 76.94 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.811 1.245 . . . . 0.0 111.247 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.1 0.27 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.077 1.322 . . . . 0.0 110.02 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.75 163.37 38.64 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.631 2.887 . . . . 0.0 111.919 -173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.86 162.36 37.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.715 2.943 . . . . 0.0 111.204 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.67 42.23 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.848 0.859 . . . . 0.0 111.039 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.92 162.86 36.82 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.778 1.231 . . . . 0.0 109.54 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.02 83.72 2.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.389 1.075 . . . . 0.0 109.192 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.31 83.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.288 1.435 . . . . 0.0 109.914 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -41.0 -60.88 1.08 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.311 1.844 . . . . 0.0 111.37 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -162.62 133.63 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.091 0.244 . . . . 0.0 110.84 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.04 94.24 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 165.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.39 70.05 10.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -75.76 161.3 29.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.391 0.615 . . . . 0.0 111.494 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -143.03 97.55 3.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.63 1.172 . . . . 0.0 108.952 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -55.91 127.33 29.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.673 1.189 . . . . 0.0 109.188 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -134.93 -163.21 1.35 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.53 1.132 . . . . 0.0 109.679 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 151.59 47.17 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.547 0.739 . . . . 0.0 110.04 173.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -58.3 124.7 20.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.969 0.908 . . . . 0.0 112.001 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -73.76 -45.3 52.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.55 176.23 37.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.95 96.81 10.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.488 1.515 . . . . 0.0 109.505 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -56.06 -55.32 34.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.299 1.04 . . . . 0.0 111.099 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.61 61.22 3.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 112.107 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 155.75 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.723 2.809 . . . . 0.0 108.213 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.59 98.1 10.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 168.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -117.45 165.35 13.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.454 0.702 . . . . 0.0 109.308 176.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -114.84 144.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.575 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.314 -1.327 . . . . 0.0 108.756 150.512 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.597 0.237 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 166.39 16.87 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.882 1.273 . . . . 0.0 111.695 -167.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -94.77 124.55 38.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.633 0.773 . . . . 0.0 111.773 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -90.52 151.93 21.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 160.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -135.39 102.64 5.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.45 1.1 . . . . 0.0 109.097 -177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.05 106.3 16.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.049 0.54 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 98.02 10.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.67 104.23 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -76.16 153.28 36.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.71 -155.51 16.23 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 123.735 0.683 . . . . 0.0 112.549 162.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.71 28.2 0.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.158 0.983 . . . . 0.0 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.87 -9.62 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.177 0.991 . . . . 0.0 113.064 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.66 164.93 18.15 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 162.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.69 3.77 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.05 142.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.35 52.73 4.77 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.434 0.54 . . . . 0.0 113.089 -165.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -87.6 51.08 2.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.466 0.706 . . . . 0.0 110.437 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -52.61 0.93 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.404 1.481 . . . . 0.0 107.238 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -47.72 -52.61 17.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.696 1.199 . . . . 0.0 110.711 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.88 -54.63 40.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.131 0.972 . . . . 0.0 111.436 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.2 -23.68 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.453 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -50.21 64.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.542 169.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.14 -53.3 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.814 1.188 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -70.7 -31.21 68.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.59 -64.18 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 167.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.6 -41.0 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.312 1.445 . . . . 0.0 112.309 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -49.1 78.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 111.279 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -87.05 14.57 7.26 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.83 57.75 17.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.179 0.895 . . . . 0.0 111.829 176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.1 mm -119.18 140.7 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.981 1.313 . . . . 0.0 109.196 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -109.95 165.2 11.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.069 1.347 . . . . 0.0 108.595 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.69 -134.14 5.5 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 118.477 0.581 . . . . 0.0 112.169 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.99 147.8 1.68 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 122.995 0.518 . . . . 0.0 111.646 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.32 84.49 2.63 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.954 1.302 . . . . 0.0 108.75 167.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.38 86.85 5.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.791 0.805 . . . . 0.0 109.544 -169.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.72 81.21 6.44 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 126.251 1.821 . . . . 0.0 109.869 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.4 mt -59.85 110.99 3.24 Favored Pre-proline 0 N--CA 1.454 -0.265 0 C-N-CA 125.363 1.465 . . . . 0.0 107.978 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.06 46.36 2.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.958 2.438 . . . . 0.0 112.945 -162.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -153.43 45.92 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.879 1.672 . . . . 0.0 107.676 167.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.07 -136.84 3.87 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 m -120.64 173.04 7.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.269 1.428 . . . . 0.0 110.266 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.62 122.39 45.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 122.965 0.506 . . . . 0.0 111.744 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -95.64 110.04 22.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.201 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -87.18 140.08 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.29 135.19 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 165.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.77 117.23 6.99 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.015 0.926 . . . . 0.0 110.101 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.69 111.4 24.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.129 0.972 . . . . 0.0 110.67 -171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.67 29.99 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -54.78 163.97 0.87 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 110.104 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.47 -44.36 64.9 Favored 'General case' 0 CA--C 1.527 0.063 0 O-C-N 122.116 -0.365 . . . . 0.0 110.629 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -47.74 -43.44 27.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.678 1.191 . . . . 0.0 111.256 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.76 0.36 52.3 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.005 1.322 . . . . 0.0 112.828 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.6 tp -68.8 -60.76 2.16 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.582 1.083 . . . . 0.0 109.461 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.3 p -40.9 -47.89 3.04 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.424 1.489 . . . . 0.0 112.32 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.35 -41.46 65.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.13 -53.44 11.02 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.89 0.476 . . . . 0.0 109.75 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.8 -52.46 60.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.53 -45.0 73.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.234 1.414 . . . . 0.0 111.542 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.95 -53.88 3.67 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.534 1.534 . . . . 0.0 110.481 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.1 mt -63.35 -65.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.25 0.22 . . . . 0.0 110.827 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -55.63 -41.26 73.28 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.93 -37.56 88.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.77 0.828 . . . . 0.0 111.805 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.33 76.61 0.24 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.436 1.494 . . . . 0.0 110.064 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.6 168.04 23.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.349 3.366 . . . . 0.0 112.129 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 169.83 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.656 2.904 . . . . 0.0 111.418 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.68 29.03 0.82 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.0 0.92 . . . . 0.0 111.335 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.85 168.23 16.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.944 1.298 . . . . 0.0 109.635 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.7 84.06 1.61 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.875 0.87 . . . . 0.0 109.881 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.49 98.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.796 0.838 . . . . 0.0 110.293 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -49.78 -55.18 15.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.549 1.539 . . . . 0.0 110.677 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -178.06 135.24 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.086 1.354 . . . . 0.0 110.981 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.1 90.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 121.601 -0.687 . . . . 0.0 109.385 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.05 77.87 6.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -78.46 171.08 15.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.36 0.6 . . . . 0.0 112.166 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -143.39 126.14 16.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.158 1.383 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.03 129.1 34.08 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -135.7 -162.57 1.28 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.281 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.59 135.74 48.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.798 1.239 . . . . 0.0 109.496 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -57.98 135.76 56.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.315 0.646 . . . . 0.0 112.505 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -79.32 -47.19 16.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.205 0.602 . . . . 0.0 109.432 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.19 -174.28 36.19 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.21 96.56 10.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.537 1.135 . . . . 0.0 110.291 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -58.81 134.32 56.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 167.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.73 71.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.736 0.814 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.06 164.04 0.26 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.422 1.889 . . . . 0.0 111.326 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.67 109.97 17.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -111.57 178.5 4.31 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 138.53 54.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.448 0.699 . . . . 0.0 109.839 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.303 167.42 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -177.06 4.34 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.321 1.048 . . . . 0.0 111.497 -168.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -106.1 135.63 47.21 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.5 ttp -77.7 157.6 30.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 157.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -144.05 88.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.324 1.449 . . . . 0.0 107.253 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.92 102.78 13.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.772 0.829 . . . . 0.0 109.96 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 97.96 9.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 t -99.32 119.78 47.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.753 0.421 . . . . 0.0 110.0 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -103.36 148.25 26.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.622 1.569 . . . . 0.0 110.387 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.55 -159.57 23.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.09 0.852 . . . . 0.0 112.003 169.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -87.78 21.85 2.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.536 0.735 . . . . 0.0 111.014 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.55 -24.4 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.282 1.033 . . . . 0.0 111.808 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.72 132.41 49.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 110.632 173.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.69 -54.33 4.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.601 0.62 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -72.41 77.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.277 1.431 . . . . 0.0 109.963 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.17 -116.97 5.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.4 t80 62.58 -68.77 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.251 2.22 . . . . 0.0 113.504 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -56.78 -35.32 68.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.626 1.17 . . . . 0.0 110.927 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -73.94 -47.48 37.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.922 0.889 . . . . 0.0 110.238 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.86 -50.17 66.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.422 1.089 . . . . 0.0 112.447 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.75 -33.75 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.651 0.38 . . . . 0.0 110.506 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -46.84 73.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 109.542 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 mm -51.53 -54.17 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.4 1.0 . . . . 0.0 110.717 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -66.27 -42.8 87.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.408 0.442 . . . . 0.0 109.963 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.56 -52.37 47.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.81 -43.63 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.416 1.087 . . . . 0.0 109.905 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -54.0 -37.68 64.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.526 0.73 . . . . 0.0 111.002 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -97.4 -1.52 44.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.838 1.655 . . . . 0.0 113.361 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.58 59.91 5.36 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.821 0.737 . . . . 0.0 111.91 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -125.13 138.49 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.859 1.664 . . . . 0.0 108.82 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -92.19 -178.9 5.1 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.909 1.284 . . . . 0.0 108.519 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -143.94 11.79 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 120.04 1.291 . . . . 0.0 112.338 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -175.3 147.18 0.87 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.858 0.863 . . . . 0.0 110.328 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.53 82.44 1.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 109.291 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -84.73 80.03 9.4 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.688 1.232 . . . . 0.0 108.636 -170.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -85.17 75.61 10.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.626 2.77 . . . . 0.0 110.042 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -61.42 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.063 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.3 -167.42 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.98 2.453 . . . . 0.0 110.537 -170.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -100.0 50.77 0.91 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.973 1.309 . . . . 0.0 109.876 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.31 -73.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.875 0 O-C-N 122.052 -0.405 . . . . 0.0 112.439 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 m -96.43 112.21 24.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.654 0.782 . . . . 0.0 110.899 -168.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.24 132.35 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.064 0 C-N-CA 124.942 1.297 . . . . 0.0 110.059 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -92.44 122.0 34.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.16 145.37 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.445 1.098 . . . . 0.0 109.22 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.35 147.89 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.709 1.204 . . . . 0.0 107.856 167.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.94 115.55 6.75 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.083 0.953 . . . . 0.0 109.379 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -112.64 112.33 23.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -160.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.78 -168.97 35.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.53 167.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.64 160.83 24.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.652 1.581 . . . . 0.0 109.197 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.06 -19.97 53.25 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.13 -47.63 76.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.61 59.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.637 0.775 . . . . 0.0 112.166 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.8 -61.61 1.87 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.066 0.848 . . . . 0.0 108.878 174.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.7 p -40.54 -44.39 2.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.406 1.482 . . . . 0.0 113.001 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.11 -45.49 88.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.845 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.12 -23.25 60.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.103 1.361 . . . . 0.0 111.549 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -56.7 3.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.663 1.185 . . . . 0.0 109.745 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -58.67 -37.14 75.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.573 1.149 . . . . 0.0 111.372 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -28.81 -52.99 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 127.068 2.147 . . . . 0.0 112.075 167.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -71.04 -69.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -167.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -51.71 -43.96 63.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -62.65 -56.83 14.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.713 0.805 . . . . 0.0 110.26 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.79 81.8 0.31 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.545 1.545 . . . . 0.0 109.599 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 160.95 47.65 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.592 2.861 . . . . 0.0 111.201 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -68.3 157.53 61.42 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.608 2.205 . . . . 0.0 109.559 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.75 36.98 0.34 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.235 0.614 . . . . 0.0 111.485 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.42 166.35 21.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.686 1.594 . . . . 0.0 109.29 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -80.55 72.86 7.48 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.13 0.572 . . . . 0.0 109.978 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -61.44 114.58 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.259 1.024 . . . . 0.0 108.475 168.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.88 -49.04 6.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 110.847 -161.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -162.42 71.09 0.31 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.467 0.651 . . . . 0.0 111.873 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.5 89.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.036 0.935 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.07 81.58 2.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 107.963 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -78.52 164.52 24.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.31 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 m -145.59 139.96 27.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.27 1.028 . . . . 0.0 109.502 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 135.64 33.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.899 1.28 . . . . 0.0 108.352 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 m -135.62 176.82 8.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.514 0.726 . . . . 0.0 111.168 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -89.32 137.58 32.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -64.88 138.77 58.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.237 1.015 . . . . 0.0 111.596 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -79.28 -51.18 9.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.818 0.847 . . . . 0.0 109.249 174.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.15 -178.2 30.99 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.62 103.95 8.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.098 0.959 . . . . 0.0 109.463 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -78.52 70.21 4.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -51.7 127.46 20.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.701 1.2 . . . . 0.0 112.347 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.59 174.95 0.24 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.907 1.683 . . . . 0.0 110.85 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.56 93.36 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -112.94 158.69 19.91 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -113.61 149.34 34.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.98 0.912 . . . . 0.0 110.362 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.003 -1.475 . . . . 0.0 108.624 148.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 159.24 34.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.1 0.96 . . . . 0.0 110.83 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -91.62 106.36 18.42 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 ptm -84.68 94.69 8.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -89.81 89.91 7.96 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.83 105.28 17.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.499 0.666 . . . . 0.0 111.225 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.29 102.99 13.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.462 1.105 . . . . 0.0 108.979 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.62 108.99 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -103.84 139.63 38.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.58 0.752 . . . . 0.0 111.089 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.92 -152.96 24.98 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.896 0.748 . . . . 0.0 111.837 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tp -82.26 20.7 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.028 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.75 35.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.371 1.469 . . . . 0.0 112.036 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -96.23 102.3 14.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.63 0.772 . . . . 0.0 110.362 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.92 48.71 61.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.409 1.004 . . . . 0.0 112.3 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.45 93.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.761 0.824 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.32 -69.17 1.39 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.216 1.388 . . . . 0.0 112.093 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -28.44 -66.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.396 3.078 . . . . 0.0 115.103 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -60.69 -30.53 69.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.044 0.538 . . . . 0.0 111.867 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -78.48 -41.41 32.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.086 0.954 . . . . 0.0 109.992 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.9 -48.98 72.33 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.328 -0.858 . . . . 0.0 111.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.92 -28.12 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.928 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -59.87 -59.86 4.75 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 118.564 -0.732 . . . . 0.0 110.022 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.3 mm -46.39 -55.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.208 0.603 . . . . 0.0 111.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -70.9 -42.56 69.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.796 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.02 -50.0 59.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.739 0.699 . . . . 0.0 112.441 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.97 -36.8 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.657 1.583 . . . . 0.0 110.975 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -44.42 89.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.847 0.459 . . . . 0.0 111.917 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.91 -17.02 27.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.971 0.908 . . . . 0.0 113.383 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.87 66.32 1.27 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.74 139.63 45.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 125.713 1.605 . . . . 0.0 108.458 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -111.69 160.06 17.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.035 1.334 . . . . 0.0 108.555 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.78 -133.17 4.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -173.22 141.1 0.91 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.008 1.323 . . . . 0.0 109.878 172.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.79 82.48 2.6 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.613 1.165 . . . . 0.0 108.43 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -92.22 89.54 6.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -163.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.17 72.56 6.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.913 1.685 . . . . 0.0 111.566 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.99 118.44 55.42 Favored Pre-proline 0 C--N 1.342 0.259 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.308 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.71 76.93 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.831 3.021 . . . . 0.0 111.853 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -163.68 28.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.84 -43.06 3.04 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.706 -0.622 . . . . 0.0 112.809 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -95.66 86.63 4.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 110.789 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.26 125.97 40.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 123.828 0.851 . . . . 0.0 109.523 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.58 135.36 34.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.31 94.57 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.8 t -67.53 122.03 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.39 154.03 39.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -127.28 113.61 16.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.646 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.57 -140.67 0.09 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.495 1.521 . . . . 0.0 113.197 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -177.38 -92.58 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.317 3.047 . . . . 0.0 107.1 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.47 -63.23 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 122.972 0.509 . . . . 0.0 110.914 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.1 -53.9 6.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.32 67.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.149 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.1 tp -53.58 -72.34 0.06 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -55.65 -47.52 76.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 0.0 112.413 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -54.25 -41.0 68.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.082 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.78 -46.3 17.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.26 0.482 . . . . 0.0 110.725 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.07 -61.93 1.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.884 -0.51 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -55.01 -43.78 73.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 111.685 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -56.13 3.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.645 1.178 . . . . 0.0 110.438 167.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -66.24 -53.8 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.125 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -49.68 65.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.204 0.456 . . . . 0.0 110.526 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -100.16 55.02 0.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 109.631 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.49 75.85 0.22 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.18 129.8 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.066 2.511 . . . . 0.0 109.595 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.56 179.37 6.55 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.165 2.577 . . . . 0.0 109.984 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.11 36.55 0.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.547 0.739 . . . . 0.0 111.974 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.94 162.05 38.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 110.004 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.74 87.97 3.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 110.287 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.69 78.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.799 1.24 . . . . 0.0 110.449 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -41.8 -59.36 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.995 2.118 . . . . 0.0 112.305 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -162.66 89.74 0.68 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-O 121.629 0.728 . . . . 0.0 112.589 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.85 92.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.89 0.876 . . . . 0.0 110.9 173.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -98.31 78.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.891 1.277 . . . . 0.0 108.292 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -72.86 164.97 25.81 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -134.21 119.22 18.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.451 1.101 . . . . 0.0 109.952 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -80.09 124.38 28.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m -136.91 176.49 8.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.797 1.239 . . . . 0.0 110.662 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.56 153.59 17.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.376 1.47 . . . . 0.0 110.116 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -45.62 104.22 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.053 1.741 . . . . 0.0 112.167 167.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -92.83 -55.03 3.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.827 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.2 146.36 13.19 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.05 107.25 19.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.509 1.123 . . . . 0.0 110.653 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -68.09 169.61 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 160.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.47 49.51 0.69 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.399 0.68 . . . . 0.0 110.676 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 170.14 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.064 2.145 . . . . 0.0 108.972 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -83.89 91.45 7.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.67 162.92 17.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.768 0.713 . . . . 0.0 110.233 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.54 138.47 34.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.231 0.612 . . . . 0.0 110.429 -173.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.7 t80 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.264 -1.35 . . . . 0.0 109.56 174.009 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 93.3 p -78.55 165.37 23.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.471 0.708 . . . . 0.0 110.98 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -129.63 -57.47 1.12 Allowed 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.89 1.276 . . . . 0.0 108.123 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -67.36 156.2 37.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.311 0.644 . . . . 0.0 110.544 172.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -158.37 159.24 35.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.581 1.153 . . . . 0.0 108.189 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -160.29 157.48 28.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.798 1.239 . . . . 0.0 108.342 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 p -123.53 160.01 27.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.811 1.645 . . . . 0.0 109.181 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -163.49 160.61 23.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.038 0.935 . . . . 0.0 109.715 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m 69.74 97.46 0.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -148.24 144.29 27.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.652 1.181 . . . . 0.0 108.293 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.34 129.02 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.098 0.559 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.46 -99.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.858 1.263 . . . . 0.0 110.149 -171.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.9 168.67 11.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.904 1.682 . . . . 0.0 110.014 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mtt 66.3 168.35 0.22 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 126.204 1.802 . . . . 0.0 113.607 171.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -171.41 154.08 3.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.553 1.141 . . . . 0.0 110.12 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.38 141.97 32.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.683 1.593 . . . . 0.0 109.975 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -83.53 111.46 19.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.203 1.001 . . . . 0.0 109.731 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.3 ptm -92.4 102.57 15.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.634 1.174 . . . . 0.0 108.343 173.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -73.46 127.52 32.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.78 105.57 7.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.721 0.772 . . . . 0.0 109.744 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.3 15.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.885 1.674 . . . . 0.0 107.434 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.36 114.05 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.46 153.31 19.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.268 1.427 . . . . 0.0 109.967 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.1 -161.13 13.92 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.507 1.051 . . . . 0.0 111.66 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tp -83.0 26.21 0.63 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.058 0.543 . . . . 0.0 111.532 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.1 -10.68 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 113.098 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -57.6 151.97 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.632 1.173 . . . . 0.0 110.009 166.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.61 -62.48 4.6 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.84 165.1 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.246 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.41 48.14 3.57 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.934 0.778 . . . . 0.0 112.465 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.01 -60.87 2.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.593 1.157 . . . . 0.0 108.921 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -61.54 -25.58 67.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 112.071 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.24 -48.96 48.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 0.0 109.474 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.29 -46.67 82.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.432 0.693 . . . . 0.0 111.167 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -55.67 -36.85 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.893 0.477 . . . . 0.0 110.635 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -57.34 11.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.852 -1.07 . . . . 0.0 110.928 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -44.15 -55.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.612 1.096 . . . . 0.0 111.638 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.4 -47.41 67.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.385 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.76 -50.86 54.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.8 -47.49 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.573 1.549 . . . . 0.0 109.018 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.58 -39.61 70.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.253 0.621 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -94.39 -0.62 54.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.514 1.525 . . . . 0.0 113.236 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.45 62.2 4.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.952 0.796 . . . . 0.0 111.735 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 mm -115.42 141.77 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 126.285 1.834 . . . . 0.0 107.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -104.06 167.56 9.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.805 1.242 . . . . 0.0 108.485 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.07 -146.92 16.58 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 118.158 0.435 . . . . 0.0 113.123 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -170.76 139.99 1.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 109.357 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.35 88.93 2.91 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.439 1.095 . . . . 0.0 108.58 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.04 77.9 4.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -164.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -72.82 74.0 1.12 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.662 1.585 . . . . 0.0 111.302 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.36 124.0 76.07 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 165.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.46 76.81 3.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.803 2.335 . . . . 0.0 110.749 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -151.14 26.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.613 1.165 . . . . 0.0 111.983 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.59 -48.64 3.71 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.611 0.624 . . . . 0.0 112.353 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 p -91.31 91.28 8.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.781 1.232 . . . . 0.0 110.873 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.51 126.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 124.111 0.964 . . . . 0.0 109.904 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 141.53 29.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.234 0.614 . . . . 0.0 109.506 175.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.69 137.15 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -118.52 61.03 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.423 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.85 156.2 39.42 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.622 1.169 . . . . 0.0 110.167 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.18 112.21 6.6 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.933 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.07 156.82 23.13 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.583 0.628 . . . . 0.0 114.012 -172.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -71.99 -92.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.047 1.739 . . . . 0.0 110.28 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.57 -80.41 0.09 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.429 1.492 . . . . 0.0 107.397 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.66 -52.21 56.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.283 0.633 . . . . 0.0 109.795 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.79 68.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.993 0.517 . . . . 0.0 111.808 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.2 tp -64.95 -66.4 0.55 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -46.38 -42.61 15.25 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.451 1.501 . . . . 0.0 112.941 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -57.41 -62.67 1.61 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.292 0.951 . . . . 0.0 110.17 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -57.37 -35.73 70.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.205 0.602 . . . . 0.0 112.219 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.64 -63.25 1.17 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.982 0.913 . . . . 0.0 110.515 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.31 -37.24 55.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.088 1.355 . . . . 0.0 111.618 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.42 -59.81 3.18 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.433 1.093 . . . . 0.0 111.12 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.33 -61.87 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.139 0.427 . . . . 0.0 111.239 -163.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -48.42 64.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 113.104 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -58.41 -51.97 67.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.262 0.625 . . . . 0.0 110.966 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.8 86.22 0.45 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.03 1.3 . . . . 0.0 109.857 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 163.71 30.91 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.287 2.658 . . . . 0.0 111.226 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.72 165.36 31.18 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.941 2.427 . . . . 0.0 111.188 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.37 43.2 0.72 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.889 0.876 . . . . 0.0 111.096 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.49 167.93 25.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.976 1.31 . . . . 0.0 109.327 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -76.53 80.52 3.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.561 1.144 . . . . 0.0 109.574 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.54 119.89 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.052 0.941 . . . . 0.0 108.673 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.56 -50.03 6.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.442 1.097 . . . . 0.0 110.387 -168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -166.09 71.59 0.14 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.413 0.625 . . . . 0.0 111.633 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -65.67 94.35 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.433 0.693 . . . . 0.0 111.122 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.94 83.72 1.88 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.093 1.357 . . . . 0.0 108.01 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -77.66 163.43 26.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.849 0.356 . . . . 0.0 110.676 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.2 m -139.08 110.18 6.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 109.665 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 120.75 10.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 m -127.69 -152.3 0.51 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.811 1.245 . . . . 0.0 109.106 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 155.99 49.15 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.481 1.112 . . . . 0.0 109.198 170.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -81.23 124.11 29.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.012 0.925 . . . . 0.0 110.658 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -73.63 -46.78 44.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 164.5 32.51 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.88 134.04 34.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.582 1.153 . . . . 0.0 109.257 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -74.21 145.88 43.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.583 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.55 87.28 0.9 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.997 0.919 . . . . 0.0 110.104 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 66.44 -160.46 0.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.477 1.111 . . . . 0.0 109.601 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.73 113.39 9.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.211 1.004 . . . . 0.0 109.283 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.93 164.56 20.51 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.638 0.775 . . . . 0.0 110.868 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.97 143.51 38.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.373 1.069 . . . . 0.0 110.408 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.018 -1.468 . . . . 0.0 111.108 168.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.5 p -157.04 154.94 30.35 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.011 0.925 . . . . 0.0 109.298 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptp -158.51 44.77 0.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.02 0.928 . . . . 0.0 109.956 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.97 34.36 5.24 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.689 1.196 . . . . 0.0 111.243 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 129.66 34.76 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -135.95 75.7 1.57 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 109.278 -173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.4 p -123.64 153.31 40.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.068 1.347 . . . . 0.0 109.631 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -160.8 -63.14 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 p -142.29 170.49 15.61 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.013 1.325 . . . . 0.0 109.446 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.3 164.99 27.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.035 1.334 . . . . 0.0 109.053 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.22 125.88 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.028 1.331 . . . . 0.0 108.666 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -139.38 -98.23 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.306 1.042 . . . . 0.0 108.523 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -124.26 136.15 53.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.976 1.71 . . . . 0.0 107.981 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.1 mtp -140.06 148.0 41.13 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.066 0.946 . . . . 0.0 109.68 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.315 0.4 OUTLIER 61.39 144.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.59 2.756 . . . . 0.0 113.937 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 173.51 9.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.148 1.379 . . . . 0.0 110.839 -167.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -100.21 127.36 46.49 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.085 0.554 . . . . 0.0 111.257 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.47 158.38 31.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 153.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.06 97.26 2.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.85 116.06 29.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.87 0.868 . . . . 0.0 110.944 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.67 107.86 19.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 108.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.92 107.74 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.1 147.88 22.96 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.103 0.961 . . . . 0.0 110.278 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.97 -161.75 27.14 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.244 0.926 . . . . 0.0 110.967 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tp -82.23 20.14 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.268 0.627 . . . . 0.0 110.648 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.26 -14.66 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.106 1.362 . . . . 0.0 112.794 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.37 117.18 7.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.857 0.863 . . . . 0.0 109.653 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.49 48.96 40.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.08 0.848 . . . . 0.0 113.304 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.09 -168.07 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 109.014 166.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.02 79.33 0.2 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.485 1.041 . . . . 0.0 111.013 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -158.42 -174.42 4.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.556 1.542 . . . . 0.0 108.573 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 73.51 -73.57 0.1 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.576 1.951 . . . . 0.0 109.53 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -56.62 -36.96 70.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.283 1.033 . . . . 0.0 110.351 172.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -48.76 -48.14 41.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.274 1.03 . . . . 0.0 111.722 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.16 -37.54 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.158 -0.338 . . . . 0.0 110.422 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.72 -49.29 66.51 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.037 -1.459 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.8 mm -43.93 -53.38 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 120.707 1.594 . . . . 0.0 111.416 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -66.9 -51.68 52.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.6 -44.84 66.25 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.85 -46.33 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 108.635 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -42.03 88.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.318 0.647 . . . . 0.0 111.012 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.3 mt -92.3 -52.53 4.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.058 1.343 . . . . 0.0 111.751 -169.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.14 66.6 0.17 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.167 1.365 . . . . 0.0 112.704 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.79 147.12 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 108.821 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -108.06 174.11 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 108.847 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.86 -150.63 22.44 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 118.619 0.645 . . . . 0.0 112.594 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -164.78 140.87 5.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.72 82.43 1.85 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.396 1.078 . . . . 0.0 110.087 -168.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.38 104.21 16.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 -164.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -78.7 126.11 30.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.3 mt -101.85 93.99 4.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.25 76.89 4.02 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.482 2.788 . . . . 0.0 111.548 -159.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 173.94 -43.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.159 2.584 . . . . 0.0 108.708 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.36 -119.25 4.56 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.737 1.16 . . . . 0.0 111.429 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -129.25 126.04 38.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.57 1.548 . . . . 0.0 109.425 -168.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.27 122.06 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.7 0.8 . . . . 0.0 110.158 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.21 140.19 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.796 0.839 . . . . 0.0 109.646 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.5 t -127.05 134.06 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.178 0.991 . . . . 0.0 108.554 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.1 74.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.71 0.804 . . . . 0.0 110.821 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.89 150.12 37.63 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -117.67 96.63 5.47 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.197 0.599 . . . . 0.0 110.951 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.25 174.52 17.39 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.932 0.777 . . . . 0.0 112.437 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.74 -98.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 108.668 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -152.14 -73.75 0.14 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.291 1.436 . . . . 0.0 108.211 -174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.68 -45.46 48.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.611 1.164 . . . . 0.0 109.338 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.6 57.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.86 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.5 tp -53.78 -56.75 14.68 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.449 0.568 . . . . 0.0 109.56 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.1 p -47.52 -36.38 10.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.888 1.275 . . . . 0.0 112.862 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -64.3 -36.4 84.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.43 1.092 . . . . 0.0 111.444 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.6 -50.15 12.0 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.646 0.778 . . . . 0.0 109.044 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -52.8 25.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.354 0.662 . . . . 0.0 111.168 -171.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.06 -35.68 77.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.281 1.433 . . . . 0.0 113.159 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -48.57 14.48 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.89 1.276 . . . . 0.0 110.73 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.46 -56.42 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 119.02 -0.514 . . . . 0.0 110.616 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.2 -54.28 38.38 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.236 0.471 . . . . 0.0 110.517 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 47.61 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.451 1.1 . . . . 0.0 109.641 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.47 66.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.55 161.3 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.512 2.808 . . . . 0.0 111.311 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.13 170.16 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.954 3.103 . . . . 0.0 111.802 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.24 48.12 1.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.092 0.957 . . . . 0.0 111.027 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -149.37 167.49 26.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.713 1.205 . . . . 0.0 110.162 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.79 89.49 1.37 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.12 86.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 109.967 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -41.54 -60.76 1.22 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.799 1.64 . . . . 0.0 111.344 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.71 140.22 3.87 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.676 0.39 . . . . 0.0 110.473 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.27 97.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 166.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.53 82.48 6.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -76.61 156.44 32.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -141.89 108.91 5.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.805 1.242 . . . . 0.0 108.764 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -69.09 127.5 33.35 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -134.83 -173.56 3.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.086 0.954 . . . . 0.0 110.398 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 141.83 38.35 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.094 0.957 . . . . 0.0 108.616 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.19 56.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -54.18 20.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 170.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.15 -176.05 34.78 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.03 119.1 28.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.278 1.031 . . . . 0.0 109.318 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -70.04 135.37 49.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.44 91.92 1.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.531 0.733 . . . . 0.0 109.979 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 67.92 -161.32 0.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.423 1.089 . . . . 0.0 109.683 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.0 89.94 3.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.635 1.174 . . . . 0.0 108.982 -175.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.53 159.75 16.46 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -115.36 144.23 44.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.306 0.643 . . . . 0.0 110.955 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.027 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.569 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 67.5 p -159.22 161.42 36.08 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.605 1.162 . . . . 0.0 108.914 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -132.19 111.1 11.13 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.603 1.161 . . . . 0.0 108.684 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 122.27 47.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.993 1.317 . . . . 0.0 109.592 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -99.35 -49.78 4.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.336 1.054 . . . . 0.0 110.213 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 75.5 t90 21.11 73.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.44 3.096 . . . . 0.0 113.541 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -106.63 60.28 0.64 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.95 1.3 . . . . 0.0 108.195 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -71.96 118.15 14.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.343 1.457 . . . . 0.0 111.272 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -161.88 137.99 7.85 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.95 0.9 . . . . 0.0 109.378 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -169.61 147.1 3.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.96 1.304 . . . . 0.0 108.35 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.45 128.02 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -144.62 -19.76 0.53 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.956 1.302 . . . . 0.0 112.052 -167.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -82.63 51.29 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.746 1.619 . . . . 0.0 111.357 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.1 mtp -146.04 175.11 10.7 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.407 1.083 . . . . 0.0 110.551 -171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 0.5 OUTLIER 66.68 127.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.278 3.031 . . . . 0.0 113.754 173.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.18 167.1 16.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.116 0.966 . . . . 0.0 112.157 -161.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -100.27 130.76 46.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.4 ttp -66.44 166.23 12.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.196 0.998 . . . . 0.0 108.795 158.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.42 86.78 1.55 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 163.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.35 105.19 17.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.465 0.706 . . . . 0.0 110.953 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 101.02 13.53 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.272 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -90.42 110.86 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -96.15 148.34 22.81 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.969 0.907 . . . . 0.0 109.295 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.41 -157.35 22.27 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.01 1.29 . . . . 0.0 111.316 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -80.46 19.62 0.77 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.517 0.727 . . . . 0.0 111.402 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.62 -23.3 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.151 0.98 . . . . 0.0 111.022 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.77 142.43 50.16 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 109.668 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.13 -65.61 2.85 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.42 169.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.842 0.821 . . . . 0.0 110.953 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.01 -94.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.493 1.044 . . . . 0.0 111.767 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.65 -59.69 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 113.26 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -38.78 -37.78 0.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.762 2.825 . . . . 0.0 113.082 170.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.79 -50.97 25.05 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.536 0.735 . . . . 0.0 109.939 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.96 -39.93 63.32 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 111.48 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.35 -42.29 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 123.44 0.696 . . . . 0.0 110.029 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.4 ' CA ' HE21 ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.42 -54.23 39.98 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 117.715 -1.136 . . . . 0.0 110.143 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.9 mm -41.63 -54.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.877 1.217 . . . . 0.0 113.054 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -73.31 -45.61 54.4 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.554 0.342 . . . . 0.0 110.72 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.64 -51.01 59.11 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.149 0.5 . . . . 0.0 111.741 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -44.6 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 126.219 1.807 . . . . 0.0 109.972 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -53.01 -39.96 63.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.803 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.44 11.7 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.781 1.233 . . . . 0.0 113.47 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.89 64.61 3.67 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 118.841 0.746 . . . . 0.0 112.112 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.5 mm -121.88 138.62 51.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.354 1.462 . . . . 0.0 108.735 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -98.56 173.38 6.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.689 1.196 . . . . 0.0 108.243 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.7 -143.92 11.19 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.499 -0.75 . . . . 0.0 111.7 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -175.26 144.2 0.71 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.551 1.14 . . . . 0.0 109.19 170.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 82.82 1.8 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -95.13 111.78 23.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.353 0.597 . . . . 0.0 110.156 -164.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -91.73 119.69 31.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 108.505 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.04 98.05 4.27 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.52 144.91 91.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.433 2.089 . . . . 0.0 110.812 -169.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.7 t0 55.95 54.73 7.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.475 1.11 . . . . 0.0 109.67 -166.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.27 -134.97 2.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -124.8 161.0 27.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.816 1.646 . . . . 0.0 110.464 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.84 117.83 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.067 0.947 . . . . 0.0 109.629 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -93.19 143.47 26.23 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.618 0.767 . . . . 0.0 110.456 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.25 123.15 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.428 1.091 . . . . 0.0 108.773 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.39 62.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.825 0.85 . . . . 0.0 110.966 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 129.75 38.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.457 0.703 . . . . 0.0 111.042 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -117.62 108.08 15.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.747 1.219 . . . . 0.0 110.503 -165.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 177.32 37.5 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-O 122.216 0.898 . . . . 0.0 114.369 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -69.87 169.65 12.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.128 1.371 . . . . 0.0 108.946 165.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -79.85 -30.25 40.3 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.12 -25.53 68.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.918 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.28 -13.54 18.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.914 0.885 . . . . 0.0 111.825 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.83 -59.79 2.71 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 p -38.57 -45.01 1.02 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.278 1.831 . . . . 0.0 112.912 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.45 -42.02 88.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.854 0.862 . . . . 0.0 112.682 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -74.11 -21.99 59.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.626 1.171 . . . . 0.0 111.551 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.7 -61.24 2.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.471 1.108 . . . . 0.0 110.317 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -53.89 -42.07 68.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 110.299 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -34.37 -47.42 0.3 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.305 2.642 . . . . 0.0 113.556 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.61 -68.25 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.608 0.763 . . . . 0.0 110.728 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -52.13 -44.93 64.75 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.84 -51.96 67.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.299 1.04 . . . . 0.0 111.186 173.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.09 85.3 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.61 160.55 45.59 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.924 2.416 . . . . 0.0 111.262 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.25 160.58 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.274 2.649 . . . . 0.0 110.765 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 48.83 1.33 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.824 0.85 . . . . 0.0 110.957 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.39 169.06 25.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 110.484 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.1 77.73 2.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.189 0.995 . . . . 0.0 109.374 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.08 125.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.953 0.901 . . . . 0.0 109.389 173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.93 -60.34 2.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 108.163 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -156.13 115.47 3.53 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.72 87.01 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 161.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.09 67.42 8.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.458 1.103 . . . . 0.0 108.268 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.2 154.38 31.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.826 -170.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -138.23 117.65 12.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.67 129.93 44.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m -127.21 -161.89 1.12 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.443 1.097 . . . . 0.0 109.24 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.23 141.48 45.79 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.617 0.767 . . . . 0.0 109.026 170.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -54.8 135.1 47.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.567 1.147 . . . . 0.0 112.96 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -73.35 -57.49 3.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 165.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.29 -177.55 40.01 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.43 122.2 16.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.56 0.744 . . . . 0.0 110.417 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -72.98 -26.5 61.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 111.468 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.51 91.31 0.07 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.637 1.575 . . . . 0.0 111.028 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.53 179.72 0.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 110.472 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.88 95.84 2.56 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.68 167.04 13.39 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 p -103.69 152.02 22.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.482 0.713 . . . . 0.0 110.791 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 153.219 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.4 m -145.39 128.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.173 0.989 . . . . 0.0 108.841 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -113.78 107.33 15.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.727 1.211 . . . . 0.0 108.249 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.5 144.03 41.38 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.715 1.206 . . . . 0.0 109.543 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 140.21 5.83 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.959 1.304 . . . . 0.0 108.556 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -144.4 156.46 44.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.855 0.862 . . . . 0.0 111.132 -172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -71.99 78.01 0.92 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.245 1.418 . . . . 0.0 109.017 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.59 -53.8 54.28 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.632 1.173 . . . . 0.0 110.528 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m 65.0 85.95 0.13 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.038 1.335 . . . . 0.0 110.53 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -141.07 57.62 1.55 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.348 1.059 . . . . 0.0 110.545 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.02 93.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.345 1.058 . . . . 0.0 108.747 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.19 -95.95 0.26 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.915 0.886 . . . . 0.0 109.725 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 173.09 11.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.716 1.206 . . . . 0.0 110.333 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -137.51 -174.71 3.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.429 1.492 . . . . 0.0 108.687 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.96 129.94 35.93 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 170.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.23 166.57 10.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.262 1.025 . . . . 0.0 109.905 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -99.15 101.56 12.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 110.347 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.3 ttp -70.01 144.77 52.15 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 164.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -124.18 136.35 54.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.993 1.717 . . . . 0.0 106.561 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 107.59 4.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.343 0.592 . . . . 0.0 109.976 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 98.93 8.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.73 101.09 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.31 149.89 26.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.267 0.627 . . . . 0.0 111.265 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.61 -163.53 18.45 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.315 1.436 . . . . 0.0 110.7 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 47.8 1.55 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.02 41.62 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.326 1.05 . . . . 0.0 110.747 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.62 150.43 33.15 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.404 1.082 . . . . 0.0 110.384 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.72 -56.83 4.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.527 0.584 . . . . 0.0 111.871 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -48.38 150.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.803 2.041 . . . . 0.0 111.292 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.82 38.45 2.34 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.825 0.726 . . . . 0.0 113.486 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -67.17 -35.87 80.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.64 0.72 . . . . 0.0 110.016 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -58.22 -31.77 67.67 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.265 1.026 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.72 -48.15 34.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.668 1.187 . . . . 0.0 109.843 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.13 -44.84 79.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.507 0.723 . . . . 0.0 111.579 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.51 -37.5 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.666 0.786 . . . . 0.0 109.969 172.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.37 -57.7 9.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.848 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -43.06 -51.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 119.451 1.023 . . . . 0.0 111.757 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -67.22 -56.6 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.841 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.68 -47.82 20.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.54 -42.88 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 126.224 1.81 . . . . 0.0 110.47 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -62.52 -34.41 76.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.766 0.426 . . . . 0.0 111.799 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.98 -0.19 55.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.855 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.17 5.32 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 118.65 0.659 . . . . 0.0 111.557 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -121.26 141.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.649 1.58 . . . . 0.0 108.311 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -103.43 166.38 10.46 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.26 -145.21 12.25 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.957 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.36 141.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 110.19 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.11 86.68 2.34 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.165 1.386 . . . . 0.0 108.727 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -100.27 90.1 4.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.862 0.865 . . . . 0.0 110.511 -164.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.73 92.76 4.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.557 1.543 . . . . 0.0 109.811 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.7 mt -66.13 106.19 1.03 Allowed Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 125.772 1.629 . . . . 0.0 108.321 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.07 43.24 1.43 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.584 2.189 . . . . 0.0 113.058 -160.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.5 47.77 0.34 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.472 1.509 . . . . 0.0 108.285 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.83 -135.7 3.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -112.6 169.34 8.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.494 1.517 . . . . 0.0 109.656 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.68 135.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 C-N-CA 124.204 1.001 . . . . 0.0 112.011 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -100.48 122.71 43.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.604 1.161 . . . . 0.0 109.183 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.38 145.11 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.639 1.176 . . . . 0.0 108.518 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.23 86.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.072 0.949 . . . . 0.0 109.827 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.42 143.02 26.67 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.028 1.331 . . . . 0.0 111.592 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -126.28 99.12 5.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.272 0.629 . . . . 0.0 110.772 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.54 164.14 30.15 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 121.598 0.554 . . . . 0.0 113.073 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -66.7 167.32 11.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 -35.58 67.28 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.977 -0.452 . . . . 0.0 111.911 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -45.3 -39.91 7.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.791 1.236 . . . . 0.0 112.159 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.08 0.85 21.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.94 1.296 . . . . 0.0 112.586 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -70.29 -59.29 2.96 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.285 0.948 . . . . 0.0 108.829 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -42.63 -45.4 4.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.269 1.428 . . . . 0.0 112.063 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.17 -32.42 64.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.718 1.607 . . . . 0.0 112.885 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.23 -53.88 4.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.07 1.348 . . . . 0.0 109.927 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -53.24 56.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.49 1.116 . . . . 0.0 111.109 -167.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -68.91 -34.6 75.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.636 1.174 . . . . 0.0 111.433 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.43 -42.26 10.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.384 1.474 . . . . 0.0 111.206 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.41 -61.61 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.217 0.607 . . . . 0.0 111.2 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.54 -48.69 80.68 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.09 0.405 . . . . 0.0 111.029 -168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -94.94 38.36 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.927 1.291 . . . . 0.0 110.275 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.3 76.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.99 162.04 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.464 2.776 . . . . 0.0 112.594 -167.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.65 -1.73 5.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.222 3.281 . . . . 0.0 114.525 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.36 28.8 4.67 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 126.163 1.785 . . . . 0.0 110.114 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.35 164.16 32.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.997 1.719 . . . . 0.0 107.995 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.15 80.5 4.57 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.076 0.551 . . . . 0.0 110.945 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.33 126.88 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.164 0.986 . . . . 0.0 109.656 170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -93.65 -53.1 4.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.455 1.102 . . . . 0.0 109.405 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -164.85 76.12 0.29 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.064 0.459 . . . . 0.0 112.165 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.4 p -67.21 89.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.282 0.633 . . . . 0.0 111.013 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.07 85.5 3.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.158 1.383 . . . . 0.0 108.046 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -77.74 170.33 16.76 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.176 0.512 . . . . 0.0 112.212 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -139.7 112.16 7.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.222 1.409 . . . . 0.0 109.843 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -66.26 138.7 57.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 163.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m -161.24 174.07 14.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.083 0.468 . . . . 0.0 109.959 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.29 146.14 27.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.086 0.954 . . . . 0.0 110.604 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.29 127.85 33.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.24 0.616 . . . . 0.0 110.164 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -42.63 18.13 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.01 161.8 34.18 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.22 149.96 21.55 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.602 1.161 . . . . 0.0 110.568 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.15 153.99 33.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.093 165.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -71.87 78.6 0.88 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.213 1.005 . . . . 0.0 109.696 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.68 -162.76 0.19 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.151 1.38 . . . . 0.0 110.296 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.66 116.01 21.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.116 1.366 . . . . 0.0 108.362 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -129.35 166.31 19.76 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.86 123.92 48.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.834 0.853 . . . . 0.0 110.26 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.53 1.532 . . . . 0.0 107.844 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.193 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.9 p -160.5 156.7 26.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.906 0.882 . . . . 0.0 109.735 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt -84.74 64.86 8.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.081 0.952 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -113.59 129.14 56.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.916 1.286 . . . . 0.0 108.758 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 149.08 46.04 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.768 0.427 . . . . 0.0 110.75 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.73 57.17 1.78 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.878 1.271 . . . . 0.0 109.604 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.6 t -128.79 73.65 1.52 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.58 1.152 . . . . 0.0 109.743 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.34 59.54 3.46 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.987 0.915 . . . . 0.0 109.835 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -86.82 72.37 10.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.672 1.189 . . . . 0.0 109.715 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.86 136.24 57.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.034 0.933 . . . . 0.0 109.483 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.21 126.17 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.802 1.241 . . . . 0.0 110.607 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -118.74 -38.39 3.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.601 1.56 . . . . 0.0 111.618 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.77 97.05 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.093 1.357 . . . . 0.0 111.703 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.7 mtt -146.92 174.81 11.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.364 1.466 . . . . 0.0 109.426 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.48 -168.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 115.09 173.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 -179.55 6.43 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.355 1.062 . . . . 0.0 111.415 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -108.96 127.4 54.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.25 0.62 . . . . 0.0 112.386 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 ttp -79.31 146.56 32.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 155.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -127.95 135.44 49.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.444 1.897 . . . . 0.0 106.335 165.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.67 110.52 5.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.394 0.616 . . . . 0.0 111.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -84.3 99.23 10.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.166 1.386 . . . . 0.0 108.084 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.12 107.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -97.32 149.65 21.85 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.439 1.096 . . . . 0.0 110.253 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.5 -158.43 26.03 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.885 1.231 . . . . 0.0 110.962 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.92 22.5 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.515 0.726 . . . . 0.0 110.977 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.84 -17.4 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.118 1.367 . . . . 0.0 111.885 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -67.47 121.04 14.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.062 0.545 . . . . 0.0 111.627 -172.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.48 37.03 93.46 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.462 1.029 . . . . 0.0 112.773 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.14 91.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.0 -139.1 44.45 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.485 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 t80 56.48 -173.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.003 1.721 . . . . 0.0 111.428 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 68.36 -76.04 0.06 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 126.126 1.771 . . . . 0.0 109.243 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -45.85 -42.35 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.303 1.441 . . . . 0.0 111.92 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.66 -53.82 50.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 111.245 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -67.23 -18.83 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 122.074 -0.392 . . . . 0.0 111.344 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -54.83 13.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.266 -1.349 . . . . 0.0 110.713 167.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.7 mm -36.27 -55.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 120.483 1.492 . . . . 0.0 112.886 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -67.62 -51.94 44.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.75 0.42 . . . . 0.0 110.759 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -45.38 -65.98 0.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.575 1.15 . . . . 0.0 111.351 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.41 -47.92 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 111.631 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -53.52 -46.68 70.19 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.06 0.544 . . . . 0.0 110.571 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.9 mt -102.29 37.33 1.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 111.851 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.23 68.43 1.67 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.981 1.277 . . . . 0.0 113.766 167.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.4 mm -117.3 141.45 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.802 1.241 . . . . 0.0 108.978 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -101.81 174.57 5.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 108.481 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.56 -152.44 24.0 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.342 0.974 . . . . 0.0 112.288 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -170.88 142.91 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.451 0.7 . . . . 0.0 110.347 167.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.74 90.2 3.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.295 1.038 . . . . 0.0 111.977 -165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -111.15 104.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.592 0.357 . . . . 0.0 111.823 -160.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -80.17 97.32 6.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.005 0.922 . . . . 0.0 109.42 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -73.73 102.52 0.62 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.04 136.5 48.48 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.891 1.728 . . . . 0.0 110.499 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 55.86 53.35 9.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 110.124 -167.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.47 -131.37 1.25 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.3 t -121.61 150.33 41.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.481 1.112 . . . . 0.0 110.134 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -99.66 94.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.51 137.81 32.23 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.051 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 143.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.04 136.84 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 164.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.91 138.25 31.91 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.083 0.953 . . . . 0.0 108.717 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.15 90.78 3.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -168.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.93 168.62 16.99 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 123.289 0.471 . . . . 0.0 112.199 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -77.07 -100.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.84 1.656 . . . . 0.0 108.942 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -150.92 -57.47 0.16 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.796 1.638 . . . . 0.0 108.188 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -49.89 -45.12 50.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.848 0.859 . . . . 0.0 109.64 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.69 -34.46 67.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.05 0.54 . . . . 0.0 111.372 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.17 -61.02 2.75 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.4 p -43.33 -47.58 6.75 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.682 1.593 . . . . 0.0 112.213 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -56.18 -41.68 75.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.403 1.081 . . . . 0.0 111.666 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.4 -24.65 31.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.711 1.605 . . . . 0.0 111.154 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.53 -60.84 2.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.139 0.976 . . . . 0.0 110.936 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.81 -43.47 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.239 1.016 . . . . 0.0 111.058 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -34.1 -50.99 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.074 2.55 . . . . 0.0 113.259 165.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -69.18 -68.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.682 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -52.49 -41.83 63.73 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.79 -53.81 44.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.723 0.809 . . . . 0.0 110.754 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.09 0.3 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.863 1.22 . . . . 0.0 110.56 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.38 161.54 42.76 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.251 2.634 . . . . 0.0 111.296 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.33 164.71 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.516 2.811 . . . . 0.0 111.793 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.12 50.18 1.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 111.02 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.22 159.34 17.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.599 1.559 . . . . 0.0 107.84 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.18 84.49 3.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.597 0.359 . . . . 0.0 110.437 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.88 127.88 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.765 0.826 . . . . 0.0 109.183 168.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.85 -61.42 1.63 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.729 1.212 . . . . 0.0 108.05 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -146.4 119.94 9.11 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.01 0.524 . . . . 0.0 112.055 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.47 101.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -100.26 79.64 2.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.238 1.415 . . . . 0.0 108.062 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.24 152.34 21.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 m -145.29 139.85 27.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.0 0.92 . . . . 0.0 110.664 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.98 127.34 42.85 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 109.033 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -136.35 -175.86 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.224 1.01 . . . . 0.0 110.639 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.59 152.53 18.45 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.536 0.734 . . . . 0.0 110.57 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.57 133.96 53.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.432 1.093 . . . . 0.0 111.39 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -71.34 -50.37 32.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.07 172.48 35.19 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.12 112.4 20.2 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.958 0.903 . . . . 0.0 109.094 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.67 133.46 54.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.61 97.43 1.71 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.68 -167.41 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.203 1.401 . . . . 0.0 110.539 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 80.54 1.94 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.12 1.368 . . . . 0.0 108.658 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -106.85 160.64 15.35 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 123.255 0.347 . . . . 0.0 110.149 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.18 141.3 47.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.496 0.718 . . . . 0.0 111.559 -165.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.405 1.482 . . . . 0.0 108.306 170.145 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.3 m -144.58 -63.84 0.36 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.965 0.906 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.75 44.51 1.32 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.705 2.002 . . . . 0.0 113.844 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -123.17 -64.98 1.12 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 125.719 1.608 . . . . 0.0 107.995 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 tptt 72.36 -68.89 0.21 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.917 2.087 . . . . 0.0 112.581 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.7 m95 34.92 55.89 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.435 2.294 . . . . 0.0 113.523 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.4 p -85.14 54.68 3.19 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -163.84 67.46 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.879 1.272 . . . . 0.0 108.394 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -118.92 68.63 0.79 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.026 1.331 . . . . 0.0 108.727 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -137.66 98.91 3.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.129 0.972 . . . . 0.0 108.82 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.25 134.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.106 1.362 . . . . 0.0 107.328 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.97 -35.75 6.06 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.386 1.075 . . . . 0.0 110.708 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.88 62.93 2.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.966 1.707 . . . . 0.0 110.792 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.2 mtm -104.0 -146.02 0.37 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 108.943 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.67 162.17 28.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.333 1.053 . . . . 0.0 111.299 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.57 152.16 32.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.293 1.837 . . . . 0.0 108.57 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -97.87 113.94 25.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.277 1.031 . . . . 0.0 110.587 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.0 ptm -86.28 161.7 18.63 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.11 85.56 1.61 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.69 96.19 10.3 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.121 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -80.88 107.2 13.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 t -91.45 90.39 3.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -168.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -65.38 148.28 51.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.13 -164.79 13.14 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.995 0.807 . . . . 0.0 112.157 166.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -90.23 36.92 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.85 0.86 . . . . 0.0 110.218 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.91 -19.39 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 142.32 45.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.011 0.924 . . . . 0.0 111.107 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.0 -43.31 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.839 0.733 . . . . 0.0 112.243 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.21 78.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.939 0.896 . . . . 0.0 109.854 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.5 -121.44 7.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.918 1.247 . . . . 0.0 111.214 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.9 t80 65.35 -56.95 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.092 2.557 . . . . 0.0 114.635 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -32.99 -51.28 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.525 2.73 . . . . 0.0 112.992 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -79.65 -41.73 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.096 0.958 . . . . 0.0 111.183 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -51.25 -41.84 60.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 111.085 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.53 -43.36 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.593 1.157 . . . . 0.0 111.375 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -57.96 10.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.728 0.811 . . . . 0.0 110.589 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.2 mm -47.47 -57.45 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 118.389 0.54 . . . . 0.0 111.3 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -69.94 -39.45 76.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.288 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.79 -61.9 1.93 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.297 0.499 . . . . 0.0 110.918 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.75 -50.62 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.732 1.613 . . . . 0.0 110.39 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -51.3 62.14 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.915 0.886 . . . . 0.0 109.804 -176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.13 4.13 46.58 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.022 1.329 . . . . 0.0 113.387 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.01 58.2 9.38 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.755 0.707 . . . . 0.0 111.454 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.52 142.75 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.784 1.634 . . . . 0.0 107.81 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.53 162.98 13.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.435 1.094 . . . . 0.0 108.58 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -149.68 21.67 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -169.59 143.35 2.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.92 82.88 1.92 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.365 1.066 . . . . 0.0 108.957 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.506 1.146 . . . . 0.0 109.638 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.5 67.35 10.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 127.531 2.332 . . . . 0.0 110.609 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.1 mt -48.79 104.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 126.393 1.877 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.47 32.73 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.115 1.877 . . . . 0.0 113.211 -164.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -147.93 44.83 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.18 1.392 . . . . 0.0 107.604 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.61 -149.86 8.16 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -120.67 151.41 39.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.686 1.194 . . . . 0.0 109.701 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.4 126.96 32.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.89 0.876 . . . . 0.0 111.47 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -92.06 127.48 37.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.68 97.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.48 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.754 0.787 . . . . 0.0 109.732 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.53 156.38 32.94 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.857 1.263 . . . . 0.0 111.38 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -146.57 122.87 10.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.343 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.05 164.92 35.66 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 118.75 0.705 . . . . 0.0 112.773 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.24 162.9 11.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.458 1.103 . . . . 0.0 108.67 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.84 -24.51 44.34 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -166.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.45 -44.08 95.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.655 0.661 . . . . 0.0 109.909 168.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.04 -14.42 59.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.507 0.723 . . . . 0.0 112.439 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.13 -62.96 1.17 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -49.45 -42.46 42.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 112.809 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -61.71 -38.96 89.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.139 0.976 . . . . 0.0 112.047 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -70.61 -55.31 9.09 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -50.95 -53.58 31.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.773 0.429 . . . . 0.0 111.554 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.06 -37.63 83.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.76 0.824 . . . . 0.0 112.246 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.66 -49.07 7.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.917 1.287 . . . . 0.0 110.8 167.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -70.4 -52.63 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.19 0.596 . . . . 0.0 110.296 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -49.94 73.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.453 0.569 . . . . 0.0 111.2 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -69.52 -36.9 76.86 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.367 1.067 . . . . 0.0 111.581 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.99 74.78 0.24 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.234 1.397 . . . . 0.0 110.22 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.77 168.49 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.826 3.017 . . . . 0.0 110.174 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.1 150.02 77.04 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.58 1.52 . . . . 0.0 108.533 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.86 45.56 0.82 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.002 0.521 . . . . 0.0 110.553 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.21 175.64 9.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 109.681 -173.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.27 74.33 3.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.639 0.776 . . . . 0.0 109.92 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 117.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -76.84 -52.28 9.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.505 1.122 . . . . 0.0 108.783 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -179.31 110.38 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.075 1.35 . . . . 0.0 110.211 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -75.74 78.07 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.339 1.056 . . . . 0.0 109.512 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -95.14 89.4 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.38 164.06 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.018 0.437 . . . . 0.0 111.944 -171.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -117.52 125.03 50.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.078 1.351 . . . . 0.0 108.769 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.25 128.75 34.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 m -136.51 179.25 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.633 0.773 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -96.47 146.69 24.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.084 1.354 . . . . 0.0 108.874 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -69.44 135.77 50.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -89.1 -57.35 2.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.018 1.327 . . . . 0.0 108.639 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 27.51 22.52 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.726 1.155 . . . . 0.0 113.536 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.86 -35.34 26.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.408 1.104 . . . . 0.0 112.887 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -83.84 82.27 8.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.08 0.552 . . . . 0.0 111.427 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.23 88.6 0.18 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.917 0.887 . . . . 0.0 109.36 171.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 90.85 145.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 128.507 2.723 . . . . 0.0 110.504 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.92 112.38 24.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.329 1.052 . . . . 0.0 108.829 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.48 165.7 15.95 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.07 0.548 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 p -108.12 146.28 32.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.834 0.854 . . . . 0.0 110.747 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.312 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.0 0 CA-C-O 119.405 -0.664 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 26.8 t 57.87 61.99 2.22 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.831 1.252 . . . . 0.0 111.086 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.33 150.58 26.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 0.0 109.455 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.21 -40.7 2.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.551 1.14 . . . . 0.0 111.368 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 68.96 150.48 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.387 1.875 . . . . 0.0 112.046 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -130.82 58.55 1.7 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.912 1.285 . . . . 0.0 108.698 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.8 m -78.82 68.52 4.8 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 110.63 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -156.9 84.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.081 1.353 . . . . 0.0 108.071 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -140.55 167.97 20.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 109.592 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 71.06 166.65 0.3 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.0 112.823 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.62 125.16 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.691 1.597 . . . . 0.0 108.019 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -172.11 92.7 0.13 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.894 0.878 . . . . 0.0 109.398 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.62 74.63 1.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.25 1.42 . . . . 0.0 109.955 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -120.49 166.54 13.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.223 1.009 . . . . 0.0 111.572 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 75.51 131.68 0.05 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.859 2.864 . . . . 0.0 112.031 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 168.51 12.35 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.777 0.831 . . . . 0.0 112.267 -169.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -93.44 114.92 27.43 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.05 0.453 . . . . 0.0 111.472 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.8 ptm -93.94 86.27 5.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 122.059 0.933 . . . . 0.0 110.529 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.38 114.83 18.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.32 110.68 16.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.316 1.047 . . . . 0.0 110.323 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 109.16 20.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.046 1.338 . . . . 0.0 107.921 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -96.24 110.12 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.52 154.77 17.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.132 0.973 . . . . 0.0 111.728 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.3 -159.05 21.3 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.735 1.636 . . . . 0.0 110.895 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -86.4 47.97 1.55 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.99 41.72 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 125.192 1.397 . . . . 0.0 110.43 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -108.16 33.93 3.87 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.355 0.662 . . . . 0.0 111.86 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.48 -160.7 26.84 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.785 1.183 . . . . 0.0 110.319 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 70.23 -175.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.965 1.306 . . . . 0.0 109.812 -175.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.99 51.19 2.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.817 0.723 . . . . 0.0 112.616 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.49 178.86 5.82 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.742 2.017 . . . . 0.0 112.075 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 61.65 -74.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.84 2.056 . . . . 0.0 111.061 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.15 -47.2 1.56 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.899 1.679 . . . . 0.0 111.137 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.23 -50.12 67.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.312 0.645 . . . . 0.0 112.127 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.0 -36.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 123.434 0.694 . . . . 0.0 110.341 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.4 -51.85 65.9 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.286 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -44.23 -50.41 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.844 1.656 . . . . 0.0 112.363 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -71.27 -49.64 40.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.854 0.462 . . . . 0.0 110.209 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.63 -48.39 58.06 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.031 0.933 . . . . 0.0 113.132 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.32 -47.16 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.327 1.851 . . . . 0.0 108.36 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.35 -42.87 67.25 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.98 0.355 . . . . 0.0 110.993 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -93.28 6.82 46.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.99 1.316 . . . . 0.0 113.285 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.62 59.83 8.21 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 118.595 0.634 . . . . 0.0 112.244 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -113.45 139.54 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 125.605 1.562 . . . . 0.0 108.399 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -103.46 157.52 16.98 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.671 1.188 . . . . 0.0 108.06 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.97 -158.78 31.58 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 118.569 0.622 . . . . 0.0 113.072 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -170.43 137.98 1.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.591 1.156 . . . . 0.0 108.641 167.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.39 87.51 2.63 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.99 0.916 . . . . 0.0 108.78 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -94.71 115.42 27.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.804 0.842 . . . . 0.0 109.807 -167.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.33 130.38 34.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.542 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -102.55 96.71 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.08 23.6 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.293 2.662 . . . . 0.0 114.43 -161.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.35 42.13 2.05 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.015 1.326 . . . . 0.0 108.303 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.69 -122.22 0.83 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -117.48 164.14 15.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.261 1.824 . . . . 0.0 110.579 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -102.85 124.75 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.595 0.758 . . . . 0.0 110.501 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -98.58 125.52 43.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.757 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -109.06 115.55 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.44 135.1 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 164.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.31 146.4 18.5 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.508 1.123 . . . . 0.0 108.733 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.81 122.63 18.81 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.334 0.654 . . . . 0.0 111.219 -171.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.95 165.3 28.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 121.91 0.728 . . . . 0.0 113.881 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.44 172.68 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.093 160.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.92 -25.54 40.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.06 -52.01 52.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.93 -14.9 62.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.31 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.61 -68.29 0.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -46.34 -43.68 16.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.66 1.184 . . . . 0.0 112.825 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.587 1.155 . . . . 0.0 111.632 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.2 -24.94 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.906 0.482 . . . . 0.0 111.592 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -59.23 2.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 109.862 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.26 -33.53 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.686 0.794 . . . . 0.0 112.207 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.94 -54.57 2.71 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.485 1.514 . . . . 0.0 111.09 170.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.2 mt -74.39 -52.45 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.658 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -54.36 42.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.582 0.628 . . . . 0.0 110.269 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -90.82 41.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.051 1.34 . . . . 0.0 110.201 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.39 73.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.52 163.58 26.58 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.962 3.108 . . . . 0.0 111.639 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.35 -8.78 23.08 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.41 2.74 . . . . 0.0 113.919 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 78.81 25.77 0.5 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.083 2.153 . . . . 0.0 111.084 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.21 169.08 14.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.29 1.836 . . . . 0.0 107.987 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.2 77.99 1.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.689 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.46 122.69 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.749 1.22 . . . . 0.0 110.018 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -82.83 -57.95 3.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.072 1.349 . . . . 0.0 107.898 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.23 136.29 6.54 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.164 0.29 . . . . 0.0 110.841 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 84.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -87.58 75.46 9.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -70.38 160.5 32.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.886 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 m -146.1 80.31 1.57 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 109.489 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.25 137.47 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.481 1.513 . . . . 0.0 112.467 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -144.85 -177.51 5.56 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 0.0 110.871 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 153.12 39.9 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.11 124.67 23.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.748 0.819 . . . . 0.0 111.578 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.18 -49.46 35.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.93 172.5 42.07 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.86 109.98 20.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.68 140.89 58.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.891 0.877 . . . . 0.0 109.935 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.25 91.82 2.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.676 0.79 . . . . 0.0 110.588 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.9 -163.41 0.23 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.43 1.092 . . . . 0.0 109.811 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.1 87.62 2.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.618 0.767 . . . . 0.0 109.638 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -104.25 -175.91 2.93 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.606 0.762 . . . . 0.0 109.079 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -125.17 158.81 33.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.118 -1.42 . . . . 0.0 109.934 159.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.154 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 47.7 t -150.91 71.7 1.04 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 108.676 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? 69.76 133.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.661 1.984 . . . . 0.0 111.829 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.57 150.91 32.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.691 1.196 . . . . 0.0 108.349 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -160.28 151.73 19.6 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.857 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -175.72 143.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.253 1.421 . . . . 0.0 108.419 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -138.28 69.36 1.38 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.037 0.935 . . . . 0.0 110.089 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -79.3 59.66 2.89 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.0 110.572 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -123.52 64.62 1.02 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.098 1.359 . . . . 0.0 109.623 -167.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -154.11 141.39 19.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.068 0.547 . . . . 0.0 109.626 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.07 107.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.852 2.061 . . . . 0.0 111.642 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -104.77 -30.93 9.58 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.536 1.135 . . . . 0.0 110.799 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -76.47 72.97 3.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.086 1.354 . . . . 0.0 110.46 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.4 mtm -62.18 -71.63 0.15 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.207 1.003 . . . . 0.0 110.38 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.37 145.69 43.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.499 0.719 . . . . 0.0 111.029 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 164.13 19.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.236 1.014 . . . . 0.0 111.592 -170.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -86.39 118.42 25.82 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.1 ptm -89.58 91.35 8.65 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.279 1.037 . . . . 0.0 108.832 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.28 128.66 35.34 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.32 14.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.097 0.475 . . . . 0.0 111.254 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -100.77 94.56 6.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.005 0.922 . . . . 0.0 109.084 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.83 103.76 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.482 0.713 . . . . 0.0 109.135 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -101.86 143.47 31.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.799 0.84 . . . . 0.0 110.569 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.72 -165.95 33.22 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.49 0.494 . . . . 0.0 112.342 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.65 20.5 0.73 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.706 0.803 . . . . 0.0 110.546 168.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.23 -3.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.97 1.308 . . . . 0.0 112.469 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -82.23 33.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.714 1.605 . . . . 0.0 112.814 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.23 57.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.96 -174.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.218 1.007 . . . . 0.0 108.402 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.86 66.53 0.65 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.188 0.899 . . . . 0.0 111.897 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -133.24 171.51 13.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.703 2.001 . . . . 0.0 107.372 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 80.32 -62.39 0.24 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.639 1.576 . . . . 0.0 107.886 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -54.26 -41.14 68.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.696 0.798 . . . . 0.0 109.478 165.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.79 -55.8 23.21 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.62 -18.57 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.875 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -57.67 -58.8 6.76 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.224 0.92 . . . . 0.0 109.324 165.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.0 mm -46.79 -56.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 123.232 0.613 . . . . 0.0 111.49 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -66.13 -44.3 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.5 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.31 -65.16 0.6 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.214 0.461 . . . . 0.0 110.766 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.93 -45.96 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.978 1.711 . . . . 0.0 111.428 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.93 -43.8 98.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 111.469 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.29 16.72 8.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.777 0.831 . . . . 0.0 112.531 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.74 58.23 15.3 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 124.334 0.969 . . . . 0.0 112.518 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.21 139.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.942 1.297 . . . . 0.0 109.916 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.11 175.13 5.63 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.238 1.415 . . . . 0.0 108.237 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.56 -140.41 11.77 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -170.88 150.67 3.21 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.027 0.413 . . . . 0.0 111.297 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.48 86.5 2.37 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.415 1.486 . . . . 0.0 108.953 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.48 108.95 20.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.24 1.016 . . . . 0.0 108.427 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.15 92.83 9.12 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.16 1.384 . . . . 0.0 109.756 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.88 113.67 32.21 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.59 72.91 5.42 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.357 2.705 . . . . 0.0 112.201 -162.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -165.25 55.93 0.12 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.85 1.66 . . . . 0.0 107.992 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.47 -40.59 1.78 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.48 1.038 . . . . 0.0 114.082 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -90.99 93.22 9.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.404 1.482 . . . . 0.0 110.93 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.37 119.83 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.74 125.79 36.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.746 1.218 . . . . 0.0 109.003 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.77 135.25 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.685 1.194 . . . . 0.0 107.881 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.59 55.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 C-N-CA 124.113 0.965 . . . . 0.0 108.981 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.96 157.54 30.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.249 1.42 . . . . 0.0 110.165 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -143.83 123.03 12.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.545 -172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.88 166.72 39.39 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.467 -1.349 . . . . 0.0 113.748 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -52.43 156.25 1.84 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 0.0 111.352 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.68 -15.05 58.95 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.9 -36.32 82.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.271 0.487 . . . . 0.0 109.942 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.73 -3.53 29.96 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.666 1.186 . . . . 0.0 112.696 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.4 tp -66.9 -61.54 1.89 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.265 0.939 . . . . 0.0 109.364 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -44.7 -41.94 7.2 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.128 1.371 . . . . 0.0 112.878 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.18 -50.31 73.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.627 1.171 . . . . 0.0 111.079 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.4 tp -71.19 -30.04 65.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.624 0.37 . . . . 0.0 111.274 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.21 -58.7 3.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.98 -38.81 68.29 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.985 0.914 . . . . 0.0 112.268 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -30.44 -52.08 0.15 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.571 1.948 . . . . 0.0 112.542 164.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.16 -72.36 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 122.752 0.421 . . . . 0.0 110.452 -169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -49.89 45.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.053 0.941 . . . . 0.0 111.869 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -89.18 29.42 1.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.467 1.107 . . . . 0.0 111.954 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.56 68.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.77 164.92 32.62 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.022 3.148 . . . . 0.0 111.546 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -178.51 4.23 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.512 2.808 . . . . 0.0 110.864 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.12 28.81 0.69 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.104 0.961 . . . . 0.0 112.251 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.25 167.0 19.94 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.732 1.213 . . . . 0.0 110.328 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.84 81.99 2.76 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.81 83.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.549 1.54 . . . . 0.0 110.607 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -39.44 -62.37 0.68 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.964 2.106 . . . . 0.0 111.458 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -165.57 129.28 2.24 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 111.702 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.68 99.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.29 80.7 9.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -74.75 142.61 44.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.0 m -148.28 85.26 1.52 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 109.593 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.98 142.4 0.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.567 1.947 . . . . 0.0 111.027 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -159.95 171.85 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.26 143.06 39.17 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.008 0.923 . . . . 0.0 109.773 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.48 145.69 52.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.085 0.469 . . . . 0.0 111.936 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -58.28 2.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.113 1.365 . . . . 0.0 108.332 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.62 167.8 39.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.54 103.05 6.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.427 0.691 . . . . 0.0 110.213 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -77.55 79.24 4.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -44.44 119.5 1.88 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.375 1.87 . . . . 0.0 112.502 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.5 t70 68.1 124.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.874 2.07 . . . . 0.0 111.595 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.35 95.1 3.15 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -118.21 160.09 22.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 0.819 . . . . 0.0 110.794 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.95 145.97 29.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.678 0.791 . . . . 0.0 112.385 -171.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.304 154.128 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.13 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.6 m -148.4 139.63 23.32 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.201 1.0 . . . . 0.0 109.154 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp -159.49 122.68 3.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.242 1.017 . . . . 0.0 108.939 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -130.78 134.11 46.58 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.19 1.396 . . . . 0.0 108.953 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.01 166.02 25.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.654 1.182 . . . . 0.0 109.473 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -129.99 176.53 7.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.792 1.637 . . . . 0.0 108.978 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -121.01 145.23 47.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.424 1.49 . . . . 0.0 109.04 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -161.59 79.49 0.57 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 108.085 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -140.48 155.76 46.57 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.794 1.238 . . . . 0.0 109.659 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -154.21 65.79 0.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -93.27 140.43 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -110.3 -103.09 0.39 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -127.32 129.02 46.88 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.261 1.424 . . . . 0.0 109.017 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtt -147.57 149.85 33.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.951 1.3 . . . . 0.0 108.629 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -171.15 156.23 4.67 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.742 0.817 . . . . 0.0 110.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 171.58 8.19 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.874 0.869 . . . . 0.0 111.731 -174.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -103.11 107.35 18.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.976 1.311 . . . . 0.0 111.375 -168.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.14 98.2 11.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 109.583 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -74.82 133.86 41.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.17 105.84 5.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.67 99.61 12.61 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.225 1.41 . . . . 0.0 108.37 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.22 116.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.462 1.105 . . . . 0.0 109.065 -170.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -98.97 158.03 15.92 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.688 1.195 . . . . 0.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.11 -162.71 14.76 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 124.631 1.11 . . . . 0.0 111.993 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.23 32.86 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.701 0.8 . . . . 0.0 110.773 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.88 -19.22 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.291 1.036 . . . . 0.0 111.212 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -56.62 133.95 54.12 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.352 1.061 . . . . 0.0 110.15 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.74 10.47 83.26 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.109 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.17 152.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.73 1.212 . . . . 0.0 107.843 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.49 45.9 3.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.769 0.7 . . . . 0.0 112.89 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -57.82 -51.69 68.54 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.676 0.79 . . . . 0.0 109.376 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -56.84 -42.29 79.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.717 0.807 . . . . 0.0 111.692 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.27 -46.08 81.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.274 1.03 . . . . 0.0 110.452 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.99 -45.19 75.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.001 0.364 . . . . 0.0 110.489 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.36 -32.8 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.969 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.54 -55.78 30.22 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.284 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mm -42.01 -57.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.766 1.166 . . . . 0.0 113.325 -172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -68.65 -48.07 64.95 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.393 0.542 . . . . 0.0 110.443 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.39 -65.4 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 111.646 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.45 -49.85 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.218 2.207 . . . . 0.0 111.5 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.87 78.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.846 0.458 . . . . 0.0 111.944 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.5 mt -102.06 23.47 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.71 65.87 3.25 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.454 1.026 . . . . 0.0 113.304 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.92 139.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 125.045 1.338 . . . . 0.0 108.004 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -101.56 167.1 10.35 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.072 1.349 . . . . 0.0 107.808 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.98 -146.52 14.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.338 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -167.45 148.6 5.54 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.576 1.15 . . . . 0.0 109.186 166.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.52 81.44 1.59 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.85 0.86 . . . . 0.0 108.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -86.83 84.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.82 87.64 2.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.724 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 123.05 85.67 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 163.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.52 69.33 7.75 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.65 2.234 . . . . 0.0 111.428 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -159.05 56.04 0.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.216 1.406 . . . . 0.0 108.527 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.82 -55.6 4.75 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.856 0.741 . . . . 0.0 113.545 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 m -94.37 66.3 3.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.424 0.689 . . . . 0.0 112.567 -161.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.67 118.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.047 0.539 . . . . 0.0 110.294 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.48 121.21 32.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.0 110.01 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.14 147.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.93 66.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.58 157.57 37.75 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.249 1.42 . . . . 0.0 110.315 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.12 116.7 11.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.742 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.03 159.84 27.47 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 118.722 0.692 . . . . 0.0 114.566 -170.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.9 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.264 1.826 . . . . 0.0 109.535 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -154.72 -75.84 0.11 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.301 1.441 . . . . 0.0 108.222 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -55.1 -48.59 73.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.0 69.38 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.986 0.515 . . . . 0.0 111.797 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.08 -66.31 0.56 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.4 t -44.98 -46.1 10.94 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.041 1.737 . . . . 0.0 112.77 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.73 -44.05 94.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.395 0.543 . . . . 0.0 111.891 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.29 -23.59 51.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.766 0.826 . . . . 0.0 111.354 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.44 -61.55 1.73 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.226 -0.921 . . . . 0.0 110.857 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.36 -36.91 79.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.875 0.87 . . . . 0.0 111.146 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -36.96 -49.59 0.83 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 165.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.81 -64.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.242 0.617 . . . . 0.0 110.056 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -51.57 62.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.831 0.852 . . . . 0.0 111.476 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -77.63 -33.14 53.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.041 0.936 . . . . 0.0 111.998 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.78 85.94 0.42 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.413 1.006 . . . . 0.0 110.686 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.66 156.23 66.19 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.965 2.443 . . . . 0.0 111.299 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.77 172.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.018 3.145 . . . . 0.0 111.715 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.01 27.76 1.53 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.162 0.985 . . . . 0.0 111.875 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.18 28.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.902 1.281 . . . . 0.0 109.445 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 81.64 3.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.45 122.41 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.56 -56.79 4.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -168.31 142.8 3.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.631 1.173 . . . . 0.0 108.667 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.49 100.24 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.76 75.01 4.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -78.71 160.38 27.5 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -135.46 109.43 8.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.734 1.614 . . . . 0.0 109.591 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 119.55 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -134.42 179.49 6.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.798 1.239 . . . . 0.0 110.461 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -104.82 135.92 45.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.128 0.971 . . . . 0.0 110.03 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -52.17 138.98 24.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.065 2.146 . . . . 0.0 112.746 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -79.33 -48.83 13.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.48 179.5 27.16 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.73 112.79 20.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.69 1.196 . . . . 0.0 107.905 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -70.05 137.79 51.56 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -68.17 90.29 0.33 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.664 0.786 . . . . 0.0 110.212 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 70.18 -164.93 0.16 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.229 1.412 . . . . 0.0 109.713 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.7 96.82 3.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.993 0.917 . . . . 0.0 108.856 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -121.56 163.28 19.15 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.483 0.713 . . . . 0.0 109.836 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.94 148.64 33.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.847 1.259 . . . . 0.0 111.73 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.28 155.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.3 t -158.45 176.11 12.85 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.457 1.103 . . . . 0.0 108.817 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.4 mtp 58.13 52.82 7.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 111.06 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.21 144.67 28.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.511 0.724 . . . . 0.0 109.892 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -76.35 -54.28 6.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 111.257 -167.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 75.7 m95 34.2 50.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.5 1.92 . . . . 0.0 113.059 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.7 p -97.12 76.89 2.68 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.945 1.298 . . . . 0.0 107.853 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -80.16 59.07 3.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.743 1.217 . . . . 0.0 111.154 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.7 p -95.51 153.86 17.49 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.378 1.471 . . . . 0.0 109.551 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.2 169.47 17.55 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.733 1.213 . . . . 0.0 109.701 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 t 58.21 69.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.466 1.506 . . . . 0.0 109.745 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -75.01 -61.58 1.84 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.66 0.784 . . . . 0.0 109.917 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.98 133.35 55.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.681 1.192 . . . . 0.0 108.356 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.9 ttm -94.13 -98.54 0.15 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 52.16 157.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.576 3.151 . . . . 0.0 117.15 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.28 168.26 12.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.788 0.835 . . . . 0.0 111.483 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -96.52 97.33 9.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.824 1.25 . . . . 0.0 109.996 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 ttp -62.93 152.33 36.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -149.92 123.73 9.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.338 1.055 . . . . 0.0 108.75 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.48 117.01 22.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.142 0.977 . . . . 0.0 110.67 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -91.37 92.74 8.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.312 1.445 . . . . 0.0 107.913 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -88.76 112.13 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -172.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.52 149.65 21.96 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.173 0.589 . . . . 0.0 111.417 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.92 -153.87 20.51 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.854 1.216 . . . . 0.0 111.855 166.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.47 14.93 1.41 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.264 1.026 . . . . 0.0 111.662 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.3 m -74.51 21.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.346 1.458 . . . . 0.0 112.914 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -97.89 60.03 1.47 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.94 0.876 . . . . 0.0 110.707 -159.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.31 61.24 0.98 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.392 1.472 . . . . 0.0 111.087 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.27 101.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 108.709 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.54 -62.59 3.81 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.274 0.94 . . . . 0.0 111.123 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -64.14 172.85 2.19 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.364 1.066 . . . . 0.0 110.772 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 76.11 -60.57 0.48 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.601 1.96 . . . . 0.0 109.93 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -74.08 -46.52 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.526 0.73 . . . . 0.0 109.555 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -54.52 -51.18 65.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.518 -0.739 . . . . 0.0 111.116 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.43 -20.84 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.095 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -60.15 4.33 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.572 0.624 . . . . 0.0 109.335 169.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -46.15 -52.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.791 0.836 . . . . 0.0 111.841 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -69.59 -46.97 65.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.436 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.34 -52.44 37.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.411 0.55 . . . . 0.0 112.148 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.8 -40.4 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.459 1.504 . . . . 0.0 110.733 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -41.59 93.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.379 0.536 . . . . 0.0 111.731 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.93 11.04 21.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.817 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.16 56.02 24.53 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.701 0.667 . . . . 0.0 112.164 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.84 139.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.436 1.494 . . . . 0.0 108.791 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -108.94 169.6 8.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.382 1.473 . . . . 0.0 107.634 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.81 -138.76 9.14 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -175.46 141.58 0.53 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 117.69 0.745 . . . . 0.0 111.099 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.6 87.19 2.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.253 1.421 . . . . 0.0 110.165 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -92.68 110.07 21.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.269 0.628 . . . . 0.0 110.222 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.07 96.94 10.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.718 1.607 . . . . 0.0 109.234 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -77.89 110.81 14.33 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.07 79.18 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.442 2.761 . . . . 0.0 112.123 -161.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -142.09 -75.39 0.29 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.263 1.825 . . . . 0.0 106.428 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -168.87 35.93 0.2 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.673 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -137.3 103.82 5.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.257 1.023 . . . . 0.0 109.943 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.56 111.08 32.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -91.73 117.22 29.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.467 1.107 . . . . 0.0 109.576 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.27 104.75 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 110.054 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.3 t -79.86 130.26 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.29 124.67 16.6 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.244 1.018 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -108.58 104.66 14.02 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 109.074 -171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.76 159.63 27.96 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -71.52 -98.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.685 1.194 . . . . 0.0 109.656 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -159.65 -53.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.35 1.06 . . . . 0.0 109.486 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -44.3 -42.48 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.27 1.428 . . . . 0.0 110.385 162.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.51 -29.48 18.92 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.514 1.126 . . . . 0.0 112.248 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.08 -58.33 8.9 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 119.045 0.839 . . . . 0.0 109.89 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 p -43.48 -44.31 5.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.39 1.476 . . . . 0.0 112.866 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.58 -33.38 74.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.952 0.901 . . . . 0.0 112.285 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.62 -53.14 7.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.647 0.779 . . . . 0.0 110.324 169.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -52.9 61.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 110.454 -170.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.16 -36.46 83.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.174 1.389 . . . . 0.0 112.15 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.9 -50.34 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.605 169.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.97 -52.55 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 123.201 0.313 . . . . 0.0 110.592 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -49.48 77.32 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.339 0.518 . . . . 0.0 111.129 -174.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.9 -44.16 81.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.096 1.358 . . . . 0.0 110.914 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.63 82.3 0.3 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.514 1.53 . . . . 0.0 109.649 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.17 164.02 26.87 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.737 2.958 . . . . 0.0 111.412 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.58 148.35 72.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.476 2.117 . . . . 0.0 109.501 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.13 49.72 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.475 0.71 . . . . 0.0 110.874 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.23 167.47 29.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.624 1.17 . . . . 0.0 109.238 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.9 77.45 2.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.697 0.799 . . . . 0.0 110.108 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.63 122.65 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.176 0.99 . . . . 0.0 109.456 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.62 -59.35 2.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -169.94 135.78 1.44 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.372 0.669 . . . . 0.0 110.152 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.59 96.87 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -87.13 71.77 10.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.37 148.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.713 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -151.87 103.01 2.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 146.85 52.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.473 0.709 . . . . 0.0 110.579 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -134.19 -174.1 3.46 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 110.383 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.39 25.58 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.099 1.36 . . . . 0.0 109.047 170.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -76.9 144.42 38.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.004 0.922 . . . . 0.0 111.718 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -83.96 -57.75 3.07 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -152.53 172.18 31.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.72 115.77 21.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.359 1.064 . . . . 0.0 108.733 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -68.63 -38.18 80.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.727 1.211 . . . . 0.0 110.506 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 56.86 62.04 2.4 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.81 1.644 . . . . 0.0 112.412 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 t70 157.2 86.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.099 2.559 . . . . 0.0 108.438 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -73.99 91.59 2.05 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -125.84 154.53 42.53 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 111.292 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 120.79 36.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.985 0.914 . . . . 0.0 109.819 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 9.4 m 66.91 179.56 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.147 1.379 . . . . 0.0 111.984 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptp -70.95 102.61 2.44 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.287 0.635 . . . . 0.0 110.318 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -119.99 -61.91 1.54 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.981 1.312 . . . . 0.0 108.851 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 145.29 37.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.474 1.11 . . . . 0.0 109.379 173.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -90.53 59.99 4.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.9 0.88 . . . . 0.0 109.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 t -129.9 151.87 49.99 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.156 1.382 . . . . 0.0 109.613 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -161.18 155.23 22.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.949 1.3 . . . . 0.0 109.113 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -131.23 173.07 11.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.166 1.386 . . . . 0.0 109.639 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.4 152.58 47.32 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.095 1.358 . . . . 0.0 109.132 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -159.8 138.09 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -173.05 27.38 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.571 0.748 . . . . 0.0 112.717 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -87.52 41.76 1.0 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.434 -0.791 . . . . 0.0 112.21 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 66.0 134.66 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.412 2.285 . . . . 0.0 113.763 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.08 146.2 36.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.353 1.061 . . . . 0.0 110.631 -173.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -173.31 3.37 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.597 1.559 . . . . 0.0 111.759 -168.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -111.99 132.59 54.69 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.067 0.947 . . . . 0.0 111.287 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.0 ttp -82.5 164.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 156.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -158.53 82.99 0.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.607 1.163 . . . . 0.0 108.239 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.59 105.89 17.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.726 0.81 . . . . 0.0 109.714 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.81 9.67 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.36 114.62 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -166.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.13 140.36 38.42 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.295 1.438 . . . . 0.0 110.87 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.17 -156.39 23.34 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.998 1.285 . . . . 0.0 111.355 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.93 15.68 0.84 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.523 0.729 . . . . 0.0 111.777 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -57.71 -30.37 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.896 0.878 . . . . 0.0 109.954 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.78 126.07 28.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 162.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.52 26.52 25.04 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.968 0.794 . . . . 0.0 111.623 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.37 151.66 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.044 1.338 . . . . 0.0 107.898 171.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.09 -69.02 1.4 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.027 0.823 . . . . 0.0 111.687 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 t80 52.79 -116.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 116.942 -1.504 . . . . 0.0 109.717 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 35.92 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.23 2.612 . . . . 0.0 114.423 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -33.03 -47.92 0.19 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.417 1.887 . . . . 0.0 112.254 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.23 -43.68 78.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.41 0.684 . . . . 0.0 111.97 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.24 -36.71 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 C-N-CA 123.53 0.732 . . . . 0.0 109.975 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -46.79 87.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.131 -0.937 . . . . 0.0 109.793 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mm -38.91 -56.47 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -174.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -67.92 -48.19 66.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.418 1.008 . . . . 0.0 111.115 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.06 -64.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.011 0.924 . . . . 0.0 111.603 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.37 -51.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 127.841 2.456 . . . . 0.0 110.621 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -42.28 62.31 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.266 0.626 . . . . 0.0 110.811 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.0 21.58 12.51 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.359 1.464 . . . . 0.0 112.371 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.12 2.93 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.146 0.879 . . . . 0.0 112.863 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 mm -119.39 142.71 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.768 1.227 . . . . 0.0 109.777 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 175.56 5.46 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.386 1.474 . . . . 0.0 108.453 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.47 -148.0 19.61 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -173.87 140.46 0.74 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 117.652 0.726 . . . . 0.0 111.173 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.34 88.03 2.82 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 124.631 1.172 . . . . 0.0 110.322 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.44 107.73 20.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.519 0.728 . . . . 0.0 110.694 -166.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.69 119.6 20.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.767 172.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.37 97.37 1.59 Allowed Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -64.31 138.51 61.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.688 1.592 . . . . 0.0 110.193 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t0 57.49 59.46 3.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.498 1.119 . . . . 0.0 109.434 -164.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.44 -140.16 3.96 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.4 p -124.1 156.46 36.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.76 1.624 . . . . 0.0 109.922 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.84 105.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 123.534 0.733 . . . . 0.0 109.512 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -93.77 134.1 36.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.482 0.713 . . . . 0.0 111.103 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.21 116.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.623 1.169 . . . . 0.0 109.418 -171.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.6 141.82 16.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.84 123.38 17.22 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.899 1.279 . . . . 0.0 108.002 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.83 90.17 3.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.546 0.738 . . . . 0.0 109.214 -162.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 162.86 22.92 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 122.086 0.826 . . . . 0.0 114.672 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.36 163.03 28.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.872 1.269 . . . . 0.0 108.01 163.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.72 -23.58 42.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -64.4 -50.01 69.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -9.83 58.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.936 0.894 . . . . 0.0 112.512 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.92 -60.96 2.01 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 119.325 0.966 . . . . 0.0 109.011 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -44.59 -44.67 9.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.566 1.146 . . . . 0.0 112.803 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -49.9 -51.6 39.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.208 1.003 . . . . 0.0 111.91 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.32 -42.48 45.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.435 1.494 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -55.48 -58.26 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.539 1.136 . . . . 0.0 110.388 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.64 -33.31 68.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.682 1.193 . . . . 0.0 111.394 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -40.08 -48.23 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.241 1.417 . . . . 0.0 111.023 165.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.57 -58.76 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.029 0.532 . . . . 0.0 111.065 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -59.52 -39.19 83.07 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.343 0.519 . . . . 0.0 111.088 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -72.93 -44.43 61.2 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.249 1.42 . . . . 0.0 111.094 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 80.91 0.28 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.069 1.318 . . . . 0.0 110.151 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -62.44 159.42 36.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.923 2.415 . . . . 0.0 111.128 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.56 156.08 54.51 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.26 2.64 . . . . 0.0 110.811 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.48 42.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.74 . . . . 0.0 111.25 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.01 167.62 28.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.73 1.612 . . . . 0.0 109.357 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.23 82.13 4.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.663 0.785 . . . . 0.0 109.015 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.69 127.52 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 109.415 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -90.07 -51.93 5.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.539 1.136 . . . . 0.0 109.517 -174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -163.1 74.6 0.37 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 112.079 -173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.39 88.08 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.657 0.741 . . . . 0.0 110.44 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.28 80.23 3.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.763 1.225 . . . . 0.0 107.791 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.29 162.39 29.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.029 0.443 . . . . 0.0 111.391 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.1 m -140.82 134.89 30.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.14 0.976 . . . . 0.0 109.301 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.71 138.37 31.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 m -137.76 177.84 7.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 111.724 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -82.39 152.2 26.29 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 124.602 1.161 . . . . 0.0 111.058 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 117.48 8.44 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 110.281 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -99.23 -55.59 2.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.969 1.308 . . . . 0.0 108.531 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.43 38.86 37.27 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 123.927 0.775 . . . . 0.0 113.255 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -85.14 -30.55 23.9 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -81.98 131.99 35.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.892 0.769 . . . . 0.0 110.586 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.68 119.44 33.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.183 1.793 . . . . 0.0 107.467 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.4 t70 64.41 171.27 0.19 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.64 1.176 . . . . 0.0 111.385 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.39 87.53 2.68 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.436 1.495 . . . . 0.0 108.357 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -105.74 152.6 22.97 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 111.128 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.15 130.15 55.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.255 1.022 . . . . 0.0 109.986 -168.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.62 1.568 . . . . 0.0 107.786 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.105 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 51.8 m -148.47 151.39 35.1 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.416 1.086 . . . . 0.0 109.088 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mmm -82.17 66.27 7.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.809 0.844 . . . . 0.0 110.102 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -78.79 166.82 22.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.04 . . . . 0.0 109.96 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mptt 69.72 118.61 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.786 2.034 . . . . 0.0 110.284 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -176.4 143.82 0.51 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.816 1.246 . . . . 0.0 108.555 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -127.36 153.7 45.88 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.248 1.419 . . . . 0.0 109.242 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.32 -50.45 69.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.239 0.616 . . . . 0.0 110.419 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -158.94 163.86 36.14 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.593 1.157 . . . . 0.0 108.551 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -161.05 154.66 22.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.714 1.205 . . . . 0.0 108.145 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.11 154.32 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.272 0.629 . . . . 0.0 110.056 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.5 t80 72.98 59.15 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.208 1.803 . . . . 0.0 110.347 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.38 131.12 47.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 163.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -64.66 -39.76 94.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.247 0.619 . . . . 0.0 110.829 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.64 126.32 27.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.348 0.659 . . . . 0.0 112.219 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 168.4 14.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.437 1.095 . . . . 0.0 111.744 -164.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -97.78 124.79 42.29 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 111.58 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -91.56 153.82 19.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -135.16 98.65 4.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.584 1.554 . . . . 0.0 109.374 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.46 109.67 21.82 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.332 0.653 . . . . 0.0 110.274 177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -92.26 91.22 7.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.304 1.041 . . . . 0.0 108.258 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.11 112.23 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.074 0.55 . . . . 0.0 109.63 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.11 146.4 25.08 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.476 1.511 . . . . 0.0 109.87 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.53 -175.62 20.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.213 0.911 . . . . 0.0 111.59 173.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 tp -82.81 28.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 0.0 110.576 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.22 -28.11 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.019 0.927 . . . . 0.0 110.939 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.74 131.84 14.6 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 109.889 162.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 -55.55 2.43 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.441 -0.644 . . . . 0.0 112.169 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 m -71.78 -178.98 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 117.936 0.868 . . . . 0.0 111.767 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.78 85.9 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.926 1.251 . . . . 0.0 111.497 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -156.48 174.62 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.923 1.289 . . . . 0.0 109.072 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 76.12 -66.31 0.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.115 1.766 . . . . 0.0 109.752 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -53.84 -45.68 70.98 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.8 -42.68 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.088 0.955 . . . . 0.0 111.604 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.88 -32.77 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 110.573 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -56.94 15.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 110.316 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -46.68 -56.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.366 0.666 . . . . 0.0 112.12 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -65.88 -47.85 73.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.033 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.78 -65.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.554 0.741 . . . . 0.0 111.415 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.13 -46.09 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 126.619 1.967 . . . . 0.0 111.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -60.93 -39.5 89.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.162 0.585 . . . . 0.0 111.116 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.85 20.36 7.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.787 0.835 . . . . 0.0 112.834 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.84 53.23 45.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.299 0.952 . . . . 0.0 113.287 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mm -108.94 135.67 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.232 1.413 . . . . 0.0 108.408 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.38 178.63 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.673 1.189 . . . . 0.0 109.126 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.3 -142.43 10.02 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 119.538 1.063 . . . . 0.0 111.917 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -178.64 141.46 0.21 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.507 1.523 . . . . 0.0 110.137 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.42 87.69 2.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.932 0.893 . . . . 0.0 110.672 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -93.78 105.01 17.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.441 0.639 . . . . 0.0 110.994 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.12 96.5 7.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.37 117.61 69.03 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.53 71.69 6.34 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.578 2.852 . . . . 0.0 111.381 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.23 41.24 0.81 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.233 1.413 . . . . 0.0 108.537 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.56 33.64 67.36 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.202 0.906 . . . . 0.0 112.795 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 m -145.78 90.66 2.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.763 0.782 . . . . 0.0 110.035 -173.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -98.65 121.7 49.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.533 0.733 . . . . 0.0 109.092 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.52 143.64 28.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.85 130.21 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.1 141.88 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 158.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.59 122.26 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 109.448 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -124.8 116.53 22.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.222 1.009 . . . . 0.0 111.483 -156.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.31 -171.1 44.09 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.34 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.87 164.0 10.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.384 1.073 . . . . 0.0 110.182 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -81.89 -24.77 35.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -63.39 -52.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.22 -21.38 63.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.4 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.34 -61.44 1.84 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.0 p -47.41 -46.27 26.15 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.904 0.882 . . . . 0.0 112.498 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -51.78 -48.96 63.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.859 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.37 -54.34 21.41 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 110.711 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.9 59.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.219 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.72 -36.56 80.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.642 1.577 . . . . 0.0 112.157 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.71 -43.43 17.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.132 1.373 . . . . 0.0 111.644 171.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.02 -59.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 110.506 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.74 -41.46 97.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.077 0.399 . . . . 0.0 111.7 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.24 -45.97 68.47 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.988 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.38 78.84 0.25 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.742 1.163 . . . . 0.0 110.874 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 157.75 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.023 2.482 . . . . 0.0 110.516 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 165.09 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.388 2.725 . . . . 0.0 111.105 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.77 42.94 0.95 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.611 0.764 . . . . 0.0 111.268 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.48 172.12 14.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.046 0.938 . . . . 0.0 110.061 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.82 86.5 0.51 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.335 1.054 . . . . 0.0 109.644 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.48 80.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.024 1.33 . . . . 0.0 109.334 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -38.74 -65.28 0.37 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.491 2.316 . . . . 0.0 111.342 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -151.56 147.43 26.78 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.389 0.676 . . . . 0.0 109.835 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.45 84.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.81 68.53 10.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -73.77 162.91 28.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -147.47 133.39 19.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.784 0.834 . . . . 0.0 109.202 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.89 135.89 34.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.819 1.248 . . . . 0.0 107.955 170.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 m -129.84 -177.55 4.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.455 1.102 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.05 166.83 13.2 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.836 0.855 . . . . 0.0 111.111 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -55.78 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.596 0.758 . . . . 0.0 110.589 166.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -100.31 -56.7 2.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.337 0.655 . . . . 0.0 110.313 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.24 135.57 3.75 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.42 100.45 9.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.774 1.229 . . . . 0.0 110.648 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -75.95 72.36 2.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.94 68.68 1.82 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.647 1.579 . . . . 0.0 112.993 -165.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 166.51 89.43 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 128.492 2.717 . . . . 0.0 106.056 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.75 83.9 6.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.0 158.81 22.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 123.482 0.489 . . . . 0.0 109.949 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.03 139.4 35.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.251 0.62 . . . . 0.0 110.309 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.161 -1.4 . . . . 0.0 109.333 166.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.5 m -58.58 -64.12 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.493 1.117 . . . . 0.0 111.569 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -129.59 28.66 5.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.64 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -104.93 125.23 50.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.864 1.266 . . . . 0.0 107.682 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -84.61 -179.96 7.25 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.102 0.961 . . . . 0.0 109.907 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 80.23 113.58 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.515 1.926 . . . . 0.0 111.245 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.5 t -70.11 133.23 46.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.952 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -65.65 -36.24 83.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.661 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m 69.3 91.77 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.713 1.605 . . . . 0.0 109.898 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 68.06 -165.14 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.125 1.77 . . . . 0.0 109.886 -170.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t 68.78 89.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.784 1.633 . . . . 0.0 109.412 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -93.04 -27.26 17.09 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.421 1.488 . . . . 0.0 111.918 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.52 121.85 32.13 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.028 0.931 . . . . 0.0 109.435 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.46 -90.1 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.164 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.82 140.23 58.85 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.356 0.662 . . . . 0.0 111.803 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 -179.44 4.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.227 1.011 . . . . 0.0 111.734 -171.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -106.38 130.8 54.14 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.303 0.641 . . . . 0.0 112.667 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 65.3 ttp -69.12 156.9 37.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 154.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.05 87.37 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 107.18 19.13 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -85.97 102.49 13.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 t -96.78 121.82 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 122.912 0.485 . . . . 0.0 110.424 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.67 153.13 20.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 -175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.46 -155.51 17.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.463 1.506 . . . . 0.0 110.695 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 16.86 0.82 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.54 0.736 . . . . 0.0 111.563 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.4 -20.59 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.936 0.895 . . . . 0.0 111.57 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.93 138.65 50.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.384 0.673 . . . . 0.0 109.325 167.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.29 -64.23 4.2 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.8 157.6 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.343 1.057 . . . . 0.0 108.715 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.16 -96.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.514 1.054 . . . . 0.0 112.728 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 t80 63.64 -62.06 0.15 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.4 2.28 . . . . 0.0 112.931 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -33.18 -44.59 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.44 2.696 . . . . 0.0 112.879 167.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -69.38 -45.77 68.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.361 0.664 . . . . 0.0 109.869 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -56.25 -46.22 79.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.44 0.696 . . . . 0.0 110.927 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.28 -37.38 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.924 0.49 . . . . 0.0 110.485 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -64.31 -49.98 69.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.261 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mm -45.42 -56.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.661 1.118 . . . . 0.0 111.515 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -64.36 -48.33 75.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.98 -51.06 59.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.63 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.391 1.476 . . . . 0.0 109.269 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -55.23 -38.57 68.65 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.496 0.718 . . . . 0.0 110.883 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.33 2.81 55.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.266 1.426 . . . . 0.0 113.161 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 62.52 4.95 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.883 0.765 . . . . 0.0 111.68 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.97 143.91 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 125.517 1.527 . . . . 0.0 108.597 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -101.84 170.01 8.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.771 1.228 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.13 -143.58 11.07 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.853 0.752 . . . . 0.0 112.344 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -174.15 142.56 0.83 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.568 1.147 . . . . 0.0 108.953 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.74 79.03 1.88 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -93.5 96.34 9.82 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.792 -164.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.78 93.89 9.62 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 126.292 1.837 . . . . 0.0 110.182 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.03 110.62 6.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.58 64.78 8.66 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.208 2.606 . . . . 0.0 111.567 -161.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -167.36 38.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.87 1.668 . . . . 0.0 109.569 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.27 -105.86 0.28 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -121.14 144.53 48.52 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.618 1.567 . . . . 0.0 110.568 -165.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.63 125.21 41.85 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.717 0.807 . . . . 0.0 110.397 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.08 116.32 27.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.0 t -112.81 123.19 68.23 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.062 0 C-N-CA 124.065 0.946 . . . . 0.0 108.682 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 m -118.0 69.3 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.5 0.72 . . . . 0.0 111.406 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.49 128.45 35.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.948 0.899 . . . . 0.0 111.293 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.65 107.6 15.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.588 0.755 . . . . 0.0 111.085 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.99 172.68 34.58 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.634 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -67.42 168.0 11.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.015 1.326 . . . . 0.0 109.026 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.99 -18.56 53.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.935 0.494 . . . . 0.0 112.093 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.71 -29.12 69.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.21 1.004 . . . . 0.0 110.683 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -2.04 15.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.114 1.366 . . . . 0.0 112.073 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.21 -66.31 0.6 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -41.2 -45.43 2.85 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 125.313 1.445 . . . . 0.0 112.129 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -54.17 -52.72 60.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.59 0.756 . . . . 0.0 111.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.12 -24.08 61.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.825 1.65 . . . . 0.0 111.947 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.61 -61.54 1.85 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.991 0.916 . . . . 0.0 111.103 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -47.15 -45.51 22.64 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.584 1.954 . . . . 0.0 111.446 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -29.76 -56.99 0.17 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.022 1.729 . . . . 0.0 112.022 164.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.02 -71.41 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 122.761 0.424 . . . . 0.0 110.876 -167.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -48.49 -44.64 36.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.137 0.975 . . . . 0.0 112.319 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -103.42 53.17 0.76 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.239 1.016 . . . . 0.0 110.57 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.71 153.17 24.65 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.02 114.0 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.775 2.983 . . . . 0.0 110.991 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.75 145.96 47.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.221 1.947 . . . . 0.0 110.838 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.01 -21.37 62.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.46 0.704 . . . . 0.0 111.777 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.1 172.15 10.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.207 1.403 . . . . 0.0 110.828 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.6 73.44 3.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.96 121.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.539 1.136 . . . . 0.0 109.096 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.97 -60.18 2.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.32 152.71 6.14 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 122.905 0.482 . . . . 0.0 110.895 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.26 97.95 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.245 1.018 . . . . 0.0 109.03 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.02 75.73 7.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -80.45 163.05 24.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.532 0.682 . . . . 0.0 112.197 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 123.52 18.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.721 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 123.86 25.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 164.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -128.72 174.31 9.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.945 0.898 . . . . 0.0 110.119 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.64 141.39 28.99 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.56 139.25 58.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.467 1.507 . . . . 0.0 111.393 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.84 -49.32 13.12 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.223 1.009 . . . . 0.0 108.931 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.43 175.56 41.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.39 106.13 17.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.43 134.04 55.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.126 0.97 . . . . 0.0 108.643 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.72 96.68 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.279 0.632 . . . . 0.0 109.61 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 71.22 -170.43 0.15 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.798 1.639 . . . . 0.0 110.668 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.01 92.11 2.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.437 1.095 . . . . 0.0 108.466 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -121.88 164.41 17.58 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.719 0.408 . . . . 0.0 109.959 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -99.01 139.34 34.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.474 0.71 . . . . 0.0 110.508 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.827 -1.559 . . . . 0.0 111.101 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 112.266 -0.334 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.6 t 57.12 37.27 28.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.161 1.384 . . . . 0.0 112.116 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.46 69.41 5.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.317 1.047 . . . . 0.0 108.902 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -125.14 149.81 47.52 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.147 0.979 . . . . 0.0 111.382 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -132.51 71.76 1.48 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.197 1.399 . . . . 0.0 107.441 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -157.5 60.4 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 p -144.67 -73.78 0.25 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.619 0.768 . . . . 0.0 110.696 -169.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t70 54.42 76.07 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.272 1.829 . . . . 0.0 111.138 -172.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 p -81.67 57.69 3.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.701 0.8 . . . . 0.0 109.105 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.57 91.1 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.484 1.113 . . . . 0.0 108.184 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -157.2 139.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.092 0.957 . . . . 0.0 109.376 175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 71.42 53.91 0.22 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.183 1.793 . . . . 0.0 113.365 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.08 125.06 21.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.658 0.783 . . . . 0.0 110.514 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.0 mtp -169.91 165.64 9.59 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.793 1.237 . . . . 0.0 109.935 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.07 164.89 4.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.719 1.608 . . . . 0.0 109.624 171.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 163.54 13.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.966 0.906 . . . . 0.0 112.309 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -84.62 114.36 21.94 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.495 0.664 . . . . 0.0 110.182 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.0 ptm -88.71 102.31 14.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.743 0.817 . . . . 0.0 110.149 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.62 108.01 18.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.908 1.283 . . . . 0.0 108.372 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.77 108.57 18.03 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.796 1.239 . . . . 0.0 110.382 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.7 116.81 29.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.588 1.955 . . . . 0.0 107.348 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.37 120.97 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.29 150.8 26.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.353 1.061 . . . . 0.0 110.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.65 -154.31 21.24 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.702 1.144 . . . . 0.0 110.743 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.36 17.81 3.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.365 0.602 . . . . 0.0 110.211 166.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.43 -36.89 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.664 1.986 . . . . 0.0 112.14 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -75.26 80.13 2.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.13 -67.04 0.05 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.95 38.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.883 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.73 -93.34 0.12 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.902 1.239 . . . . 0.0 112.499 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.2 t80 70.78 -38.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.511 2.324 . . . . 0.0 114.128 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -42.87 -44.83 4.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.297 1.439 . . . . 0.0 112.531 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -69.37 -48.83 60.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.079 0.552 . . . . 0.0 110.537 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -51.77 -43.37 62.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.494 1.118 . . . . 0.0 111.707 174.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.6 -39.7 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -45.95 79.66 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 117.32 -1.324 . . . . 0.0 112.046 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.3 mm -48.14 -54.58 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.123 1.783 . . . . 0.0 111.922 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -66.75 -47.21 72.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.132 -0.461 . . . . 0.0 109.967 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.59 -52.09 24.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.426 0.69 . . . . 0.0 112.717 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.87 -43.17 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 126.434 1.894 . . . . 0.0 110.099 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -63.61 -34.33 77.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.102 0.561 . . . . 0.0 111.791 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.2 18.67 20.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.252 . . . . 0.0 112.305 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.01 63.82 4.91 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.413 1.006 . . . . 0.0 113.512 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.14 146.51 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.757 1.623 . . . . 0.0 108.659 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.79 166.93 10.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.76 1.224 . . . . 0.0 108.403 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.79 -152.97 24.11 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.786 0.721 . . . . 0.0 112.717 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -166.28 141.09 4.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.225 1.01 . . . . 0.0 109.132 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.89 91.11 3.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.657 1.183 . . . . 0.0 108.962 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -85.94 80.91 8.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -102.91 59.25 0.78 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.456 1.102 . . . . 0.0 108.932 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.4 mt -71.52 108.81 4.36 Favored Pre-proline 0 C--N 1.34 0.188 0 C-N-CA 125.629 1.572 . . . . 0.0 108.43 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -79.71 64.07 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.845 3.03 . . . . 0.0 112.804 -163.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -173.01 54.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.903 2.081 . . . . 0.0 108.095 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 -109.3 0.33 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 m -133.09 160.53 36.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.801 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.34 95.54 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.44 134.47 42.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.595 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.8 t -106.35 133.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.26 78.05 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.19 166.86 16.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.715 1.206 . . . . 0.0 109.818 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.86 109.41 7.44 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 118.866 -0.588 . . . . 0.0 111.965 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.32 149.19 21.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.961 0.8 . . . . 0.0 113.794 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -57.48 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.405 2.282 . . . . 0.0 111.769 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -154.75 -71.16 0.13 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.04 1.736 . . . . 0.0 107.157 -165.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -51.66 -50.65 59.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 164.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.25 62.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.319 1.047 . . . . 0.0 111.949 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -67.07 -66.84 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -48.4 -36.21 14.25 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.956 1.703 . . . . 0.0 113.291 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -63.76 -50.39 69.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.75 0.705 . . . . 0.0 112.542 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.39 -22.85 60.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.707 0.685 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.22 -58.05 4.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.858 -0.526 . . . . 0.0 110.909 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.31 -31.91 73.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.37 0.668 . . . . 0.0 111.614 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -39.28 -54.2 1.85 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.078 1.351 . . . . 0.0 110.364 162.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.83 -53.0 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.032 0.533 . . . . 0.0 111.319 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.51 -38.42 91.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.297 0.499 . . . . 0.0 111.293 -168.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -76.05 -37.94 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.887 0.875 . . . . 0.0 111.482 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.15 74.58 0.24 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.319 0.961 . . . . 0.0 111.21 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.81 164.01 34.44 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.635 2.89 . . . . 0.0 111.688 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.97 128.03 11.18 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.218 2.612 . . . . 0.0 109.293 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.867 0.867 . . . . 0.0 110.058 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.99 74.38 0.43 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.459 0.704 . . . . 0.0 110.093 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 30.02 72.26 0.06 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.503 1.921 . . . . 0.0 110.877 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 90.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -50.72 -55.29 17.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.96 0.904 . . . . 0.0 110.098 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -170.47 140.56 1.81 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 171.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.09 84.37 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 165.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.67 76.25 7.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -71.73 160.12 33.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -150.39 95.56 2.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 141.26 57.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.739 0.816 . . . . 0.0 110.064 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -133.49 177.49 7.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.552 0.741 . . . . 0.0 111.456 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.03 124.02 34.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.051 1.74 . . . . 0.0 108.288 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -55.73 122.14 10.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.935 0.494 . . . . 0.0 112.017 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.65 -47.94 73.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.94 -157.02 10.11 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -89.03 107.45 19.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 109.358 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.75 73.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.05 137.04 8.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.944 1.698 . . . . 0.0 112.644 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 63.12 -165.57 0.24 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.392 1.077 . . . . 0.0 109.063 -173.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.75 82.81 1.22 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.98 162.81 13.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -171.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.11 134.06 55.14 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 111.072 -167.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.183 -1.389 . . . . 0.0 108.468 162.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.3 m -66.2 135.88 55.12 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.596 0.759 . . . . 0.0 110.435 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mtp -125.75 -80.45 0.61 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.285 1.034 . . . . 0.0 108.538 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -119.65 179.73 4.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.925 1.29 . . . . 0.0 109.776 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.3 163.73 32.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.63 1.172 . . . . 0.0 110.534 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 69.61 60.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.036 1.734 . . . . 0.0 110.507 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.1 t -77.23 69.82 3.55 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.244 1.018 . . . . 0.0 110.266 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.2 t0 66.94 164.41 0.2 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.003 2.121 . . . . 0.0 112.383 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.3 m 65.26 78.87 0.27 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.335 1.454 . . . . 0.0 110.726 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -133.41 69.25 1.48 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.95 1.3 . . . . 0.0 107.596 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.24 150.14 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.419 1.087 . . . . 0.0 109.143 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -86.7 -66.27 0.92 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.959 0.904 . . . . 0.0 110.121 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.85 148.44 46.77 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.128 1.371 . . . . 0.0 109.387 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.5 mtp -75.39 -76.65 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp -131.93 155.3 48.17 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.522 1.129 . . . . 0.0 109.867 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -178.21 3.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.413 1.085 . . . . 0.0 111.393 -174.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -99.91 127.12 46.12 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.887 0.475 . . . . 0.0 110.773 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 ptm -97.9 96.62 8.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.141 0.972 . . . . 0.0 110.266 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -87.81 108.63 19.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.5 1.12 . . . . 0.0 108.587 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.74 109.15 14.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 110.721 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.25 100.37 12.94 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.433 1.093 . . . . 0.0 108.848 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 101.74 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.78 155.51 17.61 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.269 0.627 . . . . 0.0 111.758 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.95 -155.37 21.22 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.352 1.454 . . . . 0.0 111.581 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -81.6 28.99 0.38 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.996 0.918 . . . . 0.0 110.238 173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.2 m -76.13 -6.98 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.336 1.055 . . . . 0.0 112.717 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 164.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 164.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.87 -62.9 4.47 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -171.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -72.83 155.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.56 -83.11 0.33 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 122.949 0.309 . . . . 0.0 112.383 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 47.5 56.3 7.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.594 1.558 . . . . 0.0 111.519 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.97 -41.32 0.53 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.428 1.491 . . . . 0.0 108.729 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -72.39 -48.91 37.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.328 0.651 . . . . 0.0 110.848 171.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.17 -46.37 68.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.136 0.494 . . . . 0.0 111.114 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.19 -35.48 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.246 0.619 . . . . 0.0 110.359 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -47.15 78.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.058 0.943 . . . . 0.0 110.641 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.57 -56.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.62 1.1 . . . . 0.0 110.935 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -70.41 -40.78 73.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.281 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.94 -54.91 11.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.2 0.6 . . . . 0.0 111.634 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.89 -38.81 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.119 1.368 . . . . 0.0 111.349 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -59.44 -37.1 77.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.915 0.486 . . . . 0.0 111.137 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -98.13 19.06 14.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.772 0.829 . . . . 0.0 112.869 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 56.54 22.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.023 0.821 . . . . 0.0 113.204 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -104.49 143.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 125.387 1.475 . . . . 0.0 108.91 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -104.27 171.27 7.43 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.531 1.132 . . . . 0.0 108.549 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.49 -138.72 10.27 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.207 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -166.6 145.9 5.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.508 0.654 . . . . 0.0 112.358 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.58 85.7 2.37 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.907 1.683 . . . . 0.0 108.938 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -95.39 100.84 12.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.012 0.525 . . . . 0.0 110.351 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.64 116.23 8.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 170.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.2 mt -94.13 94.12 1.04 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.57 141.52 95.5 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.387 2.058 . . . . 0.0 111.024 -170.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.49 61.57 2.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.644 1.178 . . . . 0.0 109.634 -166.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.75 -126.67 1.0 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -129.25 149.2 51.15 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.035 1.734 . . . . 0.0 109.303 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.6 99.42 5.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.25 125.34 30.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.84 1.256 . . . . 0.0 108.362 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -112.95 125.3 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.8 77.87 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 161.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.32 162.14 20.18 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.036 1.334 . . . . 0.0 108.845 172.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -138.93 105.15 5.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.069 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.03 166.23 24.96 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 118.708 0.685 . . . . 0.0 112.911 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -67.8 173.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.36 1.064 . . . . 0.0 108.632 161.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.85 -31.19 63.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.2 -20.49 65.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.128 0.571 . . . . 0.0 112.287 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.68 -12.09 18.67 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.938 0.895 . . . . 0.0 111.781 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.94 -70.7 0.24 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 p -43.81 -34.81 1.68 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.028 1.331 . . . . 0.0 113.602 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -68.73 -56.47 8.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.85 0.86 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.45 -22.16 62.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.425 0.69 . . . . 0.0 111.175 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.5 -59.77 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.6 -0.687 . . . . 0.0 110.191 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -61.69 -32.09 72.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.718 0.69 . . . . 0.0 111.85 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -43.54 -51.45 6.79 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.415 1.486 . . . . 0.0 111.952 164.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -67.29 -53.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 C-N-CA 123.246 0.619 . . . . 0.0 110.519 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -41.78 93.76 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.893 0.315 . . . . 0.0 110.63 -172.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -70.39 -42.12 72.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.447 1.499 . . . . 0.0 111.497 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.2 78.08 0.24 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.355 1.455 . . . . 0.0 111.075 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.75 169.39 17.68 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 124.033 3.155 . . . . 0.0 112.126 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.59 162.14 38.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.03 2.486 . . . . 0.0 110.944 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.91 33.74 0.33 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.807 0.843 . . . . 0.0 111.852 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.94 174.16 13.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.398 1.079 . . . . 0.0 109.857 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.26 88.52 0.85 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.07 122.24 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.872 0.869 . . . . 0.0 109.218 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -75.24 -58.04 3.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -166.11 132.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.029 0.531 . . . . 0.0 110.112 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -87.25 86.17 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 162.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.53 75.61 9.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.95 151.57 33.63 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.633 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.6 m -151.18 95.61 2.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 0.0 109.349 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -60.9 152.79 26.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.427 1.491 . . . . 0.0 110.801 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 m -157.91 176.72 12.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.67 144.54 45.79 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -65.49 132.71 49.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.53 1.132 . . . . 0.0 112.401 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -69.23 -51.88 33.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 109.119 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.91 -178.16 36.5 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.61 111.9 23.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.978 1.311 . . . . 0.0 108.524 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -75.46 -17.97 59.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.843 0.857 . . . . 0.0 111.948 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 66.12 94.94 0.06 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.71 1.604 . . . . 0.0 111.181 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 68.85 155.75 0.13 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.393 1.877 . . . . 0.0 110.986 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -101.94 92.06 4.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -110.84 160.45 16.75 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -105.36 142.77 34.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.984 0.514 . . . . 0.0 111.644 -167.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.032 174.259 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.9 m -136.2 39.22 2.72 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.88 0.872 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.3 mtt -84.47 50.33 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.733 0.813 . . . . 0.0 110.916 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -88.21 69.37 9.17 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -95.31 -64.47 1.06 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.1 0.96 . . . . 0.0 109.868 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -140.43 154.34 46.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.163 1.785 . . . . 0.0 108.549 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 m -68.3 151.63 46.63 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.415 0.686 . . . . 0.0 110.589 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.57 121.8 14.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.66 0.784 . . . . 0.0 110.296 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -77.63 133.68 38.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -141.01 170.6 15.43 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.783 1.233 . . . . 0.0 109.254 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.6 116.38 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.7 -45.4 81.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.863 1.265 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.42 51.94 2.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.737 1.215 . . . . 0.0 110.659 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -54.3 41.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.0 110.065 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 pp -102.9 156.48 17.63 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.942 0.897 . . . . 0.0 110.118 172.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.59 144.09 48.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.237 1.415 . . . . 0.0 109.761 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -83.07 108.71 16.55 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.97 0.508 . . . . 0.0 111.131 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.7 ptm -93.41 94.06 8.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.494 0.664 . . . . 0.0 109.74 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.91 133.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.09 104.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -97.1 100.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.107 1.763 . . . . 0.0 109.207 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.55 127.13 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 110.226 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -102.66 155.04 18.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.941 1.297 . . . . 0.0 110.14 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.56 -168.85 19.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.003 1.287 . . . . 0.0 110.65 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -88.8 56.04 3.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.78 3.7 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.384 1.073 . . . . 0.0 112.372 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.89 152.99 25.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.76 -56.15 4.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -69.75 -179.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.593 0.757 . . . . 0.0 110.556 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.71 -97.19 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.269 0.938 . . . . 0.0 112.863 -171.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 64.0 -65.01 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.78 2.032 . . . . 0.0 113.078 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -48.5 -31.32 6.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.185 2.194 . . . . 0.0 113.177 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.29 -46.57 15.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.493 1.517 . . . . 0.0 110.851 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.78 -49.37 77.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.021 0.528 . . . . 0.0 111.341 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.02 -26.99 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.389 172.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.99 -56.07 15.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.905 0.882 . . . . 0.0 110.173 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.5 mm -43.83 -56.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 118.876 0.762 . . . . 0.0 111.029 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -64.62 -49.59 70.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.21 -65.06 0.63 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.515 0.726 . . . . 0.0 112.212 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.61 -50.97 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 126.097 1.759 . . . . 0.0 110.132 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -56.82 -41.39 77.72 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.385 0.674 . . . . 0.0 110.864 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.9 mt -93.93 15.36 16.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.399 1.48 . . . . 0.0 113.144 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.82 48.61 84.43 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.972 0.796 . . . . 0.0 113.123 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.08 143.2 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.394 1.478 . . . . 0.0 107.846 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -104.09 169.36 8.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.425 1.09 . . . . 0.0 108.282 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.82 -150.4 22.28 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 119.162 0.892 . . . . 0.0 112.886 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -170.89 140.76 1.65 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.836 1.254 . . . . 0.0 109.172 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.15 89.86 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.37 1.068 . . . . 0.0 110.288 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.11 98.19 7.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.261 0.624 . . . . 0.0 110.796 -165.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.63 115.03 16.02 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.51 170.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.68 104.51 10.43 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.99 141.68 65.36 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.058 2.505 . . . . 0.0 111.597 -163.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 63.98 60.03 1.05 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.809 1.644 . . . . 0.0 110.426 -171.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -129.49 1.51 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 p -120.87 163.44 18.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.627 1.571 . . . . 0.0 109.835 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -116.92 125.09 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.977 0.911 . . . . 0.0 110.77 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.54 145.46 30.27 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.929 0.492 . . . . 0.0 110.656 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.91 137.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 66.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.5 155.58 29.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.473 1.109 . . . . 0.0 109.94 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -142.86 106.24 4.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.921 -0.562 . . . . 0.0 109.888 -167.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.03 149.78 19.99 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.295 0.498 . . . . 0.0 113.912 -171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -63.06 163.88 9.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.757 0.823 . . . . 0.0 108.856 162.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -78.18 -34.24 49.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.464 0.706 . . . . 0.0 111.11 -171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -69.65 -9.04 52.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.979 0.912 . . . . 0.0 111.632 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.91 4.32 10.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.672 1.189 . . . . 0.0 111.907 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -71.62 -68.56 0.44 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.427 1.012 . . . . 0.0 109.619 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.2 p -44.98 -42.47 8.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.558 1.543 . . . . 0.0 112.957 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -53.42 -48.59 68.61 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.237 1.015 . . . . 0.0 111.05 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.44 -51.97 17.91 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -52.54 -57.06 11.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.467 0.576 . . . . 0.0 111.777 -170.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.48 -40.37 68.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.056 1.343 . . . . 0.0 112.456 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.9 -51.14 7.77 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.214 1.006 . . . . 0.0 110.681 169.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.48 -53.58 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.329 -173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -46.44 71.65 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.071 0.396 . . . . 0.0 111.56 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -71.87 -55.61 7.22 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.862 0.865 . . . . 0.0 110.49 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.32 97.87 2.11 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.295 -1.281 . . . . 0.0 110.561 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.74 145.23 80.53 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.496 2.131 . . . . 0.0 109.07 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -86.93 49.54 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.913 1.742 . . . . 0.0 114.498 -153.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 56.58 37.15 28.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.36 1.064 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.3 161.72 39.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.058 0.943 . . . . 0.0 109.238 -168.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -84.55 75.89 10.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.95 135.59 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.905 1.282 . . . . 0.0 110.817 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.96 -57.57 2.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.018 1.327 . . . . 0.0 108.319 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -166.72 137.76 3.33 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 122.878 0.471 . . . . 0.0 110.996 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.33 96.4 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 121.784 -0.572 . . . . 0.0 110.169 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.97 72.26 9.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.7 161.95 28.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.476 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.5 t -137.9 127.43 24.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.606 0.762 . . . . 0.0 110.037 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.58 131.37 42.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 167.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 m -128.21 -160.06 0.99 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.292 1.037 . . . . 0.0 110.02 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -120.83 152.81 37.93 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.634 1.973 . . . . 0.0 108.967 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -52.21 86.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.919 1.688 . . . . 0.0 111.641 166.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -100.75 -54.8 2.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.727 1.211 . . . . 0.0 110.468 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.56 133.96 5.83 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.1 92.22 8.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.428 1.091 . . . . 0.0 109.809 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -72.13 87.92 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.86 143.39 56.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.635 0.774 . . . . 0.0 110.54 -174.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 64.9 -170.27 0.19 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.845 1.258 . . . . 0.0 109.374 -166.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.41 100.75 2.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.84 158.06 26.38 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 122.965 0.506 . . . . 0.0 111.391 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.67 139.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.686 1.195 . . . . 0.0 110.121 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.94 -178.719 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.8 m -150.13 54.76 0.92 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.095 0.958 . . . . 0.0 109.371 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt -85.34 54.98 3.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 0.0 110.219 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -98.46 140.12 33.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.22 1.008 . . . . 0.0 109.105 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -167.32 64.75 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -84.54 56.27 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.088 0.955 . . . . 0.0 110.951 -170.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -137.92 134.24 34.74 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.777 1.631 . . . . 0.0 108.309 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.5 t0 63.2 178.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.286 1.434 . . . . 0.0 110.576 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.5 m 77.39 -40.39 0.34 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.089 1.756 . . . . 0.0 112.236 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.91 -168.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.579 1.951 . . . . 0.0 112.336 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.15 136.96 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.113 0.965 . . . . 0.0 108.849 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -172.73 -43.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.614 1.566 . . . . 0.0 109.826 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.82 130.2 24.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.832 2.053 . . . . 0.0 111.978 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 mmt -145.47 163.31 35.07 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.064 1.745 . . . . 0.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.255 0.3 OUTLIER 72.95 134.38 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.303 2.641 . . . . 0.0 111.843 175.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 165.38 18.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.926 0.89 . . . . 0.0 111.999 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -97.55 123.81 41.57 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 121.545 0.688 . . . . 0.0 112.092 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.9 ttp -67.9 154.79 40.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 150.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.8 106.94 2.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.39 116.94 28.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.299 1.04 . . . . 0.0 109.547 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 93.73 7.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.7 110.01 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.48 0.312 . . . . 0.0 110.646 -166.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -97.96 145.46 26.45 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.204 1.002 . . . . 0.0 110.823 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.52 -166.37 30.17 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 123.751 0.691 . . . . 0.0 111.973 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.84 15.74 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.523 0.729 . . . . 0.0 110.961 169.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.5 -15.44 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.114 1.366 . . . . 0.0 112.29 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -77.13 29.41 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.369 1.468 . . . . 0.0 113.737 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.82 24.13 0.17 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.153 1.359 . . . . 0.0 112.292 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.97 169.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.227 1.011 . . . . 0.0 108.582 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.87 33.35 2.15 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.663 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.48 45.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.031 1.415 . . . . 0.0 110.594 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -141.13 -45.88 0.39 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.897 2.479 . . . . 0.0 106.526 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -71.26 -44.67 64.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.097 0.959 . . . . 0.0 110.195 169.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.93 -55.62 28.6 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.941 -0.474 . . . . 0.0 111.752 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.21 -34.64 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 122.725 0.41 . . . . 0.0 111.32 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -58.66 -38.57 78.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.404 1.482 . . . . 0.0 112.809 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.45 -57.47 11.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.352 1.433 . . . . 0.0 110.487 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -64.03 -38.98 93.04 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.6 0.636 . . . . 0.0 110.679 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.85 11.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.064 0.545 . . . . 0.0 111.966 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.94 -36.42 77.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.498 0.719 . . . . 0.0 110.861 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -52.41 -43.93 65.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.282 1.033 . . . . 0.0 109.479 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.11 23.07 13.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.05 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.22 63.77 4.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.5 1.048 . . . . 0.0 112.999 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.41 138.12 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.221 1.409 . . . . 0.0 108.304 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -100.89 165.03 11.55 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.326 1.05 . . . . 0.0 108.463 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.41 -139.34 7.09 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -176.4 148.49 0.75 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.581 0.691 . . . . 0.0 110.669 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.46 78.73 1.14 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 109.502 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -90.22 86.32 6.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.946 0.879 . . . . 0.0 109.244 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.5 97.26 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.967 1.307 . . . . 0.0 109.945 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.6 mt -78.63 102.22 0.95 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 125.059 1.344 . . . . 0.0 107.582 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 146.84 79.77 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.501 2.134 . . . . 0.0 111.118 -164.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 55.28 53.35 10.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.476 1.11 . . . . 0.0 109.489 -167.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.3 -132.95 1.63 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -127.37 149.69 49.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.743 1.617 . . . . 0.0 109.94 -169.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.96 115.8 29.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 121.594 0.711 . . . . 0.0 109.419 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.97 103.49 16.0 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.34 1.456 . . . . 0.0 107.079 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.58 132.23 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.316 0.646 . . . . 0.0 109.833 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.56 145.83 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.58 119.39 4.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.359 0.527 . . . . 0.0 110.652 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -109.67 107.44 17.49 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.307 1.443 . . . . 0.0 110.865 -166.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.66 174.94 26.33 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-O 121.826 0.681 . . . . 0.0 113.011 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -72.64 173.25 9.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 160.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.97 -30.02 63.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -64.84 -17.86 64.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.426 0.691 . . . . 0.0 112.598 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.44 -2.98 10.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.411 1.085 . . . . 0.0 112.263 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -68.18 -62.32 1.45 Allowed 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -42.69 -42.84 3.63 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.737 1.615 . . . . 0.0 113.064 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -51.49 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.953 0.501 . . . . 0.0 111.454 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.05 -24.15 63.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.499 1.12 . . . . 0.0 111.639 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.96 -61.79 1.88 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 108.835 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.23 -25.7 65.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.266 1.426 . . . . 0.0 111.766 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -54.23 0.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.185 1.394 . . . . 0.0 110.776 159.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mt -71.21 -56.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.87 -48.76 80.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.454 0.302 . . . . 0.0 110.818 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -68.92 -42.34 76.94 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.811 1.245 . . . . 0.0 111.247 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.1 0.27 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.077 1.322 . . . . 0.0 110.02 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.75 163.37 38.64 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.631 2.887 . . . . 0.0 111.919 -173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.86 162.36 37.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.715 2.943 . . . . 0.0 111.204 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.67 42.23 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.848 0.859 . . . . 0.0 111.039 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.92 162.86 36.82 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.778 1.231 . . . . 0.0 109.54 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.02 83.72 2.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.389 1.075 . . . . 0.0 109.192 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.31 83.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.288 1.435 . . . . 0.0 109.914 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -41.0 -60.88 1.08 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.311 1.844 . . . . 0.0 111.37 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -162.62 133.63 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.091 0.244 . . . . 0.0 110.84 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.04 94.24 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 165.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.39 70.05 10.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -75.76 161.3 29.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.391 0.615 . . . . 0.0 111.494 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -143.03 97.55 3.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.63 1.172 . . . . 0.0 108.952 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -55.91 127.33 29.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.673 1.189 . . . . 0.0 109.188 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -134.93 -163.21 1.35 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.53 1.132 . . . . 0.0 109.679 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 151.59 47.17 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.547 0.739 . . . . 0.0 110.04 173.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -58.3 124.7 20.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.969 0.908 . . . . 0.0 112.001 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -73.76 -45.3 52.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.55 176.23 37.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.95 96.81 10.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.488 1.515 . . . . 0.0 109.505 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -56.06 -55.32 34.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.299 1.04 . . . . 0.0 111.099 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.61 61.22 3.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 112.107 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 155.75 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.723 2.809 . . . . 0.0 108.213 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.59 98.1 10.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 168.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -117.45 165.35 13.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.454 0.702 . . . . 0.0 109.308 176.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -114.84 144.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.575 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.314 -1.327 . . . . 0.0 108.756 150.512 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.115 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.0 m -144.4 102.73 3.88 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.109 0.963 . . . . 0.0 108.652 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -90.71 60.26 4.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.219 1.007 . . . . 0.0 109.656 -171.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.05 -173.34 3.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.0 109.828 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 57.83 76.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.302 1.441 . . . . 0.0 110.071 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -116.1 158.79 22.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.568 1.547 . . . . 0.0 109.204 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.9 m -125.98 140.39 52.66 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.378 1.471 . . . . 0.0 109.606 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -162.69 -178.25 6.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.434 1.094 . . . . 0.0 109.154 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p 43.72 51.88 6.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.326 1.851 . . . . 0.0 113.02 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -117.44 75.74 1.0 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 108.855 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -162.76 143.7 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.581 1.152 . . . . 0.0 108.643 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -76.68 -56.58 4.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.949 0.499 . . . . 0.0 109.964 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.51 117.83 30.06 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.073 1.349 . . . . 0.0 109.224 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -60.15 3.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.696 0.398 . . . . 0.0 110.243 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.66 146.7 40.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.672 0.789 . . . . 0.0 110.704 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 166.39 16.87 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.882 1.273 . . . . 0.0 111.695 -167.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -94.77 124.55 38.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.633 0.773 . . . . 0.0 111.773 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -90.52 151.93 21.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 160.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -135.39 102.64 5.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.45 1.1 . . . . 0.0 109.097 -177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.05 106.3 16.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.049 0.54 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 98.02 10.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.67 104.23 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -76.16 153.28 36.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.71 -155.51 16.23 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 123.735 0.683 . . . . 0.0 112.549 162.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.71 28.2 0.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.158 0.983 . . . . 0.0 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.87 -9.62 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.177 0.991 . . . . 0.0 113.064 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.66 164.93 18.15 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 162.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.69 3.77 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.05 142.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.35 52.73 4.77 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.434 0.54 . . . . 0.0 113.089 -165.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -87.6 51.08 2.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.466 0.706 . . . . 0.0 110.437 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -52.61 0.93 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.404 1.481 . . . . 0.0 107.238 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -47.72 -52.61 17.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.696 1.199 . . . . 0.0 110.711 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.88 -54.63 40.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.131 0.972 . . . . 0.0 111.436 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.2 -23.68 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.453 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -50.21 64.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.542 169.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.14 -53.3 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.814 1.188 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -70.7 -31.21 68.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.59 -64.18 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 167.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.6 -41.0 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.312 1.445 . . . . 0.0 112.309 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -49.1 78.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 111.279 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -87.05 14.57 7.26 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.83 57.75 17.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.179 0.895 . . . . 0.0 111.829 176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.1 mm -119.18 140.7 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.981 1.313 . . . . 0.0 109.196 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -109.95 165.2 11.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.069 1.347 . . . . 0.0 108.595 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.69 -134.14 5.5 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 118.477 0.581 . . . . 0.0 112.169 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.99 147.8 1.68 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 122.995 0.518 . . . . 0.0 111.646 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.32 84.49 2.63 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.954 1.302 . . . . 0.0 108.75 167.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.38 86.85 5.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.791 0.805 . . . . 0.0 109.544 -169.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.72 81.21 6.44 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 126.251 1.821 . . . . 0.0 109.869 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.4 mt -59.85 110.99 3.24 Favored Pre-proline 0 N--CA 1.454 -0.265 0 C-N-CA 125.363 1.465 . . . . 0.0 107.978 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.06 46.36 2.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.958 2.438 . . . . 0.0 112.945 -162.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -153.43 45.92 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.879 1.672 . . . . 0.0 107.676 167.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.07 -136.84 3.87 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 m -120.64 173.04 7.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.269 1.428 . . . . 0.0 110.266 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.62 122.39 45.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 122.965 0.506 . . . . 0.0 111.744 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -95.64 110.04 22.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.201 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -87.18 140.08 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.29 135.19 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 165.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.77 117.23 6.99 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.015 0.926 . . . . 0.0 110.101 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.69 111.4 24.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.129 0.972 . . . . 0.0 110.67 -171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.67 29.99 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -54.78 163.97 0.87 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 110.104 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.47 -44.36 64.9 Favored 'General case' 0 CA--C 1.527 0.063 0 O-C-N 122.116 -0.365 . . . . 0.0 110.629 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -47.74 -43.44 27.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.678 1.191 . . . . 0.0 111.256 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.76 0.36 52.3 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.005 1.322 . . . . 0.0 112.828 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.6 tp -68.8 -60.76 2.16 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.582 1.083 . . . . 0.0 109.461 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.3 p -40.9 -47.89 3.04 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.424 1.489 . . . . 0.0 112.32 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.35 -41.46 65.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.13 -53.44 11.02 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.89 0.476 . . . . 0.0 109.75 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.8 -52.46 60.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.53 -45.0 73.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.234 1.414 . . . . 0.0 111.542 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.95 -53.88 3.67 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.534 1.534 . . . . 0.0 110.481 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.1 mt -63.35 -65.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.25 0.22 . . . . 0.0 110.827 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -55.63 -41.26 73.28 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.93 -37.56 88.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.77 0.828 . . . . 0.0 111.805 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.33 76.61 0.24 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.436 1.494 . . . . 0.0 110.064 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.6 168.04 23.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.349 3.366 . . . . 0.0 112.129 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 169.83 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.656 2.904 . . . . 0.0 111.418 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.68 29.03 0.82 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.0 0.92 . . . . 0.0 111.335 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.85 168.23 16.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.944 1.298 . . . . 0.0 109.635 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.7 84.06 1.61 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.875 0.87 . . . . 0.0 109.881 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.49 98.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.796 0.838 . . . . 0.0 110.293 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -49.78 -55.18 15.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.549 1.539 . . . . 0.0 110.677 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -178.06 135.24 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.086 1.354 . . . . 0.0 110.981 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.1 90.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 121.601 -0.687 . . . . 0.0 109.385 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.05 77.87 6.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -78.46 171.08 15.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.36 0.6 . . . . 0.0 112.166 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -143.39 126.14 16.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.158 1.383 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.03 129.1 34.08 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -135.7 -162.57 1.28 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.281 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.59 135.74 48.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.798 1.239 . . . . 0.0 109.496 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -57.98 135.76 56.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.315 0.646 . . . . 0.0 112.505 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -79.32 -47.19 16.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.205 0.602 . . . . 0.0 109.432 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.19 -174.28 36.19 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.21 96.56 10.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.537 1.135 . . . . 0.0 110.291 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -58.81 134.32 56.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 167.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.73 71.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.736 0.814 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.06 164.04 0.26 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.422 1.889 . . . . 0.0 111.326 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.67 109.97 17.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -111.57 178.5 4.31 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 138.53 54.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.448 0.699 . . . . 0.0 109.839 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.303 167.42 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 112.262 -0.335 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 33.0 p -153.5 62.76 0.74 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.199 1.0 . . . . 0.0 109.123 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -82.99 63.86 7.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.837 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 114.06 21.18 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.657 1.183 . . . . 0.0 108.464 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -132.47 121.45 23.39 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -178.89 124.62 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.115 1.366 . . . . 0.0 107.768 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 t -139.18 149.06 43.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -164.15 149.31 10.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.332 1.053 . . . . 0.0 109.111 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.3 p -130.62 158.99 38.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.24 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -140.82 176.24 8.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.239 1.415 . . . . 0.0 108.903 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.67 142.79 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.523 1.129 . . . . 0.0 108.961 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -84.45 -66.12 0.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.765 0.826 . . . . 0.0 109.823 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.42 138.76 54.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.855 1.262 . . . . 0.0 109.078 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mmt -76.47 -55.25 5.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.193 0.597 . . . . 0.0 110.317 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.158 0.983 . . . . 0.0 110.841 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -177.06 4.34 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.321 1.048 . . . . 0.0 111.497 -168.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -106.1 135.63 47.21 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.5 ttp -77.7 157.6 30.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 157.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -144.05 88.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.324 1.449 . . . . 0.0 107.253 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.92 102.78 13.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.772 0.829 . . . . 0.0 109.96 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 97.96 9.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 t -99.32 119.78 47.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.753 0.421 . . . . 0.0 110.0 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -103.36 148.25 26.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.622 1.569 . . . . 0.0 110.387 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.55 -159.57 23.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.09 0.852 . . . . 0.0 112.003 169.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -87.78 21.85 2.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.536 0.735 . . . . 0.0 111.014 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.55 -24.4 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.282 1.033 . . . . 0.0 111.808 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.72 132.41 49.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 110.632 173.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.69 -54.33 4.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.601 0.62 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -72.41 77.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.277 1.431 . . . . 0.0 109.963 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.17 -116.97 5.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.4 t80 62.58 -68.77 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.251 2.22 . . . . 0.0 113.504 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -56.78 -35.32 68.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.626 1.17 . . . . 0.0 110.927 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -73.94 -47.48 37.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.922 0.889 . . . . 0.0 110.238 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.86 -50.17 66.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.422 1.089 . . . . 0.0 112.447 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.75 -33.75 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.651 0.38 . . . . 0.0 110.506 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -46.84 73.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 109.542 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 mm -51.53 -54.17 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.4 1.0 . . . . 0.0 110.717 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -66.27 -42.8 87.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.408 0.442 . . . . 0.0 109.963 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.56 -52.37 47.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.81 -43.63 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.416 1.087 . . . . 0.0 109.905 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -54.0 -37.68 64.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.526 0.73 . . . . 0.0 111.002 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -97.4 -1.52 44.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.838 1.655 . . . . 0.0 113.361 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.58 59.91 5.36 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.821 0.737 . . . . 0.0 111.91 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -125.13 138.49 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.859 1.664 . . . . 0.0 108.82 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -92.19 -178.9 5.1 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.909 1.284 . . . . 0.0 108.519 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -143.94 11.79 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 120.04 1.291 . . . . 0.0 112.338 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -175.3 147.18 0.87 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.858 0.863 . . . . 0.0 110.328 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.53 82.44 1.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 109.291 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -84.73 80.03 9.4 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.688 1.232 . . . . 0.0 108.636 -170.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -85.17 75.61 10.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.626 2.77 . . . . 0.0 110.042 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -61.42 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.063 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.3 -167.42 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.98 2.453 . . . . 0.0 110.537 -170.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -100.0 50.77 0.91 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.973 1.309 . . . . 0.0 109.876 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.31 -73.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.875 0 O-C-N 122.052 -0.405 . . . . 0.0 112.439 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 m -96.43 112.21 24.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.654 0.782 . . . . 0.0 110.899 -168.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.24 132.35 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.064 0 C-N-CA 124.942 1.297 . . . . 0.0 110.059 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -92.44 122.0 34.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.16 145.37 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.445 1.098 . . . . 0.0 109.22 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.35 147.89 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.709 1.204 . . . . 0.0 107.856 167.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.94 115.55 6.75 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.083 0.953 . . . . 0.0 109.379 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -112.64 112.33 23.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -160.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.78 -168.97 35.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.53 167.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.64 160.83 24.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.652 1.581 . . . . 0.0 109.197 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.06 -19.97 53.25 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.13 -47.63 76.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.61 59.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.637 0.775 . . . . 0.0 112.166 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.8 -61.61 1.87 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.066 0.848 . . . . 0.0 108.878 174.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.7 p -40.54 -44.39 2.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.406 1.482 . . . . 0.0 113.001 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.11 -45.49 88.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.845 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.12 -23.25 60.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.103 1.361 . . . . 0.0 111.549 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -56.7 3.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.663 1.185 . . . . 0.0 109.745 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -58.67 -37.14 75.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.573 1.149 . . . . 0.0 111.372 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -28.81 -52.99 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 127.068 2.147 . . . . 0.0 112.075 167.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -71.04 -69.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -167.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -51.71 -43.96 63.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -62.65 -56.83 14.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.713 0.805 . . . . 0.0 110.26 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.79 81.8 0.31 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.545 1.545 . . . . 0.0 109.599 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 160.95 47.65 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.592 2.861 . . . . 0.0 111.201 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -68.3 157.53 61.42 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.608 2.205 . . . . 0.0 109.559 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.75 36.98 0.34 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.235 0.614 . . . . 0.0 111.485 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.42 166.35 21.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.686 1.594 . . . . 0.0 109.29 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -80.55 72.86 7.48 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.13 0.572 . . . . 0.0 109.978 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -61.44 114.58 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.259 1.024 . . . . 0.0 108.475 168.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.88 -49.04 6.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 110.847 -161.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -162.42 71.09 0.31 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.467 0.651 . . . . 0.0 111.873 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.5 89.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.036 0.935 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.07 81.58 2.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 107.963 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -78.52 164.52 24.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.31 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 m -145.59 139.96 27.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.27 1.028 . . . . 0.0 109.502 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 135.64 33.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.899 1.28 . . . . 0.0 108.352 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 m -135.62 176.82 8.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.514 0.726 . . . . 0.0 111.168 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -89.32 137.58 32.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -64.88 138.77 58.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.237 1.015 . . . . 0.0 111.596 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -79.28 -51.18 9.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.818 0.847 . . . . 0.0 109.249 174.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.15 -178.2 30.99 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.62 103.95 8.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.098 0.959 . . . . 0.0 109.463 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -78.52 70.21 4.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -51.7 127.46 20.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.701 1.2 . . . . 0.0 112.347 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.59 174.95 0.24 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.907 1.683 . . . . 0.0 110.85 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.56 93.36 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -112.94 158.69 19.91 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -113.61 149.34 34.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.98 0.912 . . . . 0.0 110.362 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.003 -1.475 . . . . 0.0 108.624 148.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.8 t -158.0 62.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.127 0.971 . . . . 0.0 108.778 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.27 68.12 8.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.699 0.8 . . . . 0.0 109.89 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -76.93 110.2 11.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.883 0.873 . . . . 0.0 109.143 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -121.33 161.95 21.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.258 1.423 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 74.04 145.93 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.545 1.938 . . . . 0.0 112.387 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -84.74 -172.03 3.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.135 0.974 . . . . 0.0 111.15 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -72.74 72.34 1.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.385 1.074 . . . . 0.0 108.697 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m 66.47 -77.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.435 1.894 . . . . 0.0 110.437 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -173.53 102.85 0.12 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.513 1.525 . . . . 0.0 107.538 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.6 m -102.58 144.73 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.455 1.102 . . . . 0.0 109.672 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.61 -52.8 0.81 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.418 1.087 . . . . 0.0 109.424 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.58 102.91 7.21 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.357 1.063 . . . . 0.0 109.908 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.09 -36.79 75.73 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.217 1.007 . . . . 0.0 111.62 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.85 -172.12 3.59 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.853 1.261 . . . . 0.0 110.376 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 159.24 34.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.1 0.96 . . . . 0.0 110.83 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -91.62 106.36 18.42 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 ptm -84.68 94.69 8.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -89.81 89.91 7.96 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.83 105.28 17.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.499 0.666 . . . . 0.0 111.225 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.29 102.99 13.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.462 1.105 . . . . 0.0 108.979 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.62 108.99 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -103.84 139.63 38.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.58 0.752 . . . . 0.0 111.089 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.92 -152.96 24.98 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.896 0.748 . . . . 0.0 111.837 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tp -82.26 20.7 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.028 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.75 35.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.371 1.469 . . . . 0.0 112.036 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -96.23 102.3 14.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.63 0.772 . . . . 0.0 110.362 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.92 48.71 61.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.409 1.004 . . . . 0.0 112.3 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.45 93.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.761 0.824 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.32 -69.17 1.39 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.216 1.388 . . . . 0.0 112.093 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -28.44 -66.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.396 3.078 . . . . 0.0 115.103 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -60.69 -30.53 69.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.044 0.538 . . . . 0.0 111.867 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -78.48 -41.41 32.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.086 0.954 . . . . 0.0 109.992 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.9 -48.98 72.33 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.328 -0.858 . . . . 0.0 111.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.92 -28.12 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.928 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -59.87 -59.86 4.75 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 118.564 -0.732 . . . . 0.0 110.022 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.3 mm -46.39 -55.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.208 0.603 . . . . 0.0 111.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -70.9 -42.56 69.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.796 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.02 -50.0 59.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.739 0.699 . . . . 0.0 112.441 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.97 -36.8 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.657 1.583 . . . . 0.0 110.975 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -44.42 89.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.847 0.459 . . . . 0.0 111.917 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.91 -17.02 27.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.971 0.908 . . . . 0.0 113.383 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.87 66.32 1.27 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.74 139.63 45.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 125.713 1.605 . . . . 0.0 108.458 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -111.69 160.06 17.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.035 1.334 . . . . 0.0 108.555 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.78 -133.17 4.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -173.22 141.1 0.91 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.008 1.323 . . . . 0.0 109.878 172.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.79 82.48 2.6 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.613 1.165 . . . . 0.0 108.43 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -92.22 89.54 6.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -163.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.17 72.56 6.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.913 1.685 . . . . 0.0 111.566 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.99 118.44 55.42 Favored Pre-proline 0 C--N 1.342 0.259 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.308 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.71 76.93 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.831 3.021 . . . . 0.0 111.853 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -163.68 28.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.84 -43.06 3.04 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.706 -0.622 . . . . 0.0 112.809 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -95.66 86.63 4.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 110.789 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.26 125.97 40.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 123.828 0.851 . . . . 0.0 109.523 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.58 135.36 34.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.31 94.57 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.8 t -67.53 122.03 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.39 154.03 39.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -127.28 113.61 16.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.646 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.57 -140.67 0.09 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.495 1.521 . . . . 0.0 113.197 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -177.38 -92.58 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.317 3.047 . . . . 0.0 107.1 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.47 -63.23 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 122.972 0.509 . . . . 0.0 110.914 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.1 -53.9 6.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.32 67.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.149 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.1 tp -53.58 -72.34 0.06 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -55.65 -47.52 76.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 0.0 112.413 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -54.25 -41.0 68.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.082 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.78 -46.3 17.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.26 0.482 . . . . 0.0 110.725 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.07 -61.93 1.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.884 -0.51 . . . . 0.0 110.239 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -55.01 -43.78 73.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 111.685 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -56.13 3.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.645 1.178 . . . . 0.0 110.438 167.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -66.24 -53.8 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.125 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -49.68 65.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.204 0.456 . . . . 0.0 110.526 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -100.16 55.02 0.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 109.631 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.49 75.85 0.22 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.18 129.8 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.066 2.511 . . . . 0.0 109.595 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.56 179.37 6.55 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.165 2.577 . . . . 0.0 109.984 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.11 36.55 0.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.547 0.739 . . . . 0.0 111.974 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.94 162.05 38.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 110.004 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.74 87.97 3.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 110.287 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.69 78.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.799 1.24 . . . . 0.0 110.449 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -41.8 -59.36 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.995 2.118 . . . . 0.0 112.305 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -162.66 89.74 0.68 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-O 121.629 0.728 . . . . 0.0 112.589 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.85 92.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.89 0.876 . . . . 0.0 110.9 173.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -98.31 78.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.891 1.277 . . . . 0.0 108.292 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -72.86 164.97 25.81 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -134.21 119.22 18.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.451 1.101 . . . . 0.0 109.952 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -80.09 124.38 28.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m -136.91 176.49 8.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.797 1.239 . . . . 0.0 110.662 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.56 153.59 17.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.376 1.47 . . . . 0.0 110.116 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -45.62 104.22 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.053 1.741 . . . . 0.0 112.167 167.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -92.83 -55.03 3.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.827 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.2 146.36 13.19 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.05 107.25 19.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.509 1.123 . . . . 0.0 110.653 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -68.09 169.61 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 160.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.47 49.51 0.69 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.399 0.68 . . . . 0.0 110.676 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 170.14 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.064 2.145 . . . . 0.0 108.972 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -83.89 91.45 7.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.67 162.92 17.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.768 0.713 . . . . 0.0 110.233 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.54 138.47 34.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.231 0.612 . . . . 0.0 110.429 -173.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.7 t80 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.264 -1.35 . . . . 0.0 109.56 174.009 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.38 141.97 32.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.683 1.593 . . . . 0.0 109.975 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -83.53 111.46 19.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.203 1.001 . . . . 0.0 109.731 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.3 ptm -92.4 102.57 15.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.634 1.174 . . . . 0.0 108.343 173.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -73.46 127.52 32.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.78 105.57 7.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.721 0.772 . . . . 0.0 109.744 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.3 15.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.885 1.674 . . . . 0.0 107.434 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.36 114.05 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.46 153.31 19.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.268 1.427 . . . . 0.0 109.967 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.1 -161.13 13.92 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.507 1.051 . . . . 0.0 111.66 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tp -83.0 26.21 0.63 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.058 0.543 . . . . 0.0 111.532 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.1 -10.68 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 113.098 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -57.6 151.97 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.632 1.173 . . . . 0.0 110.009 166.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.61 -62.48 4.6 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 79' ' ' ALA . 18.7 m -66.84 165.1 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.246 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.41 48.14 3.57 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.934 0.778 . . . . 0.0 112.465 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.01 -60.87 2.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.593 1.157 . . . . 0.0 108.921 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -61.54 -25.58 67.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 112.071 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.24 -48.96 48.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 0.0 109.474 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.29 -46.67 82.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.432 0.693 . . . . 0.0 111.167 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -55.67 -36.85 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.893 0.477 . . . . 0.0 110.635 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -62.3 -57.34 11.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.852 -1.07 . . . . 0.0 110.928 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -44.15 -55.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.612 1.096 . . . . 0.0 111.638 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.4 -47.41 67.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.385 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.76 -50.86 54.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.8 -47.49 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.573 1.549 . . . . 0.0 109.018 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.58 -39.61 70.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.253 0.621 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -94.39 -0.62 54.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.514 1.525 . . . . 0.0 113.236 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.45 62.2 4.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.952 0.796 . . . . 0.0 111.735 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 mm -115.42 141.77 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 126.285 1.834 . . . . 0.0 107.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -104.06 167.56 9.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.805 1.242 . . . . 0.0 108.485 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.07 -146.92 16.58 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 118.158 0.435 . . . . 0.0 113.123 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -170.76 139.99 1.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 109.357 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.35 88.93 2.91 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.439 1.095 . . . . 0.0 108.58 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.04 77.9 4.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -164.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -72.82 74.0 1.12 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.662 1.585 . . . . 0.0 111.302 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.36 124.0 76.07 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 165.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.46 76.81 3.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.803 2.335 . . . . 0.0 110.749 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -151.14 26.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.613 1.165 . . . . 0.0 111.983 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.59 -48.64 3.71 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.611 0.624 . . . . 0.0 112.353 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 p -91.31 91.28 8.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.781 1.232 . . . . 0.0 110.873 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.51 126.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 124.111 0.964 . . . . 0.0 109.904 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 141.53 29.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.234 0.614 . . . . 0.0 109.506 175.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.69 137.15 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -118.52 61.03 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.423 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.85 156.2 39.42 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.622 1.169 . . . . 0.0 110.167 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.18 112.21 6.6 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.933 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.07 156.82 23.13 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.583 0.628 . . . . 0.0 114.012 -172.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -71.99 -92.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.047 1.739 . . . . 0.0 110.28 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.57 -80.41 0.09 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.429 1.492 . . . . 0.0 107.397 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.66 -52.21 56.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.283 0.633 . . . . 0.0 109.795 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.79 68.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.993 0.517 . . . . 0.0 111.808 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.2 tp -64.95 -66.4 0.55 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -46.38 -42.61 15.25 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.451 1.501 . . . . 0.0 112.941 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -57.41 -62.67 1.61 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.292 0.951 . . . . 0.0 110.17 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -57.37 -35.73 70.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.205 0.602 . . . . 0.0 112.219 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.64 -63.25 1.17 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.982 0.913 . . . . 0.0 110.515 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.31 -37.24 55.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.088 1.355 . . . . 0.0 111.618 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.42 -59.81 3.18 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.433 1.093 . . . . 0.0 111.12 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.33 -61.87 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.139 0.427 . . . . 0.0 111.239 -163.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -48.42 64.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 113.104 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -58.41 -51.97 67.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.262 0.625 . . . . 0.0 110.966 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.8 86.22 0.45 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.03 1.3 . . . . 0.0 109.857 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 163.71 30.91 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.287 2.658 . . . . 0.0 111.226 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.72 165.36 31.18 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.941 2.427 . . . . 0.0 111.188 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.37 43.2 0.72 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.889 0.876 . . . . 0.0 111.096 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -150.49 167.93 25.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.976 1.31 . . . . 0.0 109.327 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -76.53 80.52 3.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.561 1.144 . . . . 0.0 109.574 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.54 119.89 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.052 0.941 . . . . 0.0 108.673 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.56 -50.03 6.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.442 1.097 . . . . 0.0 110.387 -168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -166.09 71.59 0.14 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.413 0.625 . . . . 0.0 111.633 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -65.67 94.35 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.433 0.693 . . . . 0.0 111.122 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.94 83.72 1.88 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.093 1.357 . . . . 0.0 108.01 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -77.66 163.43 26.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.849 0.356 . . . . 0.0 110.676 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.2 m -139.08 110.18 6.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 109.665 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 120.75 10.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 m -127.69 -152.3 0.51 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.811 1.245 . . . . 0.0 109.106 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 155.99 49.15 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.481 1.112 . . . . 0.0 109.198 170.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -81.23 124.11 29.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.012 0.925 . . . . 0.0 110.658 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -73.63 -46.78 44.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 164.5 32.51 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.88 134.04 34.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.582 1.153 . . . . 0.0 109.257 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -74.21 145.88 43.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.583 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.55 87.28 0.9 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.997 0.919 . . . . 0.0 110.104 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 66.44 -160.46 0.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.477 1.111 . . . . 0.0 109.601 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.73 113.39 9.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.211 1.004 . . . . 0.0 109.283 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.93 164.56 20.51 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.638 0.775 . . . . 0.0 110.868 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.97 143.51 38.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.373 1.069 . . . . 0.0 110.408 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.018 -1.468 . . . . 0.0 111.108 168.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.315 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 173.51 9.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.148 1.379 . . . . 0.0 110.839 -167.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -100.21 127.36 46.49 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.085 0.554 . . . . 0.0 111.257 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.47 158.38 31.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 153.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.06 97.26 2.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.85 116.06 29.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.87 0.868 . . . . 0.0 110.944 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.67 107.86 19.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 108.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.92 107.74 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.1 147.88 22.96 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.103 0.961 . . . . 0.0 110.278 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.97 -161.75 27.14 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.244 0.926 . . . . 0.0 110.967 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tp -82.23 20.14 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.268 0.627 . . . . 0.0 110.648 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.26 -14.66 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.106 1.362 . . . . 0.0 112.794 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.37 117.18 7.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.857 0.863 . . . . 0.0 109.653 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.49 48.96 40.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.08 0.848 . . . . 0.0 113.304 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.641 HG21 ' HB2' ' A' ' 79' ' ' ALA . 21.3 m -135.09 -168.07 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 109.014 166.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.02 79.33 0.2 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.485 1.041 . . . . 0.0 111.013 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -158.42 -174.42 4.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.556 1.542 . . . . 0.0 108.573 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 73.51 -73.57 0.1 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.576 1.951 . . . . 0.0 109.53 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -56.62 -36.96 70.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.283 1.033 . . . . 0.0 110.351 172.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -48.76 -48.14 41.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.274 1.03 . . . . 0.0 111.722 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.16 -37.54 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.158 -0.338 . . . . 0.0 110.422 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.72 -49.29 66.51 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.037 -1.459 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.8 mm -43.93 -53.38 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 120.707 1.594 . . . . 0.0 111.416 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -66.9 -51.68 52.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.6 -44.84 66.25 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.85 -46.33 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 108.635 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -42.03 88.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.318 0.647 . . . . 0.0 111.012 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.3 mt -92.3 -52.53 4.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.058 1.343 . . . . 0.0 111.751 -169.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.14 66.6 0.17 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.167 1.365 . . . . 0.0 112.704 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.79 147.12 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 108.821 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -108.06 174.11 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 108.847 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.86 -150.63 22.44 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 118.619 0.645 . . . . 0.0 112.594 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -164.78 140.87 5.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.72 82.43 1.85 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.396 1.078 . . . . 0.0 110.087 -168.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' CB ' ' A' ' 101' ' ' TYR . 36.0 ttmt -95.38 104.21 16.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 -164.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -78.7 126.11 30.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.3 mt -101.85 93.99 4.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.25 76.89 4.02 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.482 2.788 . . . . 0.0 111.548 -159.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 173.94 -43.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.159 2.584 . . . . 0.0 108.708 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.36 -119.25 4.56 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.737 1.16 . . . . 0.0 111.429 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -129.25 126.04 38.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.57 1.548 . . . . 0.0 109.425 -168.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.27 122.06 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.7 0.8 . . . . 0.0 110.158 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.21 140.19 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.796 0.839 . . . . 0.0 109.646 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.5 t -127.05 134.06 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.178 0.991 . . . . 0.0 108.554 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.1 74.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.71 0.804 . . . . 0.0 110.821 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.89 150.12 37.63 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -117.67 96.63 5.47 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.197 0.599 . . . . 0.0 110.951 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.25 174.52 17.39 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.932 0.777 . . . . 0.0 112.437 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.74 -98.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 108.668 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -152.14 -73.75 0.14 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.291 1.436 . . . . 0.0 108.211 -174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.68 -45.46 48.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.611 1.164 . . . . 0.0 109.338 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.6 57.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.86 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.5 tp -53.78 -56.75 14.68 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.449 0.568 . . . . 0.0 109.56 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.1 p -47.52 -36.38 10.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.888 1.275 . . . . 0.0 112.862 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -64.3 -36.4 84.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.43 1.092 . . . . 0.0 111.444 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.6 -50.15 12.0 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.646 0.778 . . . . 0.0 109.044 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -52.8 25.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.354 0.662 . . . . 0.0 111.168 -171.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.06 -35.68 77.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.281 1.433 . . . . 0.0 113.159 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -48.57 14.48 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.89 1.276 . . . . 0.0 110.73 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.46 -56.42 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 119.02 -0.514 . . . . 0.0 110.616 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.2 -54.28 38.38 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.236 0.471 . . . . 0.0 110.517 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 47.61 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.451 1.1 . . . . 0.0 109.641 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.47 66.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.55 161.3 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.512 2.808 . . . . 0.0 111.311 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.13 170.16 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.954 3.103 . . . . 0.0 111.802 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.24 48.12 1.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.092 0.957 . . . . 0.0 111.027 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -149.37 167.49 26.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.713 1.205 . . . . 0.0 110.162 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.79 89.49 1.37 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.12 86.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 109.967 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -41.54 -60.76 1.22 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.799 1.64 . . . . 0.0 111.344 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.71 140.22 3.87 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.676 0.39 . . . . 0.0 110.473 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.27 97.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 166.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.53 82.48 6.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -76.61 156.44 32.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -141.89 108.91 5.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.805 1.242 . . . . 0.0 108.764 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -69.09 127.5 33.35 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -134.83 -173.56 3.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.086 0.954 . . . . 0.0 110.398 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 141.83 38.35 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.094 0.957 . . . . 0.0 108.616 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.19 56.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -54.18 20.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 170.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.15 -176.05 34.78 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.03 119.1 28.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.278 1.031 . . . . 0.0 109.318 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -70.04 135.37 49.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.44 91.92 1.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.531 0.733 . . . . 0.0 109.979 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 67.92 -161.32 0.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.423 1.089 . . . . 0.0 109.683 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.0 89.94 3.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.635 1.174 . . . . 0.0 108.982 -175.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.53 159.75 16.46 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -115.36 144.23 44.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.306 0.643 . . . . 0.0 110.955 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CB ' ' HA ' ' A' ' 47' ' ' LYS . 2.4 t80 . . . . . 0 C--O 1.249 1.027 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.18 167.1 16.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.116 0.966 . . . . 0.0 112.157 -161.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -100.27 130.76 46.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.4 ttp -66.44 166.23 12.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.196 0.998 . . . . 0.0 108.795 158.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.42 86.78 1.55 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 163.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.35 105.19 17.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.465 0.706 . . . . 0.0 110.953 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 101.02 13.53 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.272 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -90.42 110.86 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -96.15 148.34 22.81 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.969 0.907 . . . . 0.0 109.295 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.41 -157.35 22.27 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.01 1.29 . . . . 0.0 111.316 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -80.46 19.62 0.77 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.517 0.727 . . . . 0.0 111.402 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.62 -23.3 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.151 0.98 . . . . 0.0 111.022 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.77 142.43 50.16 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 109.668 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.13 -65.61 2.85 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 79' ' ' ALA . 17.7 m -64.42 169.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.842 0.821 . . . . 0.0 110.953 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.01 -94.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.493 1.044 . . . . 0.0 111.767 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.65 -59.69 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 113.26 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -38.78 -37.78 0.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.762 2.825 . . . . 0.0 113.082 170.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.79 -50.97 25.05 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.536 0.735 . . . . 0.0 109.939 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.96 -39.93 63.32 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 111.48 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.35 -42.29 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 123.44 0.696 . . . . 0.0 110.029 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.424 HE21 ' CA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.42 -54.23 39.98 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 117.715 -1.136 . . . . 0.0 110.143 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.9 mm -41.63 -54.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.877 1.217 . . . . 0.0 113.054 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -73.31 -45.61 54.4 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.554 0.342 . . . . 0.0 110.72 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.64 -51.01 59.11 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.149 0.5 . . . . 0.0 111.741 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -44.6 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 126.219 1.807 . . . . 0.0 109.972 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -53.01 -39.96 63.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.803 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.44 11.7 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.781 1.233 . . . . 0.0 113.47 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.89 64.61 3.67 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 118.841 0.746 . . . . 0.0 112.112 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.5 mm -121.88 138.62 51.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.354 1.462 . . . . 0.0 108.735 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -98.56 173.38 6.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.689 1.196 . . . . 0.0 108.243 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.7 -143.92 11.19 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.499 -0.75 . . . . 0.0 111.7 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -175.26 144.2 0.71 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.551 1.14 . . . . 0.0 109.19 170.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 82.82 1.8 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -95.13 111.78 23.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.353 0.597 . . . . 0.0 110.156 -164.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 20.6 t-20 -91.73 119.69 31.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 108.505 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.04 98.05 4.27 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.52 144.91 91.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.433 2.089 . . . . 0.0 110.812 -169.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.7 t0 55.95 54.73 7.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.475 1.11 . . . . 0.0 109.67 -166.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.27 -134.97 2.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -124.8 161.0 27.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.816 1.646 . . . . 0.0 110.464 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.84 117.83 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.067 0.947 . . . . 0.0 109.629 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -93.19 143.47 26.23 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.618 0.767 . . . . 0.0 110.456 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.25 123.15 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.428 1.091 . . . . 0.0 108.773 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.39 62.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.825 0.85 . . . . 0.0 110.966 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 129.75 38.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.457 0.703 . . . . 0.0 111.042 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -117.62 108.08 15.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.747 1.219 . . . . 0.0 110.503 -165.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 177.32 37.5 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-O 122.216 0.898 . . . . 0.0 114.369 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -69.87 169.65 12.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.128 1.371 . . . . 0.0 108.946 165.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -79.85 -30.25 40.3 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.12 -25.53 68.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.918 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.28 -13.54 18.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.914 0.885 . . . . 0.0 111.825 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.83 -59.79 2.71 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 p -38.57 -45.01 1.02 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.278 1.831 . . . . 0.0 112.912 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.45 -42.02 88.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.854 0.862 . . . . 0.0 112.682 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -74.11 -21.99 59.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.626 1.171 . . . . 0.0 111.551 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.7 -61.24 2.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.471 1.108 . . . . 0.0 110.317 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -53.89 -42.07 68.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 110.299 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -34.37 -47.42 0.3 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.305 2.642 . . . . 0.0 113.556 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.61 -68.25 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.608 0.763 . . . . 0.0 110.728 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -52.13 -44.93 64.75 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.84 -51.96 67.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.299 1.04 . . . . 0.0 111.186 173.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.09 85.3 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.61 160.55 45.59 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.924 2.416 . . . . 0.0 111.262 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.25 160.58 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.274 2.649 . . . . 0.0 110.765 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 48.83 1.33 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.824 0.85 . . . . 0.0 110.957 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -158.39 169.06 25.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 110.484 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.1 77.73 2.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.189 0.995 . . . . 0.0 109.374 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.08 125.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.953 0.901 . . . . 0.0 109.389 173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.93 -60.34 2.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 108.163 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -156.13 115.47 3.53 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.72 87.01 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 161.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.09 67.42 8.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.458 1.103 . . . . 0.0 108.268 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.2 154.38 31.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.826 -170.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -138.23 117.65 12.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.67 129.93 44.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m -127.21 -161.89 1.12 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.443 1.097 . . . . 0.0 109.24 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.23 141.48 45.79 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.617 0.767 . . . . 0.0 109.026 170.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -54.8 135.1 47.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.567 1.147 . . . . 0.0 112.96 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -73.35 -57.49 3.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 165.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.29 -177.55 40.01 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.43 122.2 16.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.56 0.744 . . . . 0.0 110.417 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -72.98 -26.5 61.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 111.468 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.51 91.31 0.07 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.637 1.575 . . . . 0.0 111.028 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.53 179.72 0.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 110.472 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.88 95.84 2.56 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.68 167.04 13.39 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 p -103.69 152.02 22.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.482 0.713 . . . . 0.0 110.791 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 4.0 m-85 . . . . . 0 C--O 1.249 1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 153.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.23 166.57 10.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.262 1.025 . . . . 0.0 109.905 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -99.15 101.56 12.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 110.347 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.3 ttp -70.01 144.77 52.15 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 164.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -124.18 136.35 54.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.993 1.717 . . . . 0.0 106.561 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 107.59 4.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.343 0.592 . . . . 0.0 109.976 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 98.93 8.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.73 101.09 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.31 149.89 26.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.267 0.627 . . . . 0.0 111.265 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.61 -163.53 18.45 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.315 1.436 . . . . 0.0 110.7 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 47.8 1.55 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.02 41.62 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.326 1.05 . . . . 0.0 110.747 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.62 150.43 33.15 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.404 1.082 . . . . 0.0 110.384 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.72 -56.83 4.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.527 0.584 . . . . 0.0 111.871 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -48.38 150.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.803 2.041 . . . . 0.0 111.292 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.82 38.45 2.34 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.825 0.726 . . . . 0.0 113.486 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -67.17 -35.87 80.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.64 0.72 . . . . 0.0 110.016 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -58.22 -31.77 67.67 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.265 1.026 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.72 -48.15 34.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.668 1.187 . . . . 0.0 109.843 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.13 -44.84 79.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.507 0.723 . . . . 0.0 111.579 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.51 -37.5 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.666 0.786 . . . . 0.0 109.969 172.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -63.37 -57.7 9.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.848 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -43.06 -51.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 119.451 1.023 . . . . 0.0 111.757 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -67.22 -56.6 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.841 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.68 -47.82 20.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.54 -42.88 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 126.224 1.81 . . . . 0.0 110.47 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -62.52 -34.41 76.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.766 0.426 . . . . 0.0 111.799 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.98 -0.19 55.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.855 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.17 5.32 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 118.65 0.659 . . . . 0.0 111.557 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -121.26 141.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.649 1.58 . . . . 0.0 108.311 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -103.43 166.38 10.46 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.26 -145.21 12.25 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.957 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.36 141.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 110.19 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.11 86.68 2.34 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.165 1.386 . . . . 0.0 108.727 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -100.27 90.1 4.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.862 0.865 . . . . 0.0 110.511 -164.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.73 92.76 4.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.557 1.543 . . . . 0.0 109.811 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.7 mt -66.13 106.19 1.03 Allowed Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 125.772 1.629 . . . . 0.0 108.321 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.07 43.24 1.43 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.584 2.189 . . . . 0.0 113.058 -160.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.5 47.77 0.34 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.472 1.509 . . . . 0.0 108.285 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.83 -135.7 3.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -112.6 169.34 8.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.494 1.517 . . . . 0.0 109.656 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.68 135.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 C-N-CA 124.204 1.001 . . . . 0.0 112.011 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -100.48 122.71 43.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.604 1.161 . . . . 0.0 109.183 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.38 145.11 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.639 1.176 . . . . 0.0 108.518 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.23 86.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.072 0.949 . . . . 0.0 109.827 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.42 143.02 26.67 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.028 1.331 . . . . 0.0 111.592 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -126.28 99.12 5.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.272 0.629 . . . . 0.0 110.772 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.54 164.14 30.15 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 121.598 0.554 . . . . 0.0 113.073 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -66.7 167.32 11.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 -35.58 67.28 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.977 -0.452 . . . . 0.0 111.911 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -45.3 -39.91 7.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.791 1.236 . . . . 0.0 112.159 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.08 0.85 21.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.94 1.296 . . . . 0.0 112.586 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -70.29 -59.29 2.96 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.285 0.948 . . . . 0.0 108.829 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -42.63 -45.4 4.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.269 1.428 . . . . 0.0 112.063 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.17 -32.42 64.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.718 1.607 . . . . 0.0 112.885 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.23 -53.88 4.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.07 1.348 . . . . 0.0 109.927 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -53.24 56.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.49 1.116 . . . . 0.0 111.109 -167.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -68.91 -34.6 75.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.636 1.174 . . . . 0.0 111.433 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.43 -42.26 10.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.384 1.474 . . . . 0.0 111.206 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.41 -61.61 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.217 0.607 . . . . 0.0 111.2 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.54 -48.69 80.68 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.09 0.405 . . . . 0.0 111.029 -168.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -94.94 38.36 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.927 1.291 . . . . 0.0 110.275 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.3 76.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.99 162.04 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.464 2.776 . . . . 0.0 112.594 -167.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.65 -1.73 5.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.222 3.281 . . . . 0.0 114.525 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.36 28.8 4.67 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 126.163 1.785 . . . . 0.0 110.114 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.35 164.16 32.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.997 1.719 . . . . 0.0 107.995 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.15 80.5 4.57 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.076 0.551 . . . . 0.0 110.945 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.33 126.88 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.164 0.986 . . . . 0.0 109.656 170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -93.65 -53.1 4.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.455 1.102 . . . . 0.0 109.405 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -164.85 76.12 0.29 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.064 0.459 . . . . 0.0 112.165 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.4 p -67.21 89.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.282 0.633 . . . . 0.0 111.013 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.07 85.5 3.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.158 1.383 . . . . 0.0 108.046 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -77.74 170.33 16.76 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.176 0.512 . . . . 0.0 112.212 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -139.7 112.16 7.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.222 1.409 . . . . 0.0 109.843 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -66.26 138.7 57.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 163.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m -161.24 174.07 14.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.083 0.468 . . . . 0.0 109.959 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.29 146.14 27.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.086 0.954 . . . . 0.0 110.604 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.29 127.85 33.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.24 0.616 . . . . 0.0 110.164 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -42.63 18.13 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.01 161.8 34.18 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.22 149.96 21.55 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.602 1.161 . . . . 0.0 110.568 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.15 153.99 33.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.093 165.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -71.87 78.6 0.88 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.213 1.005 . . . . 0.0 109.696 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.68 -162.76 0.19 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.151 1.38 . . . . 0.0 110.296 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.66 116.01 21.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.116 1.366 . . . . 0.0 108.362 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -129.35 166.31 19.76 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.86 123.92 48.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.834 0.853 . . . . 0.0 110.26 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.53 1.532 . . . . 0.0 107.844 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 -179.55 6.43 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.355 1.062 . . . . 0.0 111.415 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -108.96 127.4 54.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.25 0.62 . . . . 0.0 112.386 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 ttp -79.31 146.56 32.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 155.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -127.95 135.44 49.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.444 1.897 . . . . 0.0 106.335 165.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.67 110.52 5.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.394 0.616 . . . . 0.0 111.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -84.3 99.23 10.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.166 1.386 . . . . 0.0 108.084 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.12 107.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -97.32 149.65 21.85 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.439 1.096 . . . . 0.0 110.253 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.5 -158.43 26.03 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.885 1.231 . . . . 0.0 110.962 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.92 22.5 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.515 0.726 . . . . 0.0 110.977 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.84 -17.4 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.118 1.367 . . . . 0.0 111.885 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -67.47 121.04 14.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.062 0.545 . . . . 0.0 111.627 -172.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.48 37.03 93.46 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.462 1.029 . . . . 0.0 112.773 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.14 91.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.0 -139.1 44.45 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.485 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 t80 56.48 -173.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.003 1.721 . . . . 0.0 111.428 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 68.36 -76.04 0.06 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 126.126 1.771 . . . . 0.0 109.243 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -45.85 -42.35 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.303 1.441 . . . . 0.0 111.92 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.66 -53.82 50.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 111.245 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -67.23 -18.83 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 122.074 -0.392 . . . . 0.0 111.344 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -54.83 13.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.266 -1.349 . . . . 0.0 110.713 167.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.7 mm -36.27 -55.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 120.483 1.492 . . . . 0.0 112.886 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -67.62 -51.94 44.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.75 0.42 . . . . 0.0 110.759 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -45.38 -65.98 0.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.575 1.15 . . . . 0.0 111.351 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.41 -47.92 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 111.631 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -53.52 -46.68 70.19 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.06 0.544 . . . . 0.0 110.571 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.9 mt -102.29 37.33 1.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 111.851 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.23 68.43 1.67 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.981 1.277 . . . . 0.0 113.766 167.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.4 mm -117.3 141.45 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.802 1.241 . . . . 0.0 108.978 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -101.81 174.57 5.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 108.481 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.56 -152.44 24.0 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.342 0.974 . . . . 0.0 112.288 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -170.88 142.91 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.451 0.7 . . . . 0.0 110.347 167.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.74 90.2 3.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.295 1.038 . . . . 0.0 111.977 -165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -111.15 104.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.592 0.357 . . . . 0.0 111.823 -160.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -80.17 97.32 6.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.005 0.922 . . . . 0.0 109.42 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -73.73 102.52 0.62 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.04 136.5 48.48 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.891 1.728 . . . . 0.0 110.499 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 55.86 53.35 9.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 110.124 -167.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.47 -131.37 1.25 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.3 t -121.61 150.33 41.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.481 1.112 . . . . 0.0 110.134 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -99.66 94.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.51 137.81 32.23 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.051 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 143.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.04 136.84 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 164.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.91 138.25 31.91 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.083 0.953 . . . . 0.0 108.717 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.15 90.78 3.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -168.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.93 168.62 16.99 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 123.289 0.471 . . . . 0.0 112.199 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -77.07 -100.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.84 1.656 . . . . 0.0 108.942 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -150.92 -57.47 0.16 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.796 1.638 . . . . 0.0 108.188 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -49.89 -45.12 50.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.848 0.859 . . . . 0.0 109.64 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.69 -34.46 67.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.05 0.54 . . . . 0.0 111.372 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.17 -61.02 2.75 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.4 p -43.33 -47.58 6.75 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.682 1.593 . . . . 0.0 112.213 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -56.18 -41.68 75.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.403 1.081 . . . . 0.0 111.666 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.4 -24.65 31.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.711 1.605 . . . . 0.0 111.154 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.53 -60.84 2.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.139 0.976 . . . . 0.0 110.936 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.81 -43.47 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.239 1.016 . . . . 0.0 111.058 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -34.1 -50.99 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.074 2.55 . . . . 0.0 113.259 165.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -69.18 -68.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.682 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -52.49 -41.83 63.73 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.79 -53.81 44.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.723 0.809 . . . . 0.0 110.754 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.09 0.3 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.863 1.22 . . . . 0.0 110.56 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.38 161.54 42.76 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.251 2.634 . . . . 0.0 111.296 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.33 164.71 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.516 2.811 . . . . 0.0 111.793 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.12 50.18 1.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 111.02 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.22 159.34 17.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.599 1.559 . . . . 0.0 107.84 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.18 84.49 3.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.597 0.359 . . . . 0.0 110.437 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.88 127.88 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.765 0.826 . . . . 0.0 109.183 168.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.85 -61.42 1.63 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.729 1.212 . . . . 0.0 108.05 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -146.4 119.94 9.11 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.01 0.524 . . . . 0.0 112.055 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.47 101.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -100.26 79.64 2.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.238 1.415 . . . . 0.0 108.062 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.24 152.34 21.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 m -145.29 139.85 27.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.0 0.92 . . . . 0.0 110.664 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.98 127.34 42.85 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 109.033 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -136.35 -175.86 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.224 1.01 . . . . 0.0 110.639 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.59 152.53 18.45 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.536 0.734 . . . . 0.0 110.57 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.57 133.96 53.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.432 1.093 . . . . 0.0 111.39 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -71.34 -50.37 32.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.07 172.48 35.19 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.12 112.4 20.2 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.958 0.903 . . . . 0.0 109.094 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.67 133.46 54.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.61 97.43 1.71 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.68 -167.41 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.203 1.401 . . . . 0.0 110.539 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 80.54 1.94 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.12 1.368 . . . . 0.0 108.658 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -106.85 160.64 15.35 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 123.255 0.347 . . . . 0.0 110.149 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.18 141.3 47.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.496 0.718 . . . . 0.0 111.559 -165.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.405 1.482 . . . . 0.0 108.306 170.145 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.57 152.16 32.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.293 1.837 . . . . 0.0 108.57 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -97.87 113.94 25.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.277 1.031 . . . . 0.0 110.587 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.0 ptm -86.28 161.7 18.63 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.11 85.56 1.61 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.69 96.19 10.3 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.121 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -80.88 107.2 13.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 t -91.45 90.39 3.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -168.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -65.38 148.28 51.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.13 -164.79 13.14 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.995 0.807 . . . . 0.0 112.157 166.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -90.23 36.92 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.85 0.86 . . . . 0.0 110.218 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.91 -19.39 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 142.32 45.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.011 0.924 . . . . 0.0 111.107 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.0 -43.31 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.839 0.733 . . . . 0.0 112.243 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.21 78.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.939 0.896 . . . . 0.0 109.854 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.5 -121.44 7.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.918 1.247 . . . . 0.0 111.214 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.9 t80 65.35 -56.95 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.092 2.557 . . . . 0.0 114.635 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -32.99 -51.28 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.525 2.73 . . . . 0.0 112.992 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -79.65 -41.73 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.096 0.958 . . . . 0.0 111.183 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -51.25 -41.84 60.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 111.085 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.53 -43.36 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.593 1.157 . . . . 0.0 111.375 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -57.96 10.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.728 0.811 . . . . 0.0 110.589 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.2 mm -47.47 -57.45 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 118.389 0.54 . . . . 0.0 111.3 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -69.94 -39.45 76.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.288 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.79 -61.9 1.93 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.297 0.499 . . . . 0.0 110.918 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.75 -50.62 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.732 1.613 . . . . 0.0 110.39 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -51.3 62.14 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.915 0.886 . . . . 0.0 109.804 -176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.13 4.13 46.58 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.022 1.329 . . . . 0.0 113.387 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.01 58.2 9.38 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.755 0.707 . . . . 0.0 111.454 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.52 142.75 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.784 1.634 . . . . 0.0 107.81 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.53 162.98 13.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.435 1.094 . . . . 0.0 108.58 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -149.68 21.67 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -169.59 143.35 2.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.92 82.88 1.92 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.365 1.066 . . . . 0.0 108.957 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.506 1.146 . . . . 0.0 109.638 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.5 67.35 10.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 127.531 2.332 . . . . 0.0 110.609 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.1 mt -48.79 104.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 126.393 1.877 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.47 32.73 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.115 1.877 . . . . 0.0 113.211 -164.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -147.93 44.83 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.18 1.392 . . . . 0.0 107.604 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.61 -149.86 8.16 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -120.67 151.41 39.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.686 1.194 . . . . 0.0 109.701 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.4 126.96 32.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.89 0.876 . . . . 0.0 111.47 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -92.06 127.48 37.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.68 97.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.48 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.754 0.787 . . . . 0.0 109.732 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.53 156.38 32.94 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.857 1.263 . . . . 0.0 111.38 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -146.57 122.87 10.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.343 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.05 164.92 35.66 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 118.75 0.705 . . . . 0.0 112.773 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.24 162.9 11.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.458 1.103 . . . . 0.0 108.67 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.84 -24.51 44.34 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -166.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.45 -44.08 95.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.655 0.661 . . . . 0.0 109.909 168.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.04 -14.42 59.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.507 0.723 . . . . 0.0 112.439 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.13 -62.96 1.17 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -49.45 -42.46 42.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 112.809 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -61.71 -38.96 89.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.139 0.976 . . . . 0.0 112.047 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -70.61 -55.31 9.09 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -50.95 -53.58 31.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.773 0.429 . . . . 0.0 111.554 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.06 -37.63 83.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.76 0.824 . . . . 0.0 112.246 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.66 -49.07 7.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.917 1.287 . . . . 0.0 110.8 167.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -70.4 -52.63 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.19 0.596 . . . . 0.0 110.296 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -49.94 73.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.453 0.569 . . . . 0.0 111.2 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -69.52 -36.9 76.86 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.367 1.067 . . . . 0.0 111.581 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.99 74.78 0.24 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.234 1.397 . . . . 0.0 110.22 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.77 168.49 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.826 3.017 . . . . 0.0 110.174 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.1 150.02 77.04 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.58 1.52 . . . . 0.0 108.533 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.86 45.56 0.82 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.002 0.521 . . . . 0.0 110.553 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.21 175.64 9.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 109.681 -173.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.27 74.33 3.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.639 0.776 . . . . 0.0 109.92 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 117.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -76.84 -52.28 9.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.505 1.122 . . . . 0.0 108.783 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -179.31 110.38 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.075 1.35 . . . . 0.0 110.211 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -75.74 78.07 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.339 1.056 . . . . 0.0 109.512 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -95.14 89.4 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.38 164.06 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.018 0.437 . . . . 0.0 111.944 -171.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -117.52 125.03 50.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.078 1.351 . . . . 0.0 108.769 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.25 128.75 34.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 m -136.51 179.25 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.633 0.773 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -96.47 146.69 24.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.084 1.354 . . . . 0.0 108.874 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -69.44 135.77 50.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -89.1 -57.35 2.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.018 1.327 . . . . 0.0 108.639 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 27.51 22.52 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.726 1.155 . . . . 0.0 113.536 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.86 -35.34 26.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.408 1.104 . . . . 0.0 112.887 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -83.84 82.27 8.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.08 0.552 . . . . 0.0 111.427 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.23 88.6 0.18 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.917 0.887 . . . . 0.0 109.36 171.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 90.85 145.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 128.507 2.723 . . . . 0.0 110.504 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.92 112.38 24.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.329 1.052 . . . . 0.0 108.829 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.48 165.7 15.95 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.07 0.548 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 p -108.12 146.28 32.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.834 0.854 . . . . 0.0 110.747 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.312 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 168.51 12.35 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.777 0.831 . . . . 0.0 112.267 -169.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -93.44 114.92 27.43 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.05 0.453 . . . . 0.0 111.472 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.8 ptm -93.94 86.27 5.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 122.059 0.933 . . . . 0.0 110.529 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.38 114.83 18.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.32 110.68 16.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.316 1.047 . . . . 0.0 110.323 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 109.16 20.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.046 1.338 . . . . 0.0 107.921 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -96.24 110.12 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.52 154.77 17.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.132 0.973 . . . . 0.0 111.728 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.3 -159.05 21.3 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.735 1.636 . . . . 0.0 110.895 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -86.4 47.97 1.55 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.99 41.72 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 125.192 1.397 . . . . 0.0 110.43 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -108.16 33.93 3.87 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.355 0.662 . . . . 0.0 111.86 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.48 -160.7 26.84 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.785 1.183 . . . . 0.0 110.319 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER 70.23 -175.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.965 1.306 . . . . 0.0 109.812 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 27' ' ' VAL . . . -74.99 51.19 2.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.817 0.723 . . . . 0.0 112.616 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.49 178.86 5.82 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.742 2.017 . . . . 0.0 112.075 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 61.65 -74.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.84 2.056 . . . . 0.0 111.061 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.15 -47.2 1.56 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.899 1.679 . . . . 0.0 111.137 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.23 -50.12 67.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.312 0.645 . . . . 0.0 112.127 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.0 -36.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 123.434 0.694 . . . . 0.0 110.341 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.4 -51.85 65.9 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.286 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -44.23 -50.41 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.844 1.656 . . . . 0.0 112.363 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -71.27 -49.64 40.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.854 0.462 . . . . 0.0 110.209 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.63 -48.39 58.06 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.031 0.933 . . . . 0.0 113.132 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.32 -47.16 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.327 1.851 . . . . 0.0 108.36 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.35 -42.87 67.25 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.98 0.355 . . . . 0.0 110.993 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -93.28 6.82 46.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.99 1.316 . . . . 0.0 113.285 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.62 59.83 8.21 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 118.595 0.634 . . . . 0.0 112.244 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -113.45 139.54 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 125.605 1.562 . . . . 0.0 108.399 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -103.46 157.52 16.98 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.671 1.188 . . . . 0.0 108.06 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.97 -158.78 31.58 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 118.569 0.622 . . . . 0.0 113.072 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -170.43 137.98 1.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.591 1.156 . . . . 0.0 108.641 167.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.39 87.51 2.63 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.99 0.916 . . . . 0.0 108.78 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -94.71 115.42 27.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.804 0.842 . . . . 0.0 109.807 -167.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.33 130.38 34.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.542 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -102.55 96.71 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.08 23.6 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.293 2.662 . . . . 0.0 114.43 -161.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.35 42.13 2.05 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.015 1.326 . . . . 0.0 108.303 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.69 -122.22 0.83 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -117.48 164.14 15.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.261 1.824 . . . . 0.0 110.579 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -102.85 124.75 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.595 0.758 . . . . 0.0 110.501 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -98.58 125.52 43.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.757 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -109.06 115.55 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.44 135.1 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 164.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.31 146.4 18.5 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.508 1.123 . . . . 0.0 108.733 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.81 122.63 18.81 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.334 0.654 . . . . 0.0 111.219 -171.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.95 165.3 28.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 121.91 0.728 . . . . 0.0 113.881 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.44 172.68 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.093 160.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.92 -25.54 40.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.06 -52.01 52.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.93 -14.9 62.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.31 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.61 -68.29 0.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -46.34 -43.68 16.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.66 1.184 . . . . 0.0 112.825 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.587 1.155 . . . . 0.0 111.632 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.2 -24.94 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.906 0.482 . . . . 0.0 111.592 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -59.23 2.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 109.862 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.26 -33.53 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.686 0.794 . . . . 0.0 112.207 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.94 -54.57 2.71 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.485 1.514 . . . . 0.0 111.09 170.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.2 mt -74.39 -52.45 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.658 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -54.36 42.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.582 0.628 . . . . 0.0 110.269 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -90.82 41.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.051 1.34 . . . . 0.0 110.201 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.39 73.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.52 163.58 26.58 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.962 3.108 . . . . 0.0 111.639 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.35 -8.78 23.08 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.41 2.74 . . . . 0.0 113.919 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 78.81 25.77 0.5 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.083 2.153 . . . . 0.0 111.084 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.21 169.08 14.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.29 1.836 . . . . 0.0 107.987 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.2 77.99 1.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.689 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.46 122.69 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.749 1.22 . . . . 0.0 110.018 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -82.83 -57.95 3.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.072 1.349 . . . . 0.0 107.898 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.23 136.29 6.54 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.164 0.29 . . . . 0.0 110.841 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 84.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -87.58 75.46 9.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -70.38 160.5 32.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.886 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 m -146.1 80.31 1.57 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 109.489 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.25 137.47 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.481 1.513 . . . . 0.0 112.467 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -144.85 -177.51 5.56 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 0.0 110.871 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 153.12 39.9 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.11 124.67 23.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.748 0.819 . . . . 0.0 111.578 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.18 -49.46 35.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.93 172.5 42.07 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.86 109.98 20.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.68 140.89 58.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.891 0.877 . . . . 0.0 109.935 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.25 91.82 2.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.676 0.79 . . . . 0.0 110.588 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.9 -163.41 0.23 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.43 1.092 . . . . 0.0 109.811 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.1 87.62 2.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.618 0.767 . . . . 0.0 109.638 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 100' ' ' THR . 21.5 tt0 -104.25 -175.91 2.93 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.606 0.762 . . . . 0.0 109.079 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.488 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.4 p -125.17 158.81 33.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.118 -1.42 . . . . 0.0 109.934 159.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.493 0.187 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 164.13 19.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.236 1.014 . . . . 0.0 111.592 -170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -86.39 118.42 25.82 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.1 ptm -89.58 91.35 8.65 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.279 1.037 . . . . 0.0 108.832 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.28 128.66 35.34 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.32 14.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.097 0.475 . . . . 0.0 111.254 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -100.77 94.56 6.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.005 0.922 . . . . 0.0 109.084 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.83 103.76 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.482 0.713 . . . . 0.0 109.135 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -101.86 143.47 31.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.799 0.84 . . . . 0.0 110.569 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.72 -165.95 33.22 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.49 0.494 . . . . 0.0 112.342 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.65 20.5 0.73 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.706 0.803 . . . . 0.0 110.546 168.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.23 -3.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.97 1.308 . . . . 0.0 112.469 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -82.23 33.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.714 1.605 . . . . 0.0 112.814 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.23 57.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -157.96 -174.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.218 1.007 . . . . 0.0 108.402 176.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.86 66.53 0.65 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.188 0.899 . . . . 0.0 111.897 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -133.24 171.51 13.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.703 2.001 . . . . 0.0 107.372 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 80.32 -62.39 0.24 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.639 1.576 . . . . 0.0 107.886 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -54.26 -41.14 68.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.696 0.798 . . . . 0.0 109.478 165.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.79 -55.8 23.21 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.62 -18.57 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.875 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -57.67 -58.8 6.76 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.224 0.92 . . . . 0.0 109.324 165.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.0 mm -46.79 -56.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 123.232 0.613 . . . . 0.0 111.49 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -66.13 -44.3 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.5 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.31 -65.16 0.6 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.214 0.461 . . . . 0.0 110.766 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.93 -45.96 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.978 1.711 . . . . 0.0 111.428 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.93 -43.8 98.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 111.469 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.29 16.72 8.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.777 0.831 . . . . 0.0 112.531 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.74 58.23 15.3 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 124.334 0.969 . . . . 0.0 112.518 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.21 139.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.942 1.297 . . . . 0.0 109.916 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.11 175.13 5.63 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.238 1.415 . . . . 0.0 108.237 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.56 -140.41 11.77 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -170.88 150.67 3.21 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.027 0.413 . . . . 0.0 111.297 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.48 86.5 2.37 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.415 1.486 . . . . 0.0 108.953 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.48 108.95 20.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.24 1.016 . . . . 0.0 108.427 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.15 92.83 9.12 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.16 1.384 . . . . 0.0 109.756 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.88 113.67 32.21 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.59 72.91 5.42 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.357 2.705 . . . . 0.0 112.201 -162.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -165.25 55.93 0.12 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.85 1.66 . . . . 0.0 107.992 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.47 -40.59 1.78 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.48 1.038 . . . . 0.0 114.082 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -90.99 93.22 9.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.404 1.482 . . . . 0.0 110.93 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.37 119.83 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.74 125.79 36.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.746 1.218 . . . . 0.0 109.003 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.77 135.25 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.685 1.194 . . . . 0.0 107.881 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.59 55.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 C-N-CA 124.113 0.965 . . . . 0.0 108.981 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.96 157.54 30.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.249 1.42 . . . . 0.0 110.165 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -143.83 123.03 12.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.545 -172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.88 166.72 39.39 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.467 -1.349 . . . . 0.0 113.748 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -52.43 156.25 1.84 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 0.0 111.352 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.68 -15.05 58.95 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.9 -36.32 82.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.271 0.487 . . . . 0.0 109.942 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.73 -3.53 29.96 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.666 1.186 . . . . 0.0 112.696 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.4 tp -66.9 -61.54 1.89 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.265 0.939 . . . . 0.0 109.364 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -44.7 -41.94 7.2 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.128 1.371 . . . . 0.0 112.878 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.18 -50.31 73.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.627 1.171 . . . . 0.0 111.079 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 68' ' ' LEU . 17.4 tp -71.19 -30.04 65.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.624 0.37 . . . . 0.0 111.274 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.21 -58.7 3.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.98 -38.81 68.29 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.985 0.914 . . . . 0.0 112.268 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -30.44 -52.08 0.15 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.571 1.948 . . . . 0.0 112.542 164.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.16 -72.36 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 122.752 0.421 . . . . 0.0 110.452 -169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -49.65 -49.89 45.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.053 0.941 . . . . 0.0 111.869 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -89.18 29.42 1.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.467 1.107 . . . . 0.0 111.954 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.56 68.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.77 164.92 32.62 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.022 3.148 . . . . 0.0 111.546 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -178.51 4.23 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.512 2.808 . . . . 0.0 110.864 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.12 28.81 0.69 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.104 0.961 . . . . 0.0 112.251 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.458 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -131.25 167.0 19.94 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.732 1.213 . . . . 0.0 110.328 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.84 81.99 2.76 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.81 83.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.549 1.54 . . . . 0.0 110.607 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -39.44 -62.37 0.68 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.964 2.106 . . . . 0.0 111.458 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -165.57 129.28 2.24 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 111.702 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.68 99.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.29 80.7 9.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -74.75 142.61 44.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.0 m -148.28 85.26 1.52 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 109.593 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.98 142.4 0.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.567 1.947 . . . . 0.0 111.027 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -159.95 171.85 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.26 143.06 39.17 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.008 0.923 . . . . 0.0 109.773 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.48 145.69 52.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.085 0.469 . . . . 0.0 111.936 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -58.28 2.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.113 1.365 . . . . 0.0 108.332 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.62 167.8 39.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.54 103.05 6.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.427 0.691 . . . . 0.0 110.213 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -77.55 79.24 4.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -44.44 119.5 1.88 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.375 1.87 . . . . 0.0 112.502 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.5 t70 68.1 124.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.874 2.07 . . . . 0.0 111.595 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.35 95.1 3.15 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -118.21 160.09 22.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 0.819 . . . . 0.0 110.794 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.95 145.97 29.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.678 0.791 . . . . 0.0 112.385 -171.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.304 154.128 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 171.58 8.19 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.874 0.869 . . . . 0.0 111.731 -174.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -103.11 107.35 18.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.976 1.311 . . . . 0.0 111.375 -168.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.14 98.2 11.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 109.583 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -74.82 133.86 41.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.17 105.84 5.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.67 99.61 12.61 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.225 1.41 . . . . 0.0 108.37 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.22 116.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.462 1.105 . . . . 0.0 109.065 -170.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -98.97 158.03 15.92 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.688 1.195 . . . . 0.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.11 -162.71 14.76 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 124.631 1.11 . . . . 0.0 111.993 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.23 32.86 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.701 0.8 . . . . 0.0 110.773 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.88 -19.22 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.291 1.036 . . . . 0.0 111.212 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -56.62 133.95 54.12 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.352 1.061 . . . . 0.0 110.15 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.74 10.47 83.26 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.109 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.17 152.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.73 1.212 . . . . 0.0 107.843 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.49 45.9 3.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.769 0.7 . . . . 0.0 112.89 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -57.82 -51.69 68.54 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.676 0.79 . . . . 0.0 109.376 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -56.84 -42.29 79.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.717 0.807 . . . . 0.0 111.692 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.27 -46.08 81.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.274 1.03 . . . . 0.0 110.452 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.99 -45.19 75.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.001 0.364 . . . . 0.0 110.489 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.36 -32.8 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.969 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -59.54 -55.78 30.22 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.284 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mm -42.01 -57.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.766 1.166 . . . . 0.0 113.325 -172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -68.65 -48.07 64.95 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.393 0.542 . . . . 0.0 110.443 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.39 -65.4 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 111.646 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.45 -49.85 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.218 2.207 . . . . 0.0 111.5 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.87 78.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.846 0.458 . . . . 0.0 111.944 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.5 mt -102.06 23.47 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.71 65.87 3.25 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.454 1.026 . . . . 0.0 113.304 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.92 139.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 125.045 1.338 . . . . 0.0 108.004 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -101.56 167.1 10.35 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.072 1.349 . . . . 0.0 107.808 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.98 -146.52 14.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.338 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -167.45 148.6 5.54 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.576 1.15 . . . . 0.0 109.186 166.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.52 81.44 1.59 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.85 0.86 . . . . 0.0 108.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -86.83 84.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.82 87.64 2.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.724 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 123.05 85.67 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 163.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.52 69.33 7.75 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.65 2.234 . . . . 0.0 111.428 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -159.05 56.04 0.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.216 1.406 . . . . 0.0 108.527 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.82 -55.6 4.75 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.856 0.741 . . . . 0.0 113.545 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 m -94.37 66.3 3.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.424 0.689 . . . . 0.0 112.567 -161.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.67 118.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.047 0.539 . . . . 0.0 110.294 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.48 121.21 32.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.0 110.01 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.14 147.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.93 66.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.58 157.57 37.75 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.249 1.42 . . . . 0.0 110.315 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.12 116.7 11.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.742 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.03 159.84 27.47 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 118.722 0.692 . . . . 0.0 114.566 -170.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.9 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.264 1.826 . . . . 0.0 109.535 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -154.72 -75.84 0.11 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.301 1.441 . . . . 0.0 108.222 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -55.1 -48.59 73.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.0 69.38 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.986 0.515 . . . . 0.0 111.797 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.08 -66.31 0.56 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.4 t -44.98 -46.1 10.94 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.041 1.737 . . . . 0.0 112.77 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.73 -44.05 94.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.395 0.543 . . . . 0.0 111.891 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.29 -23.59 51.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.766 0.826 . . . . 0.0 111.354 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.44 -61.55 1.73 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.226 -0.921 . . . . 0.0 110.857 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.36 -36.91 79.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.875 0.87 . . . . 0.0 111.146 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -36.96 -49.59 0.83 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 165.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.81 -64.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.242 0.617 . . . . 0.0 110.056 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -51.57 62.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.831 0.852 . . . . 0.0 111.476 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -77.63 -33.14 53.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.041 0.936 . . . . 0.0 111.998 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.78 85.94 0.42 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.413 1.006 . . . . 0.0 110.686 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.66 156.23 66.19 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.965 2.443 . . . . 0.0 111.299 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.77 172.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.018 3.145 . . . . 0.0 111.715 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.01 27.76 1.53 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.162 0.985 . . . . 0.0 111.875 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.18 28.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.902 1.281 . . . . 0.0 109.445 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 81.64 3.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.45 122.41 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.56 -56.79 4.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -168.31 142.8 3.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.631 1.173 . . . . 0.0 108.667 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.49 100.24 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.76 75.01 4.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -78.71 160.38 27.5 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -135.46 109.43 8.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.734 1.614 . . . . 0.0 109.591 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 119.55 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -134.42 179.49 6.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.798 1.239 . . . . 0.0 110.461 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -104.82 135.92 45.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.128 0.971 . . . . 0.0 110.03 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -52.17 138.98 24.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.065 2.146 . . . . 0.0 112.746 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -79.33 -48.83 13.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.48 179.5 27.16 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.73 112.79 20.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.69 1.196 . . . . 0.0 107.905 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -70.05 137.79 51.56 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -68.17 90.29 0.33 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.664 0.786 . . . . 0.0 110.212 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 70.18 -164.93 0.16 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.229 1.412 . . . . 0.0 109.713 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.7 96.82 3.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.993 0.917 . . . . 0.0 108.856 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -121.56 163.28 19.15 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.483 0.713 . . . . 0.0 109.836 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.94 148.64 33.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.847 1.259 . . . . 0.0 111.73 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.28 155.559 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.28 168.26 12.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.788 0.835 . . . . 0.0 111.483 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -96.52 97.33 9.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.824 1.25 . . . . 0.0 109.996 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 ttp -62.93 152.33 36.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -149.92 123.73 9.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.338 1.055 . . . . 0.0 108.75 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.48 117.01 22.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.142 0.977 . . . . 0.0 110.67 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -91.37 92.74 8.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.312 1.445 . . . . 0.0 107.913 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 24' ' ' VAL . 4.2 t -88.76 112.13 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.52 149.65 21.96 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.173 0.589 . . . . 0.0 111.417 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.92 -153.87 20.51 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.854 1.216 . . . . 0.0 111.855 166.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.47 14.93 1.41 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.264 1.026 . . . . 0.0 111.662 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 HG12 ' A' ' 20' ' ' VAL . 27.3 m -74.51 21.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.346 1.458 . . . . 0.0 112.914 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -97.89 60.03 1.47 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.94 0.876 . . . . 0.0 110.707 -159.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.31 61.24 0.98 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.392 1.472 . . . . 0.0 111.087 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.27 101.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 108.709 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.54 -62.59 3.81 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.274 0.94 . . . . 0.0 111.123 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -64.14 172.85 2.19 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.364 1.066 . . . . 0.0 110.772 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 76.11 -60.57 0.48 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.601 1.96 . . . . 0.0 109.93 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -74.08 -46.52 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.526 0.73 . . . . 0.0 109.555 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -54.52 -51.18 65.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.518 -0.739 . . . . 0.0 111.116 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.43 -20.84 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.095 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -59.06 -60.15 4.33 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.572 0.624 . . . . 0.0 109.335 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -46.15 -52.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.791 0.836 . . . . 0.0 111.841 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -69.59 -46.97 65.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.436 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.34 -52.44 37.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.411 0.55 . . . . 0.0 112.148 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.8 -40.4 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.459 1.504 . . . . 0.0 110.733 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -41.59 93.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.379 0.536 . . . . 0.0 111.731 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.93 11.04 21.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.817 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.16 56.02 24.53 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.701 0.667 . . . . 0.0 112.164 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.84 139.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.436 1.494 . . . . 0.0 108.791 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -108.94 169.6 8.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.382 1.473 . . . . 0.0 107.634 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.81 -138.76 9.14 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -175.46 141.58 0.53 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 117.69 0.745 . . . . 0.0 111.099 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.6 87.19 2.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.253 1.421 . . . . 0.0 110.165 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -92.68 110.07 21.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.269 0.628 . . . . 0.0 110.222 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.07 96.94 10.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.718 1.607 . . . . 0.0 109.234 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -77.89 110.81 14.33 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.07 79.18 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.442 2.761 . . . . 0.0 112.123 -161.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -142.09 -75.39 0.29 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.263 1.825 . . . . 0.0 106.428 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -168.87 35.93 0.2 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.673 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -137.3 103.82 5.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.257 1.023 . . . . 0.0 109.943 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.56 111.08 32.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -91.73 117.22 29.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.467 1.107 . . . . 0.0 109.576 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.27 104.75 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 110.054 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.3 t -79.86 130.26 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.29 124.67 16.6 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.244 1.018 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -108.58 104.66 14.02 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 109.074 -171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.76 159.63 27.96 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -71.52 -98.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.685 1.194 . . . . 0.0 109.656 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -159.65 -53.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.35 1.06 . . . . 0.0 109.486 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -44.3 -42.48 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.27 1.428 . . . . 0.0 110.385 162.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.51 -29.48 18.92 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.514 1.126 . . . . 0.0 112.248 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.08 -58.33 8.9 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 119.045 0.839 . . . . 0.0 109.89 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 p -43.48 -44.31 5.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.39 1.476 . . . . 0.0 112.866 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.58 -33.38 74.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.952 0.901 . . . . 0.0 112.285 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.62 -53.14 7.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.647 0.779 . . . . 0.0 110.324 169.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -52.9 61.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 110.454 -170.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.16 -36.46 83.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.174 1.389 . . . . 0.0 112.15 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.9 -50.34 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.605 169.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.97 -52.55 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 123.201 0.313 . . . . 0.0 110.592 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -49.48 77.32 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.339 0.518 . . . . 0.0 111.129 -174.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.9 -44.16 81.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.096 1.358 . . . . 0.0 110.914 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.63 82.3 0.3 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.514 1.53 . . . . 0.0 109.649 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.17 164.02 26.87 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.737 2.958 . . . . 0.0 111.412 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.58 148.35 72.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.476 2.117 . . . . 0.0 109.501 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.13 49.72 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.475 0.71 . . . . 0.0 110.874 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.23 167.47 29.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.624 1.17 . . . . 0.0 109.238 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.9 77.45 2.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.697 0.799 . . . . 0.0 110.108 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.63 122.65 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.176 0.99 . . . . 0.0 109.456 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.62 -59.35 2.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -169.94 135.78 1.44 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.372 0.669 . . . . 0.0 110.152 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.59 96.87 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -87.13 71.77 10.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.37 148.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.713 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -151.87 103.01 2.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 146.85 52.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.473 0.709 . . . . 0.0 110.579 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -134.19 -174.1 3.46 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 110.383 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.39 25.58 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.099 1.36 . . . . 0.0 109.047 170.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -76.9 144.42 38.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.004 0.922 . . . . 0.0 111.718 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -83.96 -57.75 3.07 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -152.53 172.18 31.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.72 115.77 21.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.359 1.064 . . . . 0.0 108.733 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -68.63 -38.18 80.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.727 1.211 . . . . 0.0 110.506 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 56.86 62.04 2.4 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.81 1.644 . . . . 0.0 112.412 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 t70 157.2 86.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.099 2.559 . . . . 0.0 108.438 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -73.99 91.59 2.05 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -125.84 154.53 42.53 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 111.292 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 120.79 36.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.985 0.914 . . . . 0.0 109.819 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HZ3' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -136.33 -173.31 3.37 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.597 1.559 . . . . 0.0 111.759 -168.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -111.99 132.59 54.69 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.067 0.947 . . . . 0.0 111.287 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.0 ttp -82.5 164.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 156.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -158.53 82.99 0.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.607 1.163 . . . . 0.0 108.239 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.59 105.89 17.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.726 0.81 . . . . 0.0 109.714 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.81 9.67 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.36 114.62 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -166.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.13 140.36 38.42 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.295 1.438 . . . . 0.0 110.87 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.17 -156.39 23.34 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.998 1.285 . . . . 0.0 111.355 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.93 15.68 0.84 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.523 0.729 . . . . 0.0 111.777 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -57.71 -30.37 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.896 0.878 . . . . 0.0 109.954 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.78 126.07 28.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 162.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.52 26.52 25.04 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.968 0.794 . . . . 0.0 111.623 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -154.37 151.66 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.044 1.338 . . . . 0.0 107.898 171.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.09 -69.02 1.4 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.027 0.823 . . . . 0.0 111.687 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 t80 52.79 -116.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 116.942 -1.504 . . . . 0.0 109.717 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 35.92 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.23 2.612 . . . . 0.0 114.423 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -33.03 -47.92 0.19 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.417 1.887 . . . . 0.0 112.254 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.23 -43.68 78.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.41 0.684 . . . . 0.0 111.97 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.24 -36.71 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 C-N-CA 123.53 0.732 . . . . 0.0 109.975 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -46.79 87.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.131 -0.937 . . . . 0.0 109.793 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mm -38.91 -56.47 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -174.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -67.92 -48.19 66.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.418 1.008 . . . . 0.0 111.115 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.06 -64.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.011 0.924 . . . . 0.0 111.603 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.37 -51.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 127.841 2.456 . . . . 0.0 110.621 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -42.28 62.31 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.266 0.626 . . . . 0.0 110.811 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.0 21.58 12.51 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.359 1.464 . . . . 0.0 112.371 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.12 2.93 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.146 0.879 . . . . 0.0 112.863 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 mm -119.39 142.71 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.768 1.227 . . . . 0.0 109.777 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 175.56 5.46 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.386 1.474 . . . . 0.0 108.453 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.47 -148.0 19.61 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -173.87 140.46 0.74 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 117.652 0.726 . . . . 0.0 111.173 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.34 88.03 2.82 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 124.631 1.172 . . . . 0.0 110.322 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.44 107.73 20.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.519 0.728 . . . . 0.0 110.694 -166.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.69 119.6 20.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.767 172.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.37 97.37 1.59 Allowed Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -64.31 138.51 61.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.688 1.592 . . . . 0.0 110.193 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t0 57.49 59.46 3.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.498 1.119 . . . . 0.0 109.434 -164.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.44 -140.16 3.96 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.4 p -124.1 156.46 36.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.76 1.624 . . . . 0.0 109.922 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.84 105.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 123.534 0.733 . . . . 0.0 109.512 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -93.77 134.1 36.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.482 0.713 . . . . 0.0 111.103 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.21 116.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.623 1.169 . . . . 0.0 109.418 -171.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.6 141.82 16.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.84 123.38 17.22 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.899 1.279 . . . . 0.0 108.002 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.83 90.17 3.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.546 0.738 . . . . 0.0 109.214 -162.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 162.86 22.92 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 122.086 0.826 . . . . 0.0 114.672 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.36 163.03 28.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.872 1.269 . . . . 0.0 108.01 163.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.72 -23.58 42.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -64.4 -50.01 69.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -9.83 58.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.936 0.894 . . . . 0.0 112.512 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 HD13 ' HZ3' ' A' ' 14' ' ' LYS . 25.9 tp -68.92 -60.96 2.01 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 119.325 0.966 . . . . 0.0 109.011 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -44.59 -44.67 9.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.566 1.146 . . . . 0.0 112.803 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -49.9 -51.6 39.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.208 1.003 . . . . 0.0 111.91 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.32 -42.48 45.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.435 1.494 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -55.48 -58.26 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.539 1.136 . . . . 0.0 110.388 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.64 -33.31 68.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.682 1.193 . . . . 0.0 111.394 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -40.08 -48.23 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.241 1.417 . . . . 0.0 111.023 165.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.57 -58.76 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.029 0.532 . . . . 0.0 111.065 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -59.52 -39.19 83.07 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.343 0.519 . . . . 0.0 111.088 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -72.93 -44.43 61.2 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.249 1.42 . . . . 0.0 111.094 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 80.91 0.28 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.069 1.318 . . . . 0.0 110.151 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -62.44 159.42 36.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.923 2.415 . . . . 0.0 111.128 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.56 156.08 54.51 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.26 2.64 . . . . 0.0 110.811 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.48 42.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.74 . . . . 0.0 111.25 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -153.01 167.62 28.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.73 1.612 . . . . 0.0 109.357 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.23 82.13 4.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.663 0.785 . . . . 0.0 109.015 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.69 127.52 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 109.415 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -90.07 -51.93 5.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.539 1.136 . . . . 0.0 109.517 -174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -163.1 74.6 0.37 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 112.079 -173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.39 88.08 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.657 0.741 . . . . 0.0 110.44 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.28 80.23 3.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.763 1.225 . . . . 0.0 107.791 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.29 162.39 29.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.029 0.443 . . . . 0.0 111.391 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.1 m -140.82 134.89 30.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.14 0.976 . . . . 0.0 109.301 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.71 138.37 31.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 m -137.76 177.84 7.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 111.724 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -82.39 152.2 26.29 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 124.602 1.161 . . . . 0.0 111.058 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 117.48 8.44 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 110.281 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -99.23 -55.59 2.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.969 1.308 . . . . 0.0 108.531 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.43 38.86 37.27 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 123.927 0.775 . . . . 0.0 113.255 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -85.14 -30.55 23.9 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -81.98 131.99 35.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.892 0.769 . . . . 0.0 110.586 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.68 119.44 33.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.183 1.793 . . . . 0.0 107.467 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.4 t70 64.41 171.27 0.19 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.64 1.176 . . . . 0.0 111.385 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.39 87.53 2.68 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.436 1.495 . . . . 0.0 108.357 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -105.74 152.6 22.97 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 111.128 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.15 130.15 55.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.255 1.022 . . . . 0.0 109.986 -168.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.62 1.568 . . . . 0.0 107.786 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 168.4 14.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.437 1.095 . . . . 0.0 111.744 -164.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -97.78 124.79 42.29 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 111.58 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -91.56 153.82 19.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -135.16 98.65 4.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.584 1.554 . . . . 0.0 109.374 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.46 109.67 21.82 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.332 0.653 . . . . 0.0 110.274 177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -92.26 91.22 7.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.304 1.041 . . . . 0.0 108.258 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.11 112.23 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.074 0.55 . . . . 0.0 109.63 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.11 146.4 25.08 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.476 1.511 . . . . 0.0 109.87 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.53 -175.62 20.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.213 0.911 . . . . 0.0 111.59 173.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 tp -82.81 28.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 0.0 110.576 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.22 -28.11 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.019 0.927 . . . . 0.0 110.939 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.74 131.84 14.6 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 109.889 162.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 -55.55 2.43 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.441 -0.644 . . . . 0.0 112.169 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 79' ' ' ALA . 20.3 m -71.78 -178.98 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 117.936 0.868 . . . . 0.0 111.767 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.78 85.9 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.926 1.251 . . . . 0.0 111.497 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -156.48 174.62 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.923 1.289 . . . . 0.0 109.072 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 76.12 -66.31 0.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.115 1.766 . . . . 0.0 109.752 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -53.84 -45.68 70.98 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.8 -42.68 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.088 0.955 . . . . 0.0 111.604 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.88 -32.77 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 110.573 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -56.94 15.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 110.316 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -46.68 -56.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.366 0.666 . . . . 0.0 112.12 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -65.88 -47.85 73.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.033 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.78 -65.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.554 0.741 . . . . 0.0 111.415 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.13 -46.09 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 126.619 1.967 . . . . 0.0 111.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -60.93 -39.5 89.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.162 0.585 . . . . 0.0 111.116 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.85 20.36 7.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.787 0.835 . . . . 0.0 112.834 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.84 53.23 45.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.299 0.952 . . . . 0.0 113.287 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mm -108.94 135.67 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.232 1.413 . . . . 0.0 108.408 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.38 178.63 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.673 1.189 . . . . 0.0 109.126 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.3 -142.43 10.02 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 119.538 1.063 . . . . 0.0 111.917 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -178.64 141.46 0.21 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.507 1.523 . . . . 0.0 110.137 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.42 87.69 2.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.932 0.893 . . . . 0.0 110.672 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -93.78 105.01 17.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.441 0.639 . . . . 0.0 110.994 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.12 96.5 7.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.37 117.61 69.03 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.53 71.69 6.34 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.578 2.852 . . . . 0.0 111.381 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.23 41.24 0.81 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.233 1.413 . . . . 0.0 108.537 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.56 33.64 67.36 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.202 0.906 . . . . 0.0 112.795 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 m -145.78 90.66 2.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.763 0.782 . . . . 0.0 110.035 -173.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -98.65 121.7 49.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.533 0.733 . . . . 0.0 109.092 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.52 143.64 28.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.85 130.21 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.1 141.88 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 158.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.59 122.26 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 109.448 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -124.8 116.53 22.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.222 1.009 . . . . 0.0 111.483 -156.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.31 -171.1 44.09 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.34 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.87 164.0 10.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.384 1.073 . . . . 0.0 110.182 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -81.89 -24.77 35.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -63.39 -52.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.22 -21.38 63.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.4 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.34 -61.44 1.84 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.0 p -47.41 -46.27 26.15 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.904 0.882 . . . . 0.0 112.498 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -51.78 -48.96 63.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.859 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.37 -54.34 21.41 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 110.711 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.9 59.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.219 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.72 -36.56 80.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.642 1.577 . . . . 0.0 112.157 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.71 -43.43 17.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.132 1.373 . . . . 0.0 111.644 171.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.02 -59.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 110.506 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.74 -41.46 97.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.077 0.399 . . . . 0.0 111.7 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.24 -45.97 68.47 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.988 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.38 78.84 0.25 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.742 1.163 . . . . 0.0 110.874 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 157.75 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.023 2.482 . . . . 0.0 110.516 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 165.09 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.388 2.725 . . . . 0.0 111.105 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.77 42.94 0.95 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.611 0.764 . . . . 0.0 111.268 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -148.48 172.12 14.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.046 0.938 . . . . 0.0 110.061 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.82 86.5 0.51 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.335 1.054 . . . . 0.0 109.644 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.48 80.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.024 1.33 . . . . 0.0 109.334 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -38.74 -65.28 0.37 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.491 2.316 . . . . 0.0 111.342 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -151.56 147.43 26.78 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.389 0.676 . . . . 0.0 109.835 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.45 84.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.81 68.53 10.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -73.77 162.91 28.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -147.47 133.39 19.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.784 0.834 . . . . 0.0 109.202 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.89 135.89 34.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.819 1.248 . . . . 0.0 107.955 170.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 m -129.84 -177.55 4.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.455 1.102 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.05 166.83 13.2 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.836 0.855 . . . . 0.0 111.111 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -55.78 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.596 0.758 . . . . 0.0 110.589 166.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -100.31 -56.7 2.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.337 0.655 . . . . 0.0 110.313 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.24 135.57 3.75 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.42 100.45 9.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.774 1.229 . . . . 0.0 110.648 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -75.95 72.36 2.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.94 68.68 1.82 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.647 1.579 . . . . 0.0 112.993 -165.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 166.51 89.43 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 128.492 2.717 . . . . 0.0 106.056 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.75 83.9 6.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.0 158.81 22.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 123.482 0.489 . . . . 0.0 109.949 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.03 139.4 35.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.251 0.62 . . . . 0.0 110.309 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.161 -1.4 . . . . 0.0 109.333 166.947 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 -179.44 4.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.227 1.011 . . . . 0.0 111.734 -171.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -106.38 130.8 54.14 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.303 0.641 . . . . 0.0 112.667 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 69' ' ' LEU . 65.3 ttp -69.12 156.9 37.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 154.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.05 87.37 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 107.18 19.13 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -85.97 102.49 13.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 t -96.78 121.82 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 122.912 0.485 . . . . 0.0 110.424 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.67 153.13 20.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 -175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.46 -155.51 17.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.463 1.506 . . . . 0.0 110.695 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 16.86 0.82 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.54 0.736 . . . . 0.0 111.563 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.4 -20.59 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.936 0.895 . . . . 0.0 111.57 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.93 138.65 50.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.384 0.673 . . . . 0.0 109.325 167.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.29 -64.23 4.2 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.8 157.6 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.343 1.057 . . . . 0.0 108.715 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.16 -96.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.514 1.054 . . . . 0.0 112.728 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 t80 63.64 -62.06 0.15 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.4 2.28 . . . . 0.0 112.931 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -33.18 -44.59 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.44 2.696 . . . . 0.0 112.879 167.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -69.38 -45.77 68.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.361 0.664 . . . . 0.0 109.869 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -56.25 -46.22 79.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.44 0.696 . . . . 0.0 110.927 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.28 -37.38 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.924 0.49 . . . . 0.0 110.485 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -64.31 -49.98 69.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.261 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mm -45.42 -56.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.661 1.118 . . . . 0.0 111.515 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -64.36 -48.33 75.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.98 -51.06 59.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.63 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.391 1.476 . . . . 0.0 109.269 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -55.23 -38.57 68.65 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.496 0.718 . . . . 0.0 110.883 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.33 2.81 55.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.266 1.426 . . . . 0.0 113.161 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 62.52 4.95 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.883 0.765 . . . . 0.0 111.68 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.97 143.91 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 125.517 1.527 . . . . 0.0 108.597 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -101.84 170.01 8.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.771 1.228 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.13 -143.58 11.07 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.853 0.752 . . . . 0.0 112.344 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -174.15 142.56 0.83 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.568 1.147 . . . . 0.0 108.953 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.74 79.03 1.88 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -93.5 96.34 9.82 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.792 -164.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.78 93.89 9.62 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 126.292 1.837 . . . . 0.0 110.182 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.03 110.62 6.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.58 64.78 8.66 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.208 2.606 . . . . 0.0 111.567 -161.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -167.36 38.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.87 1.668 . . . . 0.0 109.569 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.27 -105.86 0.28 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -121.14 144.53 48.52 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.618 1.567 . . . . 0.0 110.568 -165.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.63 125.21 41.85 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.717 0.807 . . . . 0.0 110.397 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.08 116.32 27.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.0 t -112.81 123.19 68.23 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.062 0 C-N-CA 124.065 0.946 . . . . 0.0 108.682 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 m -118.0 69.3 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.5 0.72 . . . . 0.0 111.406 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.49 128.45 35.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.948 0.899 . . . . 0.0 111.293 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.65 107.6 15.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.588 0.755 . . . . 0.0 111.085 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.99 172.68 34.58 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.634 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -67.42 168.0 11.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.015 1.326 . . . . 0.0 109.026 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.99 -18.56 53.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.935 0.494 . . . . 0.0 112.093 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.71 -29.12 69.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.21 1.004 . . . . 0.0 110.683 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -2.04 15.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.114 1.366 . . . . 0.0 112.073 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.21 -66.31 0.6 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -41.2 -45.43 2.85 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 125.313 1.445 . . . . 0.0 112.129 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -54.17 -52.72 60.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.59 0.756 . . . . 0.0 111.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.12 -24.08 61.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.825 1.65 . . . . 0.0 111.947 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 16' ' ' MET . 3.3 mm? -82.61 -61.54 1.85 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.991 0.916 . . . . 0.0 111.103 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -47.15 -45.51 22.64 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.584 1.954 . . . . 0.0 111.446 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -29.76 -56.99 0.17 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.022 1.729 . . . . 0.0 112.022 164.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.02 -71.41 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 122.761 0.424 . . . . 0.0 110.876 -167.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -48.49 -44.64 36.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.137 0.975 . . . . 0.0 112.319 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -103.42 53.17 0.76 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.239 1.016 . . . . 0.0 110.57 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.71 153.17 24.65 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.02 114.0 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.775 2.983 . . . . 0.0 110.991 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.75 145.96 47.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.221 1.947 . . . . 0.0 110.838 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.01 -21.37 62.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.46 0.704 . . . . 0.0 111.777 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.1 172.15 10.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.207 1.403 . . . . 0.0 110.828 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.6 73.44 3.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.96 121.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.539 1.136 . . . . 0.0 109.096 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.97 -60.18 2.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.32 152.71 6.14 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 122.905 0.482 . . . . 0.0 110.895 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.26 97.95 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.245 1.018 . . . . 0.0 109.03 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.02 75.73 7.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -80.45 163.05 24.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.532 0.682 . . . . 0.0 112.197 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 123.52 18.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.721 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 123.86 25.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 164.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -128.72 174.31 9.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.945 0.898 . . . . 0.0 110.119 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.64 141.39 28.99 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.56 139.25 58.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.467 1.507 . . . . 0.0 111.393 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.84 -49.32 13.12 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.223 1.009 . . . . 0.0 108.931 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.43 175.56 41.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.39 106.13 17.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.43 134.04 55.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.126 0.97 . . . . 0.0 108.643 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.72 96.68 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.279 0.632 . . . . 0.0 109.61 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 71.22 -170.43 0.15 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.798 1.639 . . . . 0.0 110.668 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.01 92.11 2.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.437 1.095 . . . . 0.0 108.466 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -121.88 164.41 17.58 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.719 0.408 . . . . 0.0 109.959 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -99.01 139.34 34.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.474 0.71 . . . . 0.0 110.508 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.827 -1.559 . . . . 0.0 111.101 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 163.54 13.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.966 0.906 . . . . 0.0 112.309 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -84.62 114.36 21.94 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.495 0.664 . . . . 0.0 110.182 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.0 ptm -88.71 102.31 14.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.743 0.817 . . . . 0.0 110.149 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.62 108.01 18.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.908 1.283 . . . . 0.0 108.372 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.77 108.57 18.03 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.796 1.239 . . . . 0.0 110.382 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.7 116.81 29.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.588 1.955 . . . . 0.0 107.348 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.37 120.97 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.29 150.8 26.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.353 1.061 . . . . 0.0 110.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.65 -154.31 21.24 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.702 1.144 . . . . 0.0 110.743 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.36 17.81 3.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.365 0.602 . . . . 0.0 110.211 166.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.43 -36.89 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.664 1.986 . . . . 0.0 112.14 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -75.26 80.13 2.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.13 -67.04 0.05 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.95 38.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.883 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.73 -93.34 0.12 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.902 1.239 . . . . 0.0 112.499 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.2 t80 70.78 -38.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.511 2.324 . . . . 0.0 114.128 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -42.87 -44.83 4.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.297 1.439 . . . . 0.0 112.531 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -69.37 -48.83 60.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.079 0.552 . . . . 0.0 110.537 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -51.77 -43.37 62.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.494 1.118 . . . . 0.0 111.707 174.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' N ' HH21 ' A' ' 71' ' ' ARG . 85.0 t -60.6 -39.7 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -45.95 79.66 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 117.32 -1.324 . . . . 0.0 112.046 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.3 mm -48.14 -54.58 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.123 1.783 . . . . 0.0 111.922 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -66.75 -47.21 72.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.132 -0.461 . . . . 0.0 109.967 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.59 -52.09 24.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.426 0.69 . . . . 0.0 112.717 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.87 -43.17 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 126.434 1.894 . . . . 0.0 110.099 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -63.61 -34.33 77.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.102 0.561 . . . . 0.0 111.791 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.2 18.67 20.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.252 . . . . 0.0 112.305 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.01 63.82 4.91 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.413 1.006 . . . . 0.0 113.512 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.14 146.51 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.757 1.623 . . . . 0.0 108.659 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 94' ' ' GLU . 6.9 mtmp? -109.79 166.93 10.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.76 1.224 . . . . 0.0 108.403 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.79 -152.97 24.11 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.786 0.721 . . . . 0.0 112.717 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -166.28 141.09 4.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.225 1.01 . . . . 0.0 109.132 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.89 91.11 3.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.657 1.183 . . . . 0.0 108.962 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -85.94 80.91 8.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -102.91 59.25 0.78 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.456 1.102 . . . . 0.0 108.932 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.4 mt -71.52 108.81 4.36 Favored Pre-proline 0 C--N 1.34 0.188 0 C-N-CA 125.629 1.572 . . . . 0.0 108.43 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -79.71 64.07 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.845 3.03 . . . . 0.0 112.804 -163.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -173.01 54.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.903 2.081 . . . . 0.0 108.095 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 -109.3 0.33 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 m -133.09 160.53 36.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.801 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.34 95.54 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.44 134.47 42.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.595 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.8 t -106.35 133.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.26 78.05 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.19 166.86 16.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.715 1.206 . . . . 0.0 109.818 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.86 109.41 7.44 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 118.866 -0.588 . . . . 0.0 111.965 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.32 149.19 21.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.961 0.8 . . . . 0.0 113.794 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -57.48 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.405 2.282 . . . . 0.0 111.769 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -154.75 -71.16 0.13 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.04 1.736 . . . . 0.0 107.157 -165.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -51.66 -50.65 59.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 164.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.25 62.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.319 1.047 . . . . 0.0 111.949 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -67.07 -66.84 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -48.4 -36.21 14.25 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.956 1.703 . . . . 0.0 113.291 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -63.76 -50.39 69.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.75 0.705 . . . . 0.0 112.542 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.39 -22.85 60.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.707 0.685 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.22 -58.05 4.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.858 -0.526 . . . . 0.0 110.909 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.31 -31.91 73.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.37 0.668 . . . . 0.0 111.614 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.426 HH21 ' N ' ' A' ' 33' ' ' VAL . 17.3 tpt85 -39.28 -54.2 1.85 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.078 1.351 . . . . 0.0 110.364 162.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.83 -53.0 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.032 0.533 . . . . 0.0 111.319 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.51 -38.42 91.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.297 0.499 . . . . 0.0 111.293 -168.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -76.05 -37.94 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.887 0.875 . . . . 0.0 111.482 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.15 74.58 0.24 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.319 0.961 . . . . 0.0 111.21 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.81 164.01 34.44 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.635 2.89 . . . . 0.0 111.688 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.97 128.03 11.18 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.218 2.612 . . . . 0.0 109.293 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.867 0.867 . . . . 0.0 110.058 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.99 74.38 0.43 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.459 0.704 . . . . 0.0 110.093 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 30.02 72.26 0.06 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.503 1.921 . . . . 0.0 110.877 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 90.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -50.72 -55.29 17.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.96 0.904 . . . . 0.0 110.098 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -170.47 140.56 1.81 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 171.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.09 84.37 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 165.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.67 76.25 7.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -71.73 160.12 33.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -150.39 95.56 2.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 141.26 57.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.739 0.816 . . . . 0.0 110.064 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -133.49 177.49 7.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.552 0.741 . . . . 0.0 111.456 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.03 124.02 34.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.051 1.74 . . . . 0.0 108.288 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -55.73 122.14 10.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.935 0.494 . . . . 0.0 112.017 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.65 -47.94 73.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.94 -157.02 10.11 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 13.8 pt-20 -89.03 107.45 19.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 109.358 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.75 73.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.05 137.04 8.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.944 1.698 . . . . 0.0 112.644 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 63.12 -165.57 0.24 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.392 1.077 . . . . 0.0 109.063 -173.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.75 82.81 1.22 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.98 162.81 13.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -171.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.11 134.06 55.14 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 111.072 -167.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.183 -1.389 . . . . 0.0 108.468 162.83 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.527 0.09 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -178.21 3.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.413 1.085 . . . . 0.0 111.393 -174.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -99.91 127.12 46.12 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.887 0.475 . . . . 0.0 110.773 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 10.8 ptm -97.9 96.62 8.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.141 0.972 . . . . 0.0 110.266 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -87.81 108.63 19.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.5 1.12 . . . . 0.0 108.587 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.74 109.15 14.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 110.721 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.25 100.37 12.94 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.433 1.093 . . . . 0.0 108.848 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 101.74 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.78 155.51 17.61 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.269 0.627 . . . . 0.0 111.758 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.95 -155.37 21.22 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.352 1.454 . . . . 0.0 111.581 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -81.6 28.99 0.38 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.996 0.918 . . . . 0.0 110.238 173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.2 m -76.13 -6.98 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.336 1.055 . . . . 0.0 112.717 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 164.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 164.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.87 -62.9 4.47 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -171.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -72.83 155.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.56 -83.11 0.33 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 122.949 0.309 . . . . 0.0 112.383 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 47.5 56.3 7.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.594 1.558 . . . . 0.0 111.519 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.97 -41.32 0.53 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.428 1.491 . . . . 0.0 108.729 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -72.39 -48.91 37.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.328 0.651 . . . . 0.0 110.848 171.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.17 -46.37 68.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.136 0.494 . . . . 0.0 111.114 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.19 -35.48 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.246 0.619 . . . . 0.0 110.359 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -64.96 -47.15 78.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.058 0.943 . . . . 0.0 110.641 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.57 -56.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.62 1.1 . . . . 0.0 110.935 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -70.41 -40.78 73.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.281 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.94 -54.91 11.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.2 0.6 . . . . 0.0 111.634 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.89 -38.81 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.119 1.368 . . . . 0.0 111.349 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -59.44 -37.1 77.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.915 0.486 . . . . 0.0 111.137 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -98.13 19.06 14.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.772 0.829 . . . . 0.0 112.869 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 56.54 22.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.023 0.821 . . . . 0.0 113.204 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -104.49 143.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 125.387 1.475 . . . . 0.0 108.91 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -104.27 171.27 7.43 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.531 1.132 . . . . 0.0 108.549 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.49 -138.72 10.27 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.207 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -166.6 145.9 5.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.508 0.654 . . . . 0.0 112.358 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.58 85.7 2.37 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.907 1.683 . . . . 0.0 108.938 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -95.39 100.84 12.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.012 0.525 . . . . 0.0 110.351 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.64 116.23 8.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 170.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.2 mt -94.13 94.12 1.04 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.57 141.52 95.5 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.387 2.058 . . . . 0.0 111.024 -170.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.49 61.57 2.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.644 1.178 . . . . 0.0 109.634 -166.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.75 -126.67 1.0 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -129.25 149.2 51.15 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.035 1.734 . . . . 0.0 109.303 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.6 99.42 5.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.25 125.34 30.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.84 1.256 . . . . 0.0 108.362 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -112.95 125.3 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.8 77.87 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 161.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 16' ' ' MET . . . -84.32 162.14 20.18 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.036 1.334 . . . . 0.0 108.845 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -138.93 105.15 5.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.069 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.03 166.23 24.96 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 118.708 0.685 . . . . 0.0 112.911 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -67.8 173.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.36 1.064 . . . . 0.0 108.632 161.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.85 -31.19 63.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.2 -20.49 65.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.128 0.571 . . . . 0.0 112.287 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.68 -12.09 18.67 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.938 0.895 . . . . 0.0 111.781 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.94 -70.7 0.24 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 p -43.81 -34.81 1.68 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.028 1.331 . . . . 0.0 113.602 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -68.73 -56.47 8.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.85 0.86 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.45 -22.16 62.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.425 0.69 . . . . 0.0 111.175 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.5 -59.77 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.6 -0.687 . . . . 0.0 110.191 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -61.69 -32.09 72.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.718 0.69 . . . . 0.0 111.85 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -43.54 -51.45 6.79 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.415 1.486 . . . . 0.0 111.952 164.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -67.29 -53.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 C-N-CA 123.246 0.619 . . . . 0.0 110.519 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -41.78 93.76 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.893 0.315 . . . . 0.0 110.63 -172.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -70.39 -42.12 72.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.447 1.499 . . . . 0.0 111.497 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.2 78.08 0.24 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.355 1.455 . . . . 0.0 111.075 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.75 169.39 17.68 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 124.033 3.155 . . . . 0.0 112.126 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.59 162.14 38.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.03 2.486 . . . . 0.0 110.944 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.91 33.74 0.33 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.807 0.843 . . . . 0.0 111.852 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.94 174.16 13.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.398 1.079 . . . . 0.0 109.857 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.26 88.52 0.85 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.07 122.24 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.872 0.869 . . . . 0.0 109.218 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -75.24 -58.04 3.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -166.11 132.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.029 0.531 . . . . 0.0 110.112 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -87.25 86.17 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 162.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.53 75.61 9.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.95 151.57 33.63 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.633 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.6 m -151.18 95.61 2.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 0.0 109.349 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -60.9 152.79 26.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.427 1.491 . . . . 0.0 110.801 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 m -157.91 176.72 12.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.67 144.54 45.79 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -65.49 132.71 49.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.53 1.132 . . . . 0.0 112.401 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -69.23 -51.88 33.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 109.119 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.91 -178.16 36.5 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.61 111.9 23.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.978 1.311 . . . . 0.0 108.524 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -75.46 -17.97 59.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.843 0.857 . . . . 0.0 111.948 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 66.12 94.94 0.06 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.71 1.604 . . . . 0.0 111.181 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 68.85 155.75 0.13 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.393 1.877 . . . . 0.0 110.986 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -101.94 92.06 4.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -110.84 160.45 16.75 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -105.36 142.77 34.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.984 0.514 . . . . 0.0 111.644 -167.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.032 174.259 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.59 144.09 48.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.237 1.415 . . . . 0.0 109.761 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -83.07 108.71 16.55 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.97 0.508 . . . . 0.0 111.131 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.7 ptm -93.41 94.06 8.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.494 0.664 . . . . 0.0 109.74 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.91 133.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.09 104.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -97.1 100.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.107 1.763 . . . . 0.0 109.207 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.55 127.13 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 110.226 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -102.66 155.04 18.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.941 1.297 . . . . 0.0 110.14 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.56 -168.85 19.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.003 1.287 . . . . 0.0 110.65 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -88.8 56.04 3.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.78 3.7 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.384 1.073 . . . . 0.0 112.372 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.89 152.99 25.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.76 -56.15 4.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -69.75 -179.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.593 0.757 . . . . 0.0 110.556 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.71 -97.19 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.269 0.938 . . . . 0.0 112.863 -171.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 64.0 -65.01 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.78 2.032 . . . . 0.0 113.078 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -48.5 -31.32 6.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.185 2.194 . . . . 0.0 113.177 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.29 -46.57 15.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.493 1.517 . . . . 0.0 110.851 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.78 -49.37 77.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.021 0.528 . . . . 0.0 111.341 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.02 -26.99 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.389 172.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.99 -56.07 15.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.905 0.882 . . . . 0.0 110.173 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.5 mm -43.83 -56.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 118.876 0.762 . . . . 0.0 111.029 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -64.62 -49.59 70.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.21 -65.06 0.63 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.515 0.726 . . . . 0.0 112.212 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.61 -50.97 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 126.097 1.759 . . . . 0.0 110.132 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -56.82 -41.39 77.72 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.385 0.674 . . . . 0.0 110.864 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.9 mt -93.93 15.36 16.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.399 1.48 . . . . 0.0 113.144 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.82 48.61 84.43 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.972 0.796 . . . . 0.0 113.123 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.08 143.2 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.394 1.478 . . . . 0.0 107.846 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -104.09 169.36 8.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.425 1.09 . . . . 0.0 108.282 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.82 -150.4 22.28 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 119.162 0.892 . . . . 0.0 112.886 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -170.89 140.76 1.65 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.836 1.254 . . . . 0.0 109.172 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.15 89.86 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.37 1.068 . . . . 0.0 110.288 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.11 98.19 7.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.261 0.624 . . . . 0.0 110.796 -165.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.63 115.03 16.02 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.51 170.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.68 104.51 10.43 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.99 141.68 65.36 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.058 2.505 . . . . 0.0 111.597 -163.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 63.98 60.03 1.05 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.809 1.644 . . . . 0.0 110.426 -171.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -129.49 1.51 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 p -120.87 163.44 18.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.627 1.571 . . . . 0.0 109.835 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -116.92 125.09 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.977 0.911 . . . . 0.0 110.77 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.54 145.46 30.27 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.929 0.492 . . . . 0.0 110.656 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.91 137.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 66.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.5 155.58 29.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.473 1.109 . . . . 0.0 109.94 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -142.86 106.24 4.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.921 -0.562 . . . . 0.0 109.888 -167.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.03 149.78 19.99 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.295 0.498 . . . . 0.0 113.912 -171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -63.06 163.88 9.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.757 0.823 . . . . 0.0 108.856 162.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -78.18 -34.24 49.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.464 0.706 . . . . 0.0 111.11 -171.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -69.65 -9.04 52.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.979 0.912 . . . . 0.0 111.632 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.91 4.32 10.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.672 1.189 . . . . 0.0 111.907 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -71.62 -68.56 0.44 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.427 1.012 . . . . 0.0 109.619 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.2 p -44.98 -42.47 8.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.558 1.543 . . . . 0.0 112.957 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -53.42 -48.59 68.61 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.237 1.015 . . . . 0.0 111.05 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.44 -51.97 17.91 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -52.54 -57.06 11.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.467 0.576 . . . . 0.0 111.777 -170.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.48 -40.37 68.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.056 1.343 . . . . 0.0 112.456 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.9 -51.14 7.77 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.214 1.006 . . . . 0.0 110.681 169.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.48 -53.58 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.329 -173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -46.44 71.65 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.071 0.396 . . . . 0.0 111.56 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -71.87 -55.61 7.22 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.862 0.865 . . . . 0.0 110.49 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.32 97.87 2.11 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.295 -1.281 . . . . 0.0 110.561 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.74 145.23 80.53 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.496 2.131 . . . . 0.0 109.07 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -86.93 49.54 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.913 1.742 . . . . 0.0 114.498 -153.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 56.58 37.15 28.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.36 1.064 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.3 161.72 39.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.058 0.943 . . . . 0.0 109.238 -168.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -84.55 75.89 10.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.95 135.59 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.905 1.282 . . . . 0.0 110.817 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.96 -57.57 2.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.018 1.327 . . . . 0.0 108.319 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -166.72 137.76 3.33 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 122.878 0.471 . . . . 0.0 110.996 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.33 96.4 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 121.784 -0.572 . . . . 0.0 110.169 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.97 72.26 9.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.7 161.95 28.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.476 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.5 t -137.9 127.43 24.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.606 0.762 . . . . 0.0 110.037 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.58 131.37 42.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 167.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 m -128.21 -160.06 0.99 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.292 1.037 . . . . 0.0 110.02 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -120.83 152.81 37.93 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.634 1.973 . . . . 0.0 108.967 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -52.21 86.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.919 1.688 . . . . 0.0 111.641 166.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -100.75 -54.8 2.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.727 1.211 . . . . 0.0 110.468 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.56 133.96 5.83 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.1 92.22 8.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.428 1.091 . . . . 0.0 109.809 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -72.13 87.92 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.86 143.39 56.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.635 0.774 . . . . 0.0 110.54 -174.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 64.9 -170.27 0.19 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.845 1.258 . . . . 0.0 109.374 -166.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.41 100.75 2.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.84 158.06 26.38 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 122.965 0.506 . . . . 0.0 111.391 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.67 139.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.686 1.195 . . . . 0.0 110.121 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.94 -178.719 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.255 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 165.38 18.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.926 0.89 . . . . 0.0 111.999 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -97.55 123.81 41.57 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 121.545 0.688 . . . . 0.0 112.092 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.9 ttp -67.9 154.79 40.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 150.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.8 106.94 2.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.39 116.94 28.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.299 1.04 . . . . 0.0 109.547 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 93.73 7.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.9 t -92.7 110.01 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.48 0.312 . . . . 0.0 110.646 -166.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -97.96 145.46 26.45 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.204 1.002 . . . . 0.0 110.823 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.52 -166.37 30.17 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 123.751 0.691 . . . . 0.0 111.973 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.84 15.74 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.523 0.729 . . . . 0.0 110.961 169.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.5 -15.44 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.114 1.366 . . . . 0.0 112.29 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -77.13 29.41 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.369 1.468 . . . . 0.0 113.737 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.82 24.13 0.17 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.153 1.359 . . . . 0.0 112.292 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.97 169.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.227 1.011 . . . . 0.0 108.582 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.87 33.35 2.15 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.663 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.2 t80 -78.48 45.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.031 1.415 . . . . 0.0 110.594 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -141.13 -45.88 0.39 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.897 2.479 . . . . 0.0 106.526 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -71.26 -44.67 64.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.097 0.959 . . . . 0.0 110.195 169.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.93 -55.62 28.6 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.941 -0.474 . . . . 0.0 111.752 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.21 -34.64 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 122.725 0.41 . . . . 0.0 111.32 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -58.66 -38.57 78.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.404 1.482 . . . . 0.0 112.809 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.45 -57.47 11.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.352 1.433 . . . . 0.0 110.487 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -64.03 -38.98 93.04 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.6 0.636 . . . . 0.0 110.679 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.85 11.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.064 0.545 . . . . 0.0 111.966 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.94 -36.42 77.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.498 0.719 . . . . 0.0 110.861 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -52.41 -43.93 65.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.282 1.033 . . . . 0.0 109.479 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.11 23.07 13.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.05 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.22 63.77 4.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.5 1.048 . . . . 0.0 112.999 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.41 138.12 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.221 1.409 . . . . 0.0 108.304 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -100.89 165.03 11.55 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.326 1.05 . . . . 0.0 108.463 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.41 -139.34 7.09 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -176.4 148.49 0.75 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.581 0.691 . . . . 0.0 110.669 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.46 78.73 1.14 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 109.502 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -90.22 86.32 6.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.946 0.879 . . . . 0.0 109.244 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.5 97.26 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.967 1.307 . . . . 0.0 109.945 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.6 mt -78.63 102.22 0.95 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 125.059 1.344 . . . . 0.0 107.582 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 146.84 79.77 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.501 2.134 . . . . 0.0 111.118 -164.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 55.28 53.35 10.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.476 1.11 . . . . 0.0 109.489 -167.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.3 -132.95 1.63 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -127.37 149.69 49.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.743 1.617 . . . . 0.0 109.94 -169.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.96 115.8 29.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 121.594 0.711 . . . . 0.0 109.419 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.97 103.49 16.0 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.34 1.456 . . . . 0.0 107.079 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.58 132.23 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.316 0.646 . . . . 0.0 109.833 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.56 145.83 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.58 119.39 4.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.359 0.527 . . . . 0.0 110.652 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -109.67 107.44 17.49 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.307 1.443 . . . . 0.0 110.865 -166.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.66 174.94 26.33 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-O 121.826 0.681 . . . . 0.0 113.011 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -72.64 173.25 9.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 160.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.97 -30.02 63.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -64.84 -17.86 64.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.426 0.691 . . . . 0.0 112.598 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.44 -2.98 10.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.411 1.085 . . . . 0.0 112.263 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -68.18 -62.32 1.45 Allowed 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -42.69 -42.84 3.63 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.737 1.615 . . . . 0.0 113.064 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -51.49 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.953 0.501 . . . . 0.0 111.454 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.05 -24.15 63.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.499 1.12 . . . . 0.0 111.639 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.96 -61.79 1.88 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 108.835 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.23 -25.7 65.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.266 1.426 . . . . 0.0 111.766 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -54.23 0.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.185 1.394 . . . . 0.0 110.776 159.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mt -71.21 -56.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.87 -48.76 80.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.454 0.302 . . . . 0.0 110.818 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -68.92 -42.34 76.94 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.811 1.245 . . . . 0.0 111.247 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.1 0.27 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.077 1.322 . . . . 0.0 110.02 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.75 163.37 38.64 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.631 2.887 . . . . 0.0 111.919 -173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.86 162.36 37.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.715 2.943 . . . . 0.0 111.204 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.67 42.23 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.848 0.859 . . . . 0.0 111.039 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.92 162.86 36.82 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.778 1.231 . . . . 0.0 109.54 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.02 83.72 2.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.389 1.075 . . . . 0.0 109.192 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.31 83.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.288 1.435 . . . . 0.0 109.914 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -41.0 -60.88 1.08 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.311 1.844 . . . . 0.0 111.37 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -162.62 133.63 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.091 0.244 . . . . 0.0 110.84 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.04 94.24 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 165.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.39 70.05 10.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -75.76 161.3 29.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.391 0.615 . . . . 0.0 111.494 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -143.03 97.55 3.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.63 1.172 . . . . 0.0 108.952 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -55.91 127.33 29.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.673 1.189 . . . . 0.0 109.188 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -134.93 -163.21 1.35 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.53 1.132 . . . . 0.0 109.679 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 151.59 47.17 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.547 0.739 . . . . 0.0 110.04 173.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -58.3 124.7 20.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.969 0.908 . . . . 0.0 112.001 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -73.76 -45.3 52.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.55 176.23 37.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.95 96.81 10.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.488 1.515 . . . . 0.0 109.505 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -56.06 -55.32 34.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.299 1.04 . . . . 0.0 111.099 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.61 61.22 3.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 112.107 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 155.75 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.723 2.809 . . . . 0.0 108.213 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.59 98.1 10.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 168.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -117.45 165.35 13.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.454 0.702 . . . . 0.0 109.308 176.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -114.84 144.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.575 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.314 -1.327 . . . . 0.0 108.756 150.512 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.597 0.237 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 166.39 16.87 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.882 1.273 . . . . 0.0 111.695 -167.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -94.77 124.55 38.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.633 0.773 . . . . 0.0 111.773 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -90.52 151.93 21.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 160.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -135.39 102.64 5.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.45 1.1 . . . . 0.0 109.097 -177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.05 106.3 16.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.049 0.54 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 98.02 10.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.67 104.23 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -76.16 153.28 36.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.71 -155.51 16.23 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 123.735 0.683 . . . . 0.0 112.549 162.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.71 28.2 0.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.158 0.983 . . . . 0.0 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.87 -9.62 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.177 0.991 . . . . 0.0 113.064 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.66 164.93 18.15 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 162.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.69 3.77 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.05 142.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.35 52.73 4.77 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.434 0.54 . . . . 0.0 113.089 -165.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -87.6 51.08 2.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.466 0.706 . . . . 0.0 110.437 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -52.61 0.93 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.404 1.481 . . . . 0.0 107.238 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -47.72 -52.61 17.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.696 1.199 . . . . 0.0 110.711 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.88 -54.63 40.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.131 0.972 . . . . 0.0 111.436 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.2 -23.68 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.453 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -66.1 -50.21 64.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.542 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.14 -53.3 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.814 1.188 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -70.7 -31.21 68.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.59 -64.18 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 167.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.6 -41.0 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.312 1.445 . . . . 0.0 112.309 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -49.1 78.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 111.279 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -87.05 14.57 7.26 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.83 57.75 17.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.179 0.895 . . . . 0.0 111.829 176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.1 mm -119.18 140.7 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.981 1.313 . . . . 0.0 109.196 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -109.95 165.2 11.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.069 1.347 . . . . 0.0 108.595 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.69 -134.14 5.5 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 118.477 0.581 . . . . 0.0 112.169 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.99 147.8 1.68 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 122.995 0.518 . . . . 0.0 111.646 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.32 84.49 2.63 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.954 1.302 . . . . 0.0 108.75 167.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.38 86.85 5.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.791 0.805 . . . . 0.0 109.544 -169.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.72 81.21 6.44 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 126.251 1.821 . . . . 0.0 109.869 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.4 mt -59.85 110.99 3.24 Favored Pre-proline 0 N--CA 1.454 -0.265 0 C-N-CA 125.363 1.465 . . . . 0.0 107.978 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.06 46.36 2.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.958 2.438 . . . . 0.0 112.945 -162.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -153.43 45.92 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.879 1.672 . . . . 0.0 107.676 167.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.07 -136.84 3.87 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 m -120.64 173.04 7.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.269 1.428 . . . . 0.0 110.266 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.62 122.39 45.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 122.965 0.506 . . . . 0.0 111.744 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -95.64 110.04 22.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.201 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -87.18 140.08 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.29 135.19 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 165.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.77 117.23 6.99 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.015 0.926 . . . . 0.0 110.101 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.69 111.4 24.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.129 0.972 . . . . 0.0 110.67 -171.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.67 29.99 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -54.78 163.97 0.87 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 110.104 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.47 -44.36 64.9 Favored 'General case' 0 CA--C 1.527 0.063 0 O-C-N 122.116 -0.365 . . . . 0.0 110.629 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -47.74 -43.44 27.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.678 1.191 . . . . 0.0 111.256 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.76 0.36 52.3 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.005 1.322 . . . . 0.0 112.828 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.6 tp -68.8 -60.76 2.16 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.582 1.083 . . . . 0.0 109.461 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.3 p -40.9 -47.89 3.04 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.424 1.489 . . . . 0.0 112.32 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.35 -41.46 65.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.13 -53.44 11.02 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.89 0.476 . . . . 0.0 109.75 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.8 -52.46 60.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.53 -45.0 73.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.234 1.414 . . . . 0.0 111.542 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.95 -53.88 3.67 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.534 1.534 . . . . 0.0 110.481 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.1 mt -63.35 -65.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.25 0.22 . . . . 0.0 110.827 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -55.63 -41.26 73.28 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.93 -37.56 88.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.77 0.828 . . . . 0.0 111.805 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.33 76.61 0.24 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.436 1.494 . . . . 0.0 110.064 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.6 168.04 23.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.349 3.366 . . . . 0.0 112.129 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 169.83 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.656 2.904 . . . . 0.0 111.418 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.68 29.03 0.82 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.0 0.92 . . . . 0.0 111.335 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.85 168.23 16.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.944 1.298 . . . . 0.0 109.635 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.7 84.06 1.61 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.875 0.87 . . . . 0.0 109.881 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.49 98.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.796 0.838 . . . . 0.0 110.293 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -49.78 -55.18 15.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.549 1.539 . . . . 0.0 110.677 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -178.06 135.24 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.086 1.354 . . . . 0.0 110.981 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.1 90.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 121.601 -0.687 . . . . 0.0 109.385 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.05 77.87 6.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -78.46 171.08 15.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.36 0.6 . . . . 0.0 112.166 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -143.39 126.14 16.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.158 1.383 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.03 129.1 34.08 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -135.7 -162.57 1.28 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.281 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.59 135.74 48.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.798 1.239 . . . . 0.0 109.496 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -57.98 135.76 56.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.315 0.646 . . . . 0.0 112.505 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -79.32 -47.19 16.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.205 0.602 . . . . 0.0 109.432 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.19 -174.28 36.19 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.21 96.56 10.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.537 1.135 . . . . 0.0 110.291 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -58.81 134.32 56.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 167.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.73 71.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.736 0.814 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.06 164.04 0.26 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.422 1.889 . . . . 0.0 111.326 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.67 109.97 17.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 100' ' ' THR . 28.8 tt0 -111.57 178.5 4.31 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.1 p -124.01 138.53 54.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.448 0.699 . . . . 0.0 109.839 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.303 167.42 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -177.06 4.34 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.321 1.048 . . . . 0.0 111.497 -168.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -106.1 135.63 47.21 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.5 ttp -77.7 157.6 30.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 157.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -144.05 88.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.324 1.449 . . . . 0.0 107.253 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.92 102.78 13.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.772 0.829 . . . . 0.0 109.96 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 97.96 9.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 84' ' ' VAL . 18.8 t -99.32 119.78 47.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.753 0.421 . . . . 0.0 110.0 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -103.36 148.25 26.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.622 1.569 . . . . 0.0 110.387 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.55 -159.57 23.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.09 0.852 . . . . 0.0 112.003 169.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -87.78 21.85 2.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.536 0.735 . . . . 0.0 111.014 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.55 -24.4 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.282 1.033 . . . . 0.0 111.808 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.72 132.41 49.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 110.632 173.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.69 -54.33 4.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.601 0.62 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -72.41 77.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.277 1.431 . . . . 0.0 109.963 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.17 -116.97 5.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.4 t80 62.58 -68.77 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.251 2.22 . . . . 0.0 113.504 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -56.78 -35.32 68.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.626 1.17 . . . . 0.0 110.927 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -73.94 -47.48 37.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.922 0.889 . . . . 0.0 110.238 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.86 -50.17 66.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.422 1.089 . . . . 0.0 112.447 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.75 -33.75 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.651 0.38 . . . . 0.0 110.506 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -66.83 -46.84 73.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 109.542 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 mm -51.53 -54.17 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.4 1.0 . . . . 0.0 110.717 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -66.27 -42.8 87.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.408 0.442 . . . . 0.0 109.963 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.56 -52.37 47.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.81 -43.63 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.416 1.087 . . . . 0.0 109.905 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -54.0 -37.68 64.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.526 0.73 . . . . 0.0 111.002 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -97.4 -1.52 44.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.838 1.655 . . . . 0.0 113.361 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.58 59.91 5.36 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.821 0.737 . . . . 0.0 111.91 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -125.13 138.49 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.859 1.664 . . . . 0.0 108.82 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -92.19 -178.9 5.1 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.909 1.284 . . . . 0.0 108.519 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -143.94 11.79 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 120.04 1.291 . . . . 0.0 112.338 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -175.3 147.18 0.87 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.858 0.863 . . . . 0.0 110.328 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.53 82.44 1.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 109.291 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -84.73 80.03 9.4 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.688 1.232 . . . . 0.0 108.636 -170.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 18.8 t-20 -85.17 75.61 10.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.626 2.77 . . . . 0.0 110.042 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -61.42 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.063 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.3 -167.42 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.98 2.453 . . . . 0.0 110.537 -170.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -100.0 50.77 0.91 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.973 1.309 . . . . 0.0 109.876 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.31 -73.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.875 0 O-C-N 122.052 -0.405 . . . . 0.0 112.439 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 m -96.43 112.21 24.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.654 0.782 . . . . 0.0 110.899 -168.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.24 132.35 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.064 0 C-N-CA 124.942 1.297 . . . . 0.0 110.059 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -92.44 122.0 34.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.16 145.37 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.445 1.098 . . . . 0.0 109.22 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.35 147.89 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.709 1.204 . . . . 0.0 107.856 167.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.94 115.55 6.75 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.083 0.953 . . . . 0.0 109.379 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -112.64 112.33 23.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -160.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.78 -168.97 35.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.53 167.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.64 160.83 24.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.652 1.581 . . . . 0.0 109.197 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.06 -19.97 53.25 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.13 -47.63 76.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.61 59.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.637 0.775 . . . . 0.0 112.166 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.8 -61.61 1.87 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.066 0.848 . . . . 0.0 108.878 174.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.7 p -40.54 -44.39 2.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.406 1.482 . . . . 0.0 113.001 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.11 -45.49 88.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.845 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.12 -23.25 60.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.103 1.361 . . . . 0.0 111.549 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -56.7 3.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.663 1.185 . . . . 0.0 109.745 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -58.67 -37.14 75.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.573 1.149 . . . . 0.0 111.372 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -28.81 -52.99 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 127.068 2.147 . . . . 0.0 112.075 167.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -71.04 -69.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -167.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -51.71 -43.96 63.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -62.65 -56.83 14.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.713 0.805 . . . . 0.0 110.26 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.79 81.8 0.31 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.545 1.545 . . . . 0.0 109.599 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 160.95 47.65 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.592 2.861 . . . . 0.0 111.201 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -68.3 157.53 61.42 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.608 2.205 . . . . 0.0 109.559 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.75 36.98 0.34 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.235 0.614 . . . . 0.0 111.485 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.42 166.35 21.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.686 1.594 . . . . 0.0 109.29 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -80.55 72.86 7.48 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.13 0.572 . . . . 0.0 109.978 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -61.44 114.58 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.259 1.024 . . . . 0.0 108.475 168.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.88 -49.04 6.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 110.847 -161.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -162.42 71.09 0.31 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.467 0.651 . . . . 0.0 111.873 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 HG22 ' A' ' 20' ' ' VAL . 7.1 p -69.5 89.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.036 0.935 . . . . 0.0 111.214 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.07 81.58 2.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 107.963 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -78.52 164.52 24.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.31 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 m -145.59 139.96 27.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.27 1.028 . . . . 0.0 109.502 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 135.64 33.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.899 1.28 . . . . 0.0 108.352 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 m -135.62 176.82 8.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.514 0.726 . . . . 0.0 111.168 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -89.32 137.58 32.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -64.88 138.77 58.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.237 1.015 . . . . 0.0 111.596 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -79.28 -51.18 9.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.818 0.847 . . . . 0.0 109.249 174.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.15 -178.2 30.99 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.62 103.95 8.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.098 0.959 . . . . 0.0 109.463 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -78.52 70.21 4.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -51.7 127.46 20.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.701 1.2 . . . . 0.0 112.347 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.59 174.95 0.24 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.907 1.683 . . . . 0.0 110.85 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.56 93.36 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -112.94 158.69 19.91 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -113.61 149.34 34.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.98 0.912 . . . . 0.0 110.362 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.405 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 20.8 m-30 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.003 -1.475 . . . . 0.0 108.624 148.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 159.24 34.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.1 0.96 . . . . 0.0 110.83 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -91.62 106.36 18.42 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 ptm -84.68 94.69 8.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -89.81 89.91 7.96 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.83 105.28 17.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.499 0.666 . . . . 0.0 111.225 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.29 102.99 13.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.462 1.105 . . . . 0.0 108.979 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.62 108.99 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -103.84 139.63 38.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.58 0.752 . . . . 0.0 111.089 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.92 -152.96 24.98 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.896 0.748 . . . . 0.0 111.837 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tp -82.26 20.7 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.028 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.75 35.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.371 1.469 . . . . 0.0 112.036 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -96.23 102.3 14.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.63 0.772 . . . . 0.0 110.362 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.92 48.71 61.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.409 1.004 . . . . 0.0 112.3 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.45 93.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.761 0.824 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.32 -69.17 1.39 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.216 1.388 . . . . 0.0 112.093 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -28.44 -66.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.396 3.078 . . . . 0.0 115.103 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -60.69 -30.53 69.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.044 0.538 . . . . 0.0 111.867 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -78.48 -41.41 32.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.086 0.954 . . . . 0.0 109.992 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.9 -48.98 72.33 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.328 -0.858 . . . . 0.0 111.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.92 -28.12 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.928 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -59.87 -59.86 4.75 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 118.564 -0.732 . . . . 0.0 110.022 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.3 mm -46.39 -55.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.208 0.603 . . . . 0.0 111.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -70.9 -42.56 69.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.796 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.02 -50.0 59.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.739 0.699 . . . . 0.0 112.441 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.97 -36.8 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.657 1.583 . . . . 0.0 110.975 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -44.42 89.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.847 0.459 . . . . 0.0 111.917 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.91 -17.02 27.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.971 0.908 . . . . 0.0 113.383 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.87 66.32 1.27 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.74 139.63 45.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 125.713 1.605 . . . . 0.0 108.458 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -111.69 160.06 17.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.035 1.334 . . . . 0.0 108.555 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.78 -133.17 4.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -173.22 141.1 0.91 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.008 1.323 . . . . 0.0 109.878 172.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.79 82.48 2.6 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.613 1.165 . . . . 0.0 108.43 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -92.22 89.54 6.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -163.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.17 72.56 6.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.913 1.685 . . . . 0.0 111.566 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.99 118.44 55.42 Favored Pre-proline 0 C--N 1.342 0.259 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.308 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.71 76.93 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.831 3.021 . . . . 0.0 111.853 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -163.68 28.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.84 -43.06 3.04 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.706 -0.622 . . . . 0.0 112.809 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -95.66 86.63 4.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 110.789 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.26 125.97 40.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 123.828 0.851 . . . . 0.0 109.523 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.58 135.36 34.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.31 94.57 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.8 t -67.53 122.03 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.39 154.03 39.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -127.28 113.61 16.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.646 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.57 -140.67 0.09 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.495 1.521 . . . . 0.0 113.197 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -177.38 -92.58 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.317 3.047 . . . . 0.0 107.1 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.47 -63.23 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 122.972 0.509 . . . . 0.0 110.914 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.1 -53.9 6.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.32 67.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.149 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 69' ' ' LEU . 24.1 tp -53.58 -72.34 0.06 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -55.65 -47.52 76.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 0.0 112.413 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -54.25 -41.0 68.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.082 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.78 -46.3 17.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.26 0.482 . . . . 0.0 110.725 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 65' ' ' LEU . 1.5 mm? -52.07 -61.93 1.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.884 -0.51 . . . . 0.0 110.239 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -55.01 -43.78 73.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 111.685 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -56.13 3.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.645 1.178 . . . . 0.0 110.438 167.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -66.24 -53.8 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.125 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -49.68 65.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.204 0.456 . . . . 0.0 110.526 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -100.16 55.02 0.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 109.631 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.49 75.85 0.22 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.18 129.8 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.066 2.511 . . . . 0.0 109.595 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.56 179.37 6.55 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.165 2.577 . . . . 0.0 109.984 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.11 36.55 0.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.547 0.739 . . . . 0.0 111.974 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.94 162.05 38.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 110.004 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.74 87.97 3.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 110.287 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.69 78.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.799 1.24 . . . . 0.0 110.449 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -41.8 -59.36 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.995 2.118 . . . . 0.0 112.305 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -162.66 89.74 0.68 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-O 121.629 0.728 . . . . 0.0 112.589 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.85 92.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.89 0.876 . . . . 0.0 110.9 173.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -98.31 78.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.891 1.277 . . . . 0.0 108.292 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -72.86 164.97 25.81 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -134.21 119.22 18.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.451 1.101 . . . . 0.0 109.952 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -80.09 124.38 28.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m -136.91 176.49 8.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.797 1.239 . . . . 0.0 110.662 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.56 153.59 17.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.376 1.47 . . . . 0.0 110.116 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -45.62 104.22 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.053 1.741 . . . . 0.0 112.167 167.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -92.83 -55.03 3.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.827 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.2 146.36 13.19 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.05 107.25 19.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.509 1.123 . . . . 0.0 110.653 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -68.09 169.61 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 160.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.47 49.51 0.69 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.399 0.68 . . . . 0.0 110.676 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 170.14 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.064 2.145 . . . . 0.0 108.972 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -83.89 91.45 7.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.67 162.92 17.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.768 0.713 . . . . 0.0 110.233 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.54 138.47 34.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.231 0.612 . . . . 0.0 110.429 -173.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.7 t80 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.264 -1.35 . . . . 0.0 109.56 174.009 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 93.3 p -78.55 165.37 23.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.471 0.708 . . . . 0.0 110.98 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -129.63 -57.47 1.12 Allowed 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.89 1.276 . . . . 0.0 108.123 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -67.36 156.2 37.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.311 0.644 . . . . 0.0 110.544 172.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -158.37 159.24 35.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.581 1.153 . . . . 0.0 108.189 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -160.29 157.48 28.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.798 1.239 . . . . 0.0 108.342 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 p -123.53 160.01 27.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.811 1.645 . . . . 0.0 109.181 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -163.49 160.61 23.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.038 0.935 . . . . 0.0 109.715 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m 69.74 97.46 0.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -148.24 144.29 27.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.652 1.181 . . . . 0.0 108.293 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.34 129.02 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.098 0.559 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.46 -99.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.858 1.263 . . . . 0.0 110.149 -171.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.9 168.67 11.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.904 1.682 . . . . 0.0 110.014 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mtt 66.3 168.35 0.22 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 126.204 1.802 . . . . 0.0 113.607 171.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -171.41 154.08 3.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.553 1.141 . . . . 0.0 110.12 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.38 141.97 32.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.683 1.593 . . . . 0.0 109.975 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -83.53 111.46 19.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.203 1.001 . . . . 0.0 109.731 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.3 ptm -92.4 102.57 15.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.634 1.174 . . . . 0.0 108.343 173.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -73.46 127.52 32.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.78 105.57 7.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.721 0.772 . . . . 0.0 109.744 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.3 15.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.885 1.674 . . . . 0.0 107.434 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.36 114.05 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.46 153.31 19.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.268 1.427 . . . . 0.0 109.967 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.1 -161.13 13.92 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.507 1.051 . . . . 0.0 111.66 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tp -83.0 26.21 0.63 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.058 0.543 . . . . 0.0 111.532 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.1 -10.68 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 113.098 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -57.6 151.97 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.632 1.173 . . . . 0.0 110.009 166.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.61 -62.48 4.6 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 79' ' ' ALA . 18.7 m -66.84 165.1 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.246 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.41 48.14 3.57 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.934 0.778 . . . . 0.0 112.465 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.01 -60.87 2.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.593 1.157 . . . . 0.0 108.921 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -61.54 -25.58 67.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 112.071 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.24 -48.96 48.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 0.0 109.474 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.29 -46.67 82.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.432 0.693 . . . . 0.0 111.167 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -55.67 -36.85 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.893 0.477 . . . . 0.0 110.635 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -62.3 -57.34 11.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.852 -1.07 . . . . 0.0 110.928 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -44.15 -55.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.612 1.096 . . . . 0.0 111.638 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.4 -47.41 67.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.385 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.76 -50.86 54.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.8 -47.49 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.573 1.549 . . . . 0.0 109.018 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.58 -39.61 70.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.253 0.621 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -94.39 -0.62 54.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.514 1.525 . . . . 0.0 113.236 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.45 62.2 4.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.952 0.796 . . . . 0.0 111.735 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 mm -115.42 141.77 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 126.285 1.834 . . . . 0.0 107.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -104.06 167.56 9.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.805 1.242 . . . . 0.0 108.485 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.07 -146.92 16.58 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 118.158 0.435 . . . . 0.0 113.123 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -170.76 139.99 1.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 109.357 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.35 88.93 2.91 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.439 1.095 . . . . 0.0 108.58 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.04 77.9 4.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -164.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -72.82 74.0 1.12 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.662 1.585 . . . . 0.0 111.302 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.36 124.0 76.07 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 165.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.46 76.81 3.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.803 2.335 . . . . 0.0 110.749 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -151.14 26.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.613 1.165 . . . . 0.0 111.983 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.59 -48.64 3.71 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.611 0.624 . . . . 0.0 112.353 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 p -91.31 91.28 8.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.781 1.232 . . . . 0.0 110.873 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.51 126.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 124.111 0.964 . . . . 0.0 109.904 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 141.53 29.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.234 0.614 . . . . 0.0 109.506 175.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.69 137.15 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -118.52 61.03 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.423 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.85 156.2 39.42 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.622 1.169 . . . . 0.0 110.167 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.18 112.21 6.6 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.933 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.07 156.82 23.13 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.583 0.628 . . . . 0.0 114.012 -172.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -71.99 -92.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.047 1.739 . . . . 0.0 110.28 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.57 -80.41 0.09 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.429 1.492 . . . . 0.0 107.397 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.66 -52.21 56.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.283 0.633 . . . . 0.0 109.795 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.79 68.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.993 0.517 . . . . 0.0 111.808 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.2 tp -64.95 -66.4 0.55 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -46.38 -42.61 15.25 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.451 1.501 . . . . 0.0 112.941 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -57.41 -62.67 1.61 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.292 0.951 . . . . 0.0 110.17 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -57.37 -35.73 70.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.205 0.602 . . . . 0.0 112.219 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.64 -63.25 1.17 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.982 0.913 . . . . 0.0 110.515 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.31 -37.24 55.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.088 1.355 . . . . 0.0 111.618 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.42 -59.81 3.18 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.433 1.093 . . . . 0.0 111.12 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.33 -61.87 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.139 0.427 . . . . 0.0 111.239 -163.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -48.42 64.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 113.104 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -58.41 -51.97 67.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.262 0.625 . . . . 0.0 110.966 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.8 86.22 0.45 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.03 1.3 . . . . 0.0 109.857 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 163.71 30.91 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.287 2.658 . . . . 0.0 111.226 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.72 165.36 31.18 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.941 2.427 . . . . 0.0 111.188 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.37 43.2 0.72 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.889 0.876 . . . . 0.0 111.096 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -150.49 167.93 25.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.976 1.31 . . . . 0.0 109.327 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -76.53 80.52 3.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.561 1.144 . . . . 0.0 109.574 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.54 119.89 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.052 0.941 . . . . 0.0 108.673 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.56 -50.03 6.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.442 1.097 . . . . 0.0 110.387 -168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -166.09 71.59 0.14 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.413 0.625 . . . . 0.0 111.633 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -65.67 94.35 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.433 0.693 . . . . 0.0 111.122 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.94 83.72 1.88 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.093 1.357 . . . . 0.0 108.01 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -77.66 163.43 26.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.849 0.356 . . . . 0.0 110.676 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.2 m -139.08 110.18 6.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 109.665 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 120.75 10.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 m -127.69 -152.3 0.51 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.811 1.245 . . . . 0.0 109.106 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 155.99 49.15 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.481 1.112 . . . . 0.0 109.198 170.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -81.23 124.11 29.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.012 0.925 . . . . 0.0 110.658 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -73.63 -46.78 44.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 164.5 32.51 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.88 134.04 34.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.582 1.153 . . . . 0.0 109.257 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -74.21 145.88 43.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.583 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.55 87.28 0.9 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.997 0.919 . . . . 0.0 110.104 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 66.44 -160.46 0.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.477 1.111 . . . . 0.0 109.601 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.73 113.39 9.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.211 1.004 . . . . 0.0 109.283 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.93 164.56 20.51 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.638 0.775 . . . . 0.0 110.868 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.97 143.51 38.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.373 1.069 . . . . 0.0 110.408 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.018 -1.468 . . . . 0.0 111.108 168.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.5 p -157.04 154.94 30.35 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.011 0.925 . . . . 0.0 109.298 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptp -158.51 44.77 0.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.02 0.928 . . . . 0.0 109.956 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.97 34.36 5.24 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.689 1.196 . . . . 0.0 111.243 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 129.66 34.76 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -135.95 75.7 1.57 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 109.278 -173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.4 p -123.64 153.31 40.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.068 1.347 . . . . 0.0 109.631 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -160.8 -63.14 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 p -142.29 170.49 15.61 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.013 1.325 . . . . 0.0 109.446 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.3 164.99 27.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.035 1.334 . . . . 0.0 109.053 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.22 125.88 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.028 1.331 . . . . 0.0 108.666 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -139.38 -98.23 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.306 1.042 . . . . 0.0 108.523 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -124.26 136.15 53.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.976 1.71 . . . . 0.0 107.981 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.1 mtp -140.06 148.0 41.13 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.066 0.946 . . . . 0.0 109.68 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.315 0.4 OUTLIER 61.39 144.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.59 2.756 . . . . 0.0 113.937 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 173.51 9.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.148 1.379 . . . . 0.0 110.839 -167.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -100.21 127.36 46.49 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.085 0.554 . . . . 0.0 111.257 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.47 158.38 31.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 153.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.06 97.26 2.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.85 116.06 29.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.87 0.868 . . . . 0.0 110.944 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.67 107.86 19.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 108.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.92 107.74 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.1 147.88 22.96 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.103 0.961 . . . . 0.0 110.278 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.97 -161.75 27.14 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.244 0.926 . . . . 0.0 110.967 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tp -82.23 20.14 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.268 0.627 . . . . 0.0 110.648 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.26 -14.66 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.106 1.362 . . . . 0.0 112.794 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.37 117.18 7.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.857 0.863 . . . . 0.0 109.653 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.49 48.96 40.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.08 0.848 . . . . 0.0 113.304 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.641 HG21 ' HB2' ' A' ' 79' ' ' ALA . 21.3 m -135.09 -168.07 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 109.014 166.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.02 79.33 0.2 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.485 1.041 . . . . 0.0 111.013 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -158.42 -174.42 4.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.556 1.542 . . . . 0.0 108.573 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 73.51 -73.57 0.1 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.576 1.951 . . . . 0.0 109.53 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -56.62 -36.96 70.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.283 1.033 . . . . 0.0 110.351 172.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -48.76 -48.14 41.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.274 1.03 . . . . 0.0 111.722 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.16 -37.54 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.158 -0.338 . . . . 0.0 110.422 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.72 -49.29 66.51 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.037 -1.459 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.8 mm -43.93 -53.38 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 120.707 1.594 . . . . 0.0 111.416 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -66.9 -51.68 52.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.6 -44.84 66.25 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.85 -46.33 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 108.635 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -42.03 88.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.318 0.647 . . . . 0.0 111.012 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.3 mt -92.3 -52.53 4.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.058 1.343 . . . . 0.0 111.751 -169.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.14 66.6 0.17 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.167 1.365 . . . . 0.0 112.704 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.79 147.12 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 108.821 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -108.06 174.11 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 108.847 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.86 -150.63 22.44 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 118.619 0.645 . . . . 0.0 112.594 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -164.78 140.87 5.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.72 82.43 1.85 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.396 1.078 . . . . 0.0 110.087 -168.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' CB ' ' A' ' 101' ' ' TYR . 36.0 ttmt -95.38 104.21 16.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 -164.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -78.7 126.11 30.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.3 mt -101.85 93.99 4.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.25 76.89 4.02 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.482 2.788 . . . . 0.0 111.548 -159.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 173.94 -43.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.159 2.584 . . . . 0.0 108.708 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.36 -119.25 4.56 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.737 1.16 . . . . 0.0 111.429 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -129.25 126.04 38.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.57 1.548 . . . . 0.0 109.425 -168.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.27 122.06 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.7 0.8 . . . . 0.0 110.158 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.21 140.19 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.796 0.839 . . . . 0.0 109.646 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.5 t -127.05 134.06 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.178 0.991 . . . . 0.0 108.554 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.1 74.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.71 0.804 . . . . 0.0 110.821 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.89 150.12 37.63 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -117.67 96.63 5.47 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.197 0.599 . . . . 0.0 110.951 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.25 174.52 17.39 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.932 0.777 . . . . 0.0 112.437 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.74 -98.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 108.668 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -152.14 -73.75 0.14 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.291 1.436 . . . . 0.0 108.211 -174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.68 -45.46 48.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.611 1.164 . . . . 0.0 109.338 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.6 57.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.86 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.5 tp -53.78 -56.75 14.68 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.449 0.568 . . . . 0.0 109.56 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.1 p -47.52 -36.38 10.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.888 1.275 . . . . 0.0 112.862 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -64.3 -36.4 84.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.43 1.092 . . . . 0.0 111.444 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.6 -50.15 12.0 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.646 0.778 . . . . 0.0 109.044 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -52.8 25.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.354 0.662 . . . . 0.0 111.168 -171.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.06 -35.68 77.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.281 1.433 . . . . 0.0 113.159 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -48.57 14.48 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.89 1.276 . . . . 0.0 110.73 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.46 -56.42 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 119.02 -0.514 . . . . 0.0 110.616 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.2 -54.28 38.38 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.236 0.471 . . . . 0.0 110.517 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 47.61 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.451 1.1 . . . . 0.0 109.641 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.47 66.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.55 161.3 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.512 2.808 . . . . 0.0 111.311 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.13 170.16 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.954 3.103 . . . . 0.0 111.802 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.24 48.12 1.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.092 0.957 . . . . 0.0 111.027 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -149.37 167.49 26.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.713 1.205 . . . . 0.0 110.162 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.79 89.49 1.37 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.12 86.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 109.967 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -41.54 -60.76 1.22 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.799 1.64 . . . . 0.0 111.344 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.71 140.22 3.87 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.676 0.39 . . . . 0.0 110.473 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.27 97.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 166.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.53 82.48 6.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -76.61 156.44 32.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -141.89 108.91 5.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.805 1.242 . . . . 0.0 108.764 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -69.09 127.5 33.35 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -134.83 -173.56 3.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.086 0.954 . . . . 0.0 110.398 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 141.83 38.35 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.094 0.957 . . . . 0.0 108.616 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.19 56.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -54.18 20.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 170.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.15 -176.05 34.78 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.03 119.1 28.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.278 1.031 . . . . 0.0 109.318 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -70.04 135.37 49.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.44 91.92 1.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.531 0.733 . . . . 0.0 109.979 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 67.92 -161.32 0.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.423 1.089 . . . . 0.0 109.683 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.0 89.94 3.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.635 1.174 . . . . 0.0 108.982 -175.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.53 159.75 16.46 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -115.36 144.23 44.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.306 0.643 . . . . 0.0 110.955 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CB ' ' HA ' ' A' ' 47' ' ' LYS . 2.4 t80 . . . . . 0 C--O 1.249 1.027 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 67.5 p -159.22 161.42 36.08 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.605 1.162 . . . . 0.0 108.914 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -132.19 111.1 11.13 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.603 1.161 . . . . 0.0 108.684 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 122.27 47.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.993 1.317 . . . . 0.0 109.592 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -99.35 -49.78 4.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.336 1.054 . . . . 0.0 110.213 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 75.5 t90 21.11 73.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.44 3.096 . . . . 0.0 113.541 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -106.63 60.28 0.64 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.95 1.3 . . . . 0.0 108.195 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -71.96 118.15 14.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.343 1.457 . . . . 0.0 111.272 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -161.88 137.99 7.85 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.95 0.9 . . . . 0.0 109.378 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -169.61 147.1 3.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.96 1.304 . . . . 0.0 108.35 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.45 128.02 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -144.62 -19.76 0.53 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.956 1.302 . . . . 0.0 112.052 -167.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -82.63 51.29 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.746 1.619 . . . . 0.0 111.357 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.1 mtp -146.04 175.11 10.7 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.407 1.083 . . . . 0.0 110.551 -171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 0.5 OUTLIER 66.68 127.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.278 3.031 . . . . 0.0 113.754 173.201 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.18 167.1 16.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.116 0.966 . . . . 0.0 112.157 -161.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -100.27 130.76 46.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.4 ttp -66.44 166.23 12.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.196 0.998 . . . . 0.0 108.795 158.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.42 86.78 1.55 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 163.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.35 105.19 17.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.465 0.706 . . . . 0.0 110.953 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 101.02 13.53 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.272 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -90.42 110.86 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -96.15 148.34 22.81 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.969 0.907 . . . . 0.0 109.295 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.41 -157.35 22.27 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.01 1.29 . . . . 0.0 111.316 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -80.46 19.62 0.77 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.517 0.727 . . . . 0.0 111.402 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.62 -23.3 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.151 0.98 . . . . 0.0 111.022 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.77 142.43 50.16 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 109.668 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.13 -65.61 2.85 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 79' ' ' ALA . 17.7 m -64.42 169.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.842 0.821 . . . . 0.0 110.953 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.01 -94.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.493 1.044 . . . . 0.0 111.767 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.65 -59.69 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 113.26 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -38.78 -37.78 0.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.762 2.825 . . . . 0.0 113.082 170.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.79 -50.97 25.05 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.536 0.735 . . . . 0.0 109.939 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.96 -39.93 63.32 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 111.48 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.35 -42.29 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 123.44 0.696 . . . . 0.0 110.029 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.424 HE21 ' CA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.42 -54.23 39.98 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 117.715 -1.136 . . . . 0.0 110.143 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.9 mm -41.63 -54.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.877 1.217 . . . . 0.0 113.054 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -73.31 -45.61 54.4 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.554 0.342 . . . . 0.0 110.72 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.64 -51.01 59.11 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.149 0.5 . . . . 0.0 111.741 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -44.6 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 126.219 1.807 . . . . 0.0 109.972 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -53.01 -39.96 63.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.803 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.44 11.7 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.781 1.233 . . . . 0.0 113.47 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.89 64.61 3.67 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 118.841 0.746 . . . . 0.0 112.112 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.5 mm -121.88 138.62 51.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.354 1.462 . . . . 0.0 108.735 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -98.56 173.38 6.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.689 1.196 . . . . 0.0 108.243 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.7 -143.92 11.19 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.499 -0.75 . . . . 0.0 111.7 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -175.26 144.2 0.71 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.551 1.14 . . . . 0.0 109.19 170.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 82.82 1.8 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -95.13 111.78 23.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.353 0.597 . . . . 0.0 110.156 -164.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 20.6 t-20 -91.73 119.69 31.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 108.505 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.04 98.05 4.27 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.52 144.91 91.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.433 2.089 . . . . 0.0 110.812 -169.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.7 t0 55.95 54.73 7.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.475 1.11 . . . . 0.0 109.67 -166.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.27 -134.97 2.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -124.8 161.0 27.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.816 1.646 . . . . 0.0 110.464 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.84 117.83 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.067 0.947 . . . . 0.0 109.629 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -93.19 143.47 26.23 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.618 0.767 . . . . 0.0 110.456 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.25 123.15 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.428 1.091 . . . . 0.0 108.773 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.39 62.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.825 0.85 . . . . 0.0 110.966 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 129.75 38.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.457 0.703 . . . . 0.0 111.042 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -117.62 108.08 15.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.747 1.219 . . . . 0.0 110.503 -165.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 177.32 37.5 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-O 122.216 0.898 . . . . 0.0 114.369 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -69.87 169.65 12.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.128 1.371 . . . . 0.0 108.946 165.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -79.85 -30.25 40.3 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.12 -25.53 68.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.918 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.28 -13.54 18.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.914 0.885 . . . . 0.0 111.825 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.83 -59.79 2.71 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 p -38.57 -45.01 1.02 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.278 1.831 . . . . 0.0 112.912 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.45 -42.02 88.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.854 0.862 . . . . 0.0 112.682 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -74.11 -21.99 59.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.626 1.171 . . . . 0.0 111.551 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.7 -61.24 2.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.471 1.108 . . . . 0.0 110.317 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -53.89 -42.07 68.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 110.299 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -34.37 -47.42 0.3 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.305 2.642 . . . . 0.0 113.556 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.61 -68.25 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.608 0.763 . . . . 0.0 110.728 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -52.13 -44.93 64.75 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.84 -51.96 67.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.299 1.04 . . . . 0.0 111.186 173.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.09 85.3 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.61 160.55 45.59 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.924 2.416 . . . . 0.0 111.262 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.25 160.58 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.274 2.649 . . . . 0.0 110.765 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 48.83 1.33 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.824 0.85 . . . . 0.0 110.957 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -158.39 169.06 25.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 110.484 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.1 77.73 2.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.189 0.995 . . . . 0.0 109.374 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.08 125.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.953 0.901 . . . . 0.0 109.389 173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.93 -60.34 2.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 108.163 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -156.13 115.47 3.53 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.72 87.01 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 161.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.09 67.42 8.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.458 1.103 . . . . 0.0 108.268 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.2 154.38 31.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.826 -170.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -138.23 117.65 12.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.67 129.93 44.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m -127.21 -161.89 1.12 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.443 1.097 . . . . 0.0 109.24 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.23 141.48 45.79 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.617 0.767 . . . . 0.0 109.026 170.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -54.8 135.1 47.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.567 1.147 . . . . 0.0 112.96 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -73.35 -57.49 3.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 165.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.29 -177.55 40.01 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.43 122.2 16.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.56 0.744 . . . . 0.0 110.417 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -72.98 -26.5 61.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 111.468 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.51 91.31 0.07 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.637 1.575 . . . . 0.0 111.028 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.53 179.72 0.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 110.472 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.88 95.84 2.56 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.68 167.04 13.39 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 p -103.69 152.02 22.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.482 0.713 . . . . 0.0 110.791 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 4.0 m-85 . . . . . 0 C--O 1.249 1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 153.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.4 m -145.39 128.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.173 0.989 . . . . 0.0 108.841 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -113.78 107.33 15.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.727 1.211 . . . . 0.0 108.249 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.5 144.03 41.38 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.715 1.206 . . . . 0.0 109.543 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 140.21 5.83 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.959 1.304 . . . . 0.0 108.556 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -144.4 156.46 44.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.855 0.862 . . . . 0.0 111.132 -172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -71.99 78.01 0.92 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.245 1.418 . . . . 0.0 109.017 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.59 -53.8 54.28 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.632 1.173 . . . . 0.0 110.528 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m 65.0 85.95 0.13 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.038 1.335 . . . . 0.0 110.53 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -141.07 57.62 1.55 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.348 1.059 . . . . 0.0 110.545 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.02 93.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.345 1.058 . . . . 0.0 108.747 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.19 -95.95 0.26 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.915 0.886 . . . . 0.0 109.725 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 173.09 11.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.716 1.206 . . . . 0.0 110.333 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -137.51 -174.71 3.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.429 1.492 . . . . 0.0 108.687 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.96 129.94 35.93 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 170.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.23 166.57 10.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.262 1.025 . . . . 0.0 109.905 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -99.15 101.56 12.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 110.347 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.3 ttp -70.01 144.77 52.15 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 164.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -124.18 136.35 54.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.993 1.717 . . . . 0.0 106.561 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 107.59 4.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.343 0.592 . . . . 0.0 109.976 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 98.93 8.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.73 101.09 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.31 149.89 26.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.267 0.627 . . . . 0.0 111.265 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.61 -163.53 18.45 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.315 1.436 . . . . 0.0 110.7 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 47.8 1.55 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.02 41.62 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.326 1.05 . . . . 0.0 110.747 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.62 150.43 33.15 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.404 1.082 . . . . 0.0 110.384 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.72 -56.83 4.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.527 0.584 . . . . 0.0 111.871 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -48.38 150.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.803 2.041 . . . . 0.0 111.292 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.82 38.45 2.34 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.825 0.726 . . . . 0.0 113.486 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -67.17 -35.87 80.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.64 0.72 . . . . 0.0 110.016 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -58.22 -31.77 67.67 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.265 1.026 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.72 -48.15 34.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.668 1.187 . . . . 0.0 109.843 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.13 -44.84 79.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.507 0.723 . . . . 0.0 111.579 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.51 -37.5 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.666 0.786 . . . . 0.0 109.969 172.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -63.37 -57.7 9.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.848 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -43.06 -51.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 119.451 1.023 . . . . 0.0 111.757 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -67.22 -56.6 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.841 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.68 -47.82 20.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.54 -42.88 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 126.224 1.81 . . . . 0.0 110.47 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -62.52 -34.41 76.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.766 0.426 . . . . 0.0 111.799 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.98 -0.19 55.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.855 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.17 5.32 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 118.65 0.659 . . . . 0.0 111.557 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -121.26 141.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.649 1.58 . . . . 0.0 108.311 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -103.43 166.38 10.46 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.26 -145.21 12.25 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.957 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.36 141.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 110.19 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.11 86.68 2.34 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.165 1.386 . . . . 0.0 108.727 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -100.27 90.1 4.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.862 0.865 . . . . 0.0 110.511 -164.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.73 92.76 4.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.557 1.543 . . . . 0.0 109.811 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.7 mt -66.13 106.19 1.03 Allowed Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 125.772 1.629 . . . . 0.0 108.321 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.07 43.24 1.43 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.584 2.189 . . . . 0.0 113.058 -160.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.5 47.77 0.34 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.472 1.509 . . . . 0.0 108.285 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.83 -135.7 3.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -112.6 169.34 8.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.494 1.517 . . . . 0.0 109.656 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.68 135.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 C-N-CA 124.204 1.001 . . . . 0.0 112.011 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -100.48 122.71 43.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.604 1.161 . . . . 0.0 109.183 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.38 145.11 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.639 1.176 . . . . 0.0 108.518 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.23 86.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.072 0.949 . . . . 0.0 109.827 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.42 143.02 26.67 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.028 1.331 . . . . 0.0 111.592 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -126.28 99.12 5.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.272 0.629 . . . . 0.0 110.772 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.54 164.14 30.15 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 121.598 0.554 . . . . 0.0 113.073 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -66.7 167.32 11.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 -35.58 67.28 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.977 -0.452 . . . . 0.0 111.911 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -45.3 -39.91 7.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.791 1.236 . . . . 0.0 112.159 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.08 0.85 21.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.94 1.296 . . . . 0.0 112.586 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -70.29 -59.29 2.96 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.285 0.948 . . . . 0.0 108.829 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -42.63 -45.4 4.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.269 1.428 . . . . 0.0 112.063 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.17 -32.42 64.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.718 1.607 . . . . 0.0 112.885 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.23 -53.88 4.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.07 1.348 . . . . 0.0 109.927 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -53.24 56.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.49 1.116 . . . . 0.0 111.109 -167.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -68.91 -34.6 75.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.636 1.174 . . . . 0.0 111.433 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.43 -42.26 10.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.384 1.474 . . . . 0.0 111.206 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.41 -61.61 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.217 0.607 . . . . 0.0 111.2 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.54 -48.69 80.68 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.09 0.405 . . . . 0.0 111.029 -168.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -94.94 38.36 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.927 1.291 . . . . 0.0 110.275 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.3 76.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.99 162.04 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.464 2.776 . . . . 0.0 112.594 -167.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.65 -1.73 5.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.222 3.281 . . . . 0.0 114.525 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.36 28.8 4.67 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 126.163 1.785 . . . . 0.0 110.114 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.35 164.16 32.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.997 1.719 . . . . 0.0 107.995 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.15 80.5 4.57 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.076 0.551 . . . . 0.0 110.945 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.33 126.88 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.164 0.986 . . . . 0.0 109.656 170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -93.65 -53.1 4.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.455 1.102 . . . . 0.0 109.405 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -164.85 76.12 0.29 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.064 0.459 . . . . 0.0 112.165 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.4 p -67.21 89.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.282 0.633 . . . . 0.0 111.013 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.07 85.5 3.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.158 1.383 . . . . 0.0 108.046 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -77.74 170.33 16.76 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.176 0.512 . . . . 0.0 112.212 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -139.7 112.16 7.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.222 1.409 . . . . 0.0 109.843 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -66.26 138.7 57.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 163.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m -161.24 174.07 14.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.083 0.468 . . . . 0.0 109.959 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.29 146.14 27.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.086 0.954 . . . . 0.0 110.604 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.29 127.85 33.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.24 0.616 . . . . 0.0 110.164 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -42.63 18.13 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.01 161.8 34.18 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.22 149.96 21.55 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.602 1.161 . . . . 0.0 110.568 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.15 153.99 33.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.093 165.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -71.87 78.6 0.88 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.213 1.005 . . . . 0.0 109.696 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.68 -162.76 0.19 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.151 1.38 . . . . 0.0 110.296 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.66 116.01 21.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.116 1.366 . . . . 0.0 108.362 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -129.35 166.31 19.76 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.86 123.92 48.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.834 0.853 . . . . 0.0 110.26 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.53 1.532 . . . . 0.0 107.844 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.193 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.9 p -160.5 156.7 26.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.906 0.882 . . . . 0.0 109.735 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt -84.74 64.86 8.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.081 0.952 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -113.59 129.14 56.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.916 1.286 . . . . 0.0 108.758 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 149.08 46.04 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.768 0.427 . . . . 0.0 110.75 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.73 57.17 1.78 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.878 1.271 . . . . 0.0 109.604 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.6 t -128.79 73.65 1.52 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.58 1.152 . . . . 0.0 109.743 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.34 59.54 3.46 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.987 0.915 . . . . 0.0 109.835 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -86.82 72.37 10.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.672 1.189 . . . . 0.0 109.715 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.86 136.24 57.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.034 0.933 . . . . 0.0 109.483 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.21 126.17 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.802 1.241 . . . . 0.0 110.607 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -118.74 -38.39 3.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.601 1.56 . . . . 0.0 111.618 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.77 97.05 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.093 1.357 . . . . 0.0 111.703 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.7 mtt -146.92 174.81 11.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.364 1.466 . . . . 0.0 109.426 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.48 -168.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 115.09 173.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 -179.55 6.43 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.355 1.062 . . . . 0.0 111.415 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -108.96 127.4 54.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.25 0.62 . . . . 0.0 112.386 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 ttp -79.31 146.56 32.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 155.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -127.95 135.44 49.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.444 1.897 . . . . 0.0 106.335 165.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.67 110.52 5.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.394 0.616 . . . . 0.0 111.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -84.3 99.23 10.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.166 1.386 . . . . 0.0 108.084 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.12 107.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -97.32 149.65 21.85 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.439 1.096 . . . . 0.0 110.253 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.5 -158.43 26.03 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.885 1.231 . . . . 0.0 110.962 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.92 22.5 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.515 0.726 . . . . 0.0 110.977 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.84 -17.4 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.118 1.367 . . . . 0.0 111.885 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -67.47 121.04 14.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.062 0.545 . . . . 0.0 111.627 -172.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.48 37.03 93.46 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.462 1.029 . . . . 0.0 112.773 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.14 91.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.0 -139.1 44.45 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.485 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 t80 56.48 -173.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.003 1.721 . . . . 0.0 111.428 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 68.36 -76.04 0.06 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 126.126 1.771 . . . . 0.0 109.243 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -45.85 -42.35 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.303 1.441 . . . . 0.0 111.92 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.66 -53.82 50.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 111.245 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -67.23 -18.83 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 122.074 -0.392 . . . . 0.0 111.344 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -54.83 13.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.266 -1.349 . . . . 0.0 110.713 167.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.7 mm -36.27 -55.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 120.483 1.492 . . . . 0.0 112.886 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -67.62 -51.94 44.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.75 0.42 . . . . 0.0 110.759 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -45.38 -65.98 0.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.575 1.15 . . . . 0.0 111.351 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.41 -47.92 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 111.631 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -53.52 -46.68 70.19 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.06 0.544 . . . . 0.0 110.571 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.9 mt -102.29 37.33 1.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 111.851 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.23 68.43 1.67 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.981 1.277 . . . . 0.0 113.766 167.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.4 mm -117.3 141.45 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.802 1.241 . . . . 0.0 108.978 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -101.81 174.57 5.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 108.481 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.56 -152.44 24.0 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.342 0.974 . . . . 0.0 112.288 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -170.88 142.91 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.451 0.7 . . . . 0.0 110.347 167.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.74 90.2 3.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.295 1.038 . . . . 0.0 111.977 -165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -111.15 104.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.592 0.357 . . . . 0.0 111.823 -160.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -80.17 97.32 6.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.005 0.922 . . . . 0.0 109.42 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -73.73 102.52 0.62 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.04 136.5 48.48 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.891 1.728 . . . . 0.0 110.499 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 55.86 53.35 9.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 110.124 -167.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.47 -131.37 1.25 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.3 t -121.61 150.33 41.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.481 1.112 . . . . 0.0 110.134 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -99.66 94.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.51 137.81 32.23 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.051 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 143.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.04 136.84 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 164.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.91 138.25 31.91 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.083 0.953 . . . . 0.0 108.717 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.15 90.78 3.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -168.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.93 168.62 16.99 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 123.289 0.471 . . . . 0.0 112.199 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -77.07 -100.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.84 1.656 . . . . 0.0 108.942 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -150.92 -57.47 0.16 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.796 1.638 . . . . 0.0 108.188 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -49.89 -45.12 50.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.848 0.859 . . . . 0.0 109.64 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.69 -34.46 67.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.05 0.54 . . . . 0.0 111.372 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.17 -61.02 2.75 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.4 p -43.33 -47.58 6.75 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.682 1.593 . . . . 0.0 112.213 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -56.18 -41.68 75.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.403 1.081 . . . . 0.0 111.666 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.4 -24.65 31.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.711 1.605 . . . . 0.0 111.154 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.53 -60.84 2.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.139 0.976 . . . . 0.0 110.936 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.81 -43.47 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.239 1.016 . . . . 0.0 111.058 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -34.1 -50.99 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.074 2.55 . . . . 0.0 113.259 165.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -69.18 -68.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.682 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -52.49 -41.83 63.73 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.79 -53.81 44.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.723 0.809 . . . . 0.0 110.754 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.09 0.3 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.863 1.22 . . . . 0.0 110.56 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.38 161.54 42.76 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.251 2.634 . . . . 0.0 111.296 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.33 164.71 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.516 2.811 . . . . 0.0 111.793 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.12 50.18 1.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 111.02 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.22 159.34 17.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.599 1.559 . . . . 0.0 107.84 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.18 84.49 3.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.597 0.359 . . . . 0.0 110.437 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.88 127.88 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.765 0.826 . . . . 0.0 109.183 168.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.85 -61.42 1.63 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.729 1.212 . . . . 0.0 108.05 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -146.4 119.94 9.11 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.01 0.524 . . . . 0.0 112.055 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.47 101.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -100.26 79.64 2.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.238 1.415 . . . . 0.0 108.062 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.24 152.34 21.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 m -145.29 139.85 27.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.0 0.92 . . . . 0.0 110.664 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.98 127.34 42.85 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 109.033 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -136.35 -175.86 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.224 1.01 . . . . 0.0 110.639 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.59 152.53 18.45 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.536 0.734 . . . . 0.0 110.57 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.57 133.96 53.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.432 1.093 . . . . 0.0 111.39 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -71.34 -50.37 32.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.07 172.48 35.19 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.12 112.4 20.2 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.958 0.903 . . . . 0.0 109.094 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.67 133.46 54.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.61 97.43 1.71 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.68 -167.41 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.203 1.401 . . . . 0.0 110.539 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 80.54 1.94 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.12 1.368 . . . . 0.0 108.658 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -106.85 160.64 15.35 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 123.255 0.347 . . . . 0.0 110.149 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.18 141.3 47.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.496 0.718 . . . . 0.0 111.559 -165.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.405 1.482 . . . . 0.0 108.306 170.145 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.3 m -144.58 -63.84 0.36 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.965 0.906 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.75 44.51 1.32 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.705 2.002 . . . . 0.0 113.844 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -123.17 -64.98 1.12 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 125.719 1.608 . . . . 0.0 107.995 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 tptt 72.36 -68.89 0.21 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.917 2.087 . . . . 0.0 112.581 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.7 m95 34.92 55.89 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.435 2.294 . . . . 0.0 113.523 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.4 p -85.14 54.68 3.19 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -163.84 67.46 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.879 1.272 . . . . 0.0 108.394 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -118.92 68.63 0.79 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.026 1.331 . . . . 0.0 108.727 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -137.66 98.91 3.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.129 0.972 . . . . 0.0 108.82 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.25 134.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.106 1.362 . . . . 0.0 107.328 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.97 -35.75 6.06 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.386 1.075 . . . . 0.0 110.708 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.88 62.93 2.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.966 1.707 . . . . 0.0 110.792 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.2 mtm -104.0 -146.02 0.37 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 108.943 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.67 162.17 28.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.333 1.053 . . . . 0.0 111.299 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.57 152.16 32.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.293 1.837 . . . . 0.0 108.57 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -97.87 113.94 25.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.277 1.031 . . . . 0.0 110.587 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.0 ptm -86.28 161.7 18.63 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.11 85.56 1.61 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.69 96.19 10.3 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.121 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -80.88 107.2 13.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 t -91.45 90.39 3.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -168.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -65.38 148.28 51.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.13 -164.79 13.14 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.995 0.807 . . . . 0.0 112.157 166.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -90.23 36.92 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.85 0.86 . . . . 0.0 110.218 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.91 -19.39 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 142.32 45.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.011 0.924 . . . . 0.0 111.107 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.0 -43.31 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.839 0.733 . . . . 0.0 112.243 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.21 78.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.939 0.896 . . . . 0.0 109.854 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.5 -121.44 7.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.918 1.247 . . . . 0.0 111.214 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.9 t80 65.35 -56.95 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.092 2.557 . . . . 0.0 114.635 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -32.99 -51.28 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.525 2.73 . . . . 0.0 112.992 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -79.65 -41.73 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.096 0.958 . . . . 0.0 111.183 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -51.25 -41.84 60.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 111.085 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.53 -43.36 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.593 1.157 . . . . 0.0 111.375 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -57.96 10.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.728 0.811 . . . . 0.0 110.589 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.2 mm -47.47 -57.45 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 118.389 0.54 . . . . 0.0 111.3 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -69.94 -39.45 76.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.288 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.79 -61.9 1.93 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.297 0.499 . . . . 0.0 110.918 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.75 -50.62 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.732 1.613 . . . . 0.0 110.39 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -51.3 62.14 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.915 0.886 . . . . 0.0 109.804 -176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.13 4.13 46.58 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.022 1.329 . . . . 0.0 113.387 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.01 58.2 9.38 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.755 0.707 . . . . 0.0 111.454 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.52 142.75 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.784 1.634 . . . . 0.0 107.81 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.53 162.98 13.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.435 1.094 . . . . 0.0 108.58 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -149.68 21.67 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -169.59 143.35 2.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.92 82.88 1.92 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.365 1.066 . . . . 0.0 108.957 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.506 1.146 . . . . 0.0 109.638 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.5 67.35 10.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 127.531 2.332 . . . . 0.0 110.609 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.1 mt -48.79 104.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 126.393 1.877 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.47 32.73 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.115 1.877 . . . . 0.0 113.211 -164.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -147.93 44.83 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.18 1.392 . . . . 0.0 107.604 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.61 -149.86 8.16 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -120.67 151.41 39.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.686 1.194 . . . . 0.0 109.701 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.4 126.96 32.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.89 0.876 . . . . 0.0 111.47 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -92.06 127.48 37.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.68 97.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.48 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.754 0.787 . . . . 0.0 109.732 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.53 156.38 32.94 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.857 1.263 . . . . 0.0 111.38 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -146.57 122.87 10.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.343 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.05 164.92 35.66 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 118.75 0.705 . . . . 0.0 112.773 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.24 162.9 11.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.458 1.103 . . . . 0.0 108.67 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.84 -24.51 44.34 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -166.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.45 -44.08 95.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.655 0.661 . . . . 0.0 109.909 168.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.04 -14.42 59.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.507 0.723 . . . . 0.0 112.439 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.13 -62.96 1.17 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -49.45 -42.46 42.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 112.809 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -61.71 -38.96 89.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.139 0.976 . . . . 0.0 112.047 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -70.61 -55.31 9.09 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -50.95 -53.58 31.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.773 0.429 . . . . 0.0 111.554 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.06 -37.63 83.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.76 0.824 . . . . 0.0 112.246 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.66 -49.07 7.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.917 1.287 . . . . 0.0 110.8 167.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -70.4 -52.63 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.19 0.596 . . . . 0.0 110.296 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -49.94 73.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.453 0.569 . . . . 0.0 111.2 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -69.52 -36.9 76.86 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.367 1.067 . . . . 0.0 111.581 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.99 74.78 0.24 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.234 1.397 . . . . 0.0 110.22 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.77 168.49 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.826 3.017 . . . . 0.0 110.174 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.1 150.02 77.04 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.58 1.52 . . . . 0.0 108.533 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.86 45.56 0.82 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.002 0.521 . . . . 0.0 110.553 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.21 175.64 9.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 109.681 -173.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.27 74.33 3.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.639 0.776 . . . . 0.0 109.92 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 117.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -76.84 -52.28 9.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.505 1.122 . . . . 0.0 108.783 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -179.31 110.38 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.075 1.35 . . . . 0.0 110.211 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -75.74 78.07 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.339 1.056 . . . . 0.0 109.512 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -95.14 89.4 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.38 164.06 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.018 0.437 . . . . 0.0 111.944 -171.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -117.52 125.03 50.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.078 1.351 . . . . 0.0 108.769 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.25 128.75 34.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 m -136.51 179.25 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.633 0.773 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -96.47 146.69 24.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.084 1.354 . . . . 0.0 108.874 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -69.44 135.77 50.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -89.1 -57.35 2.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.018 1.327 . . . . 0.0 108.639 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 27.51 22.52 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.726 1.155 . . . . 0.0 113.536 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.86 -35.34 26.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.408 1.104 . . . . 0.0 112.887 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -83.84 82.27 8.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.08 0.552 . . . . 0.0 111.427 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.23 88.6 0.18 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.917 0.887 . . . . 0.0 109.36 171.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 90.85 145.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 128.507 2.723 . . . . 0.0 110.504 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.92 112.38 24.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.329 1.052 . . . . 0.0 108.829 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.48 165.7 15.95 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.07 0.548 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 p -108.12 146.28 32.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.834 0.854 . . . . 0.0 110.747 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.312 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.0 0 CA-C-O 119.405 -0.664 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 26.8 t 57.87 61.99 2.22 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.831 1.252 . . . . 0.0 111.086 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.33 150.58 26.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 0.0 109.455 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.21 -40.7 2.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.551 1.14 . . . . 0.0 111.368 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 68.96 150.48 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.387 1.875 . . . . 0.0 112.046 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -130.82 58.55 1.7 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.912 1.285 . . . . 0.0 108.698 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.8 m -78.82 68.52 4.8 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 110.63 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -156.9 84.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.081 1.353 . . . . 0.0 108.071 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -140.55 167.97 20.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 109.592 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 71.06 166.65 0.3 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.0 112.823 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.62 125.16 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.691 1.597 . . . . 0.0 108.019 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -172.11 92.7 0.13 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.894 0.878 . . . . 0.0 109.398 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.62 74.63 1.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.25 1.42 . . . . 0.0 109.955 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -120.49 166.54 13.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.223 1.009 . . . . 0.0 111.572 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 75.51 131.68 0.05 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.859 2.864 . . . . 0.0 112.031 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 168.51 12.35 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.777 0.831 . . . . 0.0 112.267 -169.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -93.44 114.92 27.43 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.05 0.453 . . . . 0.0 111.472 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.8 ptm -93.94 86.27 5.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 122.059 0.933 . . . . 0.0 110.529 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.38 114.83 18.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.32 110.68 16.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.316 1.047 . . . . 0.0 110.323 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 109.16 20.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.046 1.338 . . . . 0.0 107.921 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -96.24 110.12 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.52 154.77 17.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.132 0.973 . . . . 0.0 111.728 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.3 -159.05 21.3 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.735 1.636 . . . . 0.0 110.895 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -86.4 47.97 1.55 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.99 41.72 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 125.192 1.397 . . . . 0.0 110.43 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -108.16 33.93 3.87 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.355 0.662 . . . . 0.0 111.86 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.48 -160.7 26.84 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.785 1.183 . . . . 0.0 110.319 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER 70.23 -175.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.965 1.306 . . . . 0.0 109.812 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 27' ' ' VAL . . . -74.99 51.19 2.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.817 0.723 . . . . 0.0 112.616 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.49 178.86 5.82 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.742 2.017 . . . . 0.0 112.075 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 61.65 -74.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.84 2.056 . . . . 0.0 111.061 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.15 -47.2 1.56 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.899 1.679 . . . . 0.0 111.137 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.23 -50.12 67.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.312 0.645 . . . . 0.0 112.127 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.0 -36.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 123.434 0.694 . . . . 0.0 110.341 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.4 -51.85 65.9 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.286 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -44.23 -50.41 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.844 1.656 . . . . 0.0 112.363 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -71.27 -49.64 40.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.854 0.462 . . . . 0.0 110.209 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.63 -48.39 58.06 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.031 0.933 . . . . 0.0 113.132 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.32 -47.16 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.327 1.851 . . . . 0.0 108.36 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.35 -42.87 67.25 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.98 0.355 . . . . 0.0 110.993 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -93.28 6.82 46.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.99 1.316 . . . . 0.0 113.285 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.62 59.83 8.21 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 118.595 0.634 . . . . 0.0 112.244 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -113.45 139.54 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 125.605 1.562 . . . . 0.0 108.399 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -103.46 157.52 16.98 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.671 1.188 . . . . 0.0 108.06 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.97 -158.78 31.58 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 118.569 0.622 . . . . 0.0 113.072 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -170.43 137.98 1.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.591 1.156 . . . . 0.0 108.641 167.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.39 87.51 2.63 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.99 0.916 . . . . 0.0 108.78 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -94.71 115.42 27.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.804 0.842 . . . . 0.0 109.807 -167.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.33 130.38 34.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.542 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -102.55 96.71 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.08 23.6 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.293 2.662 . . . . 0.0 114.43 -161.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.35 42.13 2.05 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.015 1.326 . . . . 0.0 108.303 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.69 -122.22 0.83 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -117.48 164.14 15.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.261 1.824 . . . . 0.0 110.579 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -102.85 124.75 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.595 0.758 . . . . 0.0 110.501 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -98.58 125.52 43.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.757 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -109.06 115.55 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.44 135.1 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 164.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.31 146.4 18.5 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.508 1.123 . . . . 0.0 108.733 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.81 122.63 18.81 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.334 0.654 . . . . 0.0 111.219 -171.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.95 165.3 28.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 121.91 0.728 . . . . 0.0 113.881 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.44 172.68 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.093 160.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.92 -25.54 40.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.06 -52.01 52.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.93 -14.9 62.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.31 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.61 -68.29 0.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -46.34 -43.68 16.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.66 1.184 . . . . 0.0 112.825 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.587 1.155 . . . . 0.0 111.632 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.2 -24.94 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.906 0.482 . . . . 0.0 111.592 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -59.23 2.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 109.862 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.26 -33.53 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.686 0.794 . . . . 0.0 112.207 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.94 -54.57 2.71 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.485 1.514 . . . . 0.0 111.09 170.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.2 mt -74.39 -52.45 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.658 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -54.36 42.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.582 0.628 . . . . 0.0 110.269 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -90.82 41.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.051 1.34 . . . . 0.0 110.201 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.39 73.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.52 163.58 26.58 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.962 3.108 . . . . 0.0 111.639 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.35 -8.78 23.08 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.41 2.74 . . . . 0.0 113.919 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 78.81 25.77 0.5 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.083 2.153 . . . . 0.0 111.084 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.21 169.08 14.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.29 1.836 . . . . 0.0 107.987 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.2 77.99 1.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.689 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.46 122.69 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.749 1.22 . . . . 0.0 110.018 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -82.83 -57.95 3.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.072 1.349 . . . . 0.0 107.898 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.23 136.29 6.54 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.164 0.29 . . . . 0.0 110.841 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 84.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -87.58 75.46 9.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -70.38 160.5 32.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.886 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 m -146.1 80.31 1.57 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 109.489 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.25 137.47 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.481 1.513 . . . . 0.0 112.467 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -144.85 -177.51 5.56 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 0.0 110.871 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 153.12 39.9 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.11 124.67 23.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.748 0.819 . . . . 0.0 111.578 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.18 -49.46 35.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.93 172.5 42.07 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.86 109.98 20.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.68 140.89 58.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.891 0.877 . . . . 0.0 109.935 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.25 91.82 2.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.676 0.79 . . . . 0.0 110.588 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.9 -163.41 0.23 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.43 1.092 . . . . 0.0 109.811 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.1 87.62 2.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.618 0.767 . . . . 0.0 109.638 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 100' ' ' THR . 21.5 tt0 -104.25 -175.91 2.93 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.606 0.762 . . . . 0.0 109.079 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.488 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.4 p -125.17 158.81 33.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.118 -1.42 . . . . 0.0 109.934 159.897 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.154 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 47.7 t -150.91 71.7 1.04 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 108.676 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? 69.76 133.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.661 1.984 . . . . 0.0 111.829 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.57 150.91 32.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.691 1.196 . . . . 0.0 108.349 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -160.28 151.73 19.6 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.857 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -175.72 143.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.253 1.421 . . . . 0.0 108.419 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -138.28 69.36 1.38 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.037 0.935 . . . . 0.0 110.089 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -79.3 59.66 2.89 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.0 110.572 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -123.52 64.62 1.02 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.098 1.359 . . . . 0.0 109.623 -167.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -154.11 141.39 19.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.068 0.547 . . . . 0.0 109.626 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.07 107.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.852 2.061 . . . . 0.0 111.642 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -104.77 -30.93 9.58 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.536 1.135 . . . . 0.0 110.799 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -76.47 72.97 3.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.086 1.354 . . . . 0.0 110.46 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.4 mtm -62.18 -71.63 0.15 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.207 1.003 . . . . 0.0 110.38 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.37 145.69 43.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.499 0.719 . . . . 0.0 111.029 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 164.13 19.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.236 1.014 . . . . 0.0 111.592 -170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -86.39 118.42 25.82 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.1 ptm -89.58 91.35 8.65 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.279 1.037 . . . . 0.0 108.832 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.28 128.66 35.34 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.32 14.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.097 0.475 . . . . 0.0 111.254 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -100.77 94.56 6.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.005 0.922 . . . . 0.0 109.084 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.83 103.76 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.482 0.713 . . . . 0.0 109.135 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -101.86 143.47 31.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.799 0.84 . . . . 0.0 110.569 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.72 -165.95 33.22 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.49 0.494 . . . . 0.0 112.342 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.65 20.5 0.73 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.706 0.803 . . . . 0.0 110.546 168.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.23 -3.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.97 1.308 . . . . 0.0 112.469 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -82.23 33.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.714 1.605 . . . . 0.0 112.814 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.23 57.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -157.96 -174.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.218 1.007 . . . . 0.0 108.402 176.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.86 66.53 0.65 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.188 0.899 . . . . 0.0 111.897 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -133.24 171.51 13.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.703 2.001 . . . . 0.0 107.372 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 80.32 -62.39 0.24 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.639 1.576 . . . . 0.0 107.886 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -54.26 -41.14 68.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.696 0.798 . . . . 0.0 109.478 165.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.79 -55.8 23.21 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.62 -18.57 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.875 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -57.67 -58.8 6.76 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.224 0.92 . . . . 0.0 109.324 165.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.0 mm -46.79 -56.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 123.232 0.613 . . . . 0.0 111.49 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -66.13 -44.3 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.5 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.31 -65.16 0.6 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.214 0.461 . . . . 0.0 110.766 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.93 -45.96 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.978 1.711 . . . . 0.0 111.428 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.93 -43.8 98.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 111.469 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.29 16.72 8.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.777 0.831 . . . . 0.0 112.531 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.74 58.23 15.3 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 124.334 0.969 . . . . 0.0 112.518 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.21 139.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.942 1.297 . . . . 0.0 109.916 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.11 175.13 5.63 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.238 1.415 . . . . 0.0 108.237 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.56 -140.41 11.77 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -170.88 150.67 3.21 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.027 0.413 . . . . 0.0 111.297 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.48 86.5 2.37 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.415 1.486 . . . . 0.0 108.953 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.48 108.95 20.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.24 1.016 . . . . 0.0 108.427 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.15 92.83 9.12 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.16 1.384 . . . . 0.0 109.756 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.88 113.67 32.21 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.59 72.91 5.42 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.357 2.705 . . . . 0.0 112.201 -162.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -165.25 55.93 0.12 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.85 1.66 . . . . 0.0 107.992 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.47 -40.59 1.78 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.48 1.038 . . . . 0.0 114.082 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -90.99 93.22 9.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.404 1.482 . . . . 0.0 110.93 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.37 119.83 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.74 125.79 36.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.746 1.218 . . . . 0.0 109.003 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.77 135.25 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.685 1.194 . . . . 0.0 107.881 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.59 55.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 C-N-CA 124.113 0.965 . . . . 0.0 108.981 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.96 157.54 30.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.249 1.42 . . . . 0.0 110.165 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -143.83 123.03 12.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.545 -172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.88 166.72 39.39 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.467 -1.349 . . . . 0.0 113.748 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -52.43 156.25 1.84 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 0.0 111.352 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.68 -15.05 58.95 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.9 -36.32 82.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.271 0.487 . . . . 0.0 109.942 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.73 -3.53 29.96 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.666 1.186 . . . . 0.0 112.696 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.4 tp -66.9 -61.54 1.89 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.265 0.939 . . . . 0.0 109.364 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -44.7 -41.94 7.2 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.128 1.371 . . . . 0.0 112.878 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.18 -50.31 73.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.627 1.171 . . . . 0.0 111.079 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 68' ' ' LEU . 17.4 tp -71.19 -30.04 65.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.624 0.37 . . . . 0.0 111.274 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.21 -58.7 3.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.98 -38.81 68.29 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.985 0.914 . . . . 0.0 112.268 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -30.44 -52.08 0.15 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.571 1.948 . . . . 0.0 112.542 164.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.16 -72.36 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 122.752 0.421 . . . . 0.0 110.452 -169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -49.65 -49.89 45.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.053 0.941 . . . . 0.0 111.869 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -89.18 29.42 1.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.467 1.107 . . . . 0.0 111.954 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.56 68.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.77 164.92 32.62 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.022 3.148 . . . . 0.0 111.546 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -178.51 4.23 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.512 2.808 . . . . 0.0 110.864 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.12 28.81 0.69 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.104 0.961 . . . . 0.0 112.251 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.458 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -131.25 167.0 19.94 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.732 1.213 . . . . 0.0 110.328 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.84 81.99 2.76 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.81 83.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.549 1.54 . . . . 0.0 110.607 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -39.44 -62.37 0.68 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.964 2.106 . . . . 0.0 111.458 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -165.57 129.28 2.24 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 111.702 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.68 99.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.29 80.7 9.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -74.75 142.61 44.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.0 m -148.28 85.26 1.52 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 109.593 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.98 142.4 0.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.567 1.947 . . . . 0.0 111.027 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -159.95 171.85 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.26 143.06 39.17 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.008 0.923 . . . . 0.0 109.773 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.48 145.69 52.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.085 0.469 . . . . 0.0 111.936 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -58.28 2.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.113 1.365 . . . . 0.0 108.332 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.62 167.8 39.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.54 103.05 6.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.427 0.691 . . . . 0.0 110.213 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -77.55 79.24 4.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -44.44 119.5 1.88 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.375 1.87 . . . . 0.0 112.502 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.5 t70 68.1 124.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.874 2.07 . . . . 0.0 111.595 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.35 95.1 3.15 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -118.21 160.09 22.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 0.819 . . . . 0.0 110.794 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.95 145.97 29.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.678 0.791 . . . . 0.0 112.385 -171.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.304 154.128 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.13 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.6 m -148.4 139.63 23.32 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.201 1.0 . . . . 0.0 109.154 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp -159.49 122.68 3.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.242 1.017 . . . . 0.0 108.939 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -130.78 134.11 46.58 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.19 1.396 . . . . 0.0 108.953 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.01 166.02 25.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.654 1.182 . . . . 0.0 109.473 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -129.99 176.53 7.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.792 1.637 . . . . 0.0 108.978 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -121.01 145.23 47.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.424 1.49 . . . . 0.0 109.04 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -161.59 79.49 0.57 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 108.085 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -140.48 155.76 46.57 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.794 1.238 . . . . 0.0 109.659 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -154.21 65.79 0.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -93.27 140.43 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -110.3 -103.09 0.39 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -127.32 129.02 46.88 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.261 1.424 . . . . 0.0 109.017 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtt -147.57 149.85 33.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.951 1.3 . . . . 0.0 108.629 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -171.15 156.23 4.67 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.742 0.817 . . . . 0.0 110.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 171.58 8.19 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.874 0.869 . . . . 0.0 111.731 -174.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -103.11 107.35 18.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.976 1.311 . . . . 0.0 111.375 -168.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.14 98.2 11.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 109.583 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -74.82 133.86 41.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.17 105.84 5.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.67 99.61 12.61 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.225 1.41 . . . . 0.0 108.37 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.22 116.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.462 1.105 . . . . 0.0 109.065 -170.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -98.97 158.03 15.92 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.688 1.195 . . . . 0.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.11 -162.71 14.76 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 124.631 1.11 . . . . 0.0 111.993 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.23 32.86 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.701 0.8 . . . . 0.0 110.773 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.88 -19.22 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.291 1.036 . . . . 0.0 111.212 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -56.62 133.95 54.12 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.352 1.061 . . . . 0.0 110.15 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.74 10.47 83.26 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.109 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.17 152.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.73 1.212 . . . . 0.0 107.843 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.49 45.9 3.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.769 0.7 . . . . 0.0 112.89 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -57.82 -51.69 68.54 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.676 0.79 . . . . 0.0 109.376 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -56.84 -42.29 79.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.717 0.807 . . . . 0.0 111.692 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.27 -46.08 81.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.274 1.03 . . . . 0.0 110.452 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.99 -45.19 75.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.001 0.364 . . . . 0.0 110.489 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.36 -32.8 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.969 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -59.54 -55.78 30.22 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.284 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mm -42.01 -57.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.766 1.166 . . . . 0.0 113.325 -172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -68.65 -48.07 64.95 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.393 0.542 . . . . 0.0 110.443 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.39 -65.4 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 111.646 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.45 -49.85 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.218 2.207 . . . . 0.0 111.5 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.87 78.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.846 0.458 . . . . 0.0 111.944 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.5 mt -102.06 23.47 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.71 65.87 3.25 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.454 1.026 . . . . 0.0 113.304 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.92 139.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 125.045 1.338 . . . . 0.0 108.004 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -101.56 167.1 10.35 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.072 1.349 . . . . 0.0 107.808 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.98 -146.52 14.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.338 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -167.45 148.6 5.54 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.576 1.15 . . . . 0.0 109.186 166.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.52 81.44 1.59 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.85 0.86 . . . . 0.0 108.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -86.83 84.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.82 87.64 2.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.724 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 123.05 85.67 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 163.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.52 69.33 7.75 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.65 2.234 . . . . 0.0 111.428 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -159.05 56.04 0.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.216 1.406 . . . . 0.0 108.527 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.82 -55.6 4.75 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.856 0.741 . . . . 0.0 113.545 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 m -94.37 66.3 3.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.424 0.689 . . . . 0.0 112.567 -161.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.67 118.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.047 0.539 . . . . 0.0 110.294 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.48 121.21 32.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.0 110.01 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.14 147.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.93 66.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.58 157.57 37.75 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.249 1.42 . . . . 0.0 110.315 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.12 116.7 11.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.742 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.03 159.84 27.47 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 118.722 0.692 . . . . 0.0 114.566 -170.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.9 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.264 1.826 . . . . 0.0 109.535 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -154.72 -75.84 0.11 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.301 1.441 . . . . 0.0 108.222 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -55.1 -48.59 73.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.0 69.38 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.986 0.515 . . . . 0.0 111.797 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.08 -66.31 0.56 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.4 t -44.98 -46.1 10.94 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.041 1.737 . . . . 0.0 112.77 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.73 -44.05 94.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.395 0.543 . . . . 0.0 111.891 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.29 -23.59 51.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.766 0.826 . . . . 0.0 111.354 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.44 -61.55 1.73 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.226 -0.921 . . . . 0.0 110.857 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.36 -36.91 79.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.875 0.87 . . . . 0.0 111.146 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -36.96 -49.59 0.83 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 165.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.81 -64.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.242 0.617 . . . . 0.0 110.056 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -51.57 62.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.831 0.852 . . . . 0.0 111.476 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -77.63 -33.14 53.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.041 0.936 . . . . 0.0 111.998 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.78 85.94 0.42 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.413 1.006 . . . . 0.0 110.686 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.66 156.23 66.19 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.965 2.443 . . . . 0.0 111.299 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.77 172.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.018 3.145 . . . . 0.0 111.715 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.01 27.76 1.53 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.162 0.985 . . . . 0.0 111.875 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.18 28.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.902 1.281 . . . . 0.0 109.445 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 81.64 3.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.45 122.41 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.56 -56.79 4.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -168.31 142.8 3.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.631 1.173 . . . . 0.0 108.667 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.49 100.24 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.76 75.01 4.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -78.71 160.38 27.5 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -135.46 109.43 8.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.734 1.614 . . . . 0.0 109.591 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 119.55 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -134.42 179.49 6.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.798 1.239 . . . . 0.0 110.461 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -104.82 135.92 45.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.128 0.971 . . . . 0.0 110.03 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -52.17 138.98 24.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.065 2.146 . . . . 0.0 112.746 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -79.33 -48.83 13.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.48 179.5 27.16 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.73 112.79 20.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.69 1.196 . . . . 0.0 107.905 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -70.05 137.79 51.56 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -68.17 90.29 0.33 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.664 0.786 . . . . 0.0 110.212 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 70.18 -164.93 0.16 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.229 1.412 . . . . 0.0 109.713 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.7 96.82 3.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.993 0.917 . . . . 0.0 108.856 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -121.56 163.28 19.15 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.483 0.713 . . . . 0.0 109.836 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.94 148.64 33.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.847 1.259 . . . . 0.0 111.73 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.28 155.559 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.3 t -158.45 176.11 12.85 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.457 1.103 . . . . 0.0 108.817 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.4 mtp 58.13 52.82 7.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 111.06 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.21 144.67 28.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.511 0.724 . . . . 0.0 109.892 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -76.35 -54.28 6.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 111.257 -167.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 75.7 m95 34.2 50.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.5 1.92 . . . . 0.0 113.059 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.7 p -97.12 76.89 2.68 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.945 1.298 . . . . 0.0 107.853 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -80.16 59.07 3.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.743 1.217 . . . . 0.0 111.154 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.7 p -95.51 153.86 17.49 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.378 1.471 . . . . 0.0 109.551 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.2 169.47 17.55 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.733 1.213 . . . . 0.0 109.701 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 t 58.21 69.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.466 1.506 . . . . 0.0 109.745 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -75.01 -61.58 1.84 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.66 0.784 . . . . 0.0 109.917 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.98 133.35 55.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.681 1.192 . . . . 0.0 108.356 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.9 ttm -94.13 -98.54 0.15 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 52.16 157.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.576 3.151 . . . . 0.0 117.15 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.28 168.26 12.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.788 0.835 . . . . 0.0 111.483 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -96.52 97.33 9.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.824 1.25 . . . . 0.0 109.996 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 ttp -62.93 152.33 36.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -149.92 123.73 9.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.338 1.055 . . . . 0.0 108.75 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.48 117.01 22.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.142 0.977 . . . . 0.0 110.67 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -91.37 92.74 8.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.312 1.445 . . . . 0.0 107.913 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 24' ' ' VAL . 4.2 t -88.76 112.13 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.52 149.65 21.96 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.173 0.589 . . . . 0.0 111.417 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.92 -153.87 20.51 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.854 1.216 . . . . 0.0 111.855 166.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.47 14.93 1.41 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.264 1.026 . . . . 0.0 111.662 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 HG12 ' A' ' 20' ' ' VAL . 27.3 m -74.51 21.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.346 1.458 . . . . 0.0 112.914 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -97.89 60.03 1.47 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.94 0.876 . . . . 0.0 110.707 -159.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.31 61.24 0.98 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.392 1.472 . . . . 0.0 111.087 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.27 101.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 108.709 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.54 -62.59 3.81 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.274 0.94 . . . . 0.0 111.123 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -64.14 172.85 2.19 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.364 1.066 . . . . 0.0 110.772 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 76.11 -60.57 0.48 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.601 1.96 . . . . 0.0 109.93 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -74.08 -46.52 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.526 0.73 . . . . 0.0 109.555 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -54.52 -51.18 65.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.518 -0.739 . . . . 0.0 111.116 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.43 -20.84 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.095 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -59.06 -60.15 4.33 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.572 0.624 . . . . 0.0 109.335 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -46.15 -52.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.791 0.836 . . . . 0.0 111.841 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -69.59 -46.97 65.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.436 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.34 -52.44 37.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.411 0.55 . . . . 0.0 112.148 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.8 -40.4 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.459 1.504 . . . . 0.0 110.733 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -41.59 93.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.379 0.536 . . . . 0.0 111.731 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.93 11.04 21.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.817 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.16 56.02 24.53 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.701 0.667 . . . . 0.0 112.164 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.84 139.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.436 1.494 . . . . 0.0 108.791 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -108.94 169.6 8.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.382 1.473 . . . . 0.0 107.634 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.81 -138.76 9.14 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -175.46 141.58 0.53 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 117.69 0.745 . . . . 0.0 111.099 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.6 87.19 2.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.253 1.421 . . . . 0.0 110.165 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -92.68 110.07 21.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.269 0.628 . . . . 0.0 110.222 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.07 96.94 10.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.718 1.607 . . . . 0.0 109.234 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -77.89 110.81 14.33 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.07 79.18 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.442 2.761 . . . . 0.0 112.123 -161.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -142.09 -75.39 0.29 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.263 1.825 . . . . 0.0 106.428 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -168.87 35.93 0.2 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.673 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -137.3 103.82 5.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.257 1.023 . . . . 0.0 109.943 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.56 111.08 32.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -91.73 117.22 29.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.467 1.107 . . . . 0.0 109.576 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.27 104.75 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 110.054 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.3 t -79.86 130.26 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.29 124.67 16.6 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.244 1.018 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -108.58 104.66 14.02 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 109.074 -171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.76 159.63 27.96 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -71.52 -98.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.685 1.194 . . . . 0.0 109.656 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -159.65 -53.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.35 1.06 . . . . 0.0 109.486 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -44.3 -42.48 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.27 1.428 . . . . 0.0 110.385 162.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.51 -29.48 18.92 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.514 1.126 . . . . 0.0 112.248 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.08 -58.33 8.9 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 119.045 0.839 . . . . 0.0 109.89 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 p -43.48 -44.31 5.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.39 1.476 . . . . 0.0 112.866 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.58 -33.38 74.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.952 0.901 . . . . 0.0 112.285 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.62 -53.14 7.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.647 0.779 . . . . 0.0 110.324 169.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -52.9 61.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 110.454 -170.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.16 -36.46 83.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.174 1.389 . . . . 0.0 112.15 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.9 -50.34 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.605 169.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.97 -52.55 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 123.201 0.313 . . . . 0.0 110.592 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -49.48 77.32 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.339 0.518 . . . . 0.0 111.129 -174.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.9 -44.16 81.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.096 1.358 . . . . 0.0 110.914 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.63 82.3 0.3 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.514 1.53 . . . . 0.0 109.649 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.17 164.02 26.87 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.737 2.958 . . . . 0.0 111.412 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.58 148.35 72.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.476 2.117 . . . . 0.0 109.501 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.13 49.72 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.475 0.71 . . . . 0.0 110.874 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.23 167.47 29.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.624 1.17 . . . . 0.0 109.238 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.9 77.45 2.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.697 0.799 . . . . 0.0 110.108 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.63 122.65 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.176 0.99 . . . . 0.0 109.456 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.62 -59.35 2.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -169.94 135.78 1.44 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.372 0.669 . . . . 0.0 110.152 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.59 96.87 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -87.13 71.77 10.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.37 148.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.713 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -151.87 103.01 2.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 146.85 52.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.473 0.709 . . . . 0.0 110.579 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -134.19 -174.1 3.46 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 110.383 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.39 25.58 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.099 1.36 . . . . 0.0 109.047 170.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -76.9 144.42 38.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.004 0.922 . . . . 0.0 111.718 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -83.96 -57.75 3.07 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -152.53 172.18 31.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.72 115.77 21.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.359 1.064 . . . . 0.0 108.733 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -68.63 -38.18 80.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.727 1.211 . . . . 0.0 110.506 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 56.86 62.04 2.4 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.81 1.644 . . . . 0.0 112.412 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 t70 157.2 86.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.099 2.559 . . . . 0.0 108.438 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -73.99 91.59 2.05 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -125.84 154.53 42.53 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 111.292 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 120.79 36.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.985 0.914 . . . . 0.0 109.819 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 9.4 m 66.91 179.56 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.147 1.379 . . . . 0.0 111.984 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptp -70.95 102.61 2.44 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.287 0.635 . . . . 0.0 110.318 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -119.99 -61.91 1.54 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.981 1.312 . . . . 0.0 108.851 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 145.29 37.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.474 1.11 . . . . 0.0 109.379 173.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -90.53 59.99 4.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.9 0.88 . . . . 0.0 109.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 t -129.9 151.87 49.99 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.156 1.382 . . . . 0.0 109.613 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -161.18 155.23 22.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.949 1.3 . . . . 0.0 109.113 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -131.23 173.07 11.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.166 1.386 . . . . 0.0 109.639 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.4 152.58 47.32 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.095 1.358 . . . . 0.0 109.132 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -159.8 138.09 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -173.05 27.38 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.571 0.748 . . . . 0.0 112.717 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -87.52 41.76 1.0 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.434 -0.791 . . . . 0.0 112.21 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 66.0 134.66 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.412 2.285 . . . . 0.0 113.763 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.08 146.2 36.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.353 1.061 . . . . 0.0 110.631 -173.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HZ3' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -136.33 -173.31 3.37 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.597 1.559 . . . . 0.0 111.759 -168.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -111.99 132.59 54.69 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.067 0.947 . . . . 0.0 111.287 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.0 ttp -82.5 164.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 156.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -158.53 82.99 0.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.607 1.163 . . . . 0.0 108.239 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.59 105.89 17.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.726 0.81 . . . . 0.0 109.714 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.81 9.67 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.36 114.62 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -166.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.13 140.36 38.42 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.295 1.438 . . . . 0.0 110.87 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.17 -156.39 23.34 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.998 1.285 . . . . 0.0 111.355 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.93 15.68 0.84 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.523 0.729 . . . . 0.0 111.777 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -57.71 -30.37 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.896 0.878 . . . . 0.0 109.954 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.78 126.07 28.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 162.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.52 26.52 25.04 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.968 0.794 . . . . 0.0 111.623 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -154.37 151.66 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.044 1.338 . . . . 0.0 107.898 171.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.09 -69.02 1.4 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.027 0.823 . . . . 0.0 111.687 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 t80 52.79 -116.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 116.942 -1.504 . . . . 0.0 109.717 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 35.92 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.23 2.612 . . . . 0.0 114.423 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -33.03 -47.92 0.19 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.417 1.887 . . . . 0.0 112.254 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.23 -43.68 78.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.41 0.684 . . . . 0.0 111.97 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.24 -36.71 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 C-N-CA 123.53 0.732 . . . . 0.0 109.975 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -46.79 87.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.131 -0.937 . . . . 0.0 109.793 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mm -38.91 -56.47 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -174.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -67.92 -48.19 66.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.418 1.008 . . . . 0.0 111.115 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.06 -64.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.011 0.924 . . . . 0.0 111.603 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.37 -51.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 127.841 2.456 . . . . 0.0 110.621 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -42.28 62.31 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.266 0.626 . . . . 0.0 110.811 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.0 21.58 12.51 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.359 1.464 . . . . 0.0 112.371 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.12 2.93 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.146 0.879 . . . . 0.0 112.863 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 mm -119.39 142.71 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.768 1.227 . . . . 0.0 109.777 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 175.56 5.46 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.386 1.474 . . . . 0.0 108.453 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.47 -148.0 19.61 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -173.87 140.46 0.74 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 117.652 0.726 . . . . 0.0 111.173 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.34 88.03 2.82 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 124.631 1.172 . . . . 0.0 110.322 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.44 107.73 20.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.519 0.728 . . . . 0.0 110.694 -166.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.69 119.6 20.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.767 172.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.37 97.37 1.59 Allowed Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -64.31 138.51 61.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.688 1.592 . . . . 0.0 110.193 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t0 57.49 59.46 3.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.498 1.119 . . . . 0.0 109.434 -164.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.44 -140.16 3.96 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.4 p -124.1 156.46 36.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.76 1.624 . . . . 0.0 109.922 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.84 105.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 123.534 0.733 . . . . 0.0 109.512 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -93.77 134.1 36.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.482 0.713 . . . . 0.0 111.103 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.21 116.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.623 1.169 . . . . 0.0 109.418 -171.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.6 141.82 16.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.84 123.38 17.22 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.899 1.279 . . . . 0.0 108.002 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.83 90.17 3.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.546 0.738 . . . . 0.0 109.214 -162.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 162.86 22.92 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 122.086 0.826 . . . . 0.0 114.672 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.36 163.03 28.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.872 1.269 . . . . 0.0 108.01 163.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.72 -23.58 42.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -64.4 -50.01 69.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -9.83 58.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.936 0.894 . . . . 0.0 112.512 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 HD13 ' HZ3' ' A' ' 14' ' ' LYS . 25.9 tp -68.92 -60.96 2.01 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 119.325 0.966 . . . . 0.0 109.011 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -44.59 -44.67 9.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.566 1.146 . . . . 0.0 112.803 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -49.9 -51.6 39.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.208 1.003 . . . . 0.0 111.91 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.32 -42.48 45.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.435 1.494 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -55.48 -58.26 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.539 1.136 . . . . 0.0 110.388 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.64 -33.31 68.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.682 1.193 . . . . 0.0 111.394 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -40.08 -48.23 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.241 1.417 . . . . 0.0 111.023 165.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.57 -58.76 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.029 0.532 . . . . 0.0 111.065 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -59.52 -39.19 83.07 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.343 0.519 . . . . 0.0 111.088 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -72.93 -44.43 61.2 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.249 1.42 . . . . 0.0 111.094 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 80.91 0.28 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.069 1.318 . . . . 0.0 110.151 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -62.44 159.42 36.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.923 2.415 . . . . 0.0 111.128 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.56 156.08 54.51 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.26 2.64 . . . . 0.0 110.811 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.48 42.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.74 . . . . 0.0 111.25 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -153.01 167.62 28.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.73 1.612 . . . . 0.0 109.357 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.23 82.13 4.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.663 0.785 . . . . 0.0 109.015 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.69 127.52 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 109.415 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -90.07 -51.93 5.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.539 1.136 . . . . 0.0 109.517 -174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -163.1 74.6 0.37 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 112.079 -173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.39 88.08 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.657 0.741 . . . . 0.0 110.44 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.28 80.23 3.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.763 1.225 . . . . 0.0 107.791 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.29 162.39 29.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.029 0.443 . . . . 0.0 111.391 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.1 m -140.82 134.89 30.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.14 0.976 . . . . 0.0 109.301 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.71 138.37 31.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 m -137.76 177.84 7.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 111.724 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -82.39 152.2 26.29 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 124.602 1.161 . . . . 0.0 111.058 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 117.48 8.44 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 110.281 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -99.23 -55.59 2.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.969 1.308 . . . . 0.0 108.531 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.43 38.86 37.27 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 123.927 0.775 . . . . 0.0 113.255 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -85.14 -30.55 23.9 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -81.98 131.99 35.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.892 0.769 . . . . 0.0 110.586 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.68 119.44 33.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.183 1.793 . . . . 0.0 107.467 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.4 t70 64.41 171.27 0.19 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.64 1.176 . . . . 0.0 111.385 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.39 87.53 2.68 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.436 1.495 . . . . 0.0 108.357 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -105.74 152.6 22.97 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 111.128 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.15 130.15 55.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.255 1.022 . . . . 0.0 109.986 -168.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.62 1.568 . . . . 0.0 107.786 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.105 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 51.8 m -148.47 151.39 35.1 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.416 1.086 . . . . 0.0 109.088 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mmm -82.17 66.27 7.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.809 0.844 . . . . 0.0 110.102 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -78.79 166.82 22.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.04 . . . . 0.0 109.96 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mptt 69.72 118.61 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.786 2.034 . . . . 0.0 110.284 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -176.4 143.82 0.51 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.816 1.246 . . . . 0.0 108.555 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -127.36 153.7 45.88 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.248 1.419 . . . . 0.0 109.242 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.32 -50.45 69.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.239 0.616 . . . . 0.0 110.419 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -158.94 163.86 36.14 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.593 1.157 . . . . 0.0 108.551 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -161.05 154.66 22.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.714 1.205 . . . . 0.0 108.145 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.11 154.32 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.272 0.629 . . . . 0.0 110.056 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.5 t80 72.98 59.15 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.208 1.803 . . . . 0.0 110.347 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.38 131.12 47.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 163.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -64.66 -39.76 94.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.247 0.619 . . . . 0.0 110.829 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.64 126.32 27.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.348 0.659 . . . . 0.0 112.219 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 168.4 14.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.437 1.095 . . . . 0.0 111.744 -164.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -97.78 124.79 42.29 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 111.58 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -91.56 153.82 19.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -135.16 98.65 4.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.584 1.554 . . . . 0.0 109.374 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.46 109.67 21.82 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.332 0.653 . . . . 0.0 110.274 177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -92.26 91.22 7.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.304 1.041 . . . . 0.0 108.258 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.11 112.23 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.074 0.55 . . . . 0.0 109.63 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.11 146.4 25.08 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.476 1.511 . . . . 0.0 109.87 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.53 -175.62 20.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.213 0.911 . . . . 0.0 111.59 173.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 tp -82.81 28.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 0.0 110.576 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.22 -28.11 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.019 0.927 . . . . 0.0 110.939 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.74 131.84 14.6 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 109.889 162.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 -55.55 2.43 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.441 -0.644 . . . . 0.0 112.169 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 79' ' ' ALA . 20.3 m -71.78 -178.98 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 117.936 0.868 . . . . 0.0 111.767 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.78 85.9 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.926 1.251 . . . . 0.0 111.497 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -156.48 174.62 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.923 1.289 . . . . 0.0 109.072 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 76.12 -66.31 0.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.115 1.766 . . . . 0.0 109.752 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -53.84 -45.68 70.98 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.8 -42.68 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.088 0.955 . . . . 0.0 111.604 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.88 -32.77 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 110.573 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -56.94 15.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 110.316 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -46.68 -56.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.366 0.666 . . . . 0.0 112.12 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -65.88 -47.85 73.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.033 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.78 -65.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.554 0.741 . . . . 0.0 111.415 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.13 -46.09 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 126.619 1.967 . . . . 0.0 111.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -60.93 -39.5 89.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.162 0.585 . . . . 0.0 111.116 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.85 20.36 7.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.787 0.835 . . . . 0.0 112.834 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.84 53.23 45.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.299 0.952 . . . . 0.0 113.287 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mm -108.94 135.67 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.232 1.413 . . . . 0.0 108.408 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.38 178.63 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.673 1.189 . . . . 0.0 109.126 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.3 -142.43 10.02 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 119.538 1.063 . . . . 0.0 111.917 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -178.64 141.46 0.21 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.507 1.523 . . . . 0.0 110.137 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.42 87.69 2.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.932 0.893 . . . . 0.0 110.672 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -93.78 105.01 17.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.441 0.639 . . . . 0.0 110.994 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.12 96.5 7.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.37 117.61 69.03 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.53 71.69 6.34 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.578 2.852 . . . . 0.0 111.381 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.23 41.24 0.81 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.233 1.413 . . . . 0.0 108.537 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.56 33.64 67.36 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.202 0.906 . . . . 0.0 112.795 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 m -145.78 90.66 2.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.763 0.782 . . . . 0.0 110.035 -173.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -98.65 121.7 49.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.533 0.733 . . . . 0.0 109.092 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.52 143.64 28.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.85 130.21 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.1 141.88 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 158.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.59 122.26 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 109.448 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -124.8 116.53 22.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.222 1.009 . . . . 0.0 111.483 -156.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.31 -171.1 44.09 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.34 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.87 164.0 10.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.384 1.073 . . . . 0.0 110.182 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -81.89 -24.77 35.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -63.39 -52.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.22 -21.38 63.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.4 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.34 -61.44 1.84 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.0 p -47.41 -46.27 26.15 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.904 0.882 . . . . 0.0 112.498 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -51.78 -48.96 63.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.859 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.37 -54.34 21.41 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 110.711 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.9 59.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.219 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.72 -36.56 80.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.642 1.577 . . . . 0.0 112.157 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.71 -43.43 17.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.132 1.373 . . . . 0.0 111.644 171.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.02 -59.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 110.506 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.74 -41.46 97.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.077 0.399 . . . . 0.0 111.7 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.24 -45.97 68.47 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.988 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.38 78.84 0.25 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.742 1.163 . . . . 0.0 110.874 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 157.75 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.023 2.482 . . . . 0.0 110.516 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 165.09 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.388 2.725 . . . . 0.0 111.105 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.77 42.94 0.95 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.611 0.764 . . . . 0.0 111.268 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -148.48 172.12 14.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.046 0.938 . . . . 0.0 110.061 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.82 86.5 0.51 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.335 1.054 . . . . 0.0 109.644 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.48 80.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.024 1.33 . . . . 0.0 109.334 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -38.74 -65.28 0.37 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.491 2.316 . . . . 0.0 111.342 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -151.56 147.43 26.78 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.389 0.676 . . . . 0.0 109.835 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.45 84.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.81 68.53 10.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -73.77 162.91 28.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -147.47 133.39 19.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.784 0.834 . . . . 0.0 109.202 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.89 135.89 34.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.819 1.248 . . . . 0.0 107.955 170.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 m -129.84 -177.55 4.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.455 1.102 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.05 166.83 13.2 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.836 0.855 . . . . 0.0 111.111 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -55.78 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.596 0.758 . . . . 0.0 110.589 166.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -100.31 -56.7 2.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.337 0.655 . . . . 0.0 110.313 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.24 135.57 3.75 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.42 100.45 9.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.774 1.229 . . . . 0.0 110.648 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -75.95 72.36 2.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.94 68.68 1.82 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.647 1.579 . . . . 0.0 112.993 -165.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 166.51 89.43 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 128.492 2.717 . . . . 0.0 106.056 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.75 83.9 6.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.0 158.81 22.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 123.482 0.489 . . . . 0.0 109.949 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.03 139.4 35.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.251 0.62 . . . . 0.0 110.309 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.161 -1.4 . . . . 0.0 109.333 166.947 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.5 m -58.58 -64.12 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.493 1.117 . . . . 0.0 111.569 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -129.59 28.66 5.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.64 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -104.93 125.23 50.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.864 1.266 . . . . 0.0 107.682 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -84.61 -179.96 7.25 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.102 0.961 . . . . 0.0 109.907 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 80.23 113.58 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.515 1.926 . . . . 0.0 111.245 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.5 t -70.11 133.23 46.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.952 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -65.65 -36.24 83.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.661 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m 69.3 91.77 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.713 1.605 . . . . 0.0 109.898 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 68.06 -165.14 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.125 1.77 . . . . 0.0 109.886 -170.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t 68.78 89.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.784 1.633 . . . . 0.0 109.412 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -93.04 -27.26 17.09 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.421 1.488 . . . . 0.0 111.918 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.52 121.85 32.13 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.028 0.931 . . . . 0.0 109.435 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.46 -90.1 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.164 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.82 140.23 58.85 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.356 0.662 . . . . 0.0 111.803 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 -179.44 4.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.227 1.011 . . . . 0.0 111.734 -171.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -106.38 130.8 54.14 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.303 0.641 . . . . 0.0 112.667 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 69' ' ' LEU . 65.3 ttp -69.12 156.9 37.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 154.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.05 87.37 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 107.18 19.13 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -85.97 102.49 13.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 t -96.78 121.82 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 122.912 0.485 . . . . 0.0 110.424 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.67 153.13 20.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 -175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.46 -155.51 17.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.463 1.506 . . . . 0.0 110.695 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 16.86 0.82 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.54 0.736 . . . . 0.0 111.563 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.4 -20.59 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.936 0.895 . . . . 0.0 111.57 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.93 138.65 50.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.384 0.673 . . . . 0.0 109.325 167.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.29 -64.23 4.2 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.8 157.6 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.343 1.057 . . . . 0.0 108.715 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.16 -96.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.514 1.054 . . . . 0.0 112.728 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 t80 63.64 -62.06 0.15 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.4 2.28 . . . . 0.0 112.931 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -33.18 -44.59 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.44 2.696 . . . . 0.0 112.879 167.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -69.38 -45.77 68.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.361 0.664 . . . . 0.0 109.869 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -56.25 -46.22 79.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.44 0.696 . . . . 0.0 110.927 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.28 -37.38 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.924 0.49 . . . . 0.0 110.485 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -64.31 -49.98 69.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.261 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mm -45.42 -56.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.661 1.118 . . . . 0.0 111.515 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -64.36 -48.33 75.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.98 -51.06 59.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.63 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.391 1.476 . . . . 0.0 109.269 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -55.23 -38.57 68.65 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.496 0.718 . . . . 0.0 110.883 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.33 2.81 55.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.266 1.426 . . . . 0.0 113.161 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 62.52 4.95 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.883 0.765 . . . . 0.0 111.68 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.97 143.91 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 125.517 1.527 . . . . 0.0 108.597 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -101.84 170.01 8.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.771 1.228 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.13 -143.58 11.07 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.853 0.752 . . . . 0.0 112.344 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -174.15 142.56 0.83 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.568 1.147 . . . . 0.0 108.953 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.74 79.03 1.88 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -93.5 96.34 9.82 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.792 -164.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.78 93.89 9.62 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 126.292 1.837 . . . . 0.0 110.182 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.03 110.62 6.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.58 64.78 8.66 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.208 2.606 . . . . 0.0 111.567 -161.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -167.36 38.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.87 1.668 . . . . 0.0 109.569 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.27 -105.86 0.28 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -121.14 144.53 48.52 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.618 1.567 . . . . 0.0 110.568 -165.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.63 125.21 41.85 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.717 0.807 . . . . 0.0 110.397 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.08 116.32 27.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.0 t -112.81 123.19 68.23 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.062 0 C-N-CA 124.065 0.946 . . . . 0.0 108.682 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 m -118.0 69.3 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.5 0.72 . . . . 0.0 111.406 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.49 128.45 35.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.948 0.899 . . . . 0.0 111.293 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.65 107.6 15.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.588 0.755 . . . . 0.0 111.085 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.99 172.68 34.58 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.634 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -67.42 168.0 11.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.015 1.326 . . . . 0.0 109.026 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.99 -18.56 53.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.935 0.494 . . . . 0.0 112.093 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.71 -29.12 69.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.21 1.004 . . . . 0.0 110.683 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -2.04 15.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.114 1.366 . . . . 0.0 112.073 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.21 -66.31 0.6 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -41.2 -45.43 2.85 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 125.313 1.445 . . . . 0.0 112.129 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -54.17 -52.72 60.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.59 0.756 . . . . 0.0 111.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.12 -24.08 61.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.825 1.65 . . . . 0.0 111.947 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 16' ' ' MET . 3.3 mm? -82.61 -61.54 1.85 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.991 0.916 . . . . 0.0 111.103 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -47.15 -45.51 22.64 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.584 1.954 . . . . 0.0 111.446 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -29.76 -56.99 0.17 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.022 1.729 . . . . 0.0 112.022 164.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.02 -71.41 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 122.761 0.424 . . . . 0.0 110.876 -167.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -48.49 -44.64 36.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.137 0.975 . . . . 0.0 112.319 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -103.42 53.17 0.76 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.239 1.016 . . . . 0.0 110.57 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.71 153.17 24.65 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.02 114.0 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.775 2.983 . . . . 0.0 110.991 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.75 145.96 47.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.221 1.947 . . . . 0.0 110.838 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.01 -21.37 62.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.46 0.704 . . . . 0.0 111.777 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.1 172.15 10.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.207 1.403 . . . . 0.0 110.828 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.6 73.44 3.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.96 121.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.539 1.136 . . . . 0.0 109.096 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.97 -60.18 2.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.32 152.71 6.14 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 122.905 0.482 . . . . 0.0 110.895 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.26 97.95 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.245 1.018 . . . . 0.0 109.03 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.02 75.73 7.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -80.45 163.05 24.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.532 0.682 . . . . 0.0 112.197 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 123.52 18.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.721 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 123.86 25.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 164.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -128.72 174.31 9.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.945 0.898 . . . . 0.0 110.119 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.64 141.39 28.99 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.56 139.25 58.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.467 1.507 . . . . 0.0 111.393 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.84 -49.32 13.12 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.223 1.009 . . . . 0.0 108.931 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.43 175.56 41.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.39 106.13 17.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.43 134.04 55.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.126 0.97 . . . . 0.0 108.643 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.72 96.68 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.279 0.632 . . . . 0.0 109.61 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 71.22 -170.43 0.15 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.798 1.639 . . . . 0.0 110.668 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.01 92.11 2.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.437 1.095 . . . . 0.0 108.466 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -121.88 164.41 17.58 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.719 0.408 . . . . 0.0 109.959 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -99.01 139.34 34.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.474 0.71 . . . . 0.0 110.508 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.827 -1.559 . . . . 0.0 111.101 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 112.266 -0.334 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.6 t 57.12 37.27 28.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.161 1.384 . . . . 0.0 112.116 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.46 69.41 5.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.317 1.047 . . . . 0.0 108.902 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -125.14 149.81 47.52 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.147 0.979 . . . . 0.0 111.382 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -132.51 71.76 1.48 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.197 1.399 . . . . 0.0 107.441 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -157.5 60.4 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 p -144.67 -73.78 0.25 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.619 0.768 . . . . 0.0 110.696 -169.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t70 54.42 76.07 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.272 1.829 . . . . 0.0 111.138 -172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 p -81.67 57.69 3.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.701 0.8 . . . . 0.0 109.105 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.57 91.1 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.484 1.113 . . . . 0.0 108.184 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -157.2 139.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.092 0.957 . . . . 0.0 109.376 175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 71.42 53.91 0.22 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.183 1.793 . . . . 0.0 113.365 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.08 125.06 21.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.658 0.783 . . . . 0.0 110.514 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.0 mtp -169.91 165.64 9.59 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.793 1.237 . . . . 0.0 109.935 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.07 164.89 4.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.719 1.608 . . . . 0.0 109.624 171.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 163.54 13.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.966 0.906 . . . . 0.0 112.309 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -84.62 114.36 21.94 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.495 0.664 . . . . 0.0 110.182 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.0 ptm -88.71 102.31 14.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.743 0.817 . . . . 0.0 110.149 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.62 108.01 18.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.908 1.283 . . . . 0.0 108.372 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.77 108.57 18.03 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.796 1.239 . . . . 0.0 110.382 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.7 116.81 29.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.588 1.955 . . . . 0.0 107.348 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.37 120.97 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.29 150.8 26.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.353 1.061 . . . . 0.0 110.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.65 -154.31 21.24 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.702 1.144 . . . . 0.0 110.743 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.36 17.81 3.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.365 0.602 . . . . 0.0 110.211 166.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.43 -36.89 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.664 1.986 . . . . 0.0 112.14 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -75.26 80.13 2.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.13 -67.04 0.05 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.95 38.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.883 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.73 -93.34 0.12 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.902 1.239 . . . . 0.0 112.499 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.2 t80 70.78 -38.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.511 2.324 . . . . 0.0 114.128 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -42.87 -44.83 4.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.297 1.439 . . . . 0.0 112.531 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -69.37 -48.83 60.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.079 0.552 . . . . 0.0 110.537 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -51.77 -43.37 62.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.494 1.118 . . . . 0.0 111.707 174.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' N ' HH21 ' A' ' 71' ' ' ARG . 85.0 t -60.6 -39.7 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -45.95 79.66 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 117.32 -1.324 . . . . 0.0 112.046 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.3 mm -48.14 -54.58 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.123 1.783 . . . . 0.0 111.922 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -66.75 -47.21 72.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.132 -0.461 . . . . 0.0 109.967 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.59 -52.09 24.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.426 0.69 . . . . 0.0 112.717 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.87 -43.17 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 126.434 1.894 . . . . 0.0 110.099 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -63.61 -34.33 77.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.102 0.561 . . . . 0.0 111.791 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.2 18.67 20.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.252 . . . . 0.0 112.305 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.01 63.82 4.91 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.413 1.006 . . . . 0.0 113.512 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.14 146.51 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.757 1.623 . . . . 0.0 108.659 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 94' ' ' GLU . 6.9 mtmp? -109.79 166.93 10.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.76 1.224 . . . . 0.0 108.403 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.79 -152.97 24.11 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.786 0.721 . . . . 0.0 112.717 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -166.28 141.09 4.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.225 1.01 . . . . 0.0 109.132 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.89 91.11 3.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.657 1.183 . . . . 0.0 108.962 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -85.94 80.91 8.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -102.91 59.25 0.78 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.456 1.102 . . . . 0.0 108.932 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.4 mt -71.52 108.81 4.36 Favored Pre-proline 0 C--N 1.34 0.188 0 C-N-CA 125.629 1.572 . . . . 0.0 108.43 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -79.71 64.07 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.845 3.03 . . . . 0.0 112.804 -163.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -173.01 54.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.903 2.081 . . . . 0.0 108.095 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 -109.3 0.33 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 m -133.09 160.53 36.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.801 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.34 95.54 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.44 134.47 42.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.595 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.8 t -106.35 133.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.26 78.05 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.19 166.86 16.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.715 1.206 . . . . 0.0 109.818 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.86 109.41 7.44 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 118.866 -0.588 . . . . 0.0 111.965 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.32 149.19 21.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.961 0.8 . . . . 0.0 113.794 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -57.48 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.405 2.282 . . . . 0.0 111.769 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -154.75 -71.16 0.13 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.04 1.736 . . . . 0.0 107.157 -165.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -51.66 -50.65 59.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 164.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.25 62.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.319 1.047 . . . . 0.0 111.949 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -67.07 -66.84 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -48.4 -36.21 14.25 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.956 1.703 . . . . 0.0 113.291 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -63.76 -50.39 69.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.75 0.705 . . . . 0.0 112.542 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.39 -22.85 60.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.707 0.685 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.22 -58.05 4.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.858 -0.526 . . . . 0.0 110.909 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.31 -31.91 73.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.37 0.668 . . . . 0.0 111.614 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.426 HH21 ' N ' ' A' ' 33' ' ' VAL . 17.3 tpt85 -39.28 -54.2 1.85 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.078 1.351 . . . . 0.0 110.364 162.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.83 -53.0 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.032 0.533 . . . . 0.0 111.319 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.51 -38.42 91.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.297 0.499 . . . . 0.0 111.293 -168.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -76.05 -37.94 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.887 0.875 . . . . 0.0 111.482 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.15 74.58 0.24 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.319 0.961 . . . . 0.0 111.21 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.81 164.01 34.44 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.635 2.89 . . . . 0.0 111.688 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.97 128.03 11.18 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.218 2.612 . . . . 0.0 109.293 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.867 0.867 . . . . 0.0 110.058 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.99 74.38 0.43 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.459 0.704 . . . . 0.0 110.093 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 30.02 72.26 0.06 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.503 1.921 . . . . 0.0 110.877 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 90.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -50.72 -55.29 17.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.96 0.904 . . . . 0.0 110.098 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -170.47 140.56 1.81 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 171.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.09 84.37 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 165.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.67 76.25 7.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -71.73 160.12 33.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -150.39 95.56 2.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 141.26 57.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.739 0.816 . . . . 0.0 110.064 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -133.49 177.49 7.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.552 0.741 . . . . 0.0 111.456 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.03 124.02 34.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.051 1.74 . . . . 0.0 108.288 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -55.73 122.14 10.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.935 0.494 . . . . 0.0 112.017 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.65 -47.94 73.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.94 -157.02 10.11 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 13.8 pt-20 -89.03 107.45 19.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 109.358 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.75 73.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.05 137.04 8.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.944 1.698 . . . . 0.0 112.644 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 63.12 -165.57 0.24 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.392 1.077 . . . . 0.0 109.063 -173.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.75 82.81 1.22 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.98 162.81 13.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -171.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.11 134.06 55.14 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 111.072 -167.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.183 -1.389 . . . . 0.0 108.468 162.83 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.3 m -66.2 135.88 55.12 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.596 0.759 . . . . 0.0 110.435 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mtp -125.75 -80.45 0.61 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.285 1.034 . . . . 0.0 108.538 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -119.65 179.73 4.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.925 1.29 . . . . 0.0 109.776 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.3 163.73 32.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.63 1.172 . . . . 0.0 110.534 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 69.61 60.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.036 1.734 . . . . 0.0 110.507 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.1 t -77.23 69.82 3.55 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.244 1.018 . . . . 0.0 110.266 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.2 t0 66.94 164.41 0.2 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.003 2.121 . . . . 0.0 112.383 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.3 m 65.26 78.87 0.27 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.335 1.454 . . . . 0.0 110.726 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -133.41 69.25 1.48 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.95 1.3 . . . . 0.0 107.596 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.24 150.14 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.419 1.087 . . . . 0.0 109.143 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -86.7 -66.27 0.92 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.959 0.904 . . . . 0.0 110.121 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.85 148.44 46.77 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.128 1.371 . . . . 0.0 109.387 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.5 mtp -75.39 -76.65 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp -131.93 155.3 48.17 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.522 1.129 . . . . 0.0 109.867 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -178.21 3.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.413 1.085 . . . . 0.0 111.393 -174.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -99.91 127.12 46.12 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.887 0.475 . . . . 0.0 110.773 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 10.8 ptm -97.9 96.62 8.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.141 0.972 . . . . 0.0 110.266 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -87.81 108.63 19.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.5 1.12 . . . . 0.0 108.587 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.74 109.15 14.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 110.721 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.25 100.37 12.94 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.433 1.093 . . . . 0.0 108.848 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 101.74 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.78 155.51 17.61 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.269 0.627 . . . . 0.0 111.758 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.95 -155.37 21.22 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.352 1.454 . . . . 0.0 111.581 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -81.6 28.99 0.38 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.996 0.918 . . . . 0.0 110.238 173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.2 m -76.13 -6.98 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.336 1.055 . . . . 0.0 112.717 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 164.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 164.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.87 -62.9 4.47 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -171.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -72.83 155.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.56 -83.11 0.33 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 122.949 0.309 . . . . 0.0 112.383 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 47.5 56.3 7.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.594 1.558 . . . . 0.0 111.519 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.97 -41.32 0.53 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.428 1.491 . . . . 0.0 108.729 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -72.39 -48.91 37.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.328 0.651 . . . . 0.0 110.848 171.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.17 -46.37 68.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.136 0.494 . . . . 0.0 111.114 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.19 -35.48 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.246 0.619 . . . . 0.0 110.359 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -64.96 -47.15 78.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.058 0.943 . . . . 0.0 110.641 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.57 -56.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.62 1.1 . . . . 0.0 110.935 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -70.41 -40.78 73.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.281 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.94 -54.91 11.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.2 0.6 . . . . 0.0 111.634 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.89 -38.81 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.119 1.368 . . . . 0.0 111.349 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -59.44 -37.1 77.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.915 0.486 . . . . 0.0 111.137 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -98.13 19.06 14.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.772 0.829 . . . . 0.0 112.869 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 56.54 22.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.023 0.821 . . . . 0.0 113.204 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -104.49 143.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 125.387 1.475 . . . . 0.0 108.91 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -104.27 171.27 7.43 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.531 1.132 . . . . 0.0 108.549 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.49 -138.72 10.27 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.207 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -166.6 145.9 5.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.508 0.654 . . . . 0.0 112.358 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.58 85.7 2.37 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.907 1.683 . . . . 0.0 108.938 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -95.39 100.84 12.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.012 0.525 . . . . 0.0 110.351 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.64 116.23 8.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 170.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.2 mt -94.13 94.12 1.04 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.57 141.52 95.5 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.387 2.058 . . . . 0.0 111.024 -170.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.49 61.57 2.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.644 1.178 . . . . 0.0 109.634 -166.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.75 -126.67 1.0 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -129.25 149.2 51.15 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.035 1.734 . . . . 0.0 109.303 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.6 99.42 5.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.25 125.34 30.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.84 1.256 . . . . 0.0 108.362 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -112.95 125.3 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.8 77.87 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 161.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 16' ' ' MET . . . -84.32 162.14 20.18 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.036 1.334 . . . . 0.0 108.845 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -138.93 105.15 5.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.069 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.03 166.23 24.96 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 118.708 0.685 . . . . 0.0 112.911 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -67.8 173.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.36 1.064 . . . . 0.0 108.632 161.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.85 -31.19 63.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.2 -20.49 65.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.128 0.571 . . . . 0.0 112.287 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.68 -12.09 18.67 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.938 0.895 . . . . 0.0 111.781 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.94 -70.7 0.24 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 p -43.81 -34.81 1.68 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.028 1.331 . . . . 0.0 113.602 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -68.73 -56.47 8.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.85 0.86 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.45 -22.16 62.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.425 0.69 . . . . 0.0 111.175 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.5 -59.77 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.6 -0.687 . . . . 0.0 110.191 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -61.69 -32.09 72.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.718 0.69 . . . . 0.0 111.85 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -43.54 -51.45 6.79 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.415 1.486 . . . . 0.0 111.952 164.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -67.29 -53.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 C-N-CA 123.246 0.619 . . . . 0.0 110.519 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -41.78 93.76 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.893 0.315 . . . . 0.0 110.63 -172.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -70.39 -42.12 72.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.447 1.499 . . . . 0.0 111.497 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.2 78.08 0.24 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.355 1.455 . . . . 0.0 111.075 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.75 169.39 17.68 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 124.033 3.155 . . . . 0.0 112.126 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.59 162.14 38.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.03 2.486 . . . . 0.0 110.944 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.91 33.74 0.33 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.807 0.843 . . . . 0.0 111.852 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.94 174.16 13.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.398 1.079 . . . . 0.0 109.857 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.26 88.52 0.85 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.07 122.24 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.872 0.869 . . . . 0.0 109.218 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -75.24 -58.04 3.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -166.11 132.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.029 0.531 . . . . 0.0 110.112 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -87.25 86.17 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 162.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.53 75.61 9.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.95 151.57 33.63 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.633 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.6 m -151.18 95.61 2.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 0.0 109.349 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -60.9 152.79 26.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.427 1.491 . . . . 0.0 110.801 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 m -157.91 176.72 12.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.67 144.54 45.79 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -65.49 132.71 49.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.53 1.132 . . . . 0.0 112.401 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -69.23 -51.88 33.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 109.119 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.91 -178.16 36.5 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.61 111.9 23.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.978 1.311 . . . . 0.0 108.524 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -75.46 -17.97 59.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.843 0.857 . . . . 0.0 111.948 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 66.12 94.94 0.06 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.71 1.604 . . . . 0.0 111.181 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 68.85 155.75 0.13 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.393 1.877 . . . . 0.0 110.986 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -101.94 92.06 4.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -110.84 160.45 16.75 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -105.36 142.77 34.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.984 0.514 . . . . 0.0 111.644 -167.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.032 174.259 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.9 m -136.2 39.22 2.72 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.88 0.872 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.3 mtt -84.47 50.33 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.733 0.813 . . . . 0.0 110.916 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -88.21 69.37 9.17 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -95.31 -64.47 1.06 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.1 0.96 . . . . 0.0 109.868 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -140.43 154.34 46.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.163 1.785 . . . . 0.0 108.549 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 m -68.3 151.63 46.63 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.415 0.686 . . . . 0.0 110.589 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.57 121.8 14.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.66 0.784 . . . . 0.0 110.296 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -77.63 133.68 38.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -141.01 170.6 15.43 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.783 1.233 . . . . 0.0 109.254 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.6 116.38 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.7 -45.4 81.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.863 1.265 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.42 51.94 2.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.737 1.215 . . . . 0.0 110.659 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -54.3 41.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.0 110.065 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 pp -102.9 156.48 17.63 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.942 0.897 . . . . 0.0 110.118 172.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.59 144.09 48.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.237 1.415 . . . . 0.0 109.761 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -83.07 108.71 16.55 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.97 0.508 . . . . 0.0 111.131 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.7 ptm -93.41 94.06 8.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.494 0.664 . . . . 0.0 109.74 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.91 133.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.09 104.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -97.1 100.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.107 1.763 . . . . 0.0 109.207 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.55 127.13 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 110.226 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -102.66 155.04 18.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.941 1.297 . . . . 0.0 110.14 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.56 -168.85 19.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.003 1.287 . . . . 0.0 110.65 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -88.8 56.04 3.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.78 3.7 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.384 1.073 . . . . 0.0 112.372 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.89 152.99 25.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.76 -56.15 4.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -69.75 -179.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.593 0.757 . . . . 0.0 110.556 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.71 -97.19 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.269 0.938 . . . . 0.0 112.863 -171.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 64.0 -65.01 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.78 2.032 . . . . 0.0 113.078 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -48.5 -31.32 6.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.185 2.194 . . . . 0.0 113.177 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.29 -46.57 15.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.493 1.517 . . . . 0.0 110.851 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.78 -49.37 77.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.021 0.528 . . . . 0.0 111.341 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.02 -26.99 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.389 172.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.99 -56.07 15.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.905 0.882 . . . . 0.0 110.173 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.5 mm -43.83 -56.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 118.876 0.762 . . . . 0.0 111.029 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -64.62 -49.59 70.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.21 -65.06 0.63 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.515 0.726 . . . . 0.0 112.212 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.61 -50.97 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 126.097 1.759 . . . . 0.0 110.132 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -56.82 -41.39 77.72 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.385 0.674 . . . . 0.0 110.864 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.9 mt -93.93 15.36 16.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.399 1.48 . . . . 0.0 113.144 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.82 48.61 84.43 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.972 0.796 . . . . 0.0 113.123 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.08 143.2 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.394 1.478 . . . . 0.0 107.846 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -104.09 169.36 8.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.425 1.09 . . . . 0.0 108.282 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.82 -150.4 22.28 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 119.162 0.892 . . . . 0.0 112.886 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -170.89 140.76 1.65 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.836 1.254 . . . . 0.0 109.172 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.15 89.86 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.37 1.068 . . . . 0.0 110.288 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.11 98.19 7.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.261 0.624 . . . . 0.0 110.796 -165.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.63 115.03 16.02 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.51 170.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.68 104.51 10.43 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.99 141.68 65.36 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.058 2.505 . . . . 0.0 111.597 -163.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 63.98 60.03 1.05 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.809 1.644 . . . . 0.0 110.426 -171.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -129.49 1.51 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 p -120.87 163.44 18.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.627 1.571 . . . . 0.0 109.835 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -116.92 125.09 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.977 0.911 . . . . 0.0 110.77 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.54 145.46 30.27 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.929 0.492 . . . . 0.0 110.656 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.91 137.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 66.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.5 155.58 29.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.473 1.109 . . . . 0.0 109.94 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -142.86 106.24 4.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.921 -0.562 . . . . 0.0 109.888 -167.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.03 149.78 19.99 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.295 0.498 . . . . 0.0 113.912 -171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -63.06 163.88 9.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.757 0.823 . . . . 0.0 108.856 162.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -78.18 -34.24 49.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.464 0.706 . . . . 0.0 111.11 -171.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -69.65 -9.04 52.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.979 0.912 . . . . 0.0 111.632 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.91 4.32 10.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.672 1.189 . . . . 0.0 111.907 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -71.62 -68.56 0.44 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.427 1.012 . . . . 0.0 109.619 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.2 p -44.98 -42.47 8.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.558 1.543 . . . . 0.0 112.957 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -53.42 -48.59 68.61 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.237 1.015 . . . . 0.0 111.05 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.44 -51.97 17.91 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -52.54 -57.06 11.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.467 0.576 . . . . 0.0 111.777 -170.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.48 -40.37 68.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.056 1.343 . . . . 0.0 112.456 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.9 -51.14 7.77 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.214 1.006 . . . . 0.0 110.681 169.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.48 -53.58 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.329 -173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -46.44 71.65 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.071 0.396 . . . . 0.0 111.56 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -71.87 -55.61 7.22 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.862 0.865 . . . . 0.0 110.49 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.32 97.87 2.11 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.295 -1.281 . . . . 0.0 110.561 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.74 145.23 80.53 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.496 2.131 . . . . 0.0 109.07 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -86.93 49.54 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.913 1.742 . . . . 0.0 114.498 -153.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 56.58 37.15 28.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.36 1.064 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.3 161.72 39.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.058 0.943 . . . . 0.0 109.238 -168.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -84.55 75.89 10.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.95 135.59 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.905 1.282 . . . . 0.0 110.817 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.96 -57.57 2.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.018 1.327 . . . . 0.0 108.319 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -166.72 137.76 3.33 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 122.878 0.471 . . . . 0.0 110.996 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.33 96.4 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 121.784 -0.572 . . . . 0.0 110.169 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.97 72.26 9.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.7 161.95 28.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.476 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.5 t -137.9 127.43 24.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.606 0.762 . . . . 0.0 110.037 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.58 131.37 42.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 167.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 m -128.21 -160.06 0.99 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.292 1.037 . . . . 0.0 110.02 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -120.83 152.81 37.93 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.634 1.973 . . . . 0.0 108.967 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -52.21 86.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.919 1.688 . . . . 0.0 111.641 166.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -100.75 -54.8 2.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.727 1.211 . . . . 0.0 110.468 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.56 133.96 5.83 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.1 92.22 8.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.428 1.091 . . . . 0.0 109.809 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -72.13 87.92 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.86 143.39 56.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.635 0.774 . . . . 0.0 110.54 -174.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 64.9 -170.27 0.19 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.845 1.258 . . . . 0.0 109.374 -166.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.41 100.75 2.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.84 158.06 26.38 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 122.965 0.506 . . . . 0.0 111.391 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.67 139.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.686 1.195 . . . . 0.0 110.121 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.94 -178.719 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.8 m -150.13 54.76 0.92 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.095 0.958 . . . . 0.0 109.371 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt -85.34 54.98 3.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 0.0 110.219 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -98.46 140.12 33.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.22 1.008 . . . . 0.0 109.105 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -167.32 64.75 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -84.54 56.27 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.088 0.955 . . . . 0.0 110.951 -170.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -137.92 134.24 34.74 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.777 1.631 . . . . 0.0 108.309 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.5 t0 63.2 178.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.286 1.434 . . . . 0.0 110.576 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.5 m 77.39 -40.39 0.34 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.089 1.756 . . . . 0.0 112.236 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.91 -168.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.579 1.951 . . . . 0.0 112.336 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.15 136.96 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.113 0.965 . . . . 0.0 108.849 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -172.73 -43.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.614 1.566 . . . . 0.0 109.826 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.82 130.2 24.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.832 2.053 . . . . 0.0 111.978 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 mmt -145.47 163.31 35.07 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.064 1.745 . . . . 0.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.255 0.3 OUTLIER 72.95 134.38 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.303 2.641 . . . . 0.0 111.843 175.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 165.38 18.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.926 0.89 . . . . 0.0 111.999 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -97.55 123.81 41.57 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 121.545 0.688 . . . . 0.0 112.092 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.9 ttp -67.9 154.79 40.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 150.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.8 106.94 2.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.39 116.94 28.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.299 1.04 . . . . 0.0 109.547 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 93.73 7.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.9 t -92.7 110.01 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.48 0.312 . . . . 0.0 110.646 -166.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -97.96 145.46 26.45 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.204 1.002 . . . . 0.0 110.823 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.52 -166.37 30.17 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 123.751 0.691 . . . . 0.0 111.973 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.84 15.74 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.523 0.729 . . . . 0.0 110.961 169.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.5 -15.44 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.114 1.366 . . . . 0.0 112.29 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -77.13 29.41 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.369 1.468 . . . . 0.0 113.737 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.82 24.13 0.17 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.153 1.359 . . . . 0.0 112.292 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.97 169.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.227 1.011 . . . . 0.0 108.582 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.87 33.35 2.15 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.663 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.2 t80 -78.48 45.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.031 1.415 . . . . 0.0 110.594 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -141.13 -45.88 0.39 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.897 2.479 . . . . 0.0 106.526 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -71.26 -44.67 64.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.097 0.959 . . . . 0.0 110.195 169.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.93 -55.62 28.6 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.941 -0.474 . . . . 0.0 111.752 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.21 -34.64 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 122.725 0.41 . . . . 0.0 111.32 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -58.66 -38.57 78.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.404 1.482 . . . . 0.0 112.809 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.45 -57.47 11.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.352 1.433 . . . . 0.0 110.487 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -64.03 -38.98 93.04 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.6 0.636 . . . . 0.0 110.679 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.85 11.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.064 0.545 . . . . 0.0 111.966 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.94 -36.42 77.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.498 0.719 . . . . 0.0 110.861 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -52.41 -43.93 65.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.282 1.033 . . . . 0.0 109.479 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.11 23.07 13.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.05 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.22 63.77 4.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.5 1.048 . . . . 0.0 112.999 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.41 138.12 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.221 1.409 . . . . 0.0 108.304 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -100.89 165.03 11.55 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.326 1.05 . . . . 0.0 108.463 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.41 -139.34 7.09 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -176.4 148.49 0.75 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.581 0.691 . . . . 0.0 110.669 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.46 78.73 1.14 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 109.502 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -90.22 86.32 6.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.946 0.879 . . . . 0.0 109.244 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.5 97.26 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.967 1.307 . . . . 0.0 109.945 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.6 mt -78.63 102.22 0.95 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 125.059 1.344 . . . . 0.0 107.582 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 146.84 79.77 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.501 2.134 . . . . 0.0 111.118 -164.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 55.28 53.35 10.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.476 1.11 . . . . 0.0 109.489 -167.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.3 -132.95 1.63 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -127.37 149.69 49.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.743 1.617 . . . . 0.0 109.94 -169.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.96 115.8 29.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 121.594 0.711 . . . . 0.0 109.419 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.97 103.49 16.0 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.34 1.456 . . . . 0.0 107.079 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.58 132.23 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.316 0.646 . . . . 0.0 109.833 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.56 145.83 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.58 119.39 4.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.359 0.527 . . . . 0.0 110.652 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -109.67 107.44 17.49 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.307 1.443 . . . . 0.0 110.865 -166.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.66 174.94 26.33 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-O 121.826 0.681 . . . . 0.0 113.011 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -72.64 173.25 9.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 160.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.97 -30.02 63.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -64.84 -17.86 64.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.426 0.691 . . . . 0.0 112.598 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.44 -2.98 10.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.411 1.085 . . . . 0.0 112.263 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -68.18 -62.32 1.45 Allowed 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -42.69 -42.84 3.63 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.737 1.615 . . . . 0.0 113.064 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -51.49 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.953 0.501 . . . . 0.0 111.454 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.05 -24.15 63.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.499 1.12 . . . . 0.0 111.639 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.96 -61.79 1.88 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 108.835 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.23 -25.7 65.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.266 1.426 . . . . 0.0 111.766 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -54.23 0.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.185 1.394 . . . . 0.0 110.776 159.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mt -71.21 -56.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.87 -48.76 80.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.454 0.302 . . . . 0.0 110.818 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -68.92 -42.34 76.94 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.811 1.245 . . . . 0.0 111.247 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.1 0.27 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.077 1.322 . . . . 0.0 110.02 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.75 163.37 38.64 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.631 2.887 . . . . 0.0 111.919 -173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.86 162.36 37.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.715 2.943 . . . . 0.0 111.204 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.67 42.23 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.848 0.859 . . . . 0.0 111.039 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.92 162.86 36.82 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.778 1.231 . . . . 0.0 109.54 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.02 83.72 2.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.389 1.075 . . . . 0.0 109.192 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.31 83.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.288 1.435 . . . . 0.0 109.914 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -41.0 -60.88 1.08 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.311 1.844 . . . . 0.0 111.37 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -162.62 133.63 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.091 0.244 . . . . 0.0 110.84 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.04 94.24 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 165.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.39 70.05 10.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -75.76 161.3 29.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.391 0.615 . . . . 0.0 111.494 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -143.03 97.55 3.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.63 1.172 . . . . 0.0 108.952 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -55.91 127.33 29.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.673 1.189 . . . . 0.0 109.188 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -134.93 -163.21 1.35 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.53 1.132 . . . . 0.0 109.679 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 151.59 47.17 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.547 0.739 . . . . 0.0 110.04 173.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -58.3 124.7 20.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.969 0.908 . . . . 0.0 112.001 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -73.76 -45.3 52.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.55 176.23 37.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.95 96.81 10.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.488 1.515 . . . . 0.0 109.505 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -56.06 -55.32 34.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.299 1.04 . . . . 0.0 111.099 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.61 61.22 3.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 112.107 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 155.75 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.723 2.809 . . . . 0.0 108.213 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.59 98.1 10.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 168.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -117.45 165.35 13.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.454 0.702 . . . . 0.0 109.308 176.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -114.84 144.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.575 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.314 -1.327 . . . . 0.0 108.756 150.512 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.115 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.0 m -144.4 102.73 3.88 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.109 0.963 . . . . 0.0 108.652 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -90.71 60.26 4.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.219 1.007 . . . . 0.0 109.656 -171.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.05 -173.34 3.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.0 109.828 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 57.83 76.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.302 1.441 . . . . 0.0 110.071 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -116.1 158.79 22.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.568 1.547 . . . . 0.0 109.204 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.9 m -125.98 140.39 52.66 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.378 1.471 . . . . 0.0 109.606 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -162.69 -178.25 6.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.434 1.094 . . . . 0.0 109.154 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p 43.72 51.88 6.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.326 1.851 . . . . 0.0 113.02 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -117.44 75.74 1.0 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 108.855 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -162.76 143.7 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.581 1.152 . . . . 0.0 108.643 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -76.68 -56.58 4.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.949 0.499 . . . . 0.0 109.964 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.51 117.83 30.06 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.073 1.349 . . . . 0.0 109.224 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -60.15 3.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.696 0.398 . . . . 0.0 110.243 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.66 146.7 40.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.672 0.789 . . . . 0.0 110.704 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 166.39 16.87 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.882 1.273 . . . . 0.0 111.695 -167.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -94.77 124.55 38.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.633 0.773 . . . . 0.0 111.773 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -90.52 151.93 21.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 160.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -135.39 102.64 5.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.45 1.1 . . . . 0.0 109.097 -177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.05 106.3 16.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.049 0.54 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 98.02 10.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.67 104.23 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -76.16 153.28 36.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.71 -155.51 16.23 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 123.735 0.683 . . . . 0.0 112.549 162.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.71 28.2 0.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.158 0.983 . . . . 0.0 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.87 -9.62 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.177 0.991 . . . . 0.0 113.064 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.66 164.93 18.15 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 162.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.69 3.77 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.05 142.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.35 52.73 4.77 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.434 0.54 . . . . 0.0 113.089 -165.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -87.6 51.08 2.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.466 0.706 . . . . 0.0 110.437 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -52.61 0.93 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.404 1.481 . . . . 0.0 107.238 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -47.72 -52.61 17.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.696 1.199 . . . . 0.0 110.711 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.88 -54.63 40.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.131 0.972 . . . . 0.0 111.436 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.2 -23.68 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.453 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -66.1 -50.21 64.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.542 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.14 -53.3 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.814 1.188 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -70.7 -31.21 68.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.59 -64.18 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 167.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.6 -41.0 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.312 1.445 . . . . 0.0 112.309 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -49.1 78.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 111.279 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -87.05 14.57 7.26 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.83 57.75 17.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.179 0.895 . . . . 0.0 111.829 176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.1 mm -119.18 140.7 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.981 1.313 . . . . 0.0 109.196 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -109.95 165.2 11.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.069 1.347 . . . . 0.0 108.595 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.69 -134.14 5.5 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 118.477 0.581 . . . . 0.0 112.169 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.99 147.8 1.68 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 122.995 0.518 . . . . 0.0 111.646 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.32 84.49 2.63 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.954 1.302 . . . . 0.0 108.75 167.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.38 86.85 5.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.791 0.805 . . . . 0.0 109.544 -169.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.72 81.21 6.44 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 126.251 1.821 . . . . 0.0 109.869 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.4 mt -59.85 110.99 3.24 Favored Pre-proline 0 N--CA 1.454 -0.265 0 C-N-CA 125.363 1.465 . . . . 0.0 107.978 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.06 46.36 2.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.958 2.438 . . . . 0.0 112.945 -162.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -153.43 45.92 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.879 1.672 . . . . 0.0 107.676 167.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.07 -136.84 3.87 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 m -120.64 173.04 7.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.269 1.428 . . . . 0.0 110.266 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.62 122.39 45.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 122.965 0.506 . . . . 0.0 111.744 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -95.64 110.04 22.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.201 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -87.18 140.08 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.29 135.19 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 165.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.77 117.23 6.99 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.015 0.926 . . . . 0.0 110.101 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.69 111.4 24.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.129 0.972 . . . . 0.0 110.67 -171.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.67 29.99 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -54.78 163.97 0.87 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 110.104 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.47 -44.36 64.9 Favored 'General case' 0 CA--C 1.527 0.063 0 O-C-N 122.116 -0.365 . . . . 0.0 110.629 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -47.74 -43.44 27.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.678 1.191 . . . . 0.0 111.256 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.76 0.36 52.3 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.005 1.322 . . . . 0.0 112.828 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.6 tp -68.8 -60.76 2.16 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.582 1.083 . . . . 0.0 109.461 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.3 p -40.9 -47.89 3.04 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.424 1.489 . . . . 0.0 112.32 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.35 -41.46 65.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.13 -53.44 11.02 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.89 0.476 . . . . 0.0 109.75 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.8 -52.46 60.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.53 -45.0 73.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.234 1.414 . . . . 0.0 111.542 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.95 -53.88 3.67 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.534 1.534 . . . . 0.0 110.481 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.1 mt -63.35 -65.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.25 0.22 . . . . 0.0 110.827 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -55.63 -41.26 73.28 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.93 -37.56 88.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.77 0.828 . . . . 0.0 111.805 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.33 76.61 0.24 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.436 1.494 . . . . 0.0 110.064 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.6 168.04 23.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.349 3.366 . . . . 0.0 112.129 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 169.83 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.656 2.904 . . . . 0.0 111.418 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.68 29.03 0.82 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.0 0.92 . . . . 0.0 111.335 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.85 168.23 16.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.944 1.298 . . . . 0.0 109.635 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.7 84.06 1.61 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.875 0.87 . . . . 0.0 109.881 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.49 98.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.796 0.838 . . . . 0.0 110.293 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -49.78 -55.18 15.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.549 1.539 . . . . 0.0 110.677 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -178.06 135.24 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.086 1.354 . . . . 0.0 110.981 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.1 90.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 121.601 -0.687 . . . . 0.0 109.385 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.05 77.87 6.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -78.46 171.08 15.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.36 0.6 . . . . 0.0 112.166 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -143.39 126.14 16.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.158 1.383 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.03 129.1 34.08 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -135.7 -162.57 1.28 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.281 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.59 135.74 48.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.798 1.239 . . . . 0.0 109.496 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -57.98 135.76 56.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.315 0.646 . . . . 0.0 112.505 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -79.32 -47.19 16.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.205 0.602 . . . . 0.0 109.432 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.19 -174.28 36.19 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.21 96.56 10.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.537 1.135 . . . . 0.0 110.291 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -58.81 134.32 56.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 167.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.73 71.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.736 0.814 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.06 164.04 0.26 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.422 1.889 . . . . 0.0 111.326 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.67 109.97 17.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 100' ' ' THR . 28.8 tt0 -111.57 178.5 4.31 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.1 p -124.01 138.53 54.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.448 0.699 . . . . 0.0 109.839 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.303 167.42 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 112.262 -0.335 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 33.0 p -153.5 62.76 0.74 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.199 1.0 . . . . 0.0 109.123 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -82.99 63.86 7.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.837 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 114.06 21.18 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.657 1.183 . . . . 0.0 108.464 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -132.47 121.45 23.39 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -178.89 124.62 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.115 1.366 . . . . 0.0 107.768 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 t -139.18 149.06 43.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -164.15 149.31 10.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.332 1.053 . . . . 0.0 109.111 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.3 p -130.62 158.99 38.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.24 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -140.82 176.24 8.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.239 1.415 . . . . 0.0 108.903 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.67 142.79 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.523 1.129 . . . . 0.0 108.961 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -84.45 -66.12 0.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.765 0.826 . . . . 0.0 109.823 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.42 138.76 54.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.855 1.262 . . . . 0.0 109.078 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mmt -76.47 -55.25 5.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.193 0.597 . . . . 0.0 110.317 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.158 0.983 . . . . 0.0 110.841 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -177.06 4.34 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.321 1.048 . . . . 0.0 111.497 -168.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -106.1 135.63 47.21 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.5 ttp -77.7 157.6 30.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 157.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -144.05 88.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.324 1.449 . . . . 0.0 107.253 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.92 102.78 13.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.772 0.829 . . . . 0.0 109.96 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 97.96 9.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 84' ' ' VAL . 18.8 t -99.32 119.78 47.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.753 0.421 . . . . 0.0 110.0 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -103.36 148.25 26.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.622 1.569 . . . . 0.0 110.387 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.55 -159.57 23.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.09 0.852 . . . . 0.0 112.003 169.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -87.78 21.85 2.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.536 0.735 . . . . 0.0 111.014 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.55 -24.4 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.282 1.033 . . . . 0.0 111.808 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.72 132.41 49.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 110.632 173.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.69 -54.33 4.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.601 0.62 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -72.41 77.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.277 1.431 . . . . 0.0 109.963 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.17 -116.97 5.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.4 t80 62.58 -68.77 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.251 2.22 . . . . 0.0 113.504 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -56.78 -35.32 68.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.626 1.17 . . . . 0.0 110.927 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -73.94 -47.48 37.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.922 0.889 . . . . 0.0 110.238 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.86 -50.17 66.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.422 1.089 . . . . 0.0 112.447 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.75 -33.75 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.651 0.38 . . . . 0.0 110.506 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -66.83 -46.84 73.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 109.542 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 mm -51.53 -54.17 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.4 1.0 . . . . 0.0 110.717 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -66.27 -42.8 87.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.408 0.442 . . . . 0.0 109.963 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.56 -52.37 47.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.81 -43.63 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.416 1.087 . . . . 0.0 109.905 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -54.0 -37.68 64.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.526 0.73 . . . . 0.0 111.002 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -97.4 -1.52 44.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.838 1.655 . . . . 0.0 113.361 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.58 59.91 5.36 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.821 0.737 . . . . 0.0 111.91 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -125.13 138.49 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.859 1.664 . . . . 0.0 108.82 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -92.19 -178.9 5.1 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.909 1.284 . . . . 0.0 108.519 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -143.94 11.79 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 120.04 1.291 . . . . 0.0 112.338 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -175.3 147.18 0.87 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.858 0.863 . . . . 0.0 110.328 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.53 82.44 1.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 109.291 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -84.73 80.03 9.4 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.688 1.232 . . . . 0.0 108.636 -170.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 18.8 t-20 -85.17 75.61 10.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.626 2.77 . . . . 0.0 110.042 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -61.42 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.063 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.3 -167.42 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.98 2.453 . . . . 0.0 110.537 -170.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -100.0 50.77 0.91 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.973 1.309 . . . . 0.0 109.876 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.31 -73.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.875 0 O-C-N 122.052 -0.405 . . . . 0.0 112.439 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 m -96.43 112.21 24.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.654 0.782 . . . . 0.0 110.899 -168.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.24 132.35 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.064 0 C-N-CA 124.942 1.297 . . . . 0.0 110.059 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -92.44 122.0 34.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.16 145.37 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.445 1.098 . . . . 0.0 109.22 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.35 147.89 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.709 1.204 . . . . 0.0 107.856 167.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.94 115.55 6.75 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.083 0.953 . . . . 0.0 109.379 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -112.64 112.33 23.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -160.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.78 -168.97 35.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.53 167.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.64 160.83 24.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.652 1.581 . . . . 0.0 109.197 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.06 -19.97 53.25 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.13 -47.63 76.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.61 59.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.637 0.775 . . . . 0.0 112.166 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.8 -61.61 1.87 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.066 0.848 . . . . 0.0 108.878 174.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.7 p -40.54 -44.39 2.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.406 1.482 . . . . 0.0 113.001 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.11 -45.49 88.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.845 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.12 -23.25 60.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.103 1.361 . . . . 0.0 111.549 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -56.7 3.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.663 1.185 . . . . 0.0 109.745 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -58.67 -37.14 75.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.573 1.149 . . . . 0.0 111.372 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -28.81 -52.99 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 127.068 2.147 . . . . 0.0 112.075 167.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -71.04 -69.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -167.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -51.71 -43.96 63.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -62.65 -56.83 14.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.713 0.805 . . . . 0.0 110.26 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.79 81.8 0.31 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.545 1.545 . . . . 0.0 109.599 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 160.95 47.65 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.592 2.861 . . . . 0.0 111.201 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -68.3 157.53 61.42 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.608 2.205 . . . . 0.0 109.559 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.75 36.98 0.34 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.235 0.614 . . . . 0.0 111.485 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.42 166.35 21.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.686 1.594 . . . . 0.0 109.29 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -80.55 72.86 7.48 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.13 0.572 . . . . 0.0 109.978 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -61.44 114.58 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.259 1.024 . . . . 0.0 108.475 168.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.88 -49.04 6.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 110.847 -161.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -162.42 71.09 0.31 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.467 0.651 . . . . 0.0 111.873 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 HG22 ' A' ' 20' ' ' VAL . 7.1 p -69.5 89.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.036 0.935 . . . . 0.0 111.214 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.07 81.58 2.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 107.963 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -78.52 164.52 24.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.31 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 m -145.59 139.96 27.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.27 1.028 . . . . 0.0 109.502 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 135.64 33.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.899 1.28 . . . . 0.0 108.352 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 m -135.62 176.82 8.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.514 0.726 . . . . 0.0 111.168 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -89.32 137.58 32.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -64.88 138.77 58.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.237 1.015 . . . . 0.0 111.596 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -79.28 -51.18 9.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.818 0.847 . . . . 0.0 109.249 174.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.15 -178.2 30.99 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.62 103.95 8.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.098 0.959 . . . . 0.0 109.463 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -78.52 70.21 4.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -51.7 127.46 20.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.701 1.2 . . . . 0.0 112.347 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.59 174.95 0.24 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.907 1.683 . . . . 0.0 110.85 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.56 93.36 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -112.94 158.69 19.91 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -113.61 149.34 34.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.98 0.912 . . . . 0.0 110.362 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.405 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 20.8 m-30 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.003 -1.475 . . . . 0.0 108.624 148.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.8 t -158.0 62.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.127 0.971 . . . . 0.0 108.778 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.27 68.12 8.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.699 0.8 . . . . 0.0 109.89 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -76.93 110.2 11.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.883 0.873 . . . . 0.0 109.143 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -121.33 161.95 21.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.258 1.423 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 74.04 145.93 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.545 1.938 . . . . 0.0 112.387 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -84.74 -172.03 3.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.135 0.974 . . . . 0.0 111.15 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -72.74 72.34 1.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.385 1.074 . . . . 0.0 108.697 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m 66.47 -77.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.435 1.894 . . . . 0.0 110.437 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -173.53 102.85 0.12 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.513 1.525 . . . . 0.0 107.538 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.6 m -102.58 144.73 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.455 1.102 . . . . 0.0 109.672 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.61 -52.8 0.81 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.418 1.087 . . . . 0.0 109.424 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.58 102.91 7.21 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.357 1.063 . . . . 0.0 109.908 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.09 -36.79 75.73 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.217 1.007 . . . . 0.0 111.62 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.85 -172.12 3.59 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.853 1.261 . . . . 0.0 110.376 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 159.24 34.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.1 0.96 . . . . 0.0 110.83 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -91.62 106.36 18.42 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 ptm -84.68 94.69 8.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -89.81 89.91 7.96 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.83 105.28 17.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.499 0.666 . . . . 0.0 111.225 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.29 102.99 13.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.462 1.105 . . . . 0.0 108.979 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.62 108.99 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -103.84 139.63 38.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.58 0.752 . . . . 0.0 111.089 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.92 -152.96 24.98 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.896 0.748 . . . . 0.0 111.837 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tp -82.26 20.7 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.028 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.75 35.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.371 1.469 . . . . 0.0 112.036 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -96.23 102.3 14.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.63 0.772 . . . . 0.0 110.362 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.92 48.71 61.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.409 1.004 . . . . 0.0 112.3 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.45 93.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.761 0.824 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.32 -69.17 1.39 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.216 1.388 . . . . 0.0 112.093 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -28.44 -66.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.396 3.078 . . . . 0.0 115.103 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -60.69 -30.53 69.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.044 0.538 . . . . 0.0 111.867 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -78.48 -41.41 32.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.086 0.954 . . . . 0.0 109.992 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.9 -48.98 72.33 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.328 -0.858 . . . . 0.0 111.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.92 -28.12 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.928 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -59.87 -59.86 4.75 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 118.564 -0.732 . . . . 0.0 110.022 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.3 mm -46.39 -55.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.208 0.603 . . . . 0.0 111.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -70.9 -42.56 69.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.796 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.02 -50.0 59.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.739 0.699 . . . . 0.0 112.441 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.97 -36.8 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.657 1.583 . . . . 0.0 110.975 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -44.42 89.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.847 0.459 . . . . 0.0 111.917 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.91 -17.02 27.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.971 0.908 . . . . 0.0 113.383 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.87 66.32 1.27 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.74 139.63 45.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 125.713 1.605 . . . . 0.0 108.458 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -111.69 160.06 17.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.035 1.334 . . . . 0.0 108.555 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.78 -133.17 4.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -173.22 141.1 0.91 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.008 1.323 . . . . 0.0 109.878 172.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.79 82.48 2.6 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.613 1.165 . . . . 0.0 108.43 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -92.22 89.54 6.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -163.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.17 72.56 6.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.913 1.685 . . . . 0.0 111.566 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.99 118.44 55.42 Favored Pre-proline 0 C--N 1.342 0.259 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.308 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.71 76.93 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.831 3.021 . . . . 0.0 111.853 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -163.68 28.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.84 -43.06 3.04 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.706 -0.622 . . . . 0.0 112.809 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -95.66 86.63 4.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 110.789 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.26 125.97 40.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 123.828 0.851 . . . . 0.0 109.523 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.58 135.36 34.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.31 94.57 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.8 t -67.53 122.03 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.39 154.03 39.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -127.28 113.61 16.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.646 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.57 -140.67 0.09 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.495 1.521 . . . . 0.0 113.197 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -177.38 -92.58 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.317 3.047 . . . . 0.0 107.1 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.47 -63.23 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 122.972 0.509 . . . . 0.0 110.914 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.1 -53.9 6.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.32 67.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.149 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 69' ' ' LEU . 24.1 tp -53.58 -72.34 0.06 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -55.65 -47.52 76.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 0.0 112.413 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -54.25 -41.0 68.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.082 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.78 -46.3 17.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.26 0.482 . . . . 0.0 110.725 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 65' ' ' LEU . 1.5 mm? -52.07 -61.93 1.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.884 -0.51 . . . . 0.0 110.239 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -55.01 -43.78 73.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 111.685 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -56.13 3.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.645 1.178 . . . . 0.0 110.438 167.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -66.24 -53.8 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.125 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -49.68 65.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.204 0.456 . . . . 0.0 110.526 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -100.16 55.02 0.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 109.631 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.49 75.85 0.22 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.18 129.8 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.066 2.511 . . . . 0.0 109.595 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.56 179.37 6.55 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.165 2.577 . . . . 0.0 109.984 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.11 36.55 0.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.547 0.739 . . . . 0.0 111.974 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.94 162.05 38.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 110.004 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.74 87.97 3.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 110.287 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.69 78.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.799 1.24 . . . . 0.0 110.449 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -41.8 -59.36 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.995 2.118 . . . . 0.0 112.305 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -162.66 89.74 0.68 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-O 121.629 0.728 . . . . 0.0 112.589 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.85 92.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.89 0.876 . . . . 0.0 110.9 173.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -98.31 78.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.891 1.277 . . . . 0.0 108.292 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -72.86 164.97 25.81 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -134.21 119.22 18.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.451 1.101 . . . . 0.0 109.952 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -80.09 124.38 28.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m -136.91 176.49 8.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.797 1.239 . . . . 0.0 110.662 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.56 153.59 17.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.376 1.47 . . . . 0.0 110.116 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -45.62 104.22 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.053 1.741 . . . . 0.0 112.167 167.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -92.83 -55.03 3.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.827 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.2 146.36 13.19 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.05 107.25 19.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.509 1.123 . . . . 0.0 110.653 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -68.09 169.61 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 160.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.47 49.51 0.69 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.399 0.68 . . . . 0.0 110.676 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 170.14 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.064 2.145 . . . . 0.0 108.972 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -83.89 91.45 7.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.67 162.92 17.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.768 0.713 . . . . 0.0 110.233 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.54 138.47 34.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.231 0.612 . . . . 0.0 110.429 -173.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.7 t80 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.264 -1.35 . . . . 0.0 109.56 174.009 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.38 141.97 32.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.683 1.593 . . . . 0.0 109.975 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -83.53 111.46 19.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.203 1.001 . . . . 0.0 109.731 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.3 ptm -92.4 102.57 15.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.634 1.174 . . . . 0.0 108.343 173.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -73.46 127.52 32.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.78 105.57 7.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.721 0.772 . . . . 0.0 109.744 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.3 15.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.885 1.674 . . . . 0.0 107.434 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.36 114.05 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.46 153.31 19.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.268 1.427 . . . . 0.0 109.967 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.1 -161.13 13.92 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.507 1.051 . . . . 0.0 111.66 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tp -83.0 26.21 0.63 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.058 0.543 . . . . 0.0 111.532 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.1 -10.68 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 113.098 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -57.6 151.97 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.632 1.173 . . . . 0.0 110.009 166.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.61 -62.48 4.6 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 79' ' ' ALA . 18.7 m -66.84 165.1 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.246 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.41 48.14 3.57 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.934 0.778 . . . . 0.0 112.465 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.01 -60.87 2.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.593 1.157 . . . . 0.0 108.921 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -61.54 -25.58 67.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 112.071 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.24 -48.96 48.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 0.0 109.474 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.29 -46.67 82.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.432 0.693 . . . . 0.0 111.167 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -55.67 -36.85 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.893 0.477 . . . . 0.0 110.635 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -57.34 11.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.852 -1.07 . . . . 0.0 110.928 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -44.15 -55.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.612 1.096 . . . . 0.0 111.638 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.4 -47.41 67.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.385 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.76 -50.86 54.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.8 -47.49 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.573 1.549 . . . . 0.0 109.018 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.58 -39.61 70.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.253 0.621 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -94.39 -0.62 54.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.514 1.525 . . . . 0.0 113.236 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.45 62.2 4.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.952 0.796 . . . . 0.0 111.735 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 mm -115.42 141.77 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 126.285 1.834 . . . . 0.0 107.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -104.06 167.56 9.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.805 1.242 . . . . 0.0 108.485 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.07 -146.92 16.58 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 118.158 0.435 . . . . 0.0 113.123 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -170.76 139.99 1.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 109.357 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.35 88.93 2.91 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.439 1.095 . . . . 0.0 108.58 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.04 77.9 4.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -164.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -72.82 74.0 1.12 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.662 1.585 . . . . 0.0 111.302 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.36 124.0 76.07 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 165.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.46 76.81 3.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.803 2.335 . . . . 0.0 110.749 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -151.14 26.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.613 1.165 . . . . 0.0 111.983 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.59 -48.64 3.71 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.611 0.624 . . . . 0.0 112.353 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 p -91.31 91.28 8.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.781 1.232 . . . . 0.0 110.873 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.51 126.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 124.111 0.964 . . . . 0.0 109.904 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 141.53 29.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.234 0.614 . . . . 0.0 109.506 175.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.69 137.15 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -118.52 61.03 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.423 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.85 156.2 39.42 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.622 1.169 . . . . 0.0 110.167 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.18 112.21 6.6 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.933 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.07 156.82 23.13 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.583 0.628 . . . . 0.0 114.012 -172.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -71.99 -92.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.047 1.739 . . . . 0.0 110.28 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.57 -80.41 0.09 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.429 1.492 . . . . 0.0 107.397 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.66 -52.21 56.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.283 0.633 . . . . 0.0 109.795 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.79 68.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.993 0.517 . . . . 0.0 111.808 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.2 tp -64.95 -66.4 0.55 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -46.38 -42.61 15.25 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.451 1.501 . . . . 0.0 112.941 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -57.41 -62.67 1.61 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.292 0.951 . . . . 0.0 110.17 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -57.37 -35.73 70.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.205 0.602 . . . . 0.0 112.219 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.64 -63.25 1.17 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.982 0.913 . . . . 0.0 110.515 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.31 -37.24 55.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.088 1.355 . . . . 0.0 111.618 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.42 -59.81 3.18 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.433 1.093 . . . . 0.0 111.12 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.33 -61.87 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.139 0.427 . . . . 0.0 111.239 -163.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -48.42 64.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 113.104 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -58.41 -51.97 67.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.262 0.625 . . . . 0.0 110.966 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.8 86.22 0.45 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.03 1.3 . . . . 0.0 109.857 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 163.71 30.91 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.287 2.658 . . . . 0.0 111.226 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.72 165.36 31.18 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.941 2.427 . . . . 0.0 111.188 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.37 43.2 0.72 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.889 0.876 . . . . 0.0 111.096 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -150.49 167.93 25.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.976 1.31 . . . . 0.0 109.327 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -76.53 80.52 3.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.561 1.144 . . . . 0.0 109.574 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.54 119.89 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.052 0.941 . . . . 0.0 108.673 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.56 -50.03 6.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.442 1.097 . . . . 0.0 110.387 -168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -166.09 71.59 0.14 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.413 0.625 . . . . 0.0 111.633 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -65.67 94.35 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.433 0.693 . . . . 0.0 111.122 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.94 83.72 1.88 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.093 1.357 . . . . 0.0 108.01 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -77.66 163.43 26.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.849 0.356 . . . . 0.0 110.676 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.2 m -139.08 110.18 6.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 109.665 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 120.75 10.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 m -127.69 -152.3 0.51 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.811 1.245 . . . . 0.0 109.106 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 155.99 49.15 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.481 1.112 . . . . 0.0 109.198 170.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -81.23 124.11 29.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.012 0.925 . . . . 0.0 110.658 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -73.63 -46.78 44.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 164.5 32.51 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.88 134.04 34.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.582 1.153 . . . . 0.0 109.257 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -74.21 145.88 43.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.583 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.55 87.28 0.9 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.997 0.919 . . . . 0.0 110.104 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 66.44 -160.46 0.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.477 1.111 . . . . 0.0 109.601 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.73 113.39 9.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.211 1.004 . . . . 0.0 109.283 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.93 164.56 20.51 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.638 0.775 . . . . 0.0 110.868 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.97 143.51 38.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.373 1.069 . . . . 0.0 110.408 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.018 -1.468 . . . . 0.0 111.108 168.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.315 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 173.51 9.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.148 1.379 . . . . 0.0 110.839 -167.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -100.21 127.36 46.49 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.085 0.554 . . . . 0.0 111.257 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.47 158.38 31.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 153.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.06 97.26 2.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.85 116.06 29.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.87 0.868 . . . . 0.0 110.944 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.67 107.86 19.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 108.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.92 107.74 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.1 147.88 22.96 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.103 0.961 . . . . 0.0 110.278 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.97 -161.75 27.14 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.244 0.926 . . . . 0.0 110.967 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tp -82.23 20.14 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.268 0.627 . . . . 0.0 110.648 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.26 -14.66 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.106 1.362 . . . . 0.0 112.794 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.37 117.18 7.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.857 0.863 . . . . 0.0 109.653 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.49 48.96 40.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.08 0.848 . . . . 0.0 113.304 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.641 HG21 ' HB2' ' A' ' 79' ' ' ALA . 21.3 m -135.09 -168.07 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 109.014 166.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.02 79.33 0.2 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.485 1.041 . . . . 0.0 111.013 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -158.42 -174.42 4.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.556 1.542 . . . . 0.0 108.573 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 73.51 -73.57 0.1 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.576 1.951 . . . . 0.0 109.53 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -56.62 -36.96 70.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.283 1.033 . . . . 0.0 110.351 172.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -48.76 -48.14 41.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.274 1.03 . . . . 0.0 111.722 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.16 -37.54 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.158 -0.338 . . . . 0.0 110.422 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.72 -49.29 66.51 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.037 -1.459 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.8 mm -43.93 -53.38 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 120.707 1.594 . . . . 0.0 111.416 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -66.9 -51.68 52.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.6 -44.84 66.25 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.85 -46.33 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 108.635 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -42.03 88.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.318 0.647 . . . . 0.0 111.012 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.3 mt -92.3 -52.53 4.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.058 1.343 . . . . 0.0 111.751 -169.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.14 66.6 0.17 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.167 1.365 . . . . 0.0 112.704 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.79 147.12 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 108.821 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -108.06 174.11 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 108.847 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.86 -150.63 22.44 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 118.619 0.645 . . . . 0.0 112.594 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -164.78 140.87 5.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.72 82.43 1.85 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.396 1.078 . . . . 0.0 110.087 -168.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' CB ' ' A' ' 101' ' ' TYR . 36.0 ttmt -95.38 104.21 16.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 -164.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -78.7 126.11 30.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.3 mt -101.85 93.99 4.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.25 76.89 4.02 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.482 2.788 . . . . 0.0 111.548 -159.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 173.94 -43.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.159 2.584 . . . . 0.0 108.708 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.36 -119.25 4.56 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.737 1.16 . . . . 0.0 111.429 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -129.25 126.04 38.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.57 1.548 . . . . 0.0 109.425 -168.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.27 122.06 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.7 0.8 . . . . 0.0 110.158 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.21 140.19 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.796 0.839 . . . . 0.0 109.646 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.5 t -127.05 134.06 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.178 0.991 . . . . 0.0 108.554 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.1 74.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.71 0.804 . . . . 0.0 110.821 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.89 150.12 37.63 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -117.67 96.63 5.47 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.197 0.599 . . . . 0.0 110.951 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.25 174.52 17.39 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.932 0.777 . . . . 0.0 112.437 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.74 -98.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 108.668 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -152.14 -73.75 0.14 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.291 1.436 . . . . 0.0 108.211 -174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.68 -45.46 48.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.611 1.164 . . . . 0.0 109.338 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.6 57.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.86 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.5 tp -53.78 -56.75 14.68 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.449 0.568 . . . . 0.0 109.56 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.1 p -47.52 -36.38 10.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.888 1.275 . . . . 0.0 112.862 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -64.3 -36.4 84.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.43 1.092 . . . . 0.0 111.444 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.6 -50.15 12.0 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.646 0.778 . . . . 0.0 109.044 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -52.8 25.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.354 0.662 . . . . 0.0 111.168 -171.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.06 -35.68 77.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.281 1.433 . . . . 0.0 113.159 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -48.57 14.48 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.89 1.276 . . . . 0.0 110.73 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.46 -56.42 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 119.02 -0.514 . . . . 0.0 110.616 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.2 -54.28 38.38 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.236 0.471 . . . . 0.0 110.517 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 47.61 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.451 1.1 . . . . 0.0 109.641 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.47 66.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.55 161.3 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.512 2.808 . . . . 0.0 111.311 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.13 170.16 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.954 3.103 . . . . 0.0 111.802 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.24 48.12 1.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.092 0.957 . . . . 0.0 111.027 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -149.37 167.49 26.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.713 1.205 . . . . 0.0 110.162 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.79 89.49 1.37 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.12 86.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 109.967 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -41.54 -60.76 1.22 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.799 1.64 . . . . 0.0 111.344 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.71 140.22 3.87 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.676 0.39 . . . . 0.0 110.473 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.27 97.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 166.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.53 82.48 6.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -76.61 156.44 32.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -141.89 108.91 5.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.805 1.242 . . . . 0.0 108.764 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -69.09 127.5 33.35 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -134.83 -173.56 3.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.086 0.954 . . . . 0.0 110.398 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 141.83 38.35 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.094 0.957 . . . . 0.0 108.616 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.19 56.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -54.18 20.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 170.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.15 -176.05 34.78 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.03 119.1 28.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.278 1.031 . . . . 0.0 109.318 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -70.04 135.37 49.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.44 91.92 1.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.531 0.733 . . . . 0.0 109.979 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 67.92 -161.32 0.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.423 1.089 . . . . 0.0 109.683 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.0 89.94 3.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.635 1.174 . . . . 0.0 108.982 -175.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.53 159.75 16.46 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -115.36 144.23 44.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.306 0.643 . . . . 0.0 110.955 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CB ' ' HA ' ' A' ' 47' ' ' LYS . 2.4 t80 . . . . . 0 C--O 1.249 1.027 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.18 167.1 16.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.116 0.966 . . . . 0.0 112.157 -161.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -100.27 130.76 46.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.4 ttp -66.44 166.23 12.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.196 0.998 . . . . 0.0 108.795 158.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.42 86.78 1.55 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 163.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.35 105.19 17.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.465 0.706 . . . . 0.0 110.953 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 101.02 13.53 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.272 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -90.42 110.86 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -96.15 148.34 22.81 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.969 0.907 . . . . 0.0 109.295 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.41 -157.35 22.27 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.01 1.29 . . . . 0.0 111.316 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -80.46 19.62 0.77 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.517 0.727 . . . . 0.0 111.402 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.62 -23.3 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.151 0.98 . . . . 0.0 111.022 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.77 142.43 50.16 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 109.668 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.13 -65.61 2.85 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 79' ' ' ALA . 17.7 m -64.42 169.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.842 0.821 . . . . 0.0 110.953 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.01 -94.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.493 1.044 . . . . 0.0 111.767 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.65 -59.69 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 113.26 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -38.78 -37.78 0.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.762 2.825 . . . . 0.0 113.082 170.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.79 -50.97 25.05 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.536 0.735 . . . . 0.0 109.939 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.96 -39.93 63.32 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 111.48 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.35 -42.29 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 123.44 0.696 . . . . 0.0 110.029 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.424 HE21 ' CA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.42 -54.23 39.98 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 117.715 -1.136 . . . . 0.0 110.143 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.9 mm -41.63 -54.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.877 1.217 . . . . 0.0 113.054 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -73.31 -45.61 54.4 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.554 0.342 . . . . 0.0 110.72 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.64 -51.01 59.11 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.149 0.5 . . . . 0.0 111.741 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -44.6 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 126.219 1.807 . . . . 0.0 109.972 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -53.01 -39.96 63.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.803 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.44 11.7 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.781 1.233 . . . . 0.0 113.47 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.89 64.61 3.67 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 118.841 0.746 . . . . 0.0 112.112 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.5 mm -121.88 138.62 51.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.354 1.462 . . . . 0.0 108.735 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -98.56 173.38 6.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.689 1.196 . . . . 0.0 108.243 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.7 -143.92 11.19 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.499 -0.75 . . . . 0.0 111.7 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -175.26 144.2 0.71 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.551 1.14 . . . . 0.0 109.19 170.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 82.82 1.8 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -95.13 111.78 23.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.353 0.597 . . . . 0.0 110.156 -164.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 20.6 t-20 -91.73 119.69 31.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 108.505 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.04 98.05 4.27 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.52 144.91 91.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.433 2.089 . . . . 0.0 110.812 -169.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.7 t0 55.95 54.73 7.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.475 1.11 . . . . 0.0 109.67 -166.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.27 -134.97 2.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -124.8 161.0 27.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.816 1.646 . . . . 0.0 110.464 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.84 117.83 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.067 0.947 . . . . 0.0 109.629 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -93.19 143.47 26.23 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.618 0.767 . . . . 0.0 110.456 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.25 123.15 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.428 1.091 . . . . 0.0 108.773 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.39 62.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.825 0.85 . . . . 0.0 110.966 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 129.75 38.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.457 0.703 . . . . 0.0 111.042 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -117.62 108.08 15.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.747 1.219 . . . . 0.0 110.503 -165.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 177.32 37.5 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-O 122.216 0.898 . . . . 0.0 114.369 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -69.87 169.65 12.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.128 1.371 . . . . 0.0 108.946 165.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -79.85 -30.25 40.3 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.12 -25.53 68.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.918 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.28 -13.54 18.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.914 0.885 . . . . 0.0 111.825 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.83 -59.79 2.71 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 p -38.57 -45.01 1.02 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.278 1.831 . . . . 0.0 112.912 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.45 -42.02 88.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.854 0.862 . . . . 0.0 112.682 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -74.11 -21.99 59.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.626 1.171 . . . . 0.0 111.551 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.7 -61.24 2.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.471 1.108 . . . . 0.0 110.317 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -53.89 -42.07 68.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 110.299 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -34.37 -47.42 0.3 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.305 2.642 . . . . 0.0 113.556 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.61 -68.25 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.608 0.763 . . . . 0.0 110.728 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -52.13 -44.93 64.75 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.84 -51.96 67.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.299 1.04 . . . . 0.0 111.186 173.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.09 85.3 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.61 160.55 45.59 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.924 2.416 . . . . 0.0 111.262 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.25 160.58 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.274 2.649 . . . . 0.0 110.765 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 48.83 1.33 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.824 0.85 . . . . 0.0 110.957 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -158.39 169.06 25.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 110.484 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.1 77.73 2.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.189 0.995 . . . . 0.0 109.374 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.08 125.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.953 0.901 . . . . 0.0 109.389 173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.93 -60.34 2.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 108.163 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -156.13 115.47 3.53 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.72 87.01 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 161.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.09 67.42 8.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.458 1.103 . . . . 0.0 108.268 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.2 154.38 31.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.826 -170.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -138.23 117.65 12.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.67 129.93 44.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m -127.21 -161.89 1.12 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.443 1.097 . . . . 0.0 109.24 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.23 141.48 45.79 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.617 0.767 . . . . 0.0 109.026 170.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -54.8 135.1 47.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.567 1.147 . . . . 0.0 112.96 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -73.35 -57.49 3.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 165.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.29 -177.55 40.01 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.43 122.2 16.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.56 0.744 . . . . 0.0 110.417 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -72.98 -26.5 61.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 111.468 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.51 91.31 0.07 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.637 1.575 . . . . 0.0 111.028 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.53 179.72 0.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 110.472 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.88 95.84 2.56 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.68 167.04 13.39 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 p -103.69 152.02 22.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.482 0.713 . . . . 0.0 110.791 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 4.0 m-85 . . . . . 0 C--O 1.249 1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 153.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.23 166.57 10.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.262 1.025 . . . . 0.0 109.905 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -99.15 101.56 12.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 110.347 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.3 ttp -70.01 144.77 52.15 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 164.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -124.18 136.35 54.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.993 1.717 . . . . 0.0 106.561 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 107.59 4.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.343 0.592 . . . . 0.0 109.976 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 98.93 8.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.73 101.09 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.31 149.89 26.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.267 0.627 . . . . 0.0 111.265 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.61 -163.53 18.45 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.315 1.436 . . . . 0.0 110.7 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 47.8 1.55 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.02 41.62 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.326 1.05 . . . . 0.0 110.747 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.62 150.43 33.15 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.404 1.082 . . . . 0.0 110.384 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.72 -56.83 4.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.527 0.584 . . . . 0.0 111.871 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -48.38 150.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.803 2.041 . . . . 0.0 111.292 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.82 38.45 2.34 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.825 0.726 . . . . 0.0 113.486 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -67.17 -35.87 80.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.64 0.72 . . . . 0.0 110.016 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -58.22 -31.77 67.67 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.265 1.026 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.72 -48.15 34.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.668 1.187 . . . . 0.0 109.843 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.13 -44.84 79.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.507 0.723 . . . . 0.0 111.579 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.51 -37.5 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.666 0.786 . . . . 0.0 109.969 172.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.37 -57.7 9.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.848 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -43.06 -51.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 119.451 1.023 . . . . 0.0 111.757 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -67.22 -56.6 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.841 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.68 -47.82 20.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.54 -42.88 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 126.224 1.81 . . . . 0.0 110.47 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -62.52 -34.41 76.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.766 0.426 . . . . 0.0 111.799 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.98 -0.19 55.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.855 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.17 5.32 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 118.65 0.659 . . . . 0.0 111.557 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -121.26 141.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.649 1.58 . . . . 0.0 108.311 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -103.43 166.38 10.46 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.26 -145.21 12.25 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.957 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.36 141.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 110.19 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.11 86.68 2.34 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.165 1.386 . . . . 0.0 108.727 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -100.27 90.1 4.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.862 0.865 . . . . 0.0 110.511 -164.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.73 92.76 4.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.557 1.543 . . . . 0.0 109.811 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.7 mt -66.13 106.19 1.03 Allowed Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 125.772 1.629 . . . . 0.0 108.321 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.07 43.24 1.43 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.584 2.189 . . . . 0.0 113.058 -160.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.5 47.77 0.34 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.472 1.509 . . . . 0.0 108.285 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.83 -135.7 3.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -112.6 169.34 8.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.494 1.517 . . . . 0.0 109.656 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.68 135.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 C-N-CA 124.204 1.001 . . . . 0.0 112.011 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -100.48 122.71 43.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.604 1.161 . . . . 0.0 109.183 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.38 145.11 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.639 1.176 . . . . 0.0 108.518 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.23 86.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.072 0.949 . . . . 0.0 109.827 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.42 143.02 26.67 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.028 1.331 . . . . 0.0 111.592 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -126.28 99.12 5.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.272 0.629 . . . . 0.0 110.772 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.54 164.14 30.15 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 121.598 0.554 . . . . 0.0 113.073 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -66.7 167.32 11.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 -35.58 67.28 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.977 -0.452 . . . . 0.0 111.911 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -45.3 -39.91 7.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.791 1.236 . . . . 0.0 112.159 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.08 0.85 21.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.94 1.296 . . . . 0.0 112.586 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -70.29 -59.29 2.96 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.285 0.948 . . . . 0.0 108.829 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -42.63 -45.4 4.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.269 1.428 . . . . 0.0 112.063 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.17 -32.42 64.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.718 1.607 . . . . 0.0 112.885 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.23 -53.88 4.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.07 1.348 . . . . 0.0 109.927 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -53.24 56.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.49 1.116 . . . . 0.0 111.109 -167.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -68.91 -34.6 75.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.636 1.174 . . . . 0.0 111.433 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.43 -42.26 10.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.384 1.474 . . . . 0.0 111.206 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.41 -61.61 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.217 0.607 . . . . 0.0 111.2 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.54 -48.69 80.68 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.09 0.405 . . . . 0.0 111.029 -168.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -94.94 38.36 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.927 1.291 . . . . 0.0 110.275 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.3 76.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.99 162.04 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.464 2.776 . . . . 0.0 112.594 -167.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.65 -1.73 5.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.222 3.281 . . . . 0.0 114.525 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.36 28.8 4.67 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 126.163 1.785 . . . . 0.0 110.114 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.35 164.16 32.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.997 1.719 . . . . 0.0 107.995 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.15 80.5 4.57 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.076 0.551 . . . . 0.0 110.945 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.33 126.88 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.164 0.986 . . . . 0.0 109.656 170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -93.65 -53.1 4.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.455 1.102 . . . . 0.0 109.405 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -164.85 76.12 0.29 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.064 0.459 . . . . 0.0 112.165 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.4 p -67.21 89.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.282 0.633 . . . . 0.0 111.013 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.07 85.5 3.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.158 1.383 . . . . 0.0 108.046 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -77.74 170.33 16.76 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.176 0.512 . . . . 0.0 112.212 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -139.7 112.16 7.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.222 1.409 . . . . 0.0 109.843 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -66.26 138.7 57.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 163.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m -161.24 174.07 14.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.083 0.468 . . . . 0.0 109.959 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.29 146.14 27.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.086 0.954 . . . . 0.0 110.604 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.29 127.85 33.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.24 0.616 . . . . 0.0 110.164 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -42.63 18.13 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.01 161.8 34.18 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.22 149.96 21.55 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.602 1.161 . . . . 0.0 110.568 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.15 153.99 33.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.093 165.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -71.87 78.6 0.88 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.213 1.005 . . . . 0.0 109.696 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.68 -162.76 0.19 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.151 1.38 . . . . 0.0 110.296 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.66 116.01 21.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.116 1.366 . . . . 0.0 108.362 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -129.35 166.31 19.76 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.86 123.92 48.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.834 0.853 . . . . 0.0 110.26 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.53 1.532 . . . . 0.0 107.844 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 -179.55 6.43 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.355 1.062 . . . . 0.0 111.415 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -108.96 127.4 54.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.25 0.62 . . . . 0.0 112.386 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 ttp -79.31 146.56 32.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 155.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -127.95 135.44 49.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.444 1.897 . . . . 0.0 106.335 165.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.67 110.52 5.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.394 0.616 . . . . 0.0 111.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -84.3 99.23 10.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.166 1.386 . . . . 0.0 108.084 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.12 107.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -97.32 149.65 21.85 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.439 1.096 . . . . 0.0 110.253 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.5 -158.43 26.03 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.885 1.231 . . . . 0.0 110.962 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.92 22.5 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.515 0.726 . . . . 0.0 110.977 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.84 -17.4 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.118 1.367 . . . . 0.0 111.885 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -67.47 121.04 14.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.062 0.545 . . . . 0.0 111.627 -172.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.48 37.03 93.46 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.462 1.029 . . . . 0.0 112.773 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.14 91.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.0 -139.1 44.45 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.485 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 t80 56.48 -173.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.003 1.721 . . . . 0.0 111.428 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 68.36 -76.04 0.06 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 126.126 1.771 . . . . 0.0 109.243 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -45.85 -42.35 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.303 1.441 . . . . 0.0 111.92 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.66 -53.82 50.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 111.245 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -67.23 -18.83 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 122.074 -0.392 . . . . 0.0 111.344 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -54.83 13.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.266 -1.349 . . . . 0.0 110.713 167.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.7 mm -36.27 -55.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 120.483 1.492 . . . . 0.0 112.886 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -67.62 -51.94 44.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.75 0.42 . . . . 0.0 110.759 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -45.38 -65.98 0.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.575 1.15 . . . . 0.0 111.351 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.41 -47.92 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 111.631 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -53.52 -46.68 70.19 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.06 0.544 . . . . 0.0 110.571 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.9 mt -102.29 37.33 1.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 111.851 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.23 68.43 1.67 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.981 1.277 . . . . 0.0 113.766 167.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.4 mm -117.3 141.45 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.802 1.241 . . . . 0.0 108.978 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -101.81 174.57 5.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 108.481 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.56 -152.44 24.0 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.342 0.974 . . . . 0.0 112.288 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -170.88 142.91 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.451 0.7 . . . . 0.0 110.347 167.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.74 90.2 3.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.295 1.038 . . . . 0.0 111.977 -165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -111.15 104.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.592 0.357 . . . . 0.0 111.823 -160.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -80.17 97.32 6.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.005 0.922 . . . . 0.0 109.42 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -73.73 102.52 0.62 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.04 136.5 48.48 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.891 1.728 . . . . 0.0 110.499 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 55.86 53.35 9.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 110.124 -167.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.47 -131.37 1.25 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.3 t -121.61 150.33 41.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.481 1.112 . . . . 0.0 110.134 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -99.66 94.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.51 137.81 32.23 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.051 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 143.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.04 136.84 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 164.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.91 138.25 31.91 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.083 0.953 . . . . 0.0 108.717 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.15 90.78 3.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -168.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.93 168.62 16.99 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 123.289 0.471 . . . . 0.0 112.199 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -77.07 -100.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.84 1.656 . . . . 0.0 108.942 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -150.92 -57.47 0.16 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.796 1.638 . . . . 0.0 108.188 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -49.89 -45.12 50.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.848 0.859 . . . . 0.0 109.64 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.69 -34.46 67.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.05 0.54 . . . . 0.0 111.372 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.17 -61.02 2.75 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.4 p -43.33 -47.58 6.75 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.682 1.593 . . . . 0.0 112.213 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -56.18 -41.68 75.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.403 1.081 . . . . 0.0 111.666 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.4 -24.65 31.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.711 1.605 . . . . 0.0 111.154 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.53 -60.84 2.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.139 0.976 . . . . 0.0 110.936 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.81 -43.47 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.239 1.016 . . . . 0.0 111.058 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -34.1 -50.99 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.074 2.55 . . . . 0.0 113.259 165.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -69.18 -68.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.682 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -52.49 -41.83 63.73 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.79 -53.81 44.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.723 0.809 . . . . 0.0 110.754 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.09 0.3 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.863 1.22 . . . . 0.0 110.56 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.38 161.54 42.76 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.251 2.634 . . . . 0.0 111.296 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.33 164.71 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.516 2.811 . . . . 0.0 111.793 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.12 50.18 1.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 111.02 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.22 159.34 17.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.599 1.559 . . . . 0.0 107.84 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.18 84.49 3.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.597 0.359 . . . . 0.0 110.437 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.88 127.88 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.765 0.826 . . . . 0.0 109.183 168.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.85 -61.42 1.63 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.729 1.212 . . . . 0.0 108.05 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -146.4 119.94 9.11 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.01 0.524 . . . . 0.0 112.055 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.47 101.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -100.26 79.64 2.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.238 1.415 . . . . 0.0 108.062 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.24 152.34 21.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 m -145.29 139.85 27.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.0 0.92 . . . . 0.0 110.664 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.98 127.34 42.85 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 109.033 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -136.35 -175.86 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.224 1.01 . . . . 0.0 110.639 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.59 152.53 18.45 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.536 0.734 . . . . 0.0 110.57 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.57 133.96 53.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.432 1.093 . . . . 0.0 111.39 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -71.34 -50.37 32.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.07 172.48 35.19 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.12 112.4 20.2 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.958 0.903 . . . . 0.0 109.094 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.67 133.46 54.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.61 97.43 1.71 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.68 -167.41 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.203 1.401 . . . . 0.0 110.539 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 80.54 1.94 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.12 1.368 . . . . 0.0 108.658 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -106.85 160.64 15.35 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 123.255 0.347 . . . . 0.0 110.149 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.18 141.3 47.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.496 0.718 . . . . 0.0 111.559 -165.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.405 1.482 . . . . 0.0 108.306 170.145 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.57 152.16 32.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.293 1.837 . . . . 0.0 108.57 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -97.87 113.94 25.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.277 1.031 . . . . 0.0 110.587 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.0 ptm -86.28 161.7 18.63 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.11 85.56 1.61 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.69 96.19 10.3 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.121 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -80.88 107.2 13.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 t -91.45 90.39 3.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -168.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -65.38 148.28 51.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.13 -164.79 13.14 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.995 0.807 . . . . 0.0 112.157 166.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -90.23 36.92 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.85 0.86 . . . . 0.0 110.218 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.91 -19.39 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 142.32 45.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.011 0.924 . . . . 0.0 111.107 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.0 -43.31 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.839 0.733 . . . . 0.0 112.243 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.21 78.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.939 0.896 . . . . 0.0 109.854 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.5 -121.44 7.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.918 1.247 . . . . 0.0 111.214 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.9 t80 65.35 -56.95 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.092 2.557 . . . . 0.0 114.635 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -32.99 -51.28 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.525 2.73 . . . . 0.0 112.992 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -79.65 -41.73 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.096 0.958 . . . . 0.0 111.183 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -51.25 -41.84 60.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 111.085 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.53 -43.36 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.593 1.157 . . . . 0.0 111.375 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -57.96 10.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.728 0.811 . . . . 0.0 110.589 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.2 mm -47.47 -57.45 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 118.389 0.54 . . . . 0.0 111.3 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -69.94 -39.45 76.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.288 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.79 -61.9 1.93 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.297 0.499 . . . . 0.0 110.918 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.75 -50.62 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.732 1.613 . . . . 0.0 110.39 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -51.3 62.14 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.915 0.886 . . . . 0.0 109.804 -176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.13 4.13 46.58 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.022 1.329 . . . . 0.0 113.387 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.01 58.2 9.38 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.755 0.707 . . . . 0.0 111.454 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.52 142.75 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.784 1.634 . . . . 0.0 107.81 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.53 162.98 13.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.435 1.094 . . . . 0.0 108.58 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -149.68 21.67 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -169.59 143.35 2.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.92 82.88 1.92 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.365 1.066 . . . . 0.0 108.957 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.506 1.146 . . . . 0.0 109.638 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.5 67.35 10.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 127.531 2.332 . . . . 0.0 110.609 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.1 mt -48.79 104.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 126.393 1.877 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.47 32.73 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.115 1.877 . . . . 0.0 113.211 -164.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -147.93 44.83 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.18 1.392 . . . . 0.0 107.604 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.61 -149.86 8.16 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -120.67 151.41 39.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.686 1.194 . . . . 0.0 109.701 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.4 126.96 32.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.89 0.876 . . . . 0.0 111.47 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -92.06 127.48 37.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.68 97.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.48 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.754 0.787 . . . . 0.0 109.732 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.53 156.38 32.94 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.857 1.263 . . . . 0.0 111.38 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -146.57 122.87 10.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.343 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.05 164.92 35.66 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 118.75 0.705 . . . . 0.0 112.773 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.24 162.9 11.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.458 1.103 . . . . 0.0 108.67 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.84 -24.51 44.34 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -166.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.45 -44.08 95.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.655 0.661 . . . . 0.0 109.909 168.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.04 -14.42 59.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.507 0.723 . . . . 0.0 112.439 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.13 -62.96 1.17 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -49.45 -42.46 42.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 112.809 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -61.71 -38.96 89.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.139 0.976 . . . . 0.0 112.047 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -70.61 -55.31 9.09 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -50.95 -53.58 31.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.773 0.429 . . . . 0.0 111.554 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.06 -37.63 83.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.76 0.824 . . . . 0.0 112.246 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.66 -49.07 7.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.917 1.287 . . . . 0.0 110.8 167.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -70.4 -52.63 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.19 0.596 . . . . 0.0 110.296 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -49.94 73.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.453 0.569 . . . . 0.0 111.2 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -69.52 -36.9 76.86 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.367 1.067 . . . . 0.0 111.581 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.99 74.78 0.24 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.234 1.397 . . . . 0.0 110.22 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.77 168.49 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.826 3.017 . . . . 0.0 110.174 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.1 150.02 77.04 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.58 1.52 . . . . 0.0 108.533 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.86 45.56 0.82 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.002 0.521 . . . . 0.0 110.553 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.21 175.64 9.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 109.681 -173.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.27 74.33 3.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.639 0.776 . . . . 0.0 109.92 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 117.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -76.84 -52.28 9.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.505 1.122 . . . . 0.0 108.783 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -179.31 110.38 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.075 1.35 . . . . 0.0 110.211 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -75.74 78.07 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.339 1.056 . . . . 0.0 109.512 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -95.14 89.4 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.38 164.06 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.018 0.437 . . . . 0.0 111.944 -171.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -117.52 125.03 50.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.078 1.351 . . . . 0.0 108.769 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.25 128.75 34.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 m -136.51 179.25 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.633 0.773 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -96.47 146.69 24.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.084 1.354 . . . . 0.0 108.874 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -69.44 135.77 50.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -89.1 -57.35 2.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.018 1.327 . . . . 0.0 108.639 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 27.51 22.52 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.726 1.155 . . . . 0.0 113.536 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.86 -35.34 26.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.408 1.104 . . . . 0.0 112.887 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -83.84 82.27 8.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.08 0.552 . . . . 0.0 111.427 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.23 88.6 0.18 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.917 0.887 . . . . 0.0 109.36 171.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 90.85 145.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 128.507 2.723 . . . . 0.0 110.504 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.92 112.38 24.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.329 1.052 . . . . 0.0 108.829 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.48 165.7 15.95 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.07 0.548 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 p -108.12 146.28 32.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.834 0.854 . . . . 0.0 110.747 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.312 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 168.51 12.35 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.777 0.831 . . . . 0.0 112.267 -169.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -93.44 114.92 27.43 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.05 0.453 . . . . 0.0 111.472 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.8 ptm -93.94 86.27 5.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 122.059 0.933 . . . . 0.0 110.529 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.38 114.83 18.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.32 110.68 16.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.316 1.047 . . . . 0.0 110.323 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 109.16 20.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.046 1.338 . . . . 0.0 107.921 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -96.24 110.12 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.52 154.77 17.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.132 0.973 . . . . 0.0 111.728 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.3 -159.05 21.3 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.735 1.636 . . . . 0.0 110.895 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -86.4 47.97 1.55 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.99 41.72 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 125.192 1.397 . . . . 0.0 110.43 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -108.16 33.93 3.87 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.355 0.662 . . . . 0.0 111.86 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.48 -160.7 26.84 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.785 1.183 . . . . 0.0 110.319 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER 70.23 -175.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.965 1.306 . . . . 0.0 109.812 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 27' ' ' VAL . . . -74.99 51.19 2.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.817 0.723 . . . . 0.0 112.616 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.49 178.86 5.82 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.742 2.017 . . . . 0.0 112.075 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 61.65 -74.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.84 2.056 . . . . 0.0 111.061 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.15 -47.2 1.56 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.899 1.679 . . . . 0.0 111.137 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.23 -50.12 67.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.312 0.645 . . . . 0.0 112.127 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.0 -36.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 123.434 0.694 . . . . 0.0 110.341 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.4 -51.85 65.9 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.286 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -44.23 -50.41 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.844 1.656 . . . . 0.0 112.363 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -71.27 -49.64 40.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.854 0.462 . . . . 0.0 110.209 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.63 -48.39 58.06 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.031 0.933 . . . . 0.0 113.132 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.32 -47.16 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.327 1.851 . . . . 0.0 108.36 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.35 -42.87 67.25 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.98 0.355 . . . . 0.0 110.993 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -93.28 6.82 46.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.99 1.316 . . . . 0.0 113.285 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.62 59.83 8.21 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 118.595 0.634 . . . . 0.0 112.244 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -113.45 139.54 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 125.605 1.562 . . . . 0.0 108.399 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -103.46 157.52 16.98 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.671 1.188 . . . . 0.0 108.06 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.97 -158.78 31.58 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 118.569 0.622 . . . . 0.0 113.072 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -170.43 137.98 1.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.591 1.156 . . . . 0.0 108.641 167.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.39 87.51 2.63 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.99 0.916 . . . . 0.0 108.78 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -94.71 115.42 27.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.804 0.842 . . . . 0.0 109.807 -167.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.33 130.38 34.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.542 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -102.55 96.71 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.08 23.6 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.293 2.662 . . . . 0.0 114.43 -161.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.35 42.13 2.05 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.015 1.326 . . . . 0.0 108.303 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.69 -122.22 0.83 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -117.48 164.14 15.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.261 1.824 . . . . 0.0 110.579 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -102.85 124.75 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.595 0.758 . . . . 0.0 110.501 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -98.58 125.52 43.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.757 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -109.06 115.55 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.44 135.1 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 164.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.31 146.4 18.5 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.508 1.123 . . . . 0.0 108.733 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.81 122.63 18.81 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.334 0.654 . . . . 0.0 111.219 -171.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.95 165.3 28.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 121.91 0.728 . . . . 0.0 113.881 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.44 172.68 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.093 160.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.92 -25.54 40.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.06 -52.01 52.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.93 -14.9 62.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.31 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.61 -68.29 0.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -46.34 -43.68 16.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.66 1.184 . . . . 0.0 112.825 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.587 1.155 . . . . 0.0 111.632 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.2 -24.94 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.906 0.482 . . . . 0.0 111.592 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -59.23 2.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 109.862 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.26 -33.53 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.686 0.794 . . . . 0.0 112.207 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.94 -54.57 2.71 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.485 1.514 . . . . 0.0 111.09 170.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.2 mt -74.39 -52.45 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.658 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -54.36 42.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.582 0.628 . . . . 0.0 110.269 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -90.82 41.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.051 1.34 . . . . 0.0 110.201 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.39 73.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.52 163.58 26.58 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.962 3.108 . . . . 0.0 111.639 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.35 -8.78 23.08 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.41 2.74 . . . . 0.0 113.919 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 78.81 25.77 0.5 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.083 2.153 . . . . 0.0 111.084 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.21 169.08 14.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.29 1.836 . . . . 0.0 107.987 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.2 77.99 1.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.689 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.46 122.69 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.749 1.22 . . . . 0.0 110.018 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -82.83 -57.95 3.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.072 1.349 . . . . 0.0 107.898 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.23 136.29 6.54 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.164 0.29 . . . . 0.0 110.841 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 84.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -87.58 75.46 9.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -70.38 160.5 32.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.886 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 m -146.1 80.31 1.57 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 109.489 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.25 137.47 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.481 1.513 . . . . 0.0 112.467 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -144.85 -177.51 5.56 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 0.0 110.871 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 153.12 39.9 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.11 124.67 23.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.748 0.819 . . . . 0.0 111.578 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.18 -49.46 35.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.93 172.5 42.07 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.86 109.98 20.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.68 140.89 58.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.891 0.877 . . . . 0.0 109.935 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.25 91.82 2.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.676 0.79 . . . . 0.0 110.588 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.9 -163.41 0.23 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.43 1.092 . . . . 0.0 109.811 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.1 87.62 2.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.618 0.767 . . . . 0.0 109.638 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 100' ' ' THR . 21.5 tt0 -104.25 -175.91 2.93 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.606 0.762 . . . . 0.0 109.079 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.488 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.4 p -125.17 158.81 33.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.118 -1.42 . . . . 0.0 109.934 159.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.493 0.187 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 164.13 19.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.236 1.014 . . . . 0.0 111.592 -170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -86.39 118.42 25.82 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.1 ptm -89.58 91.35 8.65 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.279 1.037 . . . . 0.0 108.832 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.28 128.66 35.34 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.32 14.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.097 0.475 . . . . 0.0 111.254 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -100.77 94.56 6.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.005 0.922 . . . . 0.0 109.084 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.83 103.76 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.482 0.713 . . . . 0.0 109.135 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -101.86 143.47 31.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.799 0.84 . . . . 0.0 110.569 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.72 -165.95 33.22 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.49 0.494 . . . . 0.0 112.342 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.65 20.5 0.73 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.706 0.803 . . . . 0.0 110.546 168.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.23 -3.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.97 1.308 . . . . 0.0 112.469 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -82.23 33.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.714 1.605 . . . . 0.0 112.814 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.23 57.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -157.96 -174.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.218 1.007 . . . . 0.0 108.402 176.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.86 66.53 0.65 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.188 0.899 . . . . 0.0 111.897 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -133.24 171.51 13.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.703 2.001 . . . . 0.0 107.372 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 80.32 -62.39 0.24 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.639 1.576 . . . . 0.0 107.886 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -54.26 -41.14 68.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.696 0.798 . . . . 0.0 109.478 165.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.79 -55.8 23.21 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.62 -18.57 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.875 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -57.67 -58.8 6.76 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.224 0.92 . . . . 0.0 109.324 165.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.0 mm -46.79 -56.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 123.232 0.613 . . . . 0.0 111.49 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -66.13 -44.3 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.5 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.31 -65.16 0.6 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.214 0.461 . . . . 0.0 110.766 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.93 -45.96 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.978 1.711 . . . . 0.0 111.428 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.93 -43.8 98.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 111.469 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.29 16.72 8.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.777 0.831 . . . . 0.0 112.531 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.74 58.23 15.3 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 124.334 0.969 . . . . 0.0 112.518 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.21 139.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.942 1.297 . . . . 0.0 109.916 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.11 175.13 5.63 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.238 1.415 . . . . 0.0 108.237 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.56 -140.41 11.77 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -170.88 150.67 3.21 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.027 0.413 . . . . 0.0 111.297 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.48 86.5 2.37 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.415 1.486 . . . . 0.0 108.953 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.48 108.95 20.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.24 1.016 . . . . 0.0 108.427 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.15 92.83 9.12 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.16 1.384 . . . . 0.0 109.756 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.88 113.67 32.21 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.59 72.91 5.42 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.357 2.705 . . . . 0.0 112.201 -162.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -165.25 55.93 0.12 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.85 1.66 . . . . 0.0 107.992 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.47 -40.59 1.78 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.48 1.038 . . . . 0.0 114.082 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -90.99 93.22 9.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.404 1.482 . . . . 0.0 110.93 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.37 119.83 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.74 125.79 36.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.746 1.218 . . . . 0.0 109.003 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.77 135.25 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.685 1.194 . . . . 0.0 107.881 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.59 55.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 C-N-CA 124.113 0.965 . . . . 0.0 108.981 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.96 157.54 30.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.249 1.42 . . . . 0.0 110.165 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -143.83 123.03 12.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.545 -172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.88 166.72 39.39 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.467 -1.349 . . . . 0.0 113.748 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -52.43 156.25 1.84 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 0.0 111.352 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.68 -15.05 58.95 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.9 -36.32 82.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.271 0.487 . . . . 0.0 109.942 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.73 -3.53 29.96 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.666 1.186 . . . . 0.0 112.696 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.4 tp -66.9 -61.54 1.89 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.265 0.939 . . . . 0.0 109.364 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -44.7 -41.94 7.2 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.128 1.371 . . . . 0.0 112.878 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.18 -50.31 73.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.627 1.171 . . . . 0.0 111.079 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 68' ' ' LEU . 17.4 tp -71.19 -30.04 65.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.624 0.37 . . . . 0.0 111.274 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.21 -58.7 3.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.98 -38.81 68.29 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.985 0.914 . . . . 0.0 112.268 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -30.44 -52.08 0.15 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.571 1.948 . . . . 0.0 112.542 164.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.16 -72.36 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 122.752 0.421 . . . . 0.0 110.452 -169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -49.65 -49.89 45.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.053 0.941 . . . . 0.0 111.869 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -89.18 29.42 1.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.467 1.107 . . . . 0.0 111.954 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.56 68.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.77 164.92 32.62 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.022 3.148 . . . . 0.0 111.546 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -178.51 4.23 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.512 2.808 . . . . 0.0 110.864 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.12 28.81 0.69 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.104 0.961 . . . . 0.0 112.251 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.458 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -131.25 167.0 19.94 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.732 1.213 . . . . 0.0 110.328 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.84 81.99 2.76 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.81 83.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.549 1.54 . . . . 0.0 110.607 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -39.44 -62.37 0.68 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.964 2.106 . . . . 0.0 111.458 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -165.57 129.28 2.24 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 111.702 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.68 99.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.29 80.7 9.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -74.75 142.61 44.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.0 m -148.28 85.26 1.52 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 109.593 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.98 142.4 0.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.567 1.947 . . . . 0.0 111.027 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -159.95 171.85 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.26 143.06 39.17 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.008 0.923 . . . . 0.0 109.773 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.48 145.69 52.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.085 0.469 . . . . 0.0 111.936 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -58.28 2.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.113 1.365 . . . . 0.0 108.332 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.62 167.8 39.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.54 103.05 6.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.427 0.691 . . . . 0.0 110.213 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -77.55 79.24 4.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -44.44 119.5 1.88 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.375 1.87 . . . . 0.0 112.502 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.5 t70 68.1 124.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.874 2.07 . . . . 0.0 111.595 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.35 95.1 3.15 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -118.21 160.09 22.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 0.819 . . . . 0.0 110.794 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.95 145.97 29.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.678 0.791 . . . . 0.0 112.385 -171.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.304 154.128 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 171.58 8.19 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.874 0.869 . . . . 0.0 111.731 -174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -103.11 107.35 18.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.976 1.311 . . . . 0.0 111.375 -168.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.14 98.2 11.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 109.583 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -74.82 133.86 41.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.17 105.84 5.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.67 99.61 12.61 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.225 1.41 . . . . 0.0 108.37 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.22 116.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.462 1.105 . . . . 0.0 109.065 -170.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -98.97 158.03 15.92 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.688 1.195 . . . . 0.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.11 -162.71 14.76 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 124.631 1.11 . . . . 0.0 111.993 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.23 32.86 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.701 0.8 . . . . 0.0 110.773 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.88 -19.22 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.291 1.036 . . . . 0.0 111.212 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -56.62 133.95 54.12 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.352 1.061 . . . . 0.0 110.15 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.74 10.47 83.26 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.109 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.17 152.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.73 1.212 . . . . 0.0 107.843 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.49 45.9 3.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.769 0.7 . . . . 0.0 112.89 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -57.82 -51.69 68.54 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.676 0.79 . . . . 0.0 109.376 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -56.84 -42.29 79.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.717 0.807 . . . . 0.0 111.692 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.27 -46.08 81.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.274 1.03 . . . . 0.0 110.452 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.99 -45.19 75.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.001 0.364 . . . . 0.0 110.489 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.36 -32.8 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.969 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.54 -55.78 30.22 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.284 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mm -42.01 -57.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.766 1.166 . . . . 0.0 113.325 -172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -68.65 -48.07 64.95 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.393 0.542 . . . . 0.0 110.443 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.39 -65.4 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 111.646 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.45 -49.85 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.218 2.207 . . . . 0.0 111.5 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.87 78.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.846 0.458 . . . . 0.0 111.944 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.5 mt -102.06 23.47 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.71 65.87 3.25 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.454 1.026 . . . . 0.0 113.304 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.92 139.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 125.045 1.338 . . . . 0.0 108.004 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -101.56 167.1 10.35 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.072 1.349 . . . . 0.0 107.808 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.98 -146.52 14.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.338 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -167.45 148.6 5.54 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.576 1.15 . . . . 0.0 109.186 166.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.52 81.44 1.59 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.85 0.86 . . . . 0.0 108.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -86.83 84.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.82 87.64 2.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.724 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 123.05 85.67 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 163.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.52 69.33 7.75 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.65 2.234 . . . . 0.0 111.428 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -159.05 56.04 0.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.216 1.406 . . . . 0.0 108.527 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.82 -55.6 4.75 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.856 0.741 . . . . 0.0 113.545 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 m -94.37 66.3 3.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.424 0.689 . . . . 0.0 112.567 -161.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.67 118.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.047 0.539 . . . . 0.0 110.294 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.48 121.21 32.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.0 110.01 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.14 147.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.93 66.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.58 157.57 37.75 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.249 1.42 . . . . 0.0 110.315 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.12 116.7 11.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.742 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.03 159.84 27.47 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 118.722 0.692 . . . . 0.0 114.566 -170.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.9 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.264 1.826 . . . . 0.0 109.535 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -154.72 -75.84 0.11 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.301 1.441 . . . . 0.0 108.222 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -55.1 -48.59 73.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.0 69.38 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.986 0.515 . . . . 0.0 111.797 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.08 -66.31 0.56 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.4 t -44.98 -46.1 10.94 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.041 1.737 . . . . 0.0 112.77 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.73 -44.05 94.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.395 0.543 . . . . 0.0 111.891 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.29 -23.59 51.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.766 0.826 . . . . 0.0 111.354 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.44 -61.55 1.73 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.226 -0.921 . . . . 0.0 110.857 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.36 -36.91 79.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.875 0.87 . . . . 0.0 111.146 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -36.96 -49.59 0.83 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 165.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.81 -64.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.242 0.617 . . . . 0.0 110.056 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -51.57 62.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.831 0.852 . . . . 0.0 111.476 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -77.63 -33.14 53.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.041 0.936 . . . . 0.0 111.998 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.78 85.94 0.42 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.413 1.006 . . . . 0.0 110.686 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.66 156.23 66.19 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.965 2.443 . . . . 0.0 111.299 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.77 172.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.018 3.145 . . . . 0.0 111.715 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.01 27.76 1.53 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.162 0.985 . . . . 0.0 111.875 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.18 28.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.902 1.281 . . . . 0.0 109.445 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 81.64 3.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.45 122.41 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.56 -56.79 4.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -168.31 142.8 3.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.631 1.173 . . . . 0.0 108.667 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.49 100.24 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.76 75.01 4.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -78.71 160.38 27.5 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -135.46 109.43 8.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.734 1.614 . . . . 0.0 109.591 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 119.55 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -134.42 179.49 6.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.798 1.239 . . . . 0.0 110.461 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -104.82 135.92 45.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.128 0.971 . . . . 0.0 110.03 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -52.17 138.98 24.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.065 2.146 . . . . 0.0 112.746 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -79.33 -48.83 13.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.48 179.5 27.16 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.73 112.79 20.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.69 1.196 . . . . 0.0 107.905 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -70.05 137.79 51.56 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -68.17 90.29 0.33 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.664 0.786 . . . . 0.0 110.212 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 70.18 -164.93 0.16 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.229 1.412 . . . . 0.0 109.713 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.7 96.82 3.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.993 0.917 . . . . 0.0 108.856 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -121.56 163.28 19.15 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.483 0.713 . . . . 0.0 109.836 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.94 148.64 33.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.847 1.259 . . . . 0.0 111.73 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.28 155.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.28 168.26 12.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.788 0.835 . . . . 0.0 111.483 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -96.52 97.33 9.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.824 1.25 . . . . 0.0 109.996 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 ttp -62.93 152.33 36.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -149.92 123.73 9.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.338 1.055 . . . . 0.0 108.75 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.48 117.01 22.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.142 0.977 . . . . 0.0 110.67 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -91.37 92.74 8.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.312 1.445 . . . . 0.0 107.913 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 24' ' ' VAL . 4.2 t -88.76 112.13 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.52 149.65 21.96 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.173 0.589 . . . . 0.0 111.417 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.92 -153.87 20.51 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.854 1.216 . . . . 0.0 111.855 166.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.47 14.93 1.41 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.264 1.026 . . . . 0.0 111.662 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 HG12 ' A' ' 20' ' ' VAL . 27.3 m -74.51 21.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.346 1.458 . . . . 0.0 112.914 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -97.89 60.03 1.47 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.94 0.876 . . . . 0.0 110.707 -159.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.31 61.24 0.98 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.392 1.472 . . . . 0.0 111.087 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.27 101.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 108.709 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.54 -62.59 3.81 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.274 0.94 . . . . 0.0 111.123 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -64.14 172.85 2.19 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.364 1.066 . . . . 0.0 110.772 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 76.11 -60.57 0.48 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.601 1.96 . . . . 0.0 109.93 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -74.08 -46.52 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.526 0.73 . . . . 0.0 109.555 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -54.52 -51.18 65.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.518 -0.739 . . . . 0.0 111.116 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.43 -20.84 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.095 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -60.15 4.33 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.572 0.624 . . . . 0.0 109.335 169.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -46.15 -52.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.791 0.836 . . . . 0.0 111.841 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -69.59 -46.97 65.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.436 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.34 -52.44 37.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.411 0.55 . . . . 0.0 112.148 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.8 -40.4 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.459 1.504 . . . . 0.0 110.733 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -41.59 93.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.379 0.536 . . . . 0.0 111.731 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.93 11.04 21.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.817 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.16 56.02 24.53 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.701 0.667 . . . . 0.0 112.164 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.84 139.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.436 1.494 . . . . 0.0 108.791 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -108.94 169.6 8.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.382 1.473 . . . . 0.0 107.634 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.81 -138.76 9.14 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -175.46 141.58 0.53 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 117.69 0.745 . . . . 0.0 111.099 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.6 87.19 2.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.253 1.421 . . . . 0.0 110.165 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -92.68 110.07 21.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.269 0.628 . . . . 0.0 110.222 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.07 96.94 10.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.718 1.607 . . . . 0.0 109.234 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -77.89 110.81 14.33 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.07 79.18 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.442 2.761 . . . . 0.0 112.123 -161.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -142.09 -75.39 0.29 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.263 1.825 . . . . 0.0 106.428 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -168.87 35.93 0.2 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.673 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -137.3 103.82 5.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.257 1.023 . . . . 0.0 109.943 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.56 111.08 32.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -91.73 117.22 29.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.467 1.107 . . . . 0.0 109.576 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.27 104.75 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 110.054 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.3 t -79.86 130.26 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.29 124.67 16.6 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.244 1.018 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -108.58 104.66 14.02 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 109.074 -171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.76 159.63 27.96 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -71.52 -98.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.685 1.194 . . . . 0.0 109.656 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -159.65 -53.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.35 1.06 . . . . 0.0 109.486 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -44.3 -42.48 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.27 1.428 . . . . 0.0 110.385 162.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.51 -29.48 18.92 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.514 1.126 . . . . 0.0 112.248 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.08 -58.33 8.9 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 119.045 0.839 . . . . 0.0 109.89 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 p -43.48 -44.31 5.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.39 1.476 . . . . 0.0 112.866 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.58 -33.38 74.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.952 0.901 . . . . 0.0 112.285 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.62 -53.14 7.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.647 0.779 . . . . 0.0 110.324 169.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -52.9 61.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 110.454 -170.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.16 -36.46 83.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.174 1.389 . . . . 0.0 112.15 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.9 -50.34 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.605 169.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.97 -52.55 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 123.201 0.313 . . . . 0.0 110.592 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -49.48 77.32 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.339 0.518 . . . . 0.0 111.129 -174.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.9 -44.16 81.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.096 1.358 . . . . 0.0 110.914 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.63 82.3 0.3 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.514 1.53 . . . . 0.0 109.649 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.17 164.02 26.87 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.737 2.958 . . . . 0.0 111.412 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.58 148.35 72.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.476 2.117 . . . . 0.0 109.501 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.13 49.72 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.475 0.71 . . . . 0.0 110.874 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.23 167.47 29.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.624 1.17 . . . . 0.0 109.238 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.9 77.45 2.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.697 0.799 . . . . 0.0 110.108 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.63 122.65 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.176 0.99 . . . . 0.0 109.456 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.62 -59.35 2.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -169.94 135.78 1.44 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.372 0.669 . . . . 0.0 110.152 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.59 96.87 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -87.13 71.77 10.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.37 148.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.713 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -151.87 103.01 2.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 146.85 52.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.473 0.709 . . . . 0.0 110.579 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -134.19 -174.1 3.46 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 110.383 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.39 25.58 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.099 1.36 . . . . 0.0 109.047 170.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -76.9 144.42 38.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.004 0.922 . . . . 0.0 111.718 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -83.96 -57.75 3.07 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -152.53 172.18 31.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.72 115.77 21.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.359 1.064 . . . . 0.0 108.733 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -68.63 -38.18 80.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.727 1.211 . . . . 0.0 110.506 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 56.86 62.04 2.4 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.81 1.644 . . . . 0.0 112.412 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 t70 157.2 86.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.099 2.559 . . . . 0.0 108.438 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -73.99 91.59 2.05 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -125.84 154.53 42.53 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 111.292 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 120.79 36.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.985 0.914 . . . . 0.0 109.819 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HZ3' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -136.33 -173.31 3.37 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.597 1.559 . . . . 0.0 111.759 -168.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -111.99 132.59 54.69 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.067 0.947 . . . . 0.0 111.287 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.0 ttp -82.5 164.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 156.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -158.53 82.99 0.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.607 1.163 . . . . 0.0 108.239 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.59 105.89 17.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.726 0.81 . . . . 0.0 109.714 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.81 9.67 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.36 114.62 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -166.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.13 140.36 38.42 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.295 1.438 . . . . 0.0 110.87 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.17 -156.39 23.34 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.998 1.285 . . . . 0.0 111.355 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.93 15.68 0.84 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.523 0.729 . . . . 0.0 111.777 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -57.71 -30.37 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.896 0.878 . . . . 0.0 109.954 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.78 126.07 28.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 162.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.52 26.52 25.04 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.968 0.794 . . . . 0.0 111.623 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -154.37 151.66 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.044 1.338 . . . . 0.0 107.898 171.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.09 -69.02 1.4 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.027 0.823 . . . . 0.0 111.687 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 t80 52.79 -116.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 116.942 -1.504 . . . . 0.0 109.717 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 35.92 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.23 2.612 . . . . 0.0 114.423 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -33.03 -47.92 0.19 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.417 1.887 . . . . 0.0 112.254 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.23 -43.68 78.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.41 0.684 . . . . 0.0 111.97 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.24 -36.71 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 C-N-CA 123.53 0.732 . . . . 0.0 109.975 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -46.79 87.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.131 -0.937 . . . . 0.0 109.793 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mm -38.91 -56.47 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -174.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -67.92 -48.19 66.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.418 1.008 . . . . 0.0 111.115 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.06 -64.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.011 0.924 . . . . 0.0 111.603 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.37 -51.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 127.841 2.456 . . . . 0.0 110.621 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -42.28 62.31 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.266 0.626 . . . . 0.0 110.811 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.0 21.58 12.51 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.359 1.464 . . . . 0.0 112.371 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.12 2.93 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.146 0.879 . . . . 0.0 112.863 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 mm -119.39 142.71 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.768 1.227 . . . . 0.0 109.777 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 175.56 5.46 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.386 1.474 . . . . 0.0 108.453 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.47 -148.0 19.61 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -173.87 140.46 0.74 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 117.652 0.726 . . . . 0.0 111.173 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.34 88.03 2.82 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 124.631 1.172 . . . . 0.0 110.322 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.44 107.73 20.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.519 0.728 . . . . 0.0 110.694 -166.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.69 119.6 20.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.767 172.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.37 97.37 1.59 Allowed Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -64.31 138.51 61.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.688 1.592 . . . . 0.0 110.193 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t0 57.49 59.46 3.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.498 1.119 . . . . 0.0 109.434 -164.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.44 -140.16 3.96 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.4 p -124.1 156.46 36.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.76 1.624 . . . . 0.0 109.922 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.84 105.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 123.534 0.733 . . . . 0.0 109.512 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -93.77 134.1 36.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.482 0.713 . . . . 0.0 111.103 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.21 116.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.623 1.169 . . . . 0.0 109.418 -171.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.6 141.82 16.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.84 123.38 17.22 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.899 1.279 . . . . 0.0 108.002 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.83 90.17 3.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.546 0.738 . . . . 0.0 109.214 -162.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 162.86 22.92 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 122.086 0.826 . . . . 0.0 114.672 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.36 163.03 28.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.872 1.269 . . . . 0.0 108.01 163.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.72 -23.58 42.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -64.4 -50.01 69.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -9.83 58.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.936 0.894 . . . . 0.0 112.512 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 HD13 ' HZ3' ' A' ' 14' ' ' LYS . 25.9 tp -68.92 -60.96 2.01 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 119.325 0.966 . . . . 0.0 109.011 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -44.59 -44.67 9.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.566 1.146 . . . . 0.0 112.803 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -49.9 -51.6 39.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.208 1.003 . . . . 0.0 111.91 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.32 -42.48 45.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.435 1.494 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -55.48 -58.26 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.539 1.136 . . . . 0.0 110.388 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.64 -33.31 68.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.682 1.193 . . . . 0.0 111.394 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -40.08 -48.23 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.241 1.417 . . . . 0.0 111.023 165.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.57 -58.76 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.029 0.532 . . . . 0.0 111.065 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -59.52 -39.19 83.07 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.343 0.519 . . . . 0.0 111.088 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -72.93 -44.43 61.2 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.249 1.42 . . . . 0.0 111.094 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 80.91 0.28 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.069 1.318 . . . . 0.0 110.151 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -62.44 159.42 36.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.923 2.415 . . . . 0.0 111.128 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.56 156.08 54.51 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.26 2.64 . . . . 0.0 110.811 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.48 42.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.74 . . . . 0.0 111.25 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -153.01 167.62 28.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.73 1.612 . . . . 0.0 109.357 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.23 82.13 4.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.663 0.785 . . . . 0.0 109.015 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.69 127.52 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 109.415 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -90.07 -51.93 5.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.539 1.136 . . . . 0.0 109.517 -174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -163.1 74.6 0.37 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 112.079 -173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.39 88.08 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.657 0.741 . . . . 0.0 110.44 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.28 80.23 3.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.763 1.225 . . . . 0.0 107.791 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.29 162.39 29.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.029 0.443 . . . . 0.0 111.391 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.1 m -140.82 134.89 30.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.14 0.976 . . . . 0.0 109.301 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.71 138.37 31.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 m -137.76 177.84 7.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 111.724 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -82.39 152.2 26.29 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 124.602 1.161 . . . . 0.0 111.058 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 117.48 8.44 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 110.281 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -99.23 -55.59 2.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.969 1.308 . . . . 0.0 108.531 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.43 38.86 37.27 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 123.927 0.775 . . . . 0.0 113.255 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -85.14 -30.55 23.9 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -81.98 131.99 35.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.892 0.769 . . . . 0.0 110.586 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.68 119.44 33.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.183 1.793 . . . . 0.0 107.467 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.4 t70 64.41 171.27 0.19 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.64 1.176 . . . . 0.0 111.385 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.39 87.53 2.68 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.436 1.495 . . . . 0.0 108.357 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -105.74 152.6 22.97 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 111.128 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.15 130.15 55.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.255 1.022 . . . . 0.0 109.986 -168.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.62 1.568 . . . . 0.0 107.786 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 168.4 14.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.437 1.095 . . . . 0.0 111.744 -164.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -97.78 124.79 42.29 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 111.58 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -91.56 153.82 19.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -135.16 98.65 4.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.584 1.554 . . . . 0.0 109.374 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.46 109.67 21.82 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.332 0.653 . . . . 0.0 110.274 177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -92.26 91.22 7.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.304 1.041 . . . . 0.0 108.258 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.11 112.23 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.074 0.55 . . . . 0.0 109.63 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.11 146.4 25.08 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.476 1.511 . . . . 0.0 109.87 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.53 -175.62 20.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.213 0.911 . . . . 0.0 111.59 173.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 tp -82.81 28.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 0.0 110.576 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.22 -28.11 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.019 0.927 . . . . 0.0 110.939 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.74 131.84 14.6 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 109.889 162.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 -55.55 2.43 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.441 -0.644 . . . . 0.0 112.169 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 79' ' ' ALA . 20.3 m -71.78 -178.98 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 117.936 0.868 . . . . 0.0 111.767 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.78 85.9 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.926 1.251 . . . . 0.0 111.497 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -156.48 174.62 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.923 1.289 . . . . 0.0 109.072 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 76.12 -66.31 0.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.115 1.766 . . . . 0.0 109.752 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -53.84 -45.68 70.98 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.8 -42.68 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.088 0.955 . . . . 0.0 111.604 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.88 -32.77 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 110.573 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -56.94 15.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 110.316 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -46.68 -56.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.366 0.666 . . . . 0.0 112.12 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -65.88 -47.85 73.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.033 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.78 -65.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.554 0.741 . . . . 0.0 111.415 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.13 -46.09 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 126.619 1.967 . . . . 0.0 111.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -60.93 -39.5 89.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.162 0.585 . . . . 0.0 111.116 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.85 20.36 7.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.787 0.835 . . . . 0.0 112.834 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.84 53.23 45.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.299 0.952 . . . . 0.0 113.287 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mm -108.94 135.67 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.232 1.413 . . . . 0.0 108.408 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.38 178.63 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.673 1.189 . . . . 0.0 109.126 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.3 -142.43 10.02 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 119.538 1.063 . . . . 0.0 111.917 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -178.64 141.46 0.21 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.507 1.523 . . . . 0.0 110.137 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.42 87.69 2.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.932 0.893 . . . . 0.0 110.672 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -93.78 105.01 17.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.441 0.639 . . . . 0.0 110.994 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.12 96.5 7.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.37 117.61 69.03 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.53 71.69 6.34 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.578 2.852 . . . . 0.0 111.381 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.23 41.24 0.81 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.233 1.413 . . . . 0.0 108.537 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.56 33.64 67.36 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.202 0.906 . . . . 0.0 112.795 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 m -145.78 90.66 2.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.763 0.782 . . . . 0.0 110.035 -173.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -98.65 121.7 49.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.533 0.733 . . . . 0.0 109.092 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.52 143.64 28.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.85 130.21 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.1 141.88 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 158.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.59 122.26 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 109.448 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -124.8 116.53 22.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.222 1.009 . . . . 0.0 111.483 -156.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.31 -171.1 44.09 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.34 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.87 164.0 10.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.384 1.073 . . . . 0.0 110.182 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -81.89 -24.77 35.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -63.39 -52.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.22 -21.38 63.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.4 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.34 -61.44 1.84 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.0 p -47.41 -46.27 26.15 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.904 0.882 . . . . 0.0 112.498 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -51.78 -48.96 63.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.859 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.37 -54.34 21.41 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 110.711 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.9 59.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.219 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.72 -36.56 80.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.642 1.577 . . . . 0.0 112.157 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.71 -43.43 17.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.132 1.373 . . . . 0.0 111.644 171.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.02 -59.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 110.506 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.74 -41.46 97.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.077 0.399 . . . . 0.0 111.7 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.24 -45.97 68.47 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.988 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.38 78.84 0.25 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.742 1.163 . . . . 0.0 110.874 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 157.75 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.023 2.482 . . . . 0.0 110.516 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 165.09 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.388 2.725 . . . . 0.0 111.105 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.77 42.94 0.95 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.611 0.764 . . . . 0.0 111.268 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -148.48 172.12 14.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.046 0.938 . . . . 0.0 110.061 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.82 86.5 0.51 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.335 1.054 . . . . 0.0 109.644 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.48 80.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.024 1.33 . . . . 0.0 109.334 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -38.74 -65.28 0.37 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.491 2.316 . . . . 0.0 111.342 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -151.56 147.43 26.78 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.389 0.676 . . . . 0.0 109.835 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.45 84.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.81 68.53 10.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -73.77 162.91 28.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -147.47 133.39 19.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.784 0.834 . . . . 0.0 109.202 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.89 135.89 34.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.819 1.248 . . . . 0.0 107.955 170.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 m -129.84 -177.55 4.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.455 1.102 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.05 166.83 13.2 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.836 0.855 . . . . 0.0 111.111 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -55.78 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.596 0.758 . . . . 0.0 110.589 166.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -100.31 -56.7 2.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.337 0.655 . . . . 0.0 110.313 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.24 135.57 3.75 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.42 100.45 9.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.774 1.229 . . . . 0.0 110.648 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -75.95 72.36 2.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.94 68.68 1.82 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.647 1.579 . . . . 0.0 112.993 -165.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 166.51 89.43 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 128.492 2.717 . . . . 0.0 106.056 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.75 83.9 6.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.0 158.81 22.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 123.482 0.489 . . . . 0.0 109.949 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.03 139.4 35.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.251 0.62 . . . . 0.0 110.309 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.161 -1.4 . . . . 0.0 109.333 166.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 -179.44 4.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.227 1.011 . . . . 0.0 111.734 -171.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -106.38 130.8 54.14 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.303 0.641 . . . . 0.0 112.667 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 69' ' ' LEU . 65.3 ttp -69.12 156.9 37.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 154.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.05 87.37 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 107.18 19.13 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -85.97 102.49 13.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 t -96.78 121.82 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 122.912 0.485 . . . . 0.0 110.424 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.67 153.13 20.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 -175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.46 -155.51 17.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.463 1.506 . . . . 0.0 110.695 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 16.86 0.82 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.54 0.736 . . . . 0.0 111.563 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.4 -20.59 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.936 0.895 . . . . 0.0 111.57 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.93 138.65 50.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.384 0.673 . . . . 0.0 109.325 167.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.29 -64.23 4.2 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.8 157.6 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.343 1.057 . . . . 0.0 108.715 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.16 -96.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.514 1.054 . . . . 0.0 112.728 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 t80 63.64 -62.06 0.15 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.4 2.28 . . . . 0.0 112.931 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -33.18 -44.59 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.44 2.696 . . . . 0.0 112.879 167.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -69.38 -45.77 68.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.361 0.664 . . . . 0.0 109.869 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -56.25 -46.22 79.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.44 0.696 . . . . 0.0 110.927 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.28 -37.38 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.924 0.49 . . . . 0.0 110.485 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -64.31 -49.98 69.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.261 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mm -45.42 -56.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.661 1.118 . . . . 0.0 111.515 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -64.36 -48.33 75.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.98 -51.06 59.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.63 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.391 1.476 . . . . 0.0 109.269 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -55.23 -38.57 68.65 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.496 0.718 . . . . 0.0 110.883 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.33 2.81 55.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.266 1.426 . . . . 0.0 113.161 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 62.52 4.95 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.883 0.765 . . . . 0.0 111.68 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.97 143.91 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 125.517 1.527 . . . . 0.0 108.597 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -101.84 170.01 8.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.771 1.228 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.13 -143.58 11.07 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.853 0.752 . . . . 0.0 112.344 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -174.15 142.56 0.83 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.568 1.147 . . . . 0.0 108.953 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.74 79.03 1.88 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -93.5 96.34 9.82 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.792 -164.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.78 93.89 9.62 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 126.292 1.837 . . . . 0.0 110.182 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.03 110.62 6.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.58 64.78 8.66 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.208 2.606 . . . . 0.0 111.567 -161.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -167.36 38.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.87 1.668 . . . . 0.0 109.569 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.27 -105.86 0.28 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -121.14 144.53 48.52 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.618 1.567 . . . . 0.0 110.568 -165.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.63 125.21 41.85 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.717 0.807 . . . . 0.0 110.397 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.08 116.32 27.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.0 t -112.81 123.19 68.23 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.062 0 C-N-CA 124.065 0.946 . . . . 0.0 108.682 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 m -118.0 69.3 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.5 0.72 . . . . 0.0 111.406 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.49 128.45 35.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.948 0.899 . . . . 0.0 111.293 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.65 107.6 15.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.588 0.755 . . . . 0.0 111.085 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.99 172.68 34.58 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.634 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -67.42 168.0 11.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.015 1.326 . . . . 0.0 109.026 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.99 -18.56 53.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.935 0.494 . . . . 0.0 112.093 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.71 -29.12 69.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.21 1.004 . . . . 0.0 110.683 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -2.04 15.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.114 1.366 . . . . 0.0 112.073 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.21 -66.31 0.6 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -41.2 -45.43 2.85 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 125.313 1.445 . . . . 0.0 112.129 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -54.17 -52.72 60.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.59 0.756 . . . . 0.0 111.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.12 -24.08 61.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.825 1.65 . . . . 0.0 111.947 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 16' ' ' MET . 3.3 mm? -82.61 -61.54 1.85 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.991 0.916 . . . . 0.0 111.103 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -47.15 -45.51 22.64 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.584 1.954 . . . . 0.0 111.446 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -29.76 -56.99 0.17 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.022 1.729 . . . . 0.0 112.022 164.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.02 -71.41 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 122.761 0.424 . . . . 0.0 110.876 -167.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -48.49 -44.64 36.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.137 0.975 . . . . 0.0 112.319 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -103.42 53.17 0.76 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.239 1.016 . . . . 0.0 110.57 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.71 153.17 24.65 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.02 114.0 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.775 2.983 . . . . 0.0 110.991 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.75 145.96 47.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.221 1.947 . . . . 0.0 110.838 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.01 -21.37 62.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.46 0.704 . . . . 0.0 111.777 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.1 172.15 10.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.207 1.403 . . . . 0.0 110.828 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.6 73.44 3.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.96 121.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.539 1.136 . . . . 0.0 109.096 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.97 -60.18 2.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.32 152.71 6.14 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 122.905 0.482 . . . . 0.0 110.895 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.26 97.95 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.245 1.018 . . . . 0.0 109.03 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.02 75.73 7.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -80.45 163.05 24.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.532 0.682 . . . . 0.0 112.197 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 123.52 18.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.721 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 123.86 25.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 164.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -128.72 174.31 9.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.945 0.898 . . . . 0.0 110.119 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.64 141.39 28.99 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.56 139.25 58.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.467 1.507 . . . . 0.0 111.393 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.84 -49.32 13.12 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.223 1.009 . . . . 0.0 108.931 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.43 175.56 41.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.39 106.13 17.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.43 134.04 55.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.126 0.97 . . . . 0.0 108.643 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.72 96.68 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.279 0.632 . . . . 0.0 109.61 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 71.22 -170.43 0.15 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.798 1.639 . . . . 0.0 110.668 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.01 92.11 2.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.437 1.095 . . . . 0.0 108.466 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -121.88 164.41 17.58 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.719 0.408 . . . . 0.0 109.959 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -99.01 139.34 34.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.474 0.71 . . . . 0.0 110.508 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.827 -1.559 . . . . 0.0 111.101 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 163.54 13.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.966 0.906 . . . . 0.0 112.309 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -84.62 114.36 21.94 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.495 0.664 . . . . 0.0 110.182 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.0 ptm -88.71 102.31 14.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.743 0.817 . . . . 0.0 110.149 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.62 108.01 18.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.908 1.283 . . . . 0.0 108.372 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.77 108.57 18.03 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.796 1.239 . . . . 0.0 110.382 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.7 116.81 29.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.588 1.955 . . . . 0.0 107.348 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.37 120.97 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.29 150.8 26.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.353 1.061 . . . . 0.0 110.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.65 -154.31 21.24 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.702 1.144 . . . . 0.0 110.743 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.36 17.81 3.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.365 0.602 . . . . 0.0 110.211 166.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.43 -36.89 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.664 1.986 . . . . 0.0 112.14 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -75.26 80.13 2.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.13 -67.04 0.05 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.95 38.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.883 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.73 -93.34 0.12 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.902 1.239 . . . . 0.0 112.499 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.2 t80 70.78 -38.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.511 2.324 . . . . 0.0 114.128 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -42.87 -44.83 4.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.297 1.439 . . . . 0.0 112.531 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -69.37 -48.83 60.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.079 0.552 . . . . 0.0 110.537 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -51.77 -43.37 62.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.494 1.118 . . . . 0.0 111.707 174.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' N ' HH21 ' A' ' 71' ' ' ARG . 85.0 t -60.6 -39.7 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -45.95 79.66 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 117.32 -1.324 . . . . 0.0 112.046 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.3 mm -48.14 -54.58 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.123 1.783 . . . . 0.0 111.922 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -66.75 -47.21 72.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.132 -0.461 . . . . 0.0 109.967 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.59 -52.09 24.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.426 0.69 . . . . 0.0 112.717 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.87 -43.17 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 126.434 1.894 . . . . 0.0 110.099 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -63.61 -34.33 77.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.102 0.561 . . . . 0.0 111.791 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.2 18.67 20.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.252 . . . . 0.0 112.305 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.01 63.82 4.91 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.413 1.006 . . . . 0.0 113.512 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.14 146.51 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.757 1.623 . . . . 0.0 108.659 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 94' ' ' GLU . 6.9 mtmp? -109.79 166.93 10.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.76 1.224 . . . . 0.0 108.403 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.79 -152.97 24.11 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.786 0.721 . . . . 0.0 112.717 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -166.28 141.09 4.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.225 1.01 . . . . 0.0 109.132 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.89 91.11 3.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.657 1.183 . . . . 0.0 108.962 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -85.94 80.91 8.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -102.91 59.25 0.78 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.456 1.102 . . . . 0.0 108.932 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.4 mt -71.52 108.81 4.36 Favored Pre-proline 0 C--N 1.34 0.188 0 C-N-CA 125.629 1.572 . . . . 0.0 108.43 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -79.71 64.07 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.845 3.03 . . . . 0.0 112.804 -163.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -173.01 54.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.903 2.081 . . . . 0.0 108.095 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 -109.3 0.33 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 m -133.09 160.53 36.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.801 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.34 95.54 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.44 134.47 42.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.595 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.8 t -106.35 133.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.26 78.05 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.19 166.86 16.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.715 1.206 . . . . 0.0 109.818 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.86 109.41 7.44 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 118.866 -0.588 . . . . 0.0 111.965 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.32 149.19 21.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.961 0.8 . . . . 0.0 113.794 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -57.48 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.405 2.282 . . . . 0.0 111.769 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -154.75 -71.16 0.13 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.04 1.736 . . . . 0.0 107.157 -165.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -51.66 -50.65 59.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 164.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.25 62.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.319 1.047 . . . . 0.0 111.949 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -67.07 -66.84 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -48.4 -36.21 14.25 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.956 1.703 . . . . 0.0 113.291 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -63.76 -50.39 69.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.75 0.705 . . . . 0.0 112.542 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.39 -22.85 60.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.707 0.685 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.22 -58.05 4.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.858 -0.526 . . . . 0.0 110.909 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.31 -31.91 73.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.37 0.668 . . . . 0.0 111.614 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.426 HH21 ' N ' ' A' ' 33' ' ' VAL . 17.3 tpt85 -39.28 -54.2 1.85 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.078 1.351 . . . . 0.0 110.364 162.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.83 -53.0 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.032 0.533 . . . . 0.0 111.319 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.51 -38.42 91.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.297 0.499 . . . . 0.0 111.293 -168.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -76.05 -37.94 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.887 0.875 . . . . 0.0 111.482 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.15 74.58 0.24 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.319 0.961 . . . . 0.0 111.21 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.81 164.01 34.44 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.635 2.89 . . . . 0.0 111.688 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.97 128.03 11.18 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.218 2.612 . . . . 0.0 109.293 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.867 0.867 . . . . 0.0 110.058 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.99 74.38 0.43 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.459 0.704 . . . . 0.0 110.093 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 30.02 72.26 0.06 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.503 1.921 . . . . 0.0 110.877 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 90.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -50.72 -55.29 17.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.96 0.904 . . . . 0.0 110.098 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -170.47 140.56 1.81 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 171.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.09 84.37 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 165.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.67 76.25 7.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -71.73 160.12 33.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -150.39 95.56 2.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 141.26 57.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.739 0.816 . . . . 0.0 110.064 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -133.49 177.49 7.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.552 0.741 . . . . 0.0 111.456 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.03 124.02 34.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.051 1.74 . . . . 0.0 108.288 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -55.73 122.14 10.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.935 0.494 . . . . 0.0 112.017 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.65 -47.94 73.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.94 -157.02 10.11 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 13.8 pt-20 -89.03 107.45 19.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 109.358 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.75 73.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.05 137.04 8.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.944 1.698 . . . . 0.0 112.644 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 63.12 -165.57 0.24 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.392 1.077 . . . . 0.0 109.063 -173.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.75 82.81 1.22 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.98 162.81 13.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -171.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.11 134.06 55.14 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 111.072 -167.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.183 -1.389 . . . . 0.0 108.468 162.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.527 0.09 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -178.21 3.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.413 1.085 . . . . 0.0 111.393 -174.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -99.91 127.12 46.12 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.887 0.475 . . . . 0.0 110.773 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 10.8 ptm -97.9 96.62 8.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.141 0.972 . . . . 0.0 110.266 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -87.81 108.63 19.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.5 1.12 . . . . 0.0 108.587 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.74 109.15 14.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 110.721 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.25 100.37 12.94 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.433 1.093 . . . . 0.0 108.848 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 101.74 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.78 155.51 17.61 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.269 0.627 . . . . 0.0 111.758 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.95 -155.37 21.22 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.352 1.454 . . . . 0.0 111.581 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -81.6 28.99 0.38 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.996 0.918 . . . . 0.0 110.238 173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.2 m -76.13 -6.98 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.336 1.055 . . . . 0.0 112.717 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 164.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 164.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.87 -62.9 4.47 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -171.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -72.83 155.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.56 -83.11 0.33 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 122.949 0.309 . . . . 0.0 112.383 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 47.5 56.3 7.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.594 1.558 . . . . 0.0 111.519 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.97 -41.32 0.53 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.428 1.491 . . . . 0.0 108.729 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -72.39 -48.91 37.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.328 0.651 . . . . 0.0 110.848 171.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.17 -46.37 68.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.136 0.494 . . . . 0.0 111.114 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.19 -35.48 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.246 0.619 . . . . 0.0 110.359 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -47.15 78.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.058 0.943 . . . . 0.0 110.641 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.57 -56.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.62 1.1 . . . . 0.0 110.935 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -70.41 -40.78 73.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.281 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.94 -54.91 11.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.2 0.6 . . . . 0.0 111.634 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.89 -38.81 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.119 1.368 . . . . 0.0 111.349 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -59.44 -37.1 77.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.915 0.486 . . . . 0.0 111.137 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -98.13 19.06 14.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.772 0.829 . . . . 0.0 112.869 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 56.54 22.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.023 0.821 . . . . 0.0 113.204 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -104.49 143.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 125.387 1.475 . . . . 0.0 108.91 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -104.27 171.27 7.43 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.531 1.132 . . . . 0.0 108.549 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.49 -138.72 10.27 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.207 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -166.6 145.9 5.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.508 0.654 . . . . 0.0 112.358 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.58 85.7 2.37 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.907 1.683 . . . . 0.0 108.938 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -95.39 100.84 12.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.012 0.525 . . . . 0.0 110.351 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.64 116.23 8.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 170.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.2 mt -94.13 94.12 1.04 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.57 141.52 95.5 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.387 2.058 . . . . 0.0 111.024 -170.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.49 61.57 2.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.644 1.178 . . . . 0.0 109.634 -166.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.75 -126.67 1.0 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -129.25 149.2 51.15 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.035 1.734 . . . . 0.0 109.303 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.6 99.42 5.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.25 125.34 30.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.84 1.256 . . . . 0.0 108.362 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -112.95 125.3 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.8 77.87 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 161.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 16' ' ' MET . . . -84.32 162.14 20.18 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.036 1.334 . . . . 0.0 108.845 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -138.93 105.15 5.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.069 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.03 166.23 24.96 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 118.708 0.685 . . . . 0.0 112.911 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -67.8 173.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.36 1.064 . . . . 0.0 108.632 161.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.85 -31.19 63.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.2 -20.49 65.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.128 0.571 . . . . 0.0 112.287 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.68 -12.09 18.67 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.938 0.895 . . . . 0.0 111.781 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.94 -70.7 0.24 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 p -43.81 -34.81 1.68 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.028 1.331 . . . . 0.0 113.602 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -68.73 -56.47 8.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.85 0.86 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.45 -22.16 62.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.425 0.69 . . . . 0.0 111.175 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.5 -59.77 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.6 -0.687 . . . . 0.0 110.191 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -61.69 -32.09 72.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.718 0.69 . . . . 0.0 111.85 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -43.54 -51.45 6.79 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.415 1.486 . . . . 0.0 111.952 164.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -67.29 -53.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 C-N-CA 123.246 0.619 . . . . 0.0 110.519 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -41.78 93.76 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.893 0.315 . . . . 0.0 110.63 -172.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -70.39 -42.12 72.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.447 1.499 . . . . 0.0 111.497 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.2 78.08 0.24 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.355 1.455 . . . . 0.0 111.075 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.75 169.39 17.68 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 124.033 3.155 . . . . 0.0 112.126 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.59 162.14 38.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.03 2.486 . . . . 0.0 110.944 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.91 33.74 0.33 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.807 0.843 . . . . 0.0 111.852 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.94 174.16 13.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.398 1.079 . . . . 0.0 109.857 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.26 88.52 0.85 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.07 122.24 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.872 0.869 . . . . 0.0 109.218 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -75.24 -58.04 3.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -166.11 132.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.029 0.531 . . . . 0.0 110.112 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -87.25 86.17 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 162.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.53 75.61 9.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.95 151.57 33.63 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.633 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.6 m -151.18 95.61 2.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 0.0 109.349 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -60.9 152.79 26.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.427 1.491 . . . . 0.0 110.801 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 m -157.91 176.72 12.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.67 144.54 45.79 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -65.49 132.71 49.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.53 1.132 . . . . 0.0 112.401 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -69.23 -51.88 33.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 109.119 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.91 -178.16 36.5 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.61 111.9 23.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.978 1.311 . . . . 0.0 108.524 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -75.46 -17.97 59.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.843 0.857 . . . . 0.0 111.948 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 66.12 94.94 0.06 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.71 1.604 . . . . 0.0 111.181 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 68.85 155.75 0.13 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.393 1.877 . . . . 0.0 110.986 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -101.94 92.06 4.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -110.84 160.45 16.75 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -105.36 142.77 34.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.984 0.514 . . . . 0.0 111.644 -167.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.032 174.259 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.59 144.09 48.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.237 1.415 . . . . 0.0 109.761 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -83.07 108.71 16.55 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.97 0.508 . . . . 0.0 111.131 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.7 ptm -93.41 94.06 8.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.494 0.664 . . . . 0.0 109.74 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.91 133.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.09 104.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -97.1 100.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.107 1.763 . . . . 0.0 109.207 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.55 127.13 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 110.226 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -102.66 155.04 18.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.941 1.297 . . . . 0.0 110.14 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.56 -168.85 19.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.003 1.287 . . . . 0.0 110.65 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -88.8 56.04 3.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.78 3.7 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.384 1.073 . . . . 0.0 112.372 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.89 152.99 25.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.76 -56.15 4.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -69.75 -179.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.593 0.757 . . . . 0.0 110.556 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.71 -97.19 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.269 0.938 . . . . 0.0 112.863 -171.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 64.0 -65.01 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.78 2.032 . . . . 0.0 113.078 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -48.5 -31.32 6.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.185 2.194 . . . . 0.0 113.177 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.29 -46.57 15.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.493 1.517 . . . . 0.0 110.851 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.78 -49.37 77.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.021 0.528 . . . . 0.0 111.341 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.02 -26.99 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.389 172.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.99 -56.07 15.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.905 0.882 . . . . 0.0 110.173 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.5 mm -43.83 -56.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 118.876 0.762 . . . . 0.0 111.029 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -64.62 -49.59 70.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.21 -65.06 0.63 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.515 0.726 . . . . 0.0 112.212 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.61 -50.97 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 126.097 1.759 . . . . 0.0 110.132 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -56.82 -41.39 77.72 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.385 0.674 . . . . 0.0 110.864 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.9 mt -93.93 15.36 16.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.399 1.48 . . . . 0.0 113.144 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.82 48.61 84.43 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.972 0.796 . . . . 0.0 113.123 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.08 143.2 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.394 1.478 . . . . 0.0 107.846 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -104.09 169.36 8.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.425 1.09 . . . . 0.0 108.282 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.82 -150.4 22.28 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 119.162 0.892 . . . . 0.0 112.886 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -170.89 140.76 1.65 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.836 1.254 . . . . 0.0 109.172 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.15 89.86 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.37 1.068 . . . . 0.0 110.288 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.11 98.19 7.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.261 0.624 . . . . 0.0 110.796 -165.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.63 115.03 16.02 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.51 170.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.68 104.51 10.43 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.99 141.68 65.36 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.058 2.505 . . . . 0.0 111.597 -163.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 63.98 60.03 1.05 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.809 1.644 . . . . 0.0 110.426 -171.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -129.49 1.51 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 p -120.87 163.44 18.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.627 1.571 . . . . 0.0 109.835 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -116.92 125.09 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.977 0.911 . . . . 0.0 110.77 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.54 145.46 30.27 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.929 0.492 . . . . 0.0 110.656 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.91 137.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 66.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.5 155.58 29.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.473 1.109 . . . . 0.0 109.94 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -142.86 106.24 4.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.921 -0.562 . . . . 0.0 109.888 -167.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.03 149.78 19.99 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.295 0.498 . . . . 0.0 113.912 -171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -63.06 163.88 9.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.757 0.823 . . . . 0.0 108.856 162.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -78.18 -34.24 49.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.464 0.706 . . . . 0.0 111.11 -171.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -69.65 -9.04 52.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.979 0.912 . . . . 0.0 111.632 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.91 4.32 10.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.672 1.189 . . . . 0.0 111.907 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -71.62 -68.56 0.44 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.427 1.012 . . . . 0.0 109.619 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.2 p -44.98 -42.47 8.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.558 1.543 . . . . 0.0 112.957 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -53.42 -48.59 68.61 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.237 1.015 . . . . 0.0 111.05 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.44 -51.97 17.91 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -52.54 -57.06 11.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.467 0.576 . . . . 0.0 111.777 -170.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.48 -40.37 68.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.056 1.343 . . . . 0.0 112.456 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.9 -51.14 7.77 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.214 1.006 . . . . 0.0 110.681 169.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.48 -53.58 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.329 -173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -46.44 71.65 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.071 0.396 . . . . 0.0 111.56 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -71.87 -55.61 7.22 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.862 0.865 . . . . 0.0 110.49 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.32 97.87 2.11 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.295 -1.281 . . . . 0.0 110.561 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.74 145.23 80.53 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.496 2.131 . . . . 0.0 109.07 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -86.93 49.54 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.913 1.742 . . . . 0.0 114.498 -153.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 56.58 37.15 28.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.36 1.064 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.3 161.72 39.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.058 0.943 . . . . 0.0 109.238 -168.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -84.55 75.89 10.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.95 135.59 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.905 1.282 . . . . 0.0 110.817 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.96 -57.57 2.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.018 1.327 . . . . 0.0 108.319 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -166.72 137.76 3.33 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 122.878 0.471 . . . . 0.0 110.996 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.33 96.4 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 121.784 -0.572 . . . . 0.0 110.169 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.97 72.26 9.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.7 161.95 28.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.476 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.5 t -137.9 127.43 24.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.606 0.762 . . . . 0.0 110.037 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.58 131.37 42.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 167.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 m -128.21 -160.06 0.99 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.292 1.037 . . . . 0.0 110.02 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -120.83 152.81 37.93 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.634 1.973 . . . . 0.0 108.967 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -52.21 86.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.919 1.688 . . . . 0.0 111.641 166.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -100.75 -54.8 2.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.727 1.211 . . . . 0.0 110.468 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.56 133.96 5.83 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.1 92.22 8.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.428 1.091 . . . . 0.0 109.809 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -72.13 87.92 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.86 143.39 56.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.635 0.774 . . . . 0.0 110.54 -174.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 64.9 -170.27 0.19 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.845 1.258 . . . . 0.0 109.374 -166.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.41 100.75 2.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.84 158.06 26.38 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 122.965 0.506 . . . . 0.0 111.391 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.67 139.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.686 1.195 . . . . 0.0 110.121 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.94 -178.719 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.255 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 165.38 18.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.926 0.89 . . . . 0.0 111.999 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -97.55 123.81 41.57 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 121.545 0.688 . . . . 0.0 112.092 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.9 ttp -67.9 154.79 40.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 150.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.8 106.94 2.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.39 116.94 28.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.299 1.04 . . . . 0.0 109.547 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 93.73 7.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.9 t -92.7 110.01 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.48 0.312 . . . . 0.0 110.646 -166.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -97.96 145.46 26.45 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.204 1.002 . . . . 0.0 110.823 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.52 -166.37 30.17 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 123.751 0.691 . . . . 0.0 111.973 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.84 15.74 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.523 0.729 . . . . 0.0 110.961 169.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.5 -15.44 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.114 1.366 . . . . 0.0 112.29 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -77.13 29.41 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.369 1.468 . . . . 0.0 113.737 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.82 24.13 0.17 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.153 1.359 . . . . 0.0 112.292 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.97 169.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.227 1.011 . . . . 0.0 108.582 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.87 33.35 2.15 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.663 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.2 t80 -78.48 45.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.031 1.415 . . . . 0.0 110.594 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -141.13 -45.88 0.39 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.897 2.479 . . . . 0.0 106.526 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -71.26 -44.67 64.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.097 0.959 . . . . 0.0 110.195 169.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.93 -55.62 28.6 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.941 -0.474 . . . . 0.0 111.752 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.21 -34.64 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 122.725 0.41 . . . . 0.0 111.32 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -58.66 -38.57 78.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.404 1.482 . . . . 0.0 112.809 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.45 -57.47 11.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.352 1.433 . . . . 0.0 110.487 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -64.03 -38.98 93.04 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.6 0.636 . . . . 0.0 110.679 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.85 11.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.064 0.545 . . . . 0.0 111.966 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.94 -36.42 77.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.498 0.719 . . . . 0.0 110.861 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -52.41 -43.93 65.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.282 1.033 . . . . 0.0 109.479 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.11 23.07 13.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.05 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.22 63.77 4.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.5 1.048 . . . . 0.0 112.999 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.41 138.12 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.221 1.409 . . . . 0.0 108.304 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -100.89 165.03 11.55 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.326 1.05 . . . . 0.0 108.463 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.41 -139.34 7.09 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -176.4 148.49 0.75 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.581 0.691 . . . . 0.0 110.669 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.46 78.73 1.14 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 109.502 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -90.22 86.32 6.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.946 0.879 . . . . 0.0 109.244 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.5 97.26 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.967 1.307 . . . . 0.0 109.945 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.6 mt -78.63 102.22 0.95 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 125.059 1.344 . . . . 0.0 107.582 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 146.84 79.77 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.501 2.134 . . . . 0.0 111.118 -164.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 55.28 53.35 10.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.476 1.11 . . . . 0.0 109.489 -167.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.3 -132.95 1.63 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -127.37 149.69 49.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.743 1.617 . . . . 0.0 109.94 -169.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.96 115.8 29.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 121.594 0.711 . . . . 0.0 109.419 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.97 103.49 16.0 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.34 1.456 . . . . 0.0 107.079 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.58 132.23 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.316 0.646 . . . . 0.0 109.833 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.56 145.83 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.58 119.39 4.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.359 0.527 . . . . 0.0 110.652 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -109.67 107.44 17.49 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.307 1.443 . . . . 0.0 110.865 -166.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.66 174.94 26.33 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-O 121.826 0.681 . . . . 0.0 113.011 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -72.64 173.25 9.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 160.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.97 -30.02 63.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -64.84 -17.86 64.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.426 0.691 . . . . 0.0 112.598 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.44 -2.98 10.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.411 1.085 . . . . 0.0 112.263 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -68.18 -62.32 1.45 Allowed 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -42.69 -42.84 3.63 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.737 1.615 . . . . 0.0 113.064 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -51.49 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.953 0.501 . . . . 0.0 111.454 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.05 -24.15 63.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.499 1.12 . . . . 0.0 111.639 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.96 -61.79 1.88 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 108.835 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.23 -25.7 65.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.266 1.426 . . . . 0.0 111.766 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -54.23 0.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.185 1.394 . . . . 0.0 110.776 159.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mt -71.21 -56.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.87 -48.76 80.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.454 0.302 . . . . 0.0 110.818 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -68.92 -42.34 76.94 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.811 1.245 . . . . 0.0 111.247 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.1 0.27 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.077 1.322 . . . . 0.0 110.02 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.75 163.37 38.64 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.631 2.887 . . . . 0.0 111.919 -173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.86 162.36 37.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.715 2.943 . . . . 0.0 111.204 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.67 42.23 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.848 0.859 . . . . 0.0 111.039 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.92 162.86 36.82 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.778 1.231 . . . . 0.0 109.54 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.02 83.72 2.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.389 1.075 . . . . 0.0 109.192 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.31 83.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.288 1.435 . . . . 0.0 109.914 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -41.0 -60.88 1.08 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.311 1.844 . . . . 0.0 111.37 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -162.62 133.63 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.091 0.244 . . . . 0.0 110.84 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.04 94.24 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 165.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.39 70.05 10.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -75.76 161.3 29.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.391 0.615 . . . . 0.0 111.494 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -143.03 97.55 3.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.63 1.172 . . . . 0.0 108.952 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -55.91 127.33 29.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.673 1.189 . . . . 0.0 109.188 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -134.93 -163.21 1.35 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.53 1.132 . . . . 0.0 109.679 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 151.59 47.17 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.547 0.739 . . . . 0.0 110.04 173.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -58.3 124.7 20.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.969 0.908 . . . . 0.0 112.001 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -73.76 -45.3 52.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.55 176.23 37.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.95 96.81 10.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.488 1.515 . . . . 0.0 109.505 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -56.06 -55.32 34.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.299 1.04 . . . . 0.0 111.099 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.61 61.22 3.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 112.107 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 155.75 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.723 2.809 . . . . 0.0 108.213 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.59 98.1 10.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 168.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -117.45 165.35 13.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.454 0.702 . . . . 0.0 109.308 176.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -114.84 144.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.575 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.314 -1.327 . . . . 0.0 108.756 150.512 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.597 0.237 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 166.39 16.87 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.882 1.273 . . . . 0.0 111.695 -167.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -94.77 124.55 38.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.633 0.773 . . . . 0.0 111.773 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -90.52 151.93 21.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 160.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -135.39 102.64 5.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.45 1.1 . . . . 0.0 109.097 -177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.05 106.3 16.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.049 0.54 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 98.02 10.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.67 104.23 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -76.16 153.28 36.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.71 -155.51 16.23 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 123.735 0.683 . . . . 0.0 112.549 162.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.71 28.2 0.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.158 0.983 . . . . 0.0 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.87 -9.62 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.177 0.991 . . . . 0.0 113.064 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.66 164.93 18.15 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 162.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.69 3.77 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.05 142.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.35 52.73 4.77 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.434 0.54 . . . . 0.0 113.089 -165.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -87.6 51.08 2.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.466 0.706 . . . . 0.0 110.437 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -52.61 0.93 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.404 1.481 . . . . 0.0 107.238 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -47.72 -52.61 17.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.696 1.199 . . . . 0.0 110.711 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.88 -54.63 40.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.131 0.972 . . . . 0.0 111.436 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.2 -23.68 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.453 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -50.21 64.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.542 169.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.14 -53.3 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.814 1.188 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -70.7 -31.21 68.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.59 -64.18 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 167.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.6 -41.0 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.312 1.445 . . . . 0.0 112.309 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -49.1 78.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 111.279 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -87.05 14.57 7.26 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.83 57.75 17.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.179 0.895 . . . . 0.0 111.829 176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.1 mm -119.18 140.7 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.981 1.313 . . . . 0.0 109.196 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -109.95 165.2 11.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.069 1.347 . . . . 0.0 108.595 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.69 -134.14 5.5 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 118.477 0.581 . . . . 0.0 112.169 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.99 147.8 1.68 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 122.995 0.518 . . . . 0.0 111.646 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.32 84.49 2.63 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.954 1.302 . . . . 0.0 108.75 167.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.38 86.85 5.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.791 0.805 . . . . 0.0 109.544 -169.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.72 81.21 6.44 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 126.251 1.821 . . . . 0.0 109.869 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.4 mt -59.85 110.99 3.24 Favored Pre-proline 0 N--CA 1.454 -0.265 0 C-N-CA 125.363 1.465 . . . . 0.0 107.978 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.06 46.36 2.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.958 2.438 . . . . 0.0 112.945 -162.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -153.43 45.92 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.879 1.672 . . . . 0.0 107.676 167.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.07 -136.84 3.87 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 m -120.64 173.04 7.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.269 1.428 . . . . 0.0 110.266 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.62 122.39 45.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 122.965 0.506 . . . . 0.0 111.744 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -95.64 110.04 22.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.201 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -87.18 140.08 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.29 135.19 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 165.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.77 117.23 6.99 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.015 0.926 . . . . 0.0 110.101 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.69 111.4 24.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.129 0.972 . . . . 0.0 110.67 -171.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.67 29.99 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -54.78 163.97 0.87 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 110.104 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.47 -44.36 64.9 Favored 'General case' 0 CA--C 1.527 0.063 0 O-C-N 122.116 -0.365 . . . . 0.0 110.629 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -47.74 -43.44 27.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.678 1.191 . . . . 0.0 111.256 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.76 0.36 52.3 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.005 1.322 . . . . 0.0 112.828 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.6 tp -68.8 -60.76 2.16 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.582 1.083 . . . . 0.0 109.461 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.3 p -40.9 -47.89 3.04 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.424 1.489 . . . . 0.0 112.32 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.35 -41.46 65.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.13 -53.44 11.02 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.89 0.476 . . . . 0.0 109.75 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.8 -52.46 60.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.53 -45.0 73.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.234 1.414 . . . . 0.0 111.542 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.95 -53.88 3.67 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.534 1.534 . . . . 0.0 110.481 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.1 mt -63.35 -65.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.25 0.22 . . . . 0.0 110.827 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -55.63 -41.26 73.28 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.93 -37.56 88.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.77 0.828 . . . . 0.0 111.805 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.33 76.61 0.24 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.436 1.494 . . . . 0.0 110.064 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.6 168.04 23.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.349 3.366 . . . . 0.0 112.129 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 169.83 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.656 2.904 . . . . 0.0 111.418 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.68 29.03 0.82 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.0 0.92 . . . . 0.0 111.335 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.85 168.23 16.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.944 1.298 . . . . 0.0 109.635 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.7 84.06 1.61 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.875 0.87 . . . . 0.0 109.881 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.49 98.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.796 0.838 . . . . 0.0 110.293 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -49.78 -55.18 15.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.549 1.539 . . . . 0.0 110.677 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -178.06 135.24 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.086 1.354 . . . . 0.0 110.981 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.1 90.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 121.601 -0.687 . . . . 0.0 109.385 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.05 77.87 6.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -78.46 171.08 15.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.36 0.6 . . . . 0.0 112.166 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -143.39 126.14 16.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.158 1.383 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.03 129.1 34.08 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -135.7 -162.57 1.28 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.281 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.59 135.74 48.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.798 1.239 . . . . 0.0 109.496 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -57.98 135.76 56.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.315 0.646 . . . . 0.0 112.505 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -79.32 -47.19 16.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.205 0.602 . . . . 0.0 109.432 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.19 -174.28 36.19 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.21 96.56 10.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.537 1.135 . . . . 0.0 110.291 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -58.81 134.32 56.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 167.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.73 71.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.736 0.814 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.06 164.04 0.26 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.422 1.889 . . . . 0.0 111.326 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.67 109.97 17.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 100' ' ' THR . 28.8 tt0 -111.57 178.5 4.31 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.1 p -124.01 138.53 54.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.448 0.699 . . . . 0.0 109.839 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.303 167.42 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -177.06 4.34 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.321 1.048 . . . . 0.0 111.497 -168.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -106.1 135.63 47.21 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.5 ttp -77.7 157.6 30.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 157.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -144.05 88.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.324 1.449 . . . . 0.0 107.253 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.92 102.78 13.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.772 0.829 . . . . 0.0 109.96 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 97.96 9.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 84' ' ' VAL . 18.8 t -99.32 119.78 47.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.753 0.421 . . . . 0.0 110.0 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -103.36 148.25 26.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.622 1.569 . . . . 0.0 110.387 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.55 -159.57 23.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.09 0.852 . . . . 0.0 112.003 169.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -87.78 21.85 2.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.536 0.735 . . . . 0.0 111.014 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.55 -24.4 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.282 1.033 . . . . 0.0 111.808 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.72 132.41 49.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 110.632 173.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.69 -54.33 4.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.601 0.62 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -72.41 77.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.277 1.431 . . . . 0.0 109.963 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.17 -116.97 5.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.4 t80 62.58 -68.77 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.251 2.22 . . . . 0.0 113.504 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -56.78 -35.32 68.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.626 1.17 . . . . 0.0 110.927 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -73.94 -47.48 37.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.922 0.889 . . . . 0.0 110.238 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.86 -50.17 66.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.422 1.089 . . . . 0.0 112.447 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.75 -33.75 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.651 0.38 . . . . 0.0 110.506 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -46.84 73.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 109.542 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 mm -51.53 -54.17 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.4 1.0 . . . . 0.0 110.717 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -66.27 -42.8 87.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.408 0.442 . . . . 0.0 109.963 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.56 -52.37 47.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.81 -43.63 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.416 1.087 . . . . 0.0 109.905 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -54.0 -37.68 64.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.526 0.73 . . . . 0.0 111.002 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -97.4 -1.52 44.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.838 1.655 . . . . 0.0 113.361 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.58 59.91 5.36 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.821 0.737 . . . . 0.0 111.91 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -125.13 138.49 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.859 1.664 . . . . 0.0 108.82 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -92.19 -178.9 5.1 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.909 1.284 . . . . 0.0 108.519 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -143.94 11.79 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 120.04 1.291 . . . . 0.0 112.338 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -175.3 147.18 0.87 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.858 0.863 . . . . 0.0 110.328 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.53 82.44 1.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 109.291 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -84.73 80.03 9.4 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.688 1.232 . . . . 0.0 108.636 -170.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 18.8 t-20 -85.17 75.61 10.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.626 2.77 . . . . 0.0 110.042 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -61.42 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.063 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.3 -167.42 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.98 2.453 . . . . 0.0 110.537 -170.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -100.0 50.77 0.91 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.973 1.309 . . . . 0.0 109.876 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.31 -73.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.875 0 O-C-N 122.052 -0.405 . . . . 0.0 112.439 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 m -96.43 112.21 24.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.654 0.782 . . . . 0.0 110.899 -168.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.24 132.35 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.064 0 C-N-CA 124.942 1.297 . . . . 0.0 110.059 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -92.44 122.0 34.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.16 145.37 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.445 1.098 . . . . 0.0 109.22 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.35 147.89 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.709 1.204 . . . . 0.0 107.856 167.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.94 115.55 6.75 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.083 0.953 . . . . 0.0 109.379 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -112.64 112.33 23.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -160.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.78 -168.97 35.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.53 167.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.64 160.83 24.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.652 1.581 . . . . 0.0 109.197 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.06 -19.97 53.25 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.13 -47.63 76.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.61 59.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.637 0.775 . . . . 0.0 112.166 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.8 -61.61 1.87 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.066 0.848 . . . . 0.0 108.878 174.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.7 p -40.54 -44.39 2.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.406 1.482 . . . . 0.0 113.001 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.11 -45.49 88.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.845 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.12 -23.25 60.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.103 1.361 . . . . 0.0 111.549 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -56.7 3.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.663 1.185 . . . . 0.0 109.745 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -58.67 -37.14 75.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.573 1.149 . . . . 0.0 111.372 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -28.81 -52.99 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 127.068 2.147 . . . . 0.0 112.075 167.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -71.04 -69.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -167.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -51.71 -43.96 63.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -62.65 -56.83 14.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.713 0.805 . . . . 0.0 110.26 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.79 81.8 0.31 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.545 1.545 . . . . 0.0 109.599 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 160.95 47.65 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.592 2.861 . . . . 0.0 111.201 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -68.3 157.53 61.42 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.608 2.205 . . . . 0.0 109.559 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.75 36.98 0.34 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.235 0.614 . . . . 0.0 111.485 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.42 166.35 21.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.686 1.594 . . . . 0.0 109.29 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -80.55 72.86 7.48 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.13 0.572 . . . . 0.0 109.978 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -61.44 114.58 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.259 1.024 . . . . 0.0 108.475 168.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.88 -49.04 6.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 110.847 -161.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -162.42 71.09 0.31 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.467 0.651 . . . . 0.0 111.873 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 HG22 ' A' ' 20' ' ' VAL . 7.1 p -69.5 89.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.036 0.935 . . . . 0.0 111.214 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.07 81.58 2.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 107.963 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -78.52 164.52 24.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.31 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 m -145.59 139.96 27.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.27 1.028 . . . . 0.0 109.502 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 135.64 33.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.899 1.28 . . . . 0.0 108.352 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 m -135.62 176.82 8.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.514 0.726 . . . . 0.0 111.168 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -89.32 137.58 32.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -64.88 138.77 58.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.237 1.015 . . . . 0.0 111.596 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -79.28 -51.18 9.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.818 0.847 . . . . 0.0 109.249 174.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.15 -178.2 30.99 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.62 103.95 8.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.098 0.959 . . . . 0.0 109.463 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -78.52 70.21 4.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -51.7 127.46 20.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.701 1.2 . . . . 0.0 112.347 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.59 174.95 0.24 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.907 1.683 . . . . 0.0 110.85 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.56 93.36 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -112.94 158.69 19.91 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -113.61 149.34 34.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.98 0.912 . . . . 0.0 110.362 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.405 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 20.8 m-30 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.003 -1.475 . . . . 0.0 108.624 148.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 159.24 34.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.1 0.96 . . . . 0.0 110.83 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -91.62 106.36 18.42 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 ptm -84.68 94.69 8.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -89.81 89.91 7.96 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.83 105.28 17.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.499 0.666 . . . . 0.0 111.225 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.29 102.99 13.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.462 1.105 . . . . 0.0 108.979 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.62 108.99 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -103.84 139.63 38.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.58 0.752 . . . . 0.0 111.089 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.92 -152.96 24.98 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.896 0.748 . . . . 0.0 111.837 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tp -82.26 20.7 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.028 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.75 35.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.371 1.469 . . . . 0.0 112.036 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -96.23 102.3 14.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.63 0.772 . . . . 0.0 110.362 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.92 48.71 61.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.409 1.004 . . . . 0.0 112.3 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.45 93.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.761 0.824 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.32 -69.17 1.39 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.216 1.388 . . . . 0.0 112.093 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -28.44 -66.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.396 3.078 . . . . 0.0 115.103 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -60.69 -30.53 69.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.044 0.538 . . . . 0.0 111.867 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -78.48 -41.41 32.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.086 0.954 . . . . 0.0 109.992 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.9 -48.98 72.33 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.328 -0.858 . . . . 0.0 111.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.92 -28.12 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.928 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -59.87 -59.86 4.75 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 118.564 -0.732 . . . . 0.0 110.022 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.3 mm -46.39 -55.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.208 0.603 . . . . 0.0 111.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -70.9 -42.56 69.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.796 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.02 -50.0 59.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.739 0.699 . . . . 0.0 112.441 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.97 -36.8 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.657 1.583 . . . . 0.0 110.975 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -44.42 89.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.847 0.459 . . . . 0.0 111.917 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.91 -17.02 27.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.971 0.908 . . . . 0.0 113.383 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.87 66.32 1.27 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.74 139.63 45.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 125.713 1.605 . . . . 0.0 108.458 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -111.69 160.06 17.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.035 1.334 . . . . 0.0 108.555 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.78 -133.17 4.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -173.22 141.1 0.91 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.008 1.323 . . . . 0.0 109.878 172.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.79 82.48 2.6 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.613 1.165 . . . . 0.0 108.43 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -92.22 89.54 6.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -163.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.17 72.56 6.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.913 1.685 . . . . 0.0 111.566 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.99 118.44 55.42 Favored Pre-proline 0 C--N 1.342 0.259 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.308 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.71 76.93 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.831 3.021 . . . . 0.0 111.853 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -163.68 28.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.84 -43.06 3.04 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.706 -0.622 . . . . 0.0 112.809 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -95.66 86.63 4.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 110.789 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.26 125.97 40.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 123.828 0.851 . . . . 0.0 109.523 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.58 135.36 34.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.31 94.57 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.8 t -67.53 122.03 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.39 154.03 39.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -127.28 113.61 16.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.646 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.57 -140.67 0.09 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.495 1.521 . . . . 0.0 113.197 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -177.38 -92.58 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.317 3.047 . . . . 0.0 107.1 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.47 -63.23 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 122.972 0.509 . . . . 0.0 110.914 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.1 -53.9 6.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.32 67.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.149 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 69' ' ' LEU . 24.1 tp -53.58 -72.34 0.06 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -55.65 -47.52 76.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 0.0 112.413 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -54.25 -41.0 68.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.082 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.78 -46.3 17.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.26 0.482 . . . . 0.0 110.725 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 65' ' ' LEU . 1.5 mm? -52.07 -61.93 1.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.884 -0.51 . . . . 0.0 110.239 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -55.01 -43.78 73.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 111.685 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -56.13 3.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.645 1.178 . . . . 0.0 110.438 167.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -66.24 -53.8 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.125 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -49.68 65.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.204 0.456 . . . . 0.0 110.526 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -100.16 55.02 0.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 109.631 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.49 75.85 0.22 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.18 129.8 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.066 2.511 . . . . 0.0 109.595 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.56 179.37 6.55 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.165 2.577 . . . . 0.0 109.984 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.11 36.55 0.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.547 0.739 . . . . 0.0 111.974 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.94 162.05 38.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 110.004 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.74 87.97 3.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 110.287 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.69 78.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.799 1.24 . . . . 0.0 110.449 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -41.8 -59.36 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.995 2.118 . . . . 0.0 112.305 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -162.66 89.74 0.68 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-O 121.629 0.728 . . . . 0.0 112.589 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.85 92.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.89 0.876 . . . . 0.0 110.9 173.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -98.31 78.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.891 1.277 . . . . 0.0 108.292 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -72.86 164.97 25.81 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -134.21 119.22 18.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.451 1.101 . . . . 0.0 109.952 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -80.09 124.38 28.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m -136.91 176.49 8.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.797 1.239 . . . . 0.0 110.662 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.56 153.59 17.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.376 1.47 . . . . 0.0 110.116 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -45.62 104.22 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.053 1.741 . . . . 0.0 112.167 167.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -92.83 -55.03 3.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.827 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.2 146.36 13.19 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.05 107.25 19.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.509 1.123 . . . . 0.0 110.653 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -68.09 169.61 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 160.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.47 49.51 0.69 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.399 0.68 . . . . 0.0 110.676 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 170.14 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.064 2.145 . . . . 0.0 108.972 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -83.89 91.45 7.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.67 162.92 17.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.768 0.713 . . . . 0.0 110.233 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.54 138.47 34.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.231 0.612 . . . . 0.0 110.429 -173.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.7 t80 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.264 -1.35 . . . . 0.0 109.56 174.009 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 93.3 p -78.55 165.37 23.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.471 0.708 . . . . 0.0 110.98 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -129.63 -57.47 1.12 Allowed 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.89 1.276 . . . . 0.0 108.123 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -67.36 156.2 37.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.311 0.644 . . . . 0.0 110.544 172.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -158.37 159.24 35.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.581 1.153 . . . . 0.0 108.189 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -160.29 157.48 28.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.798 1.239 . . . . 0.0 108.342 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 p -123.53 160.01 27.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.811 1.645 . . . . 0.0 109.181 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -163.49 160.61 23.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.038 0.935 . . . . 0.0 109.715 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m 69.74 97.46 0.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.165 1.786 . . . . 0.0 111.417 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -148.24 144.29 27.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.652 1.181 . . . . 0.0 108.293 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.34 129.02 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.098 0.559 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.46 -99.21 0.19 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.858 1.263 . . . . 0.0 110.149 -171.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.9 168.67 11.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.904 1.682 . . . . 0.0 110.014 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.5 mtt 66.3 168.35 0.22 Allowed 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 126.204 1.802 . . . . 0.0 113.607 171.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -171.41 154.08 3.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.553 1.141 . . . . 0.0 110.12 176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.38 141.97 32.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.683 1.593 . . . . 0.0 109.975 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -83.53 111.46 19.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.203 1.001 . . . . 0.0 109.731 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.3 ptm -92.4 102.57 15.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.634 1.174 . . . . 0.0 108.343 173.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -73.46 127.52 32.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.78 105.57 7.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.721 0.772 . . . . 0.0 109.744 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.3 15.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.885 1.674 . . . . 0.0 107.434 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.36 114.05 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.46 153.31 19.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.268 1.427 . . . . 0.0 109.967 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.1 -161.13 13.92 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 124.507 1.051 . . . . 0.0 111.66 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tp -83.0 26.21 0.63 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.058 0.543 . . . . 0.0 111.532 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.5 m -70.1 -10.68 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 113.098 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -57.6 151.97 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.632 1.173 . . . . 0.0 110.009 166.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.61 -62.48 4.6 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' A' ' 79' ' ' ALA . 18.7 m -66.84 165.1 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.246 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.41 48.14 3.57 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.934 0.778 . . . . 0.0 112.465 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.01 -60.87 2.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.593 1.157 . . . . 0.0 108.921 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -61.54 -25.58 67.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 112.071 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.24 -48.96 48.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 0.0 109.474 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.29 -46.67 82.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.432 0.693 . . . . 0.0 111.167 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.2 t -55.67 -36.85 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.893 0.477 . . . . 0.0 110.635 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -57.34 11.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 117.852 -1.07 . . . . 0.0 110.928 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -44.15 -55.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.612 1.096 . . . . 0.0 111.638 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.4 -47.41 67.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.385 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.76 -50.86 54.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.8 -47.49 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.573 1.549 . . . . 0.0 109.018 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.58 -39.61 70.91 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.253 0.621 . . . . 0.0 111.157 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -94.39 -0.62 54.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.514 1.525 . . . . 0.0 113.236 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.45 62.2 4.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.952 0.796 . . . . 0.0 111.735 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 mm -115.42 141.77 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 126.285 1.834 . . . . 0.0 107.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -104.06 167.56 9.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.805 1.242 . . . . 0.0 108.485 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.07 -146.92 16.58 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 118.158 0.435 . . . . 0.0 113.123 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -170.76 139.99 1.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.845 1.258 . . . . 0.0 109.357 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.35 88.93 2.91 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.439 1.095 . . . . 0.0 108.58 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.04 77.9 4.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -164.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -72.82 74.0 1.12 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.662 1.585 . . . . 0.0 111.302 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.36 124.0 76.07 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 165.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.46 76.81 3.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.803 2.335 . . . . 0.0 110.749 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -151.14 26.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.613 1.165 . . . . 0.0 111.983 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.59 -48.64 3.71 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.611 0.624 . . . . 0.0 112.353 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 p -91.31 91.28 8.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.781 1.232 . . . . 0.0 110.873 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.51 126.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 124.111 0.964 . . . . 0.0 109.904 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 141.53 29.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.234 0.614 . . . . 0.0 109.506 175.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.69 137.15 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -118.52 61.03 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.423 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.85 156.2 39.42 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.622 1.169 . . . . 0.0 110.167 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.18 112.21 6.6 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.933 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.07 156.82 23.13 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.583 0.628 . . . . 0.0 114.012 -172.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -71.99 -92.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.047 1.739 . . . . 0.0 110.28 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.57 -80.41 0.09 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 125.429 1.492 . . . . 0.0 107.397 -165.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -52.66 -52.21 56.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.283 0.633 . . . . 0.0 109.795 169.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.79 68.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.993 0.517 . . . . 0.0 111.808 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.2 tp -64.95 -66.4 0.55 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -46.38 -42.61 15.25 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.451 1.501 . . . . 0.0 112.941 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -57.41 -62.67 1.61 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.292 0.951 . . . . 0.0 110.17 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -57.37 -35.73 70.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.205 0.602 . . . . 0.0 112.219 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.64 -63.25 1.17 Allowed 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.982 0.913 . . . . 0.0 110.515 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.31 -37.24 55.28 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.088 1.355 . . . . 0.0 111.618 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.42 -59.81 3.18 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.433 1.093 . . . . 0.0 111.12 169.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.33 -61.87 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.139 0.427 . . . . 0.0 111.239 -163.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -48.42 64.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 113.104 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -58.41 -51.97 67.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.262 0.625 . . . . 0.0 110.966 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.8 86.22 0.45 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.03 1.3 . . . . 0.0 109.857 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 163.71 30.91 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.287 2.658 . . . . 0.0 111.226 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.72 165.36 31.18 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.941 2.427 . . . . 0.0 111.188 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.37 43.2 0.72 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.889 0.876 . . . . 0.0 111.096 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -150.49 167.93 25.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.976 1.31 . . . . 0.0 109.327 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -76.53 80.52 3.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.561 1.144 . . . . 0.0 109.574 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.54 119.89 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.052 0.941 . . . . 0.0 108.673 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -87.56 -50.03 6.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.442 1.097 . . . . 0.0 110.387 -168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -166.09 71.59 0.14 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.413 0.625 . . . . 0.0 111.633 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -65.67 94.35 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.433 0.693 . . . . 0.0 111.122 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.94 83.72 1.88 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.093 1.357 . . . . 0.0 108.01 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -77.66 163.43 26.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.849 0.356 . . . . 0.0 110.676 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.2 m -139.08 110.18 6.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 109.665 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 120.75 10.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 m -127.69 -152.3 0.51 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.811 1.245 . . . . 0.0 109.106 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 155.99 49.15 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.481 1.112 . . . . 0.0 109.198 170.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -81.23 124.11 29.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.012 0.925 . . . . 0.0 110.658 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -73.63 -46.78 44.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 164.5 32.51 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.88 134.04 34.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.582 1.153 . . . . 0.0 109.257 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -74.21 145.88 43.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.583 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.55 87.28 0.9 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.997 0.919 . . . . 0.0 110.104 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 66.44 -160.46 0.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.477 1.111 . . . . 0.0 109.601 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.73 113.39 9.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.211 1.004 . . . . 0.0 109.283 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.93 164.56 20.51 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.638 0.775 . . . . 0.0 110.868 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.97 143.51 38.15 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.373 1.069 . . . . 0.0 110.408 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.018 -1.468 . . . . 0.0 111.108 168.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.5 p -157.04 154.94 30.35 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.011 0.925 . . . . 0.0 109.298 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptp -158.51 44.77 0.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.02 0.928 . . . . 0.0 109.956 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.97 34.36 5.24 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.689 1.196 . . . . 0.0 111.243 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 129.66 34.76 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -135.95 75.7 1.57 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.941 0.896 . . . . 0.0 109.278 -173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.4 p -123.64 153.31 40.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.068 1.347 . . . . 0.0 109.631 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -160.8 -63.14 0.06 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 p -142.29 170.49 15.61 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.013 1.325 . . . . 0.0 109.446 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.3 164.99 27.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.035 1.334 . . . . 0.0 109.053 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.22 125.88 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.028 1.331 . . . . 0.0 108.666 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -139.38 -98.23 0.16 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.306 1.042 . . . . 0.0 108.523 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -124.26 136.15 53.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.976 1.71 . . . . 0.0 107.981 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.1 mtp -140.06 148.0 41.13 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.066 0.946 . . . . 0.0 109.68 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.315 0.4 OUTLIER 61.39 144.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 128.59 2.756 . . . . 0.0 113.937 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 173.51 9.21 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.148 1.379 . . . . 0.0 110.839 -167.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -100.21 127.36 46.49 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.085 0.554 . . . . 0.0 111.257 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.47 158.38 31.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 153.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -145.06 97.26 2.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.85 116.06 29.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.87 0.868 . . . . 0.0 110.944 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -94.67 107.86 19.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 108.301 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.92 107.74 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.1 147.88 22.96 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.103 0.961 . . . . 0.0 110.278 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.97 -161.75 27.14 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.244 0.926 . . . . 0.0 110.967 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tp -82.23 20.14 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.268 0.627 . . . . 0.0 110.648 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.26 -14.66 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.106 1.362 . . . . 0.0 112.794 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.37 117.18 7.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.857 0.863 . . . . 0.0 109.653 173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.49 48.96 40.86 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.08 0.848 . . . . 0.0 113.304 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.641 HG21 ' HB2' ' A' ' 79' ' ' ALA . 21.3 m -135.09 -168.07 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.968 0.907 . . . . 0.0 109.014 166.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.02 79.33 0.2 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.485 1.041 . . . . 0.0 111.013 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -158.42 -174.42 4.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.556 1.542 . . . . 0.0 108.573 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 73.51 -73.57 0.1 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.576 1.951 . . . . 0.0 109.53 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -56.62 -36.96 70.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.283 1.033 . . . . 0.0 110.351 172.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -48.76 -48.14 41.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.274 1.03 . . . . 0.0 111.722 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.16 -37.54 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 O-C-N 122.158 -0.338 . . . . 0.0 110.422 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.72 -49.29 66.51 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.037 -1.459 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.8 mm -43.93 -53.38 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 120.707 1.594 . . . . 0.0 111.416 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -66.9 -51.68 52.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.6 -44.84 66.25 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.85 -46.33 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 108.635 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -42.03 88.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.318 0.647 . . . . 0.0 111.012 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.3 mt -92.3 -52.53 4.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.058 1.343 . . . . 0.0 111.751 -169.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.14 66.6 0.17 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.167 1.365 . . . . 0.0 112.704 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.79 147.12 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 108.821 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -108.06 174.11 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 108.847 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.86 -150.63 22.44 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 118.619 0.645 . . . . 0.0 112.594 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -164.78 140.87 5.8 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 169.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.72 82.43 1.85 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 124.396 1.078 . . . . 0.0 110.087 -168.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' CB ' ' A' ' 101' ' ' TYR . 36.0 ttmt -95.38 104.21 16.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 -164.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -78.7 126.11 30.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.3 mt -101.85 93.99 4.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.25 76.89 4.02 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.482 2.788 . . . . 0.0 111.548 -159.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 173.94 -43.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.159 2.584 . . . . 0.0 108.708 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.36 -119.25 4.56 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.737 1.16 . . . . 0.0 111.429 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -129.25 126.04 38.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.57 1.548 . . . . 0.0 109.425 -168.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.27 122.06 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.7 0.8 . . . . 0.0 110.158 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.21 140.19 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.796 0.839 . . . . 0.0 109.646 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.5 t -127.05 134.06 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.178 0.991 . . . . 0.0 108.554 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.1 74.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.71 0.804 . . . . 0.0 110.821 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.89 150.12 37.63 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -117.67 96.63 5.47 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.197 0.599 . . . . 0.0 110.951 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.25 174.52 17.39 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.932 0.777 . . . . 0.0 112.437 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.74 -98.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 108.668 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -152.14 -73.75 0.14 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.291 1.436 . . . . 0.0 108.211 -174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.68 -45.46 48.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.611 1.164 . . . . 0.0 109.338 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.6 57.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.86 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.5 tp -53.78 -56.75 14.68 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.449 0.568 . . . . 0.0 109.56 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.1 p -47.52 -36.38 10.25 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.888 1.275 . . . . 0.0 112.862 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -64.3 -36.4 84.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.43 1.092 . . . . 0.0 111.444 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.6 -50.15 12.0 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.646 0.778 . . . . 0.0 109.044 170.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -52.8 25.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.354 0.662 . . . . 0.0 111.168 -171.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.06 -35.68 77.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.281 1.433 . . . . 0.0 113.159 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -48.57 14.48 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.89 1.276 . . . . 0.0 110.73 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.46 -56.42 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 119.02 -0.514 . . . . 0.0 110.616 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.2 -54.28 38.38 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.236 0.471 . . . . 0.0 110.517 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 47.61 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.451 1.1 . . . . 0.0 109.641 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.47 66.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.55 161.3 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.512 2.808 . . . . 0.0 111.311 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.13 170.16 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.954 3.103 . . . . 0.0 111.802 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.24 48.12 1.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.092 0.957 . . . . 0.0 111.027 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -149.37 167.49 26.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.713 1.205 . . . . 0.0 110.162 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.79 89.49 1.37 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.12 86.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.647 1.179 . . . . 0.0 109.967 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -41.54 -60.76 1.22 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.799 1.64 . . . . 0.0 111.344 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.71 140.22 3.87 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.676 0.39 . . . . 0.0 110.473 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.27 97.81 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 166.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.53 82.48 6.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -174.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -76.61 156.44 32.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -141.89 108.91 5.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.805 1.242 . . . . 0.0 108.764 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -69.09 127.5 33.35 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -134.83 -173.56 3.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.086 0.954 . . . . 0.0 110.398 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.52 141.83 38.35 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.094 0.957 . . . . 0.0 108.616 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.19 56.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -54.18 20.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 170.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.15 -176.05 34.78 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.03 119.1 28.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.278 1.031 . . . . 0.0 109.318 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -70.04 135.37 49.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.44 91.92 1.06 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.531 0.733 . . . . 0.0 109.979 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 67.92 -161.32 0.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.423 1.089 . . . . 0.0 109.683 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.0 89.94 3.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.635 1.174 . . . . 0.0 108.982 -175.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.53 159.75 16.46 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -115.36 144.23 44.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.306 0.643 . . . . 0.0 110.955 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CB ' ' HA ' ' A' ' 47' ' ' LYS . 2.4 t80 . . . . . 0 C--O 1.249 1.027 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 67.5 p -159.22 161.42 36.08 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.605 1.162 . . . . 0.0 108.914 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -132.19 111.1 11.13 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.603 1.161 . . . . 0.0 108.684 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 122.27 47.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.993 1.317 . . . . 0.0 109.592 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -99.35 -49.78 4.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.336 1.054 . . . . 0.0 110.213 -174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 75.5 t90 21.11 73.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.44 3.096 . . . . 0.0 113.541 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -106.63 60.28 0.64 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.95 1.3 . . . . 0.0 108.195 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -71.96 118.15 14.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.343 1.457 . . . . 0.0 111.272 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -161.88 137.99 7.85 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.95 0.9 . . . . 0.0 109.378 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -169.61 147.1 3.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.96 1.304 . . . . 0.0 108.35 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.45 128.02 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -144.62 -19.76 0.53 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.956 1.302 . . . . 0.0 112.052 -167.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -82.63 51.29 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.746 1.619 . . . . 0.0 111.357 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 79.1 mtp -146.04 175.11 10.7 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.407 1.083 . . . . 0.0 110.551 -171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.285 0.5 OUTLIER 66.68 127.84 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.278 3.031 . . . . 0.0 113.754 173.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.18 167.1 16.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.116 0.966 . . . . 0.0 112.157 -161.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -100.27 130.76 46.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 33.4 ttp -66.44 166.23 12.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.196 0.998 . . . . 0.0 108.795 158.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -148.42 86.78 1.55 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 163.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.35 105.19 17.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.465 0.706 . . . . 0.0 110.953 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 101.02 13.53 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.272 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -90.42 110.86 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -96.15 148.34 22.81 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.969 0.907 . . . . 0.0 109.295 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.41 -157.35 22.27 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.01 1.29 . . . . 0.0 111.316 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -80.46 19.62 0.77 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.517 0.727 . . . . 0.0 111.402 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.62 -23.3 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.151 0.98 . . . . 0.0 111.022 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.77 142.43 50.16 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 109.668 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.13 -65.61 2.85 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 79' ' ' ALA . 17.7 m -64.42 169.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 117.842 0.821 . . . . 0.0 110.953 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.01 -94.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.493 1.044 . . . . 0.0 111.767 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.65 -59.69 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.862 2.065 . . . . 0.0 113.26 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -38.78 -37.78 0.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.762 2.825 . . . . 0.0 113.082 170.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -71.79 -50.97 25.05 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.536 0.735 . . . . 0.0 109.939 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.96 -39.93 63.32 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 111.48 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.35 -42.29 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 123.44 0.696 . . . . 0.0 110.029 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.424 HE21 ' CA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.42 -54.23 39.98 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 117.715 -1.136 . . . . 0.0 110.143 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.9 mm -41.63 -54.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.877 1.217 . . . . 0.0 113.054 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -73.31 -45.61 54.4 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.554 0.342 . . . . 0.0 110.72 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.64 -51.01 59.11 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.149 0.5 . . . . 0.0 111.741 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.85 -44.6 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 126.219 1.807 . . . . 0.0 109.972 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -53.01 -39.96 63.48 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.803 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.44 11.7 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.781 1.233 . . . . 0.0 113.47 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.89 64.61 3.67 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 118.841 0.746 . . . . 0.0 112.112 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.5 mm -121.88 138.62 51.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.354 1.462 . . . . 0.0 108.735 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -98.56 173.38 6.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.689 1.196 . . . . 0.0 108.243 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.7 -143.92 11.19 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.499 -0.75 . . . . 0.0 111.7 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -175.26 144.2 0.71 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.551 1.14 . . . . 0.0 109.19 170.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.21 82.82 1.8 Allowed 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -95.13 111.78 23.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.353 0.597 . . . . 0.0 110.156 -164.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 20.6 t-20 -91.73 119.69 31.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 108.505 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.04 98.05 4.27 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.52 144.91 91.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.433 2.089 . . . . 0.0 110.812 -169.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.7 t0 55.95 54.73 7.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.475 1.11 . . . . 0.0 109.67 -166.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.27 -134.97 2.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -124.8 161.0 27.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.816 1.646 . . . . 0.0 110.464 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.84 117.83 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.067 0.947 . . . . 0.0 109.629 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -93.19 143.47 26.23 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.618 0.767 . . . . 0.0 110.456 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.25 123.15 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.428 1.091 . . . . 0.0 108.773 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.39 62.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.825 0.85 . . . . 0.0 110.966 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 129.75 38.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.457 0.703 . . . . 0.0 111.042 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -117.62 108.08 15.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.747 1.219 . . . . 0.0 110.503 -165.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 177.32 37.5 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-O 122.216 0.898 . . . . 0.0 114.369 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -69.87 169.65 12.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.128 1.371 . . . . 0.0 108.946 165.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -79.85 -30.25 40.3 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.12 -25.53 68.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.918 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.28 -13.54 18.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.914 0.885 . . . . 0.0 111.825 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.83 -59.79 2.71 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 p -38.57 -45.01 1.02 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.278 1.831 . . . . 0.0 112.912 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.45 -42.02 88.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.854 0.862 . . . . 0.0 112.682 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -74.11 -21.99 59.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.626 1.171 . . . . 0.0 111.551 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.7 -61.24 2.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.471 1.108 . . . . 0.0 110.317 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -53.89 -42.07 68.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 110.299 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt85 -34.37 -47.42 0.3 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.305 2.642 . . . . 0.0 113.556 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.61 -68.25 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.608 0.763 . . . . 0.0 110.728 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -52.13 -44.93 64.75 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.84 -51.96 67.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.299 1.04 . . . . 0.0 111.186 173.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.09 85.3 0.39 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.61 160.55 45.59 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.924 2.416 . . . . 0.0 111.262 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.25 160.58 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.274 2.649 . . . . 0.0 110.765 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.31 48.83 1.33 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.824 0.85 . . . . 0.0 110.957 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -158.39 169.06 25.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 110.484 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.1 77.73 2.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.189 0.995 . . . . 0.0 109.374 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.08 125.84 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.953 0.901 . . . . 0.0 109.389 173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.93 -60.34 2.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 108.163 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -156.13 115.47 3.53 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.72 87.01 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 161.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.09 67.42 8.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.458 1.103 . . . . 0.0 108.268 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.2 154.38 31.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.826 -170.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -138.23 117.65 12.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.67 129.93 44.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m -127.21 -161.89 1.12 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.443 1.097 . . . . 0.0 109.24 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.23 141.48 45.79 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.617 0.767 . . . . 0.0 109.026 170.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -54.8 135.1 47.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.567 1.147 . . . . 0.0 112.96 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -73.35 -57.49 3.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 165.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -169.29 -177.55 40.01 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.43 122.2 16.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.56 0.744 . . . . 0.0 110.417 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -72.98 -26.5 61.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 111.468 172.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.51 91.31 0.07 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.637 1.575 . . . . 0.0 111.028 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.53 179.72 0.23 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 110.472 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.88 95.84 2.56 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.68 167.04 13.39 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 p -103.69 152.02 22.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.482 0.713 . . . . 0.0 110.791 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.417 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 4.0 m-85 . . . . . 0 C--O 1.249 1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 153.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.4 m -145.39 128.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.173 0.989 . . . . 0.0 108.841 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -113.78 107.33 15.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.727 1.211 . . . . 0.0 108.249 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.5 144.03 41.38 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.715 1.206 . . . . 0.0 109.543 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 140.21 5.83 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.959 1.304 . . . . 0.0 108.556 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -144.4 156.46 44.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.855 0.862 . . . . 0.0 111.132 -172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -71.99 78.01 0.92 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.245 1.418 . . . . 0.0 109.017 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.59 -53.8 54.28 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.632 1.173 . . . . 0.0 110.528 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 m 65.0 85.95 0.13 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.038 1.335 . . . . 0.0 110.53 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -141.07 57.62 1.55 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.348 1.059 . . . . 0.0 110.545 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.02 93.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.345 1.058 . . . . 0.0 108.747 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.19 -95.95 0.26 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.915 0.886 . . . . 0.0 109.725 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 173.09 11.15 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.716 1.206 . . . . 0.0 110.333 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -137.51 -174.71 3.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.429 1.492 . . . . 0.0 108.687 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.96 129.94 35.93 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 170.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.23 166.57 10.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.262 1.025 . . . . 0.0 109.905 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -99.15 101.56 12.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 110.347 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.3 ttp -70.01 144.77 52.15 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 164.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -124.18 136.35 54.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.993 1.717 . . . . 0.0 106.561 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 107.59 4.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.343 0.592 . . . . 0.0 109.976 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 98.93 8.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.73 101.09 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.31 149.89 26.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.267 0.627 . . . . 0.0 111.265 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.61 -163.53 18.45 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.315 1.436 . . . . 0.0 110.7 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 47.8 1.55 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.02 41.62 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.326 1.05 . . . . 0.0 110.747 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.62 150.43 33.15 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.404 1.082 . . . . 0.0 110.384 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.72 -56.83 4.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.527 0.584 . . . . 0.0 111.871 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -48.38 150.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.803 2.041 . . . . 0.0 111.292 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.82 38.45 2.34 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.825 0.726 . . . . 0.0 113.486 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -67.17 -35.87 80.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.64 0.72 . . . . 0.0 110.016 174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -58.22 -31.77 67.67 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.265 1.026 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.72 -48.15 34.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.668 1.187 . . . . 0.0 109.843 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.13 -44.84 79.57 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.507 0.723 . . . . 0.0 111.579 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.51 -37.5 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.666 0.786 . . . . 0.0 109.969 172.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.37 -57.7 9.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.848 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -43.06 -51.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 119.451 1.023 . . . . 0.0 111.757 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -67.22 -56.6 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.841 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.68 -47.82 20.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.54 -42.88 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 126.224 1.81 . . . . 0.0 110.47 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -62.52 -34.41 76.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.766 0.426 . . . . 0.0 111.799 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.8 mt -93.98 -0.19 55.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.855 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.17 5.32 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 118.65 0.659 . . . . 0.0 111.557 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -121.26 141.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.649 1.58 . . . . 0.0 108.311 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -103.43 166.38 10.46 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.26 -145.21 12.25 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.957 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.36 141.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 110.19 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.11 86.68 2.34 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.165 1.386 . . . . 0.0 108.727 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -100.27 90.1 4.22 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.862 0.865 . . . . 0.0 110.511 -164.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.73 92.76 4.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.557 1.543 . . . . 0.0 109.811 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.7 mt -66.13 106.19 1.03 Allowed Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 125.772 1.629 . . . . 0.0 108.321 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.07 43.24 1.43 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.584 2.189 . . . . 0.0 113.058 -160.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -158.5 47.77 0.34 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.472 1.509 . . . . 0.0 108.285 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.83 -135.7 3.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -112.6 169.34 8.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.494 1.517 . . . . 0.0 109.656 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -97.68 135.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 C-N-CA 124.204 1.001 . . . . 0.0 112.011 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -100.48 122.71 43.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.604 1.161 . . . . 0.0 109.183 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.38 145.11 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.639 1.176 . . . . 0.0 108.518 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.23 86.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.072 0.949 . . . . 0.0 109.827 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.42 143.02 26.67 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.028 1.331 . . . . 0.0 111.592 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -126.28 99.12 5.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.272 0.629 . . . . 0.0 110.772 -167.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.54 164.14 30.15 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 121.598 0.554 . . . . 0.0 113.073 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -66.7 167.32 11.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 -35.58 67.28 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.977 -0.452 . . . . 0.0 111.911 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -45.3 -39.91 7.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.791 1.236 . . . . 0.0 112.159 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.08 0.85 21.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.94 1.296 . . . . 0.0 112.586 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -70.29 -59.29 2.96 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.285 0.948 . . . . 0.0 108.829 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -42.63 -45.4 4.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.269 1.428 . . . . 0.0 112.063 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -56.17 -32.42 64.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.718 1.607 . . . . 0.0 112.885 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.23 -53.88 4.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.07 1.348 . . . . 0.0 109.927 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -53.24 56.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.49 1.116 . . . . 0.0 111.109 -167.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -68.91 -34.6 75.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.636 1.174 . . . . 0.0 111.433 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.43 -42.26 10.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.384 1.474 . . . . 0.0 111.206 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.41 -61.61 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.217 0.607 . . . . 0.0 111.2 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -59.54 -48.69 80.68 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.09 0.405 . . . . 0.0 111.029 -168.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -94.94 38.36 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.927 1.291 . . . . 0.0 110.275 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.3 76.34 0.05 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.99 162.04 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.464 2.776 . . . . 0.0 112.594 -167.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.65 -1.73 5.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.222 3.281 . . . . 0.0 114.525 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.36 28.8 4.67 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 126.163 1.785 . . . . 0.0 110.114 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.35 164.16 32.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.997 1.719 . . . . 0.0 107.995 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.15 80.5 4.57 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.076 0.551 . . . . 0.0 110.945 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.33 126.88 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.164 0.986 . . . . 0.0 109.656 170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -93.65 -53.1 4.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.455 1.102 . . . . 0.0 109.405 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -164.85 76.12 0.29 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.064 0.459 . . . . 0.0 112.165 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.4 p -67.21 89.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.282 0.633 . . . . 0.0 111.013 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.07 85.5 3.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.158 1.383 . . . . 0.0 108.046 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -77.74 170.33 16.76 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.176 0.512 . . . . 0.0 112.212 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 m -139.7 112.16 7.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.222 1.409 . . . . 0.0 109.843 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -66.26 138.7 57.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 163.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m -161.24 174.07 14.13 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.083 0.468 . . . . 0.0 109.959 173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.29 146.14 27.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.086 0.954 . . . . 0.0 110.604 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -77.29 127.85 33.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.24 0.616 . . . . 0.0 110.164 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -42.63 18.13 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.01 161.8 34.18 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.22 149.96 21.55 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.602 1.161 . . . . 0.0 110.568 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -77.15 153.99 33.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.093 165.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -71.87 78.6 0.88 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.213 1.005 . . . . 0.0 109.696 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.68 -162.76 0.19 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.151 1.38 . . . . 0.0 110.296 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.66 116.01 21.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.116 1.366 . . . . 0.0 108.362 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -129.35 166.31 19.76 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.86 123.92 48.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.834 0.853 . . . . 0.0 110.26 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.53 1.532 . . . . 0.0 107.844 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.193 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 62.9 p -160.5 156.7 26.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.906 0.882 . . . . 0.0 109.735 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt -84.74 64.86 8.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.081 0.952 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -113.59 129.14 56.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.916 1.286 . . . . 0.0 108.758 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.56 149.08 46.04 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.768 0.427 . . . . 0.0 110.75 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.73 57.17 1.78 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.878 1.271 . . . . 0.0 109.604 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.6 t -128.79 73.65 1.52 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.58 1.152 . . . . 0.0 109.743 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.34 59.54 3.46 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.987 0.915 . . . . 0.0 109.835 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -86.82 72.37 10.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.672 1.189 . . . . 0.0 109.715 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.86 136.24 57.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.034 0.933 . . . . 0.0 109.483 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.21 126.17 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.802 1.241 . . . . 0.0 110.607 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -118.74 -38.39 3.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.601 1.56 . . . . 0.0 111.618 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.77 97.05 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.093 1.357 . . . . 0.0 111.703 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.7 mtt -146.92 174.81 11.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.364 1.466 . . . . 0.0 109.426 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.48 -168.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 115.09 173.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 -179.55 6.43 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.355 1.062 . . . . 0.0 111.415 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -108.96 127.4 54.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.25 0.62 . . . . 0.0 112.386 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.1 ttp -79.31 146.56 32.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 155.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -127.95 135.44 49.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.444 1.897 . . . . 0.0 106.335 165.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.67 110.52 5.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.394 0.616 . . . . 0.0 111.092 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -84.3 99.23 10.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.166 1.386 . . . . 0.0 108.084 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.12 107.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -97.32 149.65 21.85 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.439 1.096 . . . . 0.0 110.253 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.5 -158.43 26.03 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 124.885 1.231 . . . . 0.0 110.962 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.92 22.5 0.76 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.515 0.726 . . . . 0.0 110.977 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.84 -17.4 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.118 1.367 . . . . 0.0 111.885 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -67.47 121.04 14.95 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.062 0.545 . . . . 0.0 111.627 -172.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.48 37.03 93.46 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.462 1.029 . . . . 0.0 112.773 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.14 91.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.0 -139.1 44.45 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.485 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 t80 56.48 -173.19 0.07 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.003 1.721 . . . . 0.0 111.428 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 68.36 -76.04 0.06 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 126.126 1.771 . . . . 0.0 109.243 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -45.85 -42.35 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.303 1.441 . . . . 0.0 111.92 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.66 -53.82 50.99 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.999 0.92 . . . . 0.0 111.245 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -67.23 -18.83 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 122.074 -0.392 . . . . 0.0 111.344 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.0 -54.83 13.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.266 -1.349 . . . . 0.0 110.713 167.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.7 mm -36.27 -55.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 120.483 1.492 . . . . 0.0 112.886 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -67.62 -51.94 44.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.75 0.42 . . . . 0.0 110.759 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -45.38 -65.98 0.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.575 1.15 . . . . 0.0 111.351 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -44.41 -47.92 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 111.631 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -53.52 -46.68 70.19 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.06 0.544 . . . . 0.0 110.571 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.9 mt -102.29 37.33 1.91 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.626 0.77 . . . . 0.0 111.851 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.23 68.43 1.67 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.981 1.277 . . . . 0.0 113.766 167.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.4 mm -117.3 141.45 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.802 1.241 . . . . 0.0 108.978 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -101.81 174.57 5.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 108.481 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.56 -152.44 24.0 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.342 0.974 . . . . 0.0 112.288 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -170.88 142.91 1.97 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.451 0.7 . . . . 0.0 110.347 167.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.74 90.2 3.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.295 1.038 . . . . 0.0 111.977 -165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -111.15 104.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.592 0.357 . . . . 0.0 111.823 -160.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -80.17 97.32 6.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.005 0.922 . . . . 0.0 109.42 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -73.73 102.52 0.62 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.04 136.5 48.48 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.891 1.728 . . . . 0.0 110.499 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 55.86 53.35 9.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 110.124 -167.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.47 -131.37 1.25 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.3 t -121.61 150.33 41.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.481 1.112 . . . . 0.0 110.134 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -99.66 94.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.51 137.81 32.23 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.051 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 143.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.04 136.84 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 164.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.91 138.25 31.91 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.083 0.953 . . . . 0.0 108.717 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.15 90.78 3.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -168.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.93 168.62 16.99 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 123.289 0.471 . . . . 0.0 112.199 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -77.07 -100.82 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.84 1.656 . . . . 0.0 108.942 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -150.92 -57.47 0.16 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.796 1.638 . . . . 0.0 108.188 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -49.89 -45.12 50.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.848 0.859 . . . . 0.0 109.64 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.69 -34.46 67.18 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.05 0.54 . . . . 0.0 111.372 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.17 -61.02 2.75 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.4 p -43.33 -47.58 6.75 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.682 1.593 . . . . 0.0 112.213 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -56.18 -41.68 75.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.403 1.081 . . . . 0.0 111.666 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.4 -24.65 31.86 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.711 1.605 . . . . 0.0 111.154 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.53 -60.84 2.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.139 0.976 . . . . 0.0 110.936 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.81 -43.47 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.239 1.016 . . . . 0.0 111.058 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -34.1 -50.99 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.074 2.55 . . . . 0.0 113.259 165.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -69.18 -68.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.682 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -52.49 -41.83 63.73 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.79 -53.81 44.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.723 0.809 . . . . 0.0 110.754 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.09 0.3 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.863 1.22 . . . . 0.0 110.56 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.38 161.54 42.76 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.251 2.634 . . . . 0.0 111.296 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.33 164.71 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.516 2.811 . . . . 0.0 111.793 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.12 50.18 1.37 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 111.02 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.22 159.34 17.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.599 1.559 . . . . 0.0 107.84 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.18 84.49 3.0 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.597 0.359 . . . . 0.0 110.437 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.88 127.88 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.765 0.826 . . . . 0.0 109.183 168.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.85 -61.42 1.63 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.729 1.212 . . . . 0.0 108.05 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -146.4 119.94 9.11 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.01 0.524 . . . . 0.0 112.055 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.47 101.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -100.26 79.64 2.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.238 1.415 . . . . 0.0 108.062 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.24 152.34 21.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 m -145.29 139.85 27.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.0 0.92 . . . . 0.0 110.664 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.98 127.34 42.85 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.437 1.495 . . . . 0.0 109.033 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -136.35 -175.86 4.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.224 1.01 . . . . 0.0 110.639 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.59 152.53 18.45 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.536 0.734 . . . . 0.0 110.57 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.57 133.96 53.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.432 1.093 . . . . 0.0 111.39 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -71.34 -50.37 32.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.07 172.48 35.19 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.12 112.4 20.2 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.958 0.903 . . . . 0.0 109.094 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -62.67 133.46 54.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.61 97.43 1.71 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.68 -167.41 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.203 1.401 . . . . 0.0 110.539 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 80.54 1.94 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.12 1.368 . . . . 0.0 108.658 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -106.85 160.64 15.35 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 123.255 0.347 . . . . 0.0 110.149 -172.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.18 141.3 47.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.496 0.718 . . . . 0.0 111.559 -165.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.405 1.482 . . . . 0.0 108.306 170.145 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.3 m -144.58 -63.84 0.36 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.965 0.906 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.75 44.51 1.32 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.705 2.002 . . . . 0.0 113.844 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -123.17 -64.98 1.12 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 125.719 1.608 . . . . 0.0 107.995 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 tptt 72.36 -68.89 0.21 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.917 2.087 . . . . 0.0 112.581 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.7 m95 34.92 55.89 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.435 2.294 . . . . 0.0 113.523 177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.4 p -85.14 54.68 3.19 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.927 0.891 . . . . 0.0 110.169 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -163.84 67.46 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.879 1.272 . . . . 0.0 108.394 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -118.92 68.63 0.79 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.026 1.331 . . . . 0.0 108.727 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -137.66 98.91 3.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.129 0.972 . . . . 0.0 108.82 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.25 134.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.106 1.362 . . . . 0.0 107.328 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.97 -35.75 6.06 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 124.386 1.075 . . . . 0.0 110.708 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.88 62.93 2.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.966 1.707 . . . . 0.0 110.792 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.2 mtm -104.0 -146.02 0.37 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 108.943 177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.67 162.17 28.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.333 1.053 . . . . 0.0 111.299 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.57 152.16 32.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.293 1.837 . . . . 0.0 108.57 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -97.87 113.94 25.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.277 1.031 . . . . 0.0 110.587 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 18.0 ptm -86.28 161.7 18.63 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.11 85.56 1.61 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.69 96.19 10.3 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.121 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -80.88 107.2 13.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 t -91.45 90.39 3.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -168.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -65.38 148.28 51.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -168.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.13 -164.79 13.14 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.995 0.807 . . . . 0.0 112.157 166.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -90.23 36.92 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.85 0.86 . . . . 0.0 110.218 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.91 -19.39 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 142.32 45.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.011 0.924 . . . . 0.0 111.107 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.0 -43.31 3.23 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.839 0.733 . . . . 0.0 112.243 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.21 78.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.939 0.896 . . . . 0.0 109.854 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.5 -121.44 7.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.918 1.247 . . . . 0.0 111.214 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.9 t80 65.35 -56.95 0.31 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.092 2.557 . . . . 0.0 114.635 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -32.99 -51.28 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.525 2.73 . . . . 0.0 112.992 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -79.65 -41.73 26.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.096 0.958 . . . . 0.0 111.183 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -51.25 -41.84 60.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.65 0.78 . . . . 0.0 111.085 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.53 -43.36 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.593 1.157 . . . . 0.0 111.375 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -57.96 10.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.728 0.811 . . . . 0.0 110.589 175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.2 mm -47.47 -57.45 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 118.389 0.54 . . . . 0.0 111.3 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -69.94 -39.45 76.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.288 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.79 -61.9 1.93 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.297 0.499 . . . . 0.0 110.918 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.75 -50.62 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.732 1.613 . . . . 0.0 110.39 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -51.3 62.14 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.915 0.886 . . . . 0.0 109.804 -176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.13 4.13 46.58 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.022 1.329 . . . . 0.0 113.387 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.01 58.2 9.38 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.755 0.707 . . . . 0.0 111.454 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.52 142.75 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.784 1.634 . . . . 0.0 107.81 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.53 162.98 13.01 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.435 1.094 . . . . 0.0 108.58 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.5 -149.68 21.67 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -169.59 143.35 2.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.92 82.88 1.92 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.365 1.066 . . . . 0.0 108.957 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.506 1.146 . . . . 0.0 109.638 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.5 67.35 10.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 127.531 2.332 . . . . 0.0 110.609 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.1 mt -48.79 104.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 126.393 1.877 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.47 32.73 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.115 1.877 . . . . 0.0 113.211 -164.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -147.93 44.83 1.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.18 1.392 . . . . 0.0 107.604 164.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.61 -149.86 8.16 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -120.67 151.41 39.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.686 1.194 . . . . 0.0 109.701 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.4 126.96 32.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.89 0.876 . . . . 0.0 111.47 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -92.06 127.48 37.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.68 97.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.8 p -89.48 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.754 0.787 . . . . 0.0 109.732 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.53 156.38 32.94 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.857 1.263 . . . . 0.0 111.38 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -146.57 122.87 10.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.343 -172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.05 164.92 35.66 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 118.75 0.705 . . . . 0.0 112.773 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.24 162.9 11.23 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.458 1.103 . . . . 0.0 108.67 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.84 -24.51 44.34 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -166.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.45 -44.08 95.52 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.655 0.661 . . . . 0.0 109.909 168.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.04 -14.42 59.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.507 0.723 . . . . 0.0 112.439 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -67.13 -62.96 1.17 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -49.45 -42.46 42.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 112.809 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -61.71 -38.96 89.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.139 0.976 . . . . 0.0 112.047 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -70.61 -55.31 9.09 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -50.95 -53.58 31.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.773 0.429 . . . . 0.0 111.554 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.06 -37.63 83.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.76 0.824 . . . . 0.0 112.246 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.66 -49.07 7.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.917 1.287 . . . . 0.0 110.8 167.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -70.4 -52.63 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.19 0.596 . . . . 0.0 110.296 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.5 -49.94 73.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.453 0.569 . . . . 0.0 111.2 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -69.52 -36.9 76.86 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.367 1.067 . . . . 0.0 111.581 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.99 74.78 0.24 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.234 1.397 . . . . 0.0 110.22 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.77 168.49 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.826 3.017 . . . . 0.0 110.174 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.1 150.02 77.04 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.58 1.52 . . . . 0.0 108.533 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.86 45.56 0.82 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.002 0.521 . . . . 0.0 110.553 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.21 175.64 9.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 109.681 -173.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.27 74.33 3.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.639 0.776 . . . . 0.0 109.92 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.51 117.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -76.84 -52.28 9.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.505 1.122 . . . . 0.0 108.783 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -179.31 110.38 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.075 1.35 . . . . 0.0 110.211 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -75.74 78.07 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.339 1.056 . . . . 0.0 109.512 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -95.14 89.4 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.38 164.06 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.018 0.437 . . . . 0.0 111.944 -171.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -117.52 125.03 50.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.078 1.351 . . . . 0.0 108.769 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -83.25 128.75 34.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.3 m -136.51 179.25 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.633 0.773 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -96.47 146.69 24.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.084 1.354 . . . . 0.0 108.874 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -69.44 135.77 50.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -89.1 -57.35 2.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.018 1.327 . . . . 0.0 108.639 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 27.51 22.52 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.726 1.155 . . . . 0.0 113.536 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.86 -35.34 26.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.408 1.104 . . . . 0.0 112.887 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -83.84 82.27 8.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.08 0.552 . . . . 0.0 111.427 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.23 88.6 0.18 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.917 0.887 . . . . 0.0 109.36 171.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 90.85 145.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 128.507 2.723 . . . . 0.0 110.504 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.92 112.38 24.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.329 1.052 . . . . 0.0 108.829 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.48 165.7 15.95 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.07 0.548 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 p -108.12 146.28 32.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.834 0.854 . . . . 0.0 110.747 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.312 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.0 0 CA-C-O 119.405 -0.664 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 26.8 t 57.87 61.99 2.22 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.831 1.252 . . . . 0.0 111.086 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.33 150.58 26.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 0.0 109.455 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.21 -40.7 2.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.551 1.14 . . . . 0.0 111.368 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 68.96 150.48 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.387 1.875 . . . . 0.0 112.046 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -130.82 58.55 1.7 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.912 1.285 . . . . 0.0 108.698 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.8 m -78.82 68.52 4.8 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 110.63 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -156.9 84.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.081 1.353 . . . . 0.0 108.071 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.1 p -140.55 167.97 20.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.746 1.218 . . . . 0.0 109.592 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 71.06 166.65 0.3 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.0 112.823 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.7 t -93.62 125.16 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.691 1.597 . . . . 0.0 108.019 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -172.11 92.7 0.13 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.894 0.878 . . . . 0.0 109.398 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.62 74.63 1.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.25 1.42 . . . . 0.0 109.955 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -120.49 166.54 13.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.223 1.009 . . . . 0.0 111.572 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 75.51 131.68 0.05 OUTLIER 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.859 2.864 . . . . 0.0 112.031 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 168.51 12.35 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.777 0.831 . . . . 0.0 112.267 -169.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -93.44 114.92 27.43 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.05 0.453 . . . . 0.0 111.472 -175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 8.8 ptm -93.94 86.27 5.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 122.059 0.933 . . . . 0.0 110.529 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.38 114.83 18.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.32 110.68 16.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.316 1.047 . . . . 0.0 110.323 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 109.16 20.6 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.046 1.338 . . . . 0.0 107.921 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -96.24 110.12 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.52 154.77 17.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.132 0.973 . . . . 0.0 111.728 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.3 -159.05 21.3 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.735 1.636 . . . . 0.0 110.895 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -86.4 47.97 1.55 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.99 41.72 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 125.192 1.397 . . . . 0.0 110.43 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -108.16 33.93 3.87 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.355 0.662 . . . . 0.0 111.86 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.48 -160.7 26.84 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.785 1.183 . . . . 0.0 110.319 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER 70.23 -175.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.965 1.306 . . . . 0.0 109.812 -175.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 27' ' ' VAL . . . -74.99 51.19 2.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.817 0.723 . . . . 0.0 112.616 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.49 178.86 5.82 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.742 2.017 . . . . 0.0 112.075 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 61.65 -74.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.84 2.056 . . . . 0.0 111.061 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.15 -47.2 1.56 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.899 1.679 . . . . 0.0 111.137 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.23 -50.12 67.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.312 0.645 . . . . 0.0 112.127 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.0 -36.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 123.434 0.694 . . . . 0.0 110.341 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.4 -51.85 65.9 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.286 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.0 mm -44.23 -50.41 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.844 1.656 . . . . 0.0 112.363 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -71.27 -49.64 40.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.854 0.462 . . . . 0.0 110.209 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.63 -48.39 58.06 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.031 0.933 . . . . 0.0 113.132 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.32 -47.16 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.327 1.851 . . . . 0.0 108.36 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -53.35 -42.87 67.25 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.98 0.355 . . . . 0.0 110.993 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -93.28 6.82 46.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.99 1.316 . . . . 0.0 113.285 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.62 59.83 8.21 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 118.595 0.634 . . . . 0.0 112.244 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -113.45 139.54 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 125.605 1.562 . . . . 0.0 108.399 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -103.46 157.52 16.98 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.671 1.188 . . . . 0.0 108.06 172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.97 -158.78 31.58 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 118.569 0.622 . . . . 0.0 113.072 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -170.43 137.98 1.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.591 1.156 . . . . 0.0 108.641 167.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.39 87.51 2.63 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.99 0.916 . . . . 0.0 108.78 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -94.71 115.42 27.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.804 0.842 . . . . 0.0 109.807 -167.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.33 130.38 34.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.542 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -102.55 96.71 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 170.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.08 23.6 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.293 2.662 . . . . 0.0 114.43 -161.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.35 42.13 2.05 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.015 1.326 . . . . 0.0 108.303 169.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.69 -122.22 0.83 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -117.48 164.14 15.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.261 1.824 . . . . 0.0 110.579 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.2 p -102.85 124.75 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.595 0.758 . . . . 0.0 110.501 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -98.58 125.52 43.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.506 1.122 . . . . 0.0 109.757 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -109.06 115.55 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.44 135.1 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 164.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.31 146.4 18.5 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.508 1.123 . . . . 0.0 108.733 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.81 122.63 18.81 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.334 0.654 . . . . 0.0 111.219 -171.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.95 165.3 28.52 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-O 121.91 0.728 . . . . 0.0 113.881 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.44 172.68 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.093 160.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.92 -25.54 40.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.06 -52.01 52.87 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.93 -14.9 62.54 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.31 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.61 -68.29 0.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -46.34 -43.68 16.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.66 1.184 . . . . 0.0 112.825 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.587 1.155 . . . . 0.0 111.632 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.2 -24.94 54.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.906 0.482 . . . . 0.0 111.592 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -59.23 2.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.581 -0.7 . . . . 0.0 109.862 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.26 -33.53 69.49 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.686 0.794 . . . . 0.0 112.207 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.94 -54.57 2.71 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.485 1.514 . . . . 0.0 111.09 170.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.2 mt -74.39 -52.45 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.658 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -54.36 42.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.582 0.628 . . . . 0.0 110.269 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -90.82 41.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.051 1.34 . . . . 0.0 110.201 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.39 73.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.52 163.58 26.58 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.962 3.108 . . . . 0.0 111.639 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.35 -8.78 23.08 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.41 2.74 . . . . 0.0 113.919 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 78.81 25.77 0.5 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.083 2.153 . . . . 0.0 111.084 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.21 169.08 14.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.29 1.836 . . . . 0.0 107.987 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.2 77.99 1.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.623 0.769 . . . . 0.0 110.689 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.46 122.69 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.749 1.22 . . . . 0.0 110.018 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -82.83 -57.95 3.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.072 1.349 . . . . 0.0 107.898 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -162.23 136.29 6.54 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.164 0.29 . . . . 0.0 110.841 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 84.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -87.58 75.46 9.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -70.38 160.5 32.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.886 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 m -146.1 80.31 1.57 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 109.489 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.25 137.47 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.481 1.513 . . . . 0.0 112.467 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -144.85 -177.51 5.56 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.283 1.033 . . . . 0.0 110.871 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.96 153.12 39.9 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -67.11 124.67 23.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.748 0.819 . . . . 0.0 111.578 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.18 -49.46 35.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.93 172.5 42.07 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.86 109.98 20.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -65.68 140.89 58.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.891 0.877 . . . . 0.0 109.935 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.25 91.82 2.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.676 0.79 . . . . 0.0 110.588 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.9 -163.41 0.23 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.43 1.092 . . . . 0.0 109.811 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.1 87.62 2.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.618 0.767 . . . . 0.0 109.638 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 100' ' ' THR . 21.5 tt0 -104.25 -175.91 2.93 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.606 0.762 . . . . 0.0 109.079 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.488 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.4 p -125.17 158.81 33.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.118 -1.42 . . . . 0.0 109.934 159.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.154 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 47.7 t -150.91 71.7 1.04 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 108.676 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? 69.76 133.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.661 1.984 . . . . 0.0 111.829 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.57 150.91 32.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.691 1.196 . . . . 0.0 108.349 177.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -160.28 151.73 19.6 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.857 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -175.72 143.51 0.6 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.253 1.421 . . . . 0.0 108.419 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 t -138.28 69.36 1.38 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.037 0.935 . . . . 0.0 110.089 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -79.3 59.66 2.89 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.0 110.572 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -123.52 64.62 1.02 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.098 1.359 . . . . 0.0 109.623 -167.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -154.11 141.39 19.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.068 0.547 . . . . 0.0 109.626 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.07 107.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.852 2.061 . . . . 0.0 111.642 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -104.77 -30.93 9.58 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.536 1.135 . . . . 0.0 110.799 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -76.47 72.97 3.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.086 1.354 . . . . 0.0 110.46 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.4 mtm -62.18 -71.63 0.15 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.207 1.003 . . . . 0.0 110.38 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.37 145.69 43.6 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.499 0.719 . . . . 0.0 111.029 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 164.13 19.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.236 1.014 . . . . 0.0 111.592 -170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -86.39 118.42 25.82 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.1 ptm -89.58 91.35 8.65 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.279 1.037 . . . . 0.0 108.832 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -76.28 128.66 35.34 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.32 128.32 14.54 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.097 0.475 . . . . 0.0 111.254 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -100.77 94.56 6.13 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.005 0.922 . . . . 0.0 109.084 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.83 103.76 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.482 0.713 . . . . 0.0 109.135 -173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -101.86 143.47 31.71 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.799 0.84 . . . . 0.0 110.569 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.72 -165.95 33.22 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.49 0.494 . . . . 0.0 112.342 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.65 20.5 0.73 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.706 0.803 . . . . 0.0 110.546 168.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -71.23 -3.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.97 1.308 . . . . 0.0 112.469 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -82.23 33.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.714 1.605 . . . . 0.0 112.814 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.23 57.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -157.96 -174.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.218 1.007 . . . . 0.0 108.402 176.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.86 66.53 0.65 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.188 0.899 . . . . 0.0 111.897 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -133.24 171.51 13.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.703 2.001 . . . . 0.0 107.372 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 80.32 -62.39 0.24 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.639 1.576 . . . . 0.0 107.886 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -54.26 -41.14 68.48 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.696 0.798 . . . . 0.0 109.478 165.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.79 -55.8 23.21 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.62 -18.57 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.875 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -57.67 -58.8 6.76 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.224 0.92 . . . . 0.0 109.324 165.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.0 mm -46.79 -56.69 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 123.232 0.613 . . . . 0.0 111.49 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -66.13 -44.3 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.5 -175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.31 -65.16 0.6 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.214 0.461 . . . . 0.0 110.766 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.93 -45.96 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.978 1.711 . . . . 0.0 111.428 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.93 -43.8 98.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 111.469 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.29 16.72 8.16 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.777 0.831 . . . . 0.0 112.531 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.74 58.23 15.3 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 124.334 0.969 . . . . 0.0 112.518 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.21 139.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.942 1.297 . . . . 0.0 109.916 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.11 175.13 5.63 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.238 1.415 . . . . 0.0 108.237 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.56 -140.41 11.77 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -170.88 150.67 3.21 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 117.027 0.413 . . . . 0.0 111.297 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.48 86.5 2.37 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.415 1.486 . . . . 0.0 108.953 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -93.48 108.95 20.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.24 1.016 . . . . 0.0 108.427 -170.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.15 92.83 9.12 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.16 1.384 . . . . 0.0 109.756 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.88 113.67 32.21 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 169.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.59 72.91 5.42 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.357 2.705 . . . . 0.0 112.201 -162.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -165.25 55.93 0.12 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.85 1.66 . . . . 0.0 107.992 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.47 -40.59 1.78 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.48 1.038 . . . . 0.0 114.082 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 p -90.99 93.22 9.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.404 1.482 . . . . 0.0 110.93 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.37 119.83 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.74 125.79 36.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.746 1.218 . . . . 0.0 109.003 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.77 135.25 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.685 1.194 . . . . 0.0 107.881 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.59 55.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 C-N-CA 124.113 0.965 . . . . 0.0 108.981 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.96 157.54 30.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.249 1.42 . . . . 0.0 110.165 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -143.83 123.03 12.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.545 -172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.88 166.72 39.39 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.467 -1.349 . . . . 0.0 113.748 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -52.43 156.25 1.84 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.65 1.58 . . . . 0.0 111.352 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.68 -15.05 58.95 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.9 -36.32 82.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 118.271 0.487 . . . . 0.0 109.942 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.73 -3.53 29.96 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.666 1.186 . . . . 0.0 112.696 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.4 tp -66.9 -61.54 1.89 Allowed 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.265 0.939 . . . . 0.0 109.364 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -44.7 -41.94 7.2 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.128 1.371 . . . . 0.0 112.878 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.18 -50.31 73.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.627 1.171 . . . . 0.0 111.079 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 68' ' ' LEU . 17.4 tp -71.19 -30.04 65.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.624 0.37 . . . . 0.0 111.274 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.21 -58.7 3.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.54 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.98 -38.81 68.29 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 123.985 0.914 . . . . 0.0 112.268 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -30.44 -52.08 0.15 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.571 1.948 . . . . 0.0 112.542 164.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.16 -72.36 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 122.752 0.421 . . . . 0.0 110.452 -169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -49.65 -49.89 45.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.053 0.941 . . . . 0.0 111.869 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -89.18 29.42 1.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.467 1.107 . . . . 0.0 111.954 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.56 68.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.77 164.92 32.62 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.022 3.148 . . . . 0.0 111.546 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.02 -178.51 4.23 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.512 2.808 . . . . 0.0 110.864 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.12 28.81 0.69 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.104 0.961 . . . . 0.0 112.251 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.458 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -131.25 167.0 19.94 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.732 1.213 . . . . 0.0 110.328 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.84 81.99 2.76 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.81 83.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.549 1.54 . . . . 0.0 110.607 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -39.44 -62.37 0.68 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.964 2.106 . . . . 0.0 111.458 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -165.57 129.28 2.24 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 111.702 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.68 99.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.29 80.7 9.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -74.75 142.61 44.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.0 m -148.28 85.26 1.52 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 109.593 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.98 142.4 0.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.567 1.947 . . . . 0.0 111.027 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -159.95 171.85 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.26 143.06 39.17 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.008 0.923 . . . . 0.0 109.773 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -69.48 145.69 52.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.085 0.469 . . . . 0.0 111.936 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -58.28 2.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.113 1.365 . . . . 0.0 108.332 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.62 167.8 39.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.54 103.05 6.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.427 0.691 . . . . 0.0 110.213 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -77.55 79.24 4.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -44.44 119.5 1.88 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.375 1.87 . . . . 0.0 112.502 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.5 t70 68.1 124.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.874 2.07 . . . . 0.0 111.595 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.35 95.1 3.15 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -118.21 160.09 22.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 0.819 . . . . 0.0 110.794 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.95 145.97 29.68 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.678 0.791 . . . . 0.0 112.385 -171.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.304 154.128 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.13 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.6 m -148.4 139.63 23.32 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.201 1.0 . . . . 0.0 109.154 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp -159.49 122.68 3.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.242 1.017 . . . . 0.0 108.939 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -130.78 134.11 46.58 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.19 1.396 . . . . 0.0 108.953 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.01 166.02 25.87 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.654 1.182 . . . . 0.0 109.473 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -129.99 176.53 7.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.792 1.637 . . . . 0.0 108.978 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -121.01 145.23 47.99 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.424 1.49 . . . . 0.0 109.04 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -161.59 79.49 0.57 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 108.085 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -140.48 155.76 46.57 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.794 1.238 . . . . 0.0 109.659 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -154.21 65.79 0.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -93.27 140.43 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -110.3 -103.09 0.39 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -127.32 129.02 46.88 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.261 1.424 . . . . 0.0 109.017 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtt -147.57 149.85 33.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.951 1.3 . . . . 0.0 108.629 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -171.15 156.23 4.67 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.742 0.817 . . . . 0.0 110.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 171.58 8.19 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.874 0.869 . . . . 0.0 111.731 -174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -103.11 107.35 18.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.976 1.311 . . . . 0.0 111.375 -168.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.14 98.2 11.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.292 0.567 . . . . 0.0 109.583 172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -74.82 133.86 41.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.17 105.84 5.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -90.67 99.61 12.61 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.225 1.41 . . . . 0.0 108.37 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.22 116.3 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.462 1.105 . . . . 0.0 109.065 -170.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -98.97 158.03 15.92 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.688 1.195 . . . . 0.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.11 -162.71 14.76 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 124.631 1.11 . . . . 0.0 111.993 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.23 32.86 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.701 0.8 . . . . 0.0 110.773 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.88 -19.22 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.291 1.036 . . . . 0.0 111.212 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -56.62 133.95 54.12 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.352 1.061 . . . . 0.0 110.15 170.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.74 10.47 83.26 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.109 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.17 152.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.73 1.212 . . . . 0.0 107.843 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.49 45.9 3.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.769 0.7 . . . . 0.0 112.89 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -57.82 -51.69 68.54 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.676 0.79 . . . . 0.0 109.376 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -56.84 -42.29 79.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.717 0.807 . . . . 0.0 111.692 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.27 -46.08 81.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.274 1.03 . . . . 0.0 110.452 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.99 -45.19 75.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.001 0.364 . . . . 0.0 110.489 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.36 -32.8 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.969 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.54 -55.78 30.22 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.284 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.8 mm -42.01 -57.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.766 1.166 . . . . 0.0 113.325 -172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -68.65 -48.07 64.95 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.393 0.542 . . . . 0.0 110.443 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.39 -65.4 0.57 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 111.646 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.45 -49.85 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.218 2.207 . . . . 0.0 111.5 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.87 78.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.846 0.458 . . . . 0.0 111.944 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.5 mt -102.06 23.47 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.149 0.98 . . . . 0.0 112.455 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.71 65.87 3.25 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.454 1.026 . . . . 0.0 113.304 173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.92 139.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 125.045 1.338 . . . . 0.0 108.004 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -101.56 167.1 10.35 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.072 1.349 . . . . 0.0 107.808 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.98 -146.52 14.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.338 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -167.45 148.6 5.54 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.576 1.15 . . . . 0.0 109.186 166.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.52 81.44 1.59 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.85 0.86 . . . . 0.0 108.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -86.83 84.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -171.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.82 87.64 2.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.724 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 123.05 85.67 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 163.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.52 69.33 7.75 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.65 2.234 . . . . 0.0 111.428 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -159.05 56.04 0.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.216 1.406 . . . . 0.0 108.527 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.82 -55.6 4.75 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.856 0.741 . . . . 0.0 113.545 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 m -94.37 66.3 3.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.424 0.689 . . . . 0.0 112.567 -161.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.67 118.15 5.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.047 0.539 . . . . 0.0 110.294 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.48 121.21 32.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.0 110.01 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.14 147.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.93 66.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.58 157.57 37.75 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.249 1.42 . . . . 0.0 110.315 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.12 116.7 11.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.742 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.03 159.84 27.47 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 118.722 0.692 . . . . 0.0 114.566 -170.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.9 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.264 1.826 . . . . 0.0 109.535 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -154.72 -75.84 0.11 Allowed 'General case' 0 C--N 1.34 0.182 0 C-N-CA 125.301 1.441 . . . . 0.0 108.222 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -55.1 -48.59 73.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.0 69.38 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.986 0.515 . . . . 0.0 111.797 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.08 -66.31 0.56 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.4 t -44.98 -46.1 10.94 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.041 1.737 . . . . 0.0 112.77 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.73 -44.05 94.71 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.395 0.543 . . . . 0.0 111.891 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.29 -23.59 51.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.766 0.826 . . . . 0.0 111.354 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.44 -61.55 1.73 Allowed 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.226 -0.921 . . . . 0.0 110.857 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.36 -36.91 79.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.875 0.87 . . . . 0.0 111.146 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -36.96 -49.59 0.83 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.377 1.871 . . . . 0.0 111.934 165.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.81 -64.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.242 0.617 . . . . 0.0 110.056 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -51.57 62.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.831 0.852 . . . . 0.0 111.476 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -77.63 -33.14 53.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.041 0.936 . . . . 0.0 111.998 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.78 85.94 0.42 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.413 1.006 . . . . 0.0 110.686 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.66 156.23 66.19 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.965 2.443 . . . . 0.0 111.299 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -79.77 172.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.018 3.145 . . . . 0.0 111.715 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.01 27.76 1.53 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.162 0.985 . . . . 0.0 111.875 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.48 164.18 28.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.902 1.281 . . . . 0.0 109.445 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 81.64 3.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.45 122.41 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.56 -56.79 4.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -168.31 142.8 3.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.631 1.173 . . . . 0.0 108.667 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.49 100.24 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.76 75.01 4.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -78.71 160.38 27.5 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -135.46 109.43 8.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.734 1.614 . . . . 0.0 109.591 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 119.55 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 m -134.42 179.49 6.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.798 1.239 . . . . 0.0 110.461 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -104.82 135.92 45.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.128 0.971 . . . . 0.0 110.03 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -52.17 138.98 24.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.065 2.146 . . . . 0.0 112.746 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -79.33 -48.83 13.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.48 179.5 27.16 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.73 112.79 20.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.69 1.196 . . . . 0.0 107.905 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -70.05 137.79 51.56 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -68.17 90.29 0.33 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.664 0.786 . . . . 0.0 110.212 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 70.18 -164.93 0.16 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.229 1.412 . . . . 0.0 109.713 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.7 96.82 3.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.993 0.917 . . . . 0.0 108.856 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -121.56 163.28 19.15 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.483 0.713 . . . . 0.0 109.836 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.94 148.64 33.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.847 1.259 . . . . 0.0 111.73 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.28 155.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.3 t -158.45 176.11 12.85 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.457 1.103 . . . . 0.0 108.817 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.4 mtp 58.13 52.82 7.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 111.06 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.21 144.67 28.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.511 0.724 . . . . 0.0 109.892 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -76.35 -54.28 6.97 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 111.257 -167.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 75.7 m95 34.2 50.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.5 1.92 . . . . 0.0 113.059 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.7 p -97.12 76.89 2.68 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.945 1.298 . . . . 0.0 107.853 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -80.16 59.07 3.2 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.743 1.217 . . . . 0.0 111.154 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.7 p -95.51 153.86 17.49 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.378 1.471 . . . . 0.0 109.551 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.2 169.47 17.55 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.733 1.213 . . . . 0.0 109.701 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 t 58.21 69.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.466 1.506 . . . . 0.0 109.745 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -75.01 -61.58 1.84 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.66 0.784 . . . . 0.0 109.917 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.98 133.35 55.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.681 1.192 . . . . 0.0 108.356 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.9 ttm -94.13 -98.54 0.15 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 52.16 157.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.576 3.151 . . . . 0.0 117.15 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.28 168.26 12.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.788 0.835 . . . . 0.0 111.483 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -96.52 97.33 9.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.824 1.25 . . . . 0.0 109.996 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 ttp -62.93 152.33 36.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -149.92 123.73 9.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.338 1.055 . . . . 0.0 108.75 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.48 117.01 22.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.142 0.977 . . . . 0.0 110.67 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -91.37 92.74 8.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.312 1.445 . . . . 0.0 107.913 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 24' ' ' VAL . 4.2 t -88.76 112.13 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.52 149.65 21.96 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.173 0.589 . . . . 0.0 111.417 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.92 -153.87 20.51 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.854 1.216 . . . . 0.0 111.855 166.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tp -79.47 14.93 1.41 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.264 1.026 . . . . 0.0 111.662 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 HG12 ' A' ' 20' ' ' VAL . 27.3 m -74.51 21.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.346 1.458 . . . . 0.0 112.914 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -97.89 60.03 1.47 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.94 0.876 . . . . 0.0 110.707 -159.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.31 61.24 0.98 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.392 1.472 . . . . 0.0 111.087 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.27 101.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 108.709 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.54 -62.59 3.81 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.274 0.94 . . . . 0.0 111.123 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -64.14 172.85 2.19 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.364 1.066 . . . . 0.0 110.772 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 76.11 -60.57 0.48 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.601 1.96 . . . . 0.0 109.93 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -74.08 -46.52 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.526 0.73 . . . . 0.0 109.555 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -54.52 -51.18 65.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.518 -0.739 . . . . 0.0 111.116 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.43 -20.84 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.095 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -60.15 4.33 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.572 0.624 . . . . 0.0 109.335 169.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -46.15 -52.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.791 0.836 . . . . 0.0 111.841 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -69.59 -46.97 65.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.436 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.34 -52.44 37.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.411 0.55 . . . . 0.0 112.148 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.8 -40.4 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.459 1.504 . . . . 0.0 110.733 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -41.59 93.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.379 0.536 . . . . 0.0 111.731 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.93 11.04 21.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.424 1.09 . . . . 0.0 112.817 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.16 56.02 24.53 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.701 0.667 . . . . 0.0 112.164 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.84 139.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.436 1.494 . . . . 0.0 108.791 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -108.94 169.6 8.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.382 1.473 . . . . 0.0 107.634 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.81 -138.76 9.14 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -175.46 141.58 0.53 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 117.69 0.745 . . . . 0.0 111.099 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.6 87.19 2.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.253 1.421 . . . . 0.0 110.165 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -92.68 110.07 21.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.269 0.628 . . . . 0.0 110.222 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.07 96.94 10.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.718 1.607 . . . . 0.0 109.234 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -77.89 110.81 14.33 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.07 79.18 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.442 2.761 . . . . 0.0 112.123 -161.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -142.09 -75.39 0.29 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.263 1.825 . . . . 0.0 106.428 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -168.87 35.93 0.2 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.673 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -137.3 103.82 5.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.257 1.023 . . . . 0.0 109.943 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.56 111.08 32.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -91.73 117.22 29.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.467 1.107 . . . . 0.0 109.576 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.27 104.75 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 110.054 -177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.3 t -79.86 130.26 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.29 124.67 16.6 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.244 1.018 . . . . 0.0 110.137 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -108.58 104.66 14.02 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 109.074 -171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.76 159.63 27.96 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -71.52 -98.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.685 1.194 . . . . 0.0 109.656 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -159.65 -53.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.35 1.06 . . . . 0.0 109.486 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -44.3 -42.48 6.75 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.27 1.428 . . . . 0.0 110.385 162.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.51 -29.48 18.92 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.514 1.126 . . . . 0.0 112.248 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.08 -58.33 8.9 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 119.045 0.839 . . . . 0.0 109.89 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 p -43.48 -44.31 5.86 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.39 1.476 . . . . 0.0 112.866 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.58 -33.38 74.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.952 0.901 . . . . 0.0 112.285 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.62 -53.14 7.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.647 0.779 . . . . 0.0 110.324 169.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -52.9 61.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 110.454 -170.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.16 -36.46 83.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.174 1.389 . . . . 0.0 112.15 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.9 -50.34 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.605 169.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.97 -52.55 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 123.201 0.313 . . . . 0.0 110.592 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -49.48 77.32 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.339 0.518 . . . . 0.0 111.129 -174.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -66.9 -44.16 81.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.096 1.358 . . . . 0.0 110.914 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.63 82.3 0.3 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.514 1.53 . . . . 0.0 109.649 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.17 164.02 26.87 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.737 2.958 . . . . 0.0 111.412 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.58 148.35 72.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.476 2.117 . . . . 0.0 109.501 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.13 49.72 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.475 0.71 . . . . 0.0 110.874 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.23 167.47 29.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.624 1.17 . . . . 0.0 109.238 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.9 77.45 2.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.697 0.799 . . . . 0.0 110.108 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.63 122.65 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.176 0.99 . . . . 0.0 109.456 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.62 -59.35 2.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -169.94 135.78 1.44 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.372 0.669 . . . . 0.0 110.152 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.59 96.87 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -87.13 71.77 10.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.37 148.9 38.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.713 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -151.87 103.01 2.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.98 146.85 52.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.473 0.709 . . . . 0.0 110.579 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -134.19 -174.1 3.46 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 110.383 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.49 148.39 25.58 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.099 1.36 . . . . 0.0 109.047 170.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -76.9 144.42 38.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.004 0.922 . . . . 0.0 111.718 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -83.96 -57.75 3.07 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -152.53 172.18 31.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.72 115.77 21.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.359 1.064 . . . . 0.0 108.733 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -68.63 -38.18 80.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.727 1.211 . . . . 0.0 110.506 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 56.86 62.04 2.4 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.81 1.644 . . . . 0.0 112.412 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 t70 157.2 86.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.099 2.559 . . . . 0.0 108.438 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -73.99 91.59 2.05 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -125.84 154.53 42.53 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 111.292 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 120.79 36.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.985 0.914 . . . . 0.0 109.819 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 9.4 m 66.91 179.56 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.147 1.379 . . . . 0.0 111.984 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptp -70.95 102.61 2.44 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.287 0.635 . . . . 0.0 110.318 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -119.99 -61.91 1.54 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.981 1.312 . . . . 0.0 108.851 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 145.29 37.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.474 1.11 . . . . 0.0 109.379 173.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -90.53 59.99 4.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.9 0.88 . . . . 0.0 109.343 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 t -129.9 151.87 49.99 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.156 1.382 . . . . 0.0 109.613 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -161.18 155.23 22.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.949 1.3 . . . . 0.0 109.113 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.8 p -131.23 173.07 11.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.166 1.386 . . . . 0.0 109.639 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.4 152.58 47.32 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.095 1.358 . . . . 0.0 109.132 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -159.8 138.09 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -173.05 27.38 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.571 0.748 . . . . 0.0 112.717 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -87.52 41.76 1.0 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.434 -0.791 . . . . 0.0 112.21 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 66.0 134.66 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 127.412 2.285 . . . . 0.0 113.763 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.08 146.2 36.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.353 1.061 . . . . 0.0 110.631 -173.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HZ3' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -136.33 -173.31 3.37 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.597 1.559 . . . . 0.0 111.759 -168.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -111.99 132.59 54.69 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.067 0.947 . . . . 0.0 111.287 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.0 ttp -82.5 164.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 156.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -158.53 82.99 0.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.607 1.163 . . . . 0.0 108.239 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.59 105.89 17.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.726 0.81 . . . . 0.0 109.714 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.81 9.67 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.36 114.62 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -166.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.13 140.36 38.42 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.295 1.438 . . . . 0.0 110.87 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.17 -156.39 23.34 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.998 1.285 . . . . 0.0 111.355 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.3 tp -77.93 15.68 0.84 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.523 0.729 . . . . 0.0 111.777 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 m -57.71 -30.37 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.896 0.878 . . . . 0.0 109.954 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.78 126.07 28.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 162.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.52 26.52 25.04 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.968 0.794 . . . . 0.0 111.623 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -154.37 151.66 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.044 1.338 . . . . 0.0 107.898 171.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.09 -69.02 1.4 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.027 0.823 . . . . 0.0 111.687 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.3 t80 52.79 -116.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 116.942 -1.504 . . . . 0.0 109.717 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 35.92 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.23 2.612 . . . . 0.0 114.423 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -33.03 -47.92 0.19 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.417 1.887 . . . . 0.0 112.254 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.23 -43.68 78.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.41 0.684 . . . . 0.0 111.97 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.24 -36.71 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 C-N-CA 123.53 0.732 . . . . 0.0 109.975 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -46.79 87.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.131 -0.937 . . . . 0.0 109.793 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mm -38.91 -56.47 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -174.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -67.92 -48.19 66.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.418 1.008 . . . . 0.0 111.115 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.06 -64.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.011 0.924 . . . . 0.0 111.603 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.37 -51.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 127.841 2.456 . . . . 0.0 110.621 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -42.28 62.31 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.266 0.626 . . . . 0.0 110.811 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.0 21.58 12.51 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.359 1.464 . . . . 0.0 112.371 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.25 66.12 2.93 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.146 0.879 . . . . 0.0 112.863 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 mm -119.39 142.71 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.768 1.227 . . . . 0.0 109.777 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 175.56 5.46 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.386 1.474 . . . . 0.0 108.453 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.47 -148.0 19.61 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -173.87 140.46 0.74 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 117.652 0.726 . . . . 0.0 111.173 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.34 88.03 2.82 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 124.631 1.172 . . . . 0.0 110.322 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -99.44 107.73 20.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.519 0.728 . . . . 0.0 110.694 -166.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.69 119.6 20.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.767 172.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.37 97.37 1.59 Allowed Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -64.31 138.51 61.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.688 1.592 . . . . 0.0 110.193 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t0 57.49 59.46 3.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.498 1.119 . . . . 0.0 109.434 -164.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.44 -140.16 3.96 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.4 p -124.1 156.46 36.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.76 1.624 . . . . 0.0 109.922 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -108.84 105.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 123.534 0.733 . . . . 0.0 109.512 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pm0 -93.77 134.1 36.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.482 0.713 . . . . 0.0 111.103 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.21 116.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.623 1.169 . . . . 0.0 109.418 -171.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.6 141.82 16.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.84 123.38 17.22 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.899 1.279 . . . . 0.0 108.002 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.83 90.17 3.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.546 0.738 . . . . 0.0 109.214 -162.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.82 162.86 22.92 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-O 122.086 0.826 . . . . 0.0 114.672 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.36 163.03 28.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.872 1.269 . . . . 0.0 108.01 163.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -79.72 -23.58 42.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -64.4 -50.01 69.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.95 -9.83 58.91 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.936 0.894 . . . . 0.0 112.512 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 HD13 ' HZ3' ' A' ' 14' ' ' LYS . 25.9 tp -68.92 -60.96 2.01 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 119.325 0.966 . . . . 0.0 109.011 177.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -44.59 -44.67 9.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.566 1.146 . . . . 0.0 112.803 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -49.9 -51.6 39.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.208 1.003 . . . . 0.0 111.91 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.32 -42.48 45.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.435 1.494 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -55.48 -58.26 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.539 1.136 . . . . 0.0 110.388 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.64 -33.31 68.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.682 1.193 . . . . 0.0 111.394 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -40.08 -48.23 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.241 1.417 . . . . 0.0 111.023 165.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mt -67.57 -58.76 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.029 0.532 . . . . 0.0 111.065 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -59.52 -39.19 83.07 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.343 0.519 . . . . 0.0 111.088 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -72.93 -44.43 61.2 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.249 1.42 . . . . 0.0 111.094 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.98 80.91 0.28 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.069 1.318 . . . . 0.0 110.151 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -62.44 159.42 36.09 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.923 2.415 . . . . 0.0 111.128 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.56 156.08 54.51 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.26 2.64 . . . . 0.0 110.811 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.48 42.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.74 . . . . 0.0 111.25 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB2' HG11 ' A' ' 27' ' ' VAL . . . -153.01 167.62 28.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.73 1.612 . . . . 0.0 109.357 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.23 82.13 4.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.663 0.785 . . . . 0.0 109.015 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.69 127.52 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 109.415 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -90.07 -51.93 5.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.539 1.136 . . . . 0.0 109.517 -174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -163.1 74.6 0.37 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 112.079 -173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.39 88.08 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.657 0.741 . . . . 0.0 110.44 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -96.28 80.23 3.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.763 1.225 . . . . 0.0 107.791 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.29 162.39 29.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.029 0.443 . . . . 0.0 111.391 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.1 m -140.82 134.89 30.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.14 0.976 . . . . 0.0 109.301 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.71 138.37 31.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 m -137.76 177.84 7.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 111.724 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -82.39 152.2 26.29 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 124.602 1.161 . . . . 0.0 111.058 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 117.48 8.44 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 110.281 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -99.23 -55.59 2.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.969 1.308 . . . . 0.0 108.531 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.43 38.86 37.27 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 123.927 0.775 . . . . 0.0 113.255 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -85.14 -30.55 23.9 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -81.98 131.99 35.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.892 0.769 . . . . 0.0 110.586 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.68 119.44 33.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.183 1.793 . . . . 0.0 107.467 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 31.4 t70 64.41 171.27 0.19 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.64 1.176 . . . . 0.0 111.385 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.39 87.53 2.68 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.436 1.495 . . . . 0.0 108.357 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -105.74 152.6 22.97 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 111.128 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.15 130.15 55.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.255 1.022 . . . . 0.0 109.986 -168.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.62 1.568 . . . . 0.0 107.786 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.105 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 51.8 m -148.47 151.39 35.1 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.416 1.086 . . . . 0.0 109.088 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mmm -82.17 66.27 7.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.809 0.844 . . . . 0.0 110.102 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -78.79 166.82 22.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.04 . . . . 0.0 109.96 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mptt 69.72 118.61 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.786 2.034 . . . . 0.0 110.284 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -176.4 143.82 0.51 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.816 1.246 . . . . 0.0 108.555 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -127.36 153.7 45.88 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.248 1.419 . . . . 0.0 109.242 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -63.32 -50.45 69.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.239 0.616 . . . . 0.0 110.419 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -158.94 163.86 36.14 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.593 1.157 . . . . 0.0 108.551 174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -161.05 154.66 22.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.714 1.205 . . . . 0.0 108.145 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.11 154.32 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.272 0.629 . . . . 0.0 110.056 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.5 t80 72.98 59.15 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.208 1.803 . . . . 0.0 110.347 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.38 131.12 47.63 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 163.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -64.66 -39.76 94.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.247 0.619 . . . . 0.0 110.829 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.64 126.32 27.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.348 0.659 . . . . 0.0 112.219 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 168.4 14.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.437 1.095 . . . . 0.0 111.744 -164.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -97.78 124.79 42.29 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 120.74 0.305 . . . . 0.0 111.58 173.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -91.56 153.82 19.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -135.16 98.65 4.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.584 1.554 . . . . 0.0 109.374 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.46 109.67 21.82 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.332 0.653 . . . . 0.0 110.274 177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -92.26 91.22 7.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.304 1.041 . . . . 0.0 108.258 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.11 112.23 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.074 0.55 . . . . 0.0 109.63 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.11 146.4 25.08 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.476 1.511 . . . . 0.0 109.87 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.53 -175.62 20.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.213 0.911 . . . . 0.0 111.59 173.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 tp -82.81 28.84 0.47 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 0.0 110.576 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.22 -28.11 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.019 0.927 . . . . 0.0 110.939 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.74 131.84 14.6 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 109.889 162.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 -55.55 2.43 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.441 -0.644 . . . . 0.0 112.169 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 79' ' ' ALA . 20.3 m -71.78 -178.98 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 117.936 0.868 . . . . 0.0 111.767 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.78 85.9 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.926 1.251 . . . . 0.0 111.497 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -156.48 174.62 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.923 1.289 . . . . 0.0 109.072 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 76.12 -66.31 0.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.115 1.766 . . . . 0.0 109.752 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -53.84 -45.68 70.98 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 171.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.8 -42.68 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.088 0.955 . . . . 0.0 111.604 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.88 -32.77 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 110.573 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -56.94 15.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 110.316 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.1 mm -46.68 -56.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.366 0.666 . . . . 0.0 112.12 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -65.88 -47.85 73.48 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.033 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.78 -65.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.554 0.741 . . . . 0.0 111.415 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.13 -46.09 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 126.619 1.967 . . . . 0.0 111.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -60.93 -39.5 89.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.162 0.585 . . . . 0.0 111.116 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.85 20.36 7.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.787 0.835 . . . . 0.0 112.834 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.84 53.23 45.69 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.299 0.952 . . . . 0.0 113.287 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mm -108.94 135.67 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.232 1.413 . . . . 0.0 108.408 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -96.38 178.63 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.673 1.189 . . . . 0.0 109.126 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.3 -142.43 10.02 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 119.538 1.063 . . . . 0.0 111.917 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -178.64 141.46 0.21 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.507 1.523 . . . . 0.0 110.137 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.42 87.69 2.76 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.932 0.893 . . . . 0.0 110.672 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -93.78 105.01 17.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.441 0.639 . . . . 0.0 110.994 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.12 96.5 7.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.742 1.617 . . . . 0.0 110.206 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.37 117.61 69.03 Favored Pre-proline 0 N--CA 1.45 -0.466 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.53 71.69 6.34 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.578 2.852 . . . . 0.0 111.381 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -150.23 41.24 0.81 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.233 1.413 . . . . 0.0 108.537 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.56 33.64 67.36 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.202 0.906 . . . . 0.0 112.795 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 m -145.78 90.66 2.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.763 0.782 . . . . 0.0 110.035 -173.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -98.65 121.7 49.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.533 0.733 . . . . 0.0 109.092 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.52 143.64 28.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.85 130.21 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.1 141.88 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 158.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.59 122.26 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 109.448 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -124.8 116.53 22.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.222 1.009 . . . . 0.0 111.483 -156.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.31 -171.1 44.09 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.34 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -63.87 164.0 10.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.384 1.073 . . . . 0.0 110.182 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -81.89 -24.77 35.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -63.39 -52.39 61.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.22 -21.38 63.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.4 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.34 -61.44 1.84 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.0 p -47.41 -46.27 26.15 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.904 0.882 . . . . 0.0 112.498 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -51.78 -48.96 63.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.859 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.37 -54.34 21.41 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 110.711 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.15 -49.9 59.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.219 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.72 -36.56 80.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.642 1.577 . . . . 0.0 112.157 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.71 -43.43 17.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.132 1.373 . . . . 0.0 111.644 171.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.02 -59.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 110.506 174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -61.74 -41.46 97.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.077 0.399 . . . . 0.0 111.7 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.24 -45.97 68.47 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.988 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.38 78.84 0.25 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.742 1.163 . . . . 0.0 110.874 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 157.75 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.023 2.482 . . . . 0.0 110.516 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 165.09 33.02 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.388 2.725 . . . . 0.0 111.105 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.77 42.94 0.95 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.611 0.764 . . . . 0.0 111.268 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 27' ' ' VAL . . . -148.48 172.12 14.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.046 0.938 . . . . 0.0 110.061 176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.82 86.5 0.51 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.335 1.054 . . . . 0.0 109.644 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.48 80.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 125.024 1.33 . . . . 0.0 109.334 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -38.74 -65.28 0.37 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.491 2.316 . . . . 0.0 111.342 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -151.56 147.43 26.78 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.389 0.676 . . . . 0.0 109.835 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.45 84.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.81 68.53 10.14 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -73.77 162.91 28.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -147.47 133.39 19.13 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.784 0.834 . . . . 0.0 109.202 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.89 135.89 34.31 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.819 1.248 . . . . 0.0 107.955 170.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 m -129.84 -177.55 4.33 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.455 1.102 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.05 166.83 13.2 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.836 0.855 . . . . 0.0 111.111 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -55.78 96.82 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.596 0.758 . . . . 0.0 110.589 166.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -100.31 -56.7 2.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.337 0.655 . . . . 0.0 110.313 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.24 135.57 3.75 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.42 100.45 9.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.774 1.229 . . . . 0.0 110.648 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -75.95 72.36 2.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.94 68.68 1.82 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.647 1.579 . . . . 0.0 112.993 -165.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 166.51 89.43 0.0 OUTLIER 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 128.492 2.717 . . . . 0.0 106.056 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.75 83.9 6.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.0 158.81 22.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 123.482 0.489 . . . . 0.0 109.949 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.03 139.4 35.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.251 0.62 . . . . 0.0 110.309 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.161 -1.4 . . . . 0.0 109.333 166.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.5 m -58.58 -64.12 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.493 1.117 . . . . 0.0 111.569 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -129.59 28.66 5.14 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.64 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -104.93 125.23 50.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.864 1.266 . . . . 0.0 107.682 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -84.61 -179.96 7.25 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.102 0.961 . . . . 0.0 109.907 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 80.23 113.58 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.515 1.926 . . . . 0.0 111.245 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.5 t -70.11 133.23 46.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.952 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -65.65 -36.24 83.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.661 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m 69.3 91.77 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.713 1.605 . . . . 0.0 109.898 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 68.06 -165.14 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.125 1.77 . . . . 0.0 109.886 -170.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t 68.78 89.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.784 1.633 . . . . 0.0 109.412 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -93.04 -27.26 17.09 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.421 1.488 . . . . 0.0 111.918 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.52 121.85 32.13 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.028 0.931 . . . . 0.0 109.435 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.46 -90.1 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.164 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.82 140.23 58.85 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.356 0.662 . . . . 0.0 111.803 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 -179.44 4.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.227 1.011 . . . . 0.0 111.734 -171.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -106.38 130.8 54.14 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.303 0.641 . . . . 0.0 112.667 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 69' ' ' LEU . 65.3 ttp -69.12 156.9 37.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 154.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.05 87.37 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.12 107.18 19.13 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.839 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -85.97 102.49 13.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 t -96.78 121.82 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 122.912 0.485 . . . . 0.0 110.424 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.67 153.13 20.98 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.655 1.182 . . . . 0.0 111.384 -175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.46 -155.51 17.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.463 1.506 . . . . 0.0 110.695 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 16.86 0.82 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.54 0.736 . . . . 0.0 111.563 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.4 -20.59 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.936 0.895 . . . . 0.0 111.57 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.93 138.65 50.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.384 0.673 . . . . 0.0 109.325 167.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.29 -64.23 4.2 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.8 157.6 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.343 1.057 . . . . 0.0 108.715 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.16 -96.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.514 1.054 . . . . 0.0 112.728 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 t80 63.64 -62.06 0.15 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.4 2.28 . . . . 0.0 112.931 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -33.18 -44.59 0.13 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.44 2.696 . . . . 0.0 112.879 167.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -69.38 -45.77 68.51 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.361 0.664 . . . . 0.0 109.869 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -56.25 -46.22 79.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.44 0.696 . . . . 0.0 110.927 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.28 -37.38 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.924 0.49 . . . . 0.0 110.485 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -64.31 -49.98 69.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.261 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mm -45.42 -56.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.661 1.118 . . . . 0.0 111.515 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -64.36 -48.33 75.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.98 -51.06 59.73 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.63 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.391 1.476 . . . . 0.0 109.269 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -55.23 -38.57 68.65 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.496 0.718 . . . . 0.0 110.883 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.33 2.81 55.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.266 1.426 . . . . 0.0 113.161 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 62.52 4.95 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.883 0.765 . . . . 0.0 111.68 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -116.97 143.91 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 125.517 1.527 . . . . 0.0 108.597 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -101.84 170.01 8.43 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.771 1.228 . . . . 0.0 109.038 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.13 -143.58 11.07 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.853 0.752 . . . . 0.0 112.344 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -174.15 142.56 0.83 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.568 1.147 . . . . 0.0 108.953 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.74 79.03 1.88 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -93.5 96.34 9.82 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.792 -164.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.78 93.89 9.62 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 126.292 1.837 . . . . 0.0 110.182 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.03 110.62 6.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.58 64.78 8.66 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.208 2.606 . . . . 0.0 111.567 -161.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -167.36 38.26 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.87 1.668 . . . . 0.0 109.569 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.27 -105.86 0.28 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -121.14 144.53 48.52 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.618 1.567 . . . . 0.0 110.568 -165.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.63 125.21 41.85 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.717 0.807 . . . . 0.0 110.397 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.08 116.32 27.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.0 t -112.81 123.19 68.23 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.062 0 C-N-CA 124.065 0.946 . . . . 0.0 108.682 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 m -118.0 69.3 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.5 0.72 . . . . 0.0 111.406 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.49 128.45 35.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.948 0.899 . . . . 0.0 111.293 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.65 107.6 15.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.588 0.755 . . . . 0.0 111.085 -167.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.99 172.68 34.58 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.634 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -67.42 168.0 11.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.015 1.326 . . . . 0.0 109.026 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.99 -18.56 53.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.935 0.494 . . . . 0.0 112.093 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.71 -29.12 69.03 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.21 1.004 . . . . 0.0 110.683 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -111.91 -2.04 15.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.114 1.366 . . . . 0.0 112.073 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.21 -66.31 0.6 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -41.2 -45.43 2.85 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 125.313 1.445 . . . . 0.0 112.129 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -54.17 -52.72 60.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.59 0.756 . . . . 0.0 111.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.12 -24.08 61.42 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.825 1.65 . . . . 0.0 111.947 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 16' ' ' MET . 3.3 mm? -82.61 -61.54 1.85 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.991 0.916 . . . . 0.0 111.103 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -47.15 -45.51 22.64 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.584 1.954 . . . . 0.0 111.446 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -29.76 -56.99 0.17 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.022 1.729 . . . . 0.0 112.022 164.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.3 mt -73.02 -71.41 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 122.761 0.424 . . . . 0.0 110.876 -167.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -48.49 -44.64 36.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.137 0.975 . . . . 0.0 112.319 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -103.42 53.17 0.76 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.239 1.016 . . . . 0.0 110.57 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.71 153.17 24.65 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 165.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.02 114.0 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.775 2.983 . . . . 0.0 110.991 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.75 145.96 47.38 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.221 1.947 . . . . 0.0 110.838 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.01 -21.37 62.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.46 0.704 . . . . 0.0 111.777 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.1 172.15 10.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.207 1.403 . . . . 0.0 110.828 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.6 73.44 3.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.96 121.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 124.539 1.136 . . . . 0.0 109.096 170.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -77.97 -60.18 2.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.32 152.71 6.14 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 122.905 0.482 . . . . 0.0 110.895 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.26 97.95 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.245 1.018 . . . . 0.0 109.03 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.02 75.73 7.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -80.45 163.05 24.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.532 0.682 . . . . 0.0 112.197 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 123.52 18.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.721 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 123.86 25.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 164.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -128.72 174.31 9.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.945 0.898 . . . . 0.0 110.119 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.64 141.39 28.99 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 169.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.56 139.25 58.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.467 1.507 . . . . 0.0 111.393 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -78.84 -49.32 13.12 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.223 1.009 . . . . 0.0 108.931 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.43 175.56 41.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -86.39 106.13 17.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 109.153 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -63.43 134.04 55.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.126 0.97 . . . . 0.0 108.643 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.72 96.68 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.279 0.632 . . . . 0.0 109.61 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 71.22 -170.43 0.15 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.798 1.639 . . . . 0.0 110.668 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.01 92.11 2.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.437 1.095 . . . . 0.0 108.466 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -121.88 164.41 17.58 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.719 0.408 . . . . 0.0 109.959 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -99.01 139.34 34.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.474 0.71 . . . . 0.0 110.508 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.827 -1.559 . . . . 0.0 111.101 -179.173 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 112.266 -0.334 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.6 t 57.12 37.27 28.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.161 1.384 . . . . 0.0 112.116 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.46 69.41 5.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.317 1.047 . . . . 0.0 108.902 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -125.14 149.81 47.52 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.147 0.979 . . . . 0.0 111.382 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -132.51 71.76 1.48 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.197 1.399 . . . . 0.0 107.441 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -157.5 60.4 0.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 p -144.67 -73.78 0.25 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.619 0.768 . . . . 0.0 110.696 -169.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 t70 54.42 76.07 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.272 1.829 . . . . 0.0 111.138 -172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 p -81.67 57.69 3.47 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.701 0.8 . . . . 0.0 109.105 172.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.57 91.1 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.484 1.113 . . . . 0.0 108.184 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -157.2 139.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.092 0.957 . . . . 0.0 109.376 175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 71.42 53.91 0.22 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.183 1.793 . . . . 0.0 113.365 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -138.08 125.06 21.3 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.658 0.783 . . . . 0.0 110.514 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.0 mtp -169.91 165.64 9.59 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.793 1.237 . . . . 0.0 109.935 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.07 164.89 4.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.719 1.608 . . . . 0.0 109.624 171.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 163.54 13.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.966 0.906 . . . . 0.0 112.309 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -84.62 114.36 21.94 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.495 0.664 . . . . 0.0 110.182 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.0 ptm -88.71 102.31 14.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.743 0.817 . . . . 0.0 110.149 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.62 108.01 18.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.908 1.283 . . . . 0.0 108.372 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.77 108.57 18.03 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.796 1.239 . . . . 0.0 110.382 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.7 116.81 29.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.588 1.955 . . . . 0.0 107.348 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.37 120.97 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.29 150.8 26.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.353 1.061 . . . . 0.0 110.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.65 -154.31 21.24 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.702 1.144 . . . . 0.0 110.743 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.36 17.81 3.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.365 0.602 . . . . 0.0 110.211 166.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.43 -36.89 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.664 1.986 . . . . 0.0 112.14 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -75.26 80.13 2.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.13 -67.04 0.05 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.95 38.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.883 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.73 -93.34 0.12 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.902 1.239 . . . . 0.0 112.499 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.2 t80 70.78 -38.29 0.41 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.511 2.324 . . . . 0.0 114.128 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -42.87 -44.83 4.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.297 1.439 . . . . 0.0 112.531 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -69.37 -48.83 60.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.079 0.552 . . . . 0.0 110.537 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -51.77 -43.37 62.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.494 1.118 . . . . 0.0 111.707 174.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' N ' HH21 ' A' ' 71' ' ' ARG . 85.0 t -60.6 -39.7 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -45.95 79.66 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 117.32 -1.324 . . . . 0.0 112.046 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.3 mm -48.14 -54.58 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.123 1.783 . . . . 0.0 111.922 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -66.75 -47.21 72.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.132 -0.461 . . . . 0.0 109.967 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.59 -52.09 24.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.426 0.69 . . . . 0.0 112.717 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.87 -43.17 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 126.434 1.894 . . . . 0.0 110.099 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -63.61 -34.33 77.59 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.102 0.561 . . . . 0.0 111.791 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.2 18.67 20.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.252 . . . . 0.0 112.305 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.01 63.82 4.91 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.413 1.006 . . . . 0.0 113.512 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.14 146.51 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.757 1.623 . . . . 0.0 108.659 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HZ1' ' HB2' ' A' ' 94' ' ' GLU . 6.9 mtmp? -109.79 166.93 10.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.76 1.224 . . . . 0.0 108.403 173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.79 -152.97 24.11 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.786 0.721 . . . . 0.0 112.717 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -166.28 141.09 4.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.225 1.01 . . . . 0.0 109.132 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.89 91.11 3.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.657 1.183 . . . . 0.0 108.962 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -85.94 80.91 8.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -102.91 59.25 0.78 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.456 1.102 . . . . 0.0 108.932 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.4 mt -71.52 108.81 4.36 Favored Pre-proline 0 C--N 1.34 0.188 0 C-N-CA 125.629 1.572 . . . . 0.0 108.43 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -79.71 64.07 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.845 3.03 . . . . 0.0 112.804 -163.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -173.01 54.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.903 2.081 . . . . 0.0 108.095 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 -109.3 0.33 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 m -133.09 160.53 36.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.607 1.163 . . . . 0.0 110.801 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.34 95.54 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.424 1.09 . . . . 0.0 110.344 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.44 134.47 42.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.595 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.8 t -106.35 133.38 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.26 78.05 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.19 166.86 16.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.715 1.206 . . . . 0.0 109.818 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.86 109.41 7.44 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 118.866 -0.588 . . . . 0.0 111.965 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.32 149.19 21.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.961 0.8 . . . . 0.0 113.794 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -57.48 -87.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.405 2.282 . . . . 0.0 111.769 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -154.75 -71.16 0.13 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.04 1.736 . . . . 0.0 107.157 -165.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -51.66 -50.65 59.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 164.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.25 62.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.319 1.047 . . . . 0.0 111.949 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -67.07 -66.84 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -48.4 -36.21 14.25 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.956 1.703 . . . . 0.0 113.291 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -63.76 -50.39 69.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.75 0.705 . . . . 0.0 112.542 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.39 -22.85 60.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.707 0.685 . . . . 0.0 111.134 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.22 -58.05 4.22 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.858 -0.526 . . . . 0.0 110.909 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.31 -31.91 73.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.37 0.668 . . . . 0.0 111.614 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.426 HH21 ' N ' ' A' ' 33' ' ' VAL . 17.3 tpt85 -39.28 -54.2 1.85 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.078 1.351 . . . . 0.0 110.364 162.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.83 -53.0 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.032 0.533 . . . . 0.0 111.319 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.51 -38.42 91.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.297 0.499 . . . . 0.0 111.293 -168.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -76.05 -37.94 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.887 0.875 . . . . 0.0 111.482 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.15 74.58 0.24 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.319 0.961 . . . . 0.0 111.21 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.81 164.01 34.44 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.635 2.89 . . . . 0.0 111.688 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.97 128.03 11.18 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.218 2.612 . . . . 0.0 109.293 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.62 65.2 6.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.867 0.867 . . . . 0.0 110.058 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.99 74.38 0.43 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.459 0.704 . . . . 0.0 110.093 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 30.02 72.26 0.06 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.503 1.921 . . . . 0.0 110.877 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 90.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -50.72 -55.29 17.29 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.96 0.904 . . . . 0.0 110.098 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -170.47 140.56 1.81 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 171.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.09 84.37 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 165.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.67 76.25 7.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -71.73 160.12 33.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.9 m -150.39 95.56 2.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 141.26 57.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.739 0.816 . . . . 0.0 110.064 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m -133.49 177.49 7.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.552 0.741 . . . . 0.0 111.456 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.03 124.02 34.94 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.051 1.74 . . . . 0.0 108.288 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -55.73 122.14 10.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.935 0.494 . . . . 0.0 112.017 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.65 -47.94 73.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.94 -157.02 10.11 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 13.8 pt-20 -89.03 107.45 19.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.659 1.184 . . . . 0.0 109.358 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.75 73.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.05 137.04 8.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.944 1.698 . . . . 0.0 112.644 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 63.12 -165.57 0.24 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.392 1.077 . . . . 0.0 109.063 -173.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.75 82.81 1.22 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 169.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -108.98 162.81 13.87 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -171.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.11 134.06 55.14 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 111.072 -167.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.183 -1.389 . . . . 0.0 108.468 162.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.3 m -66.2 135.88 55.12 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.596 0.759 . . . . 0.0 110.435 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mtp -125.75 -80.45 0.61 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.285 1.034 . . . . 0.0 108.538 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -119.65 179.73 4.14 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.925 1.29 . . . . 0.0 109.776 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.3 163.73 32.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.63 1.172 . . . . 0.0 110.534 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 69.61 60.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.036 1.734 . . . . 0.0 110.507 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.1 t -77.23 69.82 3.55 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.244 1.018 . . . . 0.0 110.266 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.2 t0 66.94 164.41 0.2 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.003 2.121 . . . . 0.0 112.383 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.3 m 65.26 78.87 0.27 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.335 1.454 . . . . 0.0 110.726 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -133.41 69.25 1.48 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.95 1.3 . . . . 0.0 107.596 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.24 150.14 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.419 1.087 . . . . 0.0 109.143 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -86.7 -66.27 0.92 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.959 0.904 . . . . 0.0 110.121 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.85 148.44 46.77 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.128 1.371 . . . . 0.0 109.387 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 90.5 mtp -75.39 -76.65 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp -131.93 155.3 48.17 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.522 1.129 . . . . 0.0 109.867 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -178.21 3.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.413 1.085 . . . . 0.0 111.393 -174.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -99.91 127.12 46.12 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.887 0.475 . . . . 0.0 110.773 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 10.8 ptm -97.9 96.62 8.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.141 0.972 . . . . 0.0 110.266 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -87.81 108.63 19.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.5 1.12 . . . . 0.0 108.587 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.74 109.15 14.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 110.721 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.25 100.37 12.94 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.433 1.093 . . . . 0.0 108.848 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 101.74 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -92.78 155.51 17.61 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.269 0.627 . . . . 0.0 111.758 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.95 -155.37 21.22 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.352 1.454 . . . . 0.0 111.581 170.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -81.6 28.99 0.38 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.996 0.918 . . . . 0.0 110.238 173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.2 m -76.13 -6.98 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.336 1.055 . . . . 0.0 112.717 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 164.83 25.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 164.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.87 -62.9 4.47 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -171.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -72.83 155.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.56 -83.11 0.33 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 122.949 0.309 . . . . 0.0 112.383 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 47.5 56.3 7.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.594 1.558 . . . . 0.0 111.519 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.97 -41.32 0.53 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.428 1.491 . . . . 0.0 108.729 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -72.39 -48.91 37.82 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.328 0.651 . . . . 0.0 110.848 171.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.17 -46.37 68.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.136 0.494 . . . . 0.0 111.114 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.19 -35.48 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.246 0.619 . . . . 0.0 110.359 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -47.15 78.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.058 0.943 . . . . 0.0 110.641 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.57 -56.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.62 1.1 . . . . 0.0 110.935 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -70.41 -40.78 73.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.281 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.94 -54.91 11.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.2 0.6 . . . . 0.0 111.634 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.89 -38.81 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.119 1.368 . . . . 0.0 111.349 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -59.44 -37.1 77.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.915 0.486 . . . . 0.0 111.137 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -98.13 19.06 14.75 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.772 0.829 . . . . 0.0 112.869 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 56.54 22.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.023 0.821 . . . . 0.0 113.204 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -104.49 143.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 125.387 1.475 . . . . 0.0 108.91 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -104.27 171.27 7.43 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.531 1.132 . . . . 0.0 108.549 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.49 -138.72 10.27 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.207 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -166.6 145.9 5.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.508 0.654 . . . . 0.0 112.358 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.58 85.7 2.37 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.907 1.683 . . . . 0.0 108.938 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -95.39 100.84 12.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.012 0.525 . . . . 0.0 110.351 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.64 116.23 8.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 170.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.2 mt -94.13 94.12 1.04 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.57 141.52 95.5 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.387 2.058 . . . . 0.0 111.024 -170.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.49 61.57 2.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.644 1.178 . . . . 0.0 109.634 -166.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.75 -126.67 1.0 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -129.25 149.2 51.15 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.035 1.734 . . . . 0.0 109.303 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.6 99.42 5.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.25 125.34 30.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.84 1.256 . . . . 0.0 108.362 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -112.95 125.3 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.8 77.87 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 161.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' HG3' ' A' ' 16' ' ' MET . . . -84.32 162.14 20.18 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.036 1.334 . . . . 0.0 108.845 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -138.93 105.15 5.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.069 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.03 166.23 24.96 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 118.708 0.685 . . . . 0.0 112.911 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -67.8 173.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.36 1.064 . . . . 0.0 108.632 161.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.85 -31.19 63.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.2 -20.49 65.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.128 0.571 . . . . 0.0 112.287 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.68 -12.09 18.67 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.938 0.895 . . . . 0.0 111.781 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.94 -70.7 0.24 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 p -43.81 -34.81 1.68 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.028 1.331 . . . . 0.0 113.602 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -68.73 -56.47 8.0 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.85 0.86 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.45 -22.16 62.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.425 0.69 . . . . 0.0 111.175 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.5 -59.77 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.6 -0.687 . . . . 0.0 110.191 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -61.69 -32.09 72.26 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.718 0.69 . . . . 0.0 111.85 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -43.54 -51.45 6.79 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.415 1.486 . . . . 0.0 111.952 164.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -67.29 -53.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 C-N-CA 123.246 0.619 . . . . 0.0 110.519 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -41.78 93.76 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.893 0.315 . . . . 0.0 110.63 -172.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -70.39 -42.12 72.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.447 1.499 . . . . 0.0 111.497 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.2 78.08 0.24 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.355 1.455 . . . . 0.0 111.075 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.75 169.39 17.68 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 124.033 3.155 . . . . 0.0 112.126 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.59 162.14 38.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.03 2.486 . . . . 0.0 110.944 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.91 33.74 0.33 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.807 0.843 . . . . 0.0 111.852 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -150.94 174.16 13.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.398 1.079 . . . . 0.0 109.857 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.26 88.52 0.85 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.0 p -67.07 122.24 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.872 0.869 . . . . 0.0 109.218 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -75.24 -58.04 3.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -166.11 132.67 2.59 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.029 0.531 . . . . 0.0 110.112 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -87.25 86.17 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 162.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.53 75.61 9.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.95 151.57 33.63 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.633 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.6 m -151.18 95.61 2.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.624 0.77 . . . . 0.0 109.349 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -60.9 152.79 26.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.427 1.491 . . . . 0.0 110.801 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.0 m -157.91 176.72 12.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.67 144.54 45.79 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -65.49 132.71 49.59 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.53 1.132 . . . . 0.0 112.401 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -69.23 -51.88 33.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 109.119 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.91 -178.16 36.5 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.61 111.9 23.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.978 1.311 . . . . 0.0 108.524 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -75.46 -17.97 59.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.843 0.857 . . . . 0.0 111.948 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 66.12 94.94 0.06 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.71 1.604 . . . . 0.0 111.181 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 68.85 155.75 0.13 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.393 1.877 . . . . 0.0 110.986 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -101.94 92.06 4.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -110.84 160.45 16.75 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -105.36 142.77 34.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.984 0.514 . . . . 0.0 111.644 -167.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.032 174.259 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 35.9 m -136.2 39.22 2.72 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.88 0.872 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.3 mtt -84.47 50.33 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.733 0.813 . . . . 0.0 110.916 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -88.21 69.37 9.17 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -95.31 -64.47 1.06 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.1 0.96 . . . . 0.0 109.868 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -140.43 154.34 46.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.163 1.785 . . . . 0.0 108.549 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 m -68.3 151.63 46.63 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.415 0.686 . . . . 0.0 110.589 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.57 121.8 14.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.66 0.784 . . . . 0.0 110.296 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -77.63 133.68 38.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -141.01 170.6 15.43 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.783 1.233 . . . . 0.0 109.254 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.6 116.38 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.7 -45.4 81.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.863 1.265 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.42 51.94 2.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.737 1.215 . . . . 0.0 110.659 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -54.3 41.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.0 110.065 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 pp -102.9 156.48 17.63 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.942 0.897 . . . . 0.0 110.118 172.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.59 144.09 48.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.237 1.415 . . . . 0.0 109.761 -166.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -83.07 108.71 16.55 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.97 0.508 . . . . 0.0 111.131 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.7 ptm -93.41 94.06 8.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.494 0.664 . . . . 0.0 109.74 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.91 133.48 43.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.09 104.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -97.1 100.52 12.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.107 1.763 . . . . 0.0 109.207 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.55 127.13 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 110.226 177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -102.66 155.04 18.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.941 1.297 . . . . 0.0 110.14 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.56 -168.85 19.48 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.003 1.287 . . . . 0.0 110.65 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -88.8 56.04 3.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.78 3.7 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.384 1.073 . . . . 0.0 112.372 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.89 152.99 25.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.76 -56.15 4.67 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -69.75 -179.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.593 0.757 . . . . 0.0 110.556 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.71 -97.19 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.269 0.938 . . . . 0.0 112.863 -171.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.9 t80 64.0 -65.01 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.78 2.032 . . . . 0.0 113.078 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -48.5 -31.32 6.26 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 127.185 2.194 . . . . 0.0 113.177 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.29 -46.57 15.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.493 1.517 . . . . 0.0 110.851 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.78 -49.37 77.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.021 0.528 . . . . 0.0 111.341 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.02 -26.99 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.389 172.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -64.99 -56.07 15.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.905 0.882 . . . . 0.0 110.173 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.5 mm -43.83 -56.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 118.876 0.762 . . . . 0.0 111.029 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -64.62 -49.59 70.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.21 -65.06 0.63 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.515 0.726 . . . . 0.0 112.212 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.61 -50.97 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 126.097 1.759 . . . . 0.0 110.132 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -56.82 -41.39 77.72 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.385 0.674 . . . . 0.0 110.864 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.9 mt -93.93 15.36 16.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.399 1.48 . . . . 0.0 113.144 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.82 48.61 84.43 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.972 0.796 . . . . 0.0 113.123 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.08 143.2 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.394 1.478 . . . . 0.0 107.846 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -104.09 169.36 8.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.425 1.09 . . . . 0.0 108.282 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.82 -150.4 22.28 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 119.162 0.892 . . . . 0.0 112.886 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -170.89 140.76 1.65 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.836 1.254 . . . . 0.0 109.172 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.15 89.86 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.37 1.068 . . . . 0.0 110.288 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.11 98.19 7.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.261 0.624 . . . . 0.0 110.796 -165.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.63 115.03 16.02 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.51 170.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.68 104.51 10.43 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.99 141.68 65.36 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.058 2.505 . . . . 0.0 111.597 -163.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 63.98 60.03 1.05 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.809 1.644 . . . . 0.0 110.426 -171.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -129.49 1.51 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 p -120.87 163.44 18.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.627 1.571 . . . . 0.0 109.835 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -116.92 125.09 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.977 0.911 . . . . 0.0 110.77 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.54 145.46 30.27 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 122.929 0.492 . . . . 0.0 110.656 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.91 137.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 66.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.5 155.58 29.73 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.473 1.109 . . . . 0.0 109.94 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -142.86 106.24 4.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.921 -0.562 . . . . 0.0 109.888 -167.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.03 149.78 19.99 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.295 0.498 . . . . 0.0 113.912 -171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -63.06 163.88 9.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.757 0.823 . . . . 0.0 108.856 162.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -78.18 -34.24 49.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.464 0.706 . . . . 0.0 111.11 -171.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -69.65 -9.04 52.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.979 0.912 . . . . 0.0 111.632 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.91 4.32 10.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.672 1.189 . . . . 0.0 111.907 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.6 tp -71.62 -68.56 0.44 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.427 1.012 . . . . 0.0 109.619 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.2 p -44.98 -42.47 8.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.558 1.543 . . . . 0.0 112.957 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -53.42 -48.59 68.61 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.237 1.015 . . . . 0.0 111.05 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.44 -51.97 17.91 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -52.54 -57.06 11.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.467 0.576 . . . . 0.0 111.777 -170.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -54.48 -40.37 68.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.056 1.343 . . . . 0.0 112.456 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.9 -51.14 7.77 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.214 1.006 . . . . 0.0 110.681 169.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -69.48 -53.58 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.329 -173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -46.44 71.65 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.071 0.396 . . . . 0.0 111.56 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -71.87 -55.61 7.22 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.862 0.865 . . . . 0.0 110.49 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.32 97.87 2.11 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.295 -1.281 . . . . 0.0 110.561 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.74 145.23 80.53 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.496 2.131 . . . . 0.0 109.07 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -86.93 49.54 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.913 1.742 . . . . 0.0 114.498 -153.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 56.58 37.15 28.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.36 1.064 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.3 161.72 39.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.058 0.943 . . . . 0.0 109.238 -168.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -84.55 75.89 10.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.95 135.59 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.905 1.282 . . . . 0.0 110.817 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.96 -57.57 2.32 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.018 1.327 . . . . 0.0 108.319 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -166.72 137.76 3.33 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 122.878 0.471 . . . . 0.0 110.996 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.33 96.4 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 O-C-N 121.784 -0.572 . . . . 0.0 110.169 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.97 72.26 9.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.7 161.95 28.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.476 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.5 t -137.9 127.43 24.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.606 0.762 . . . . 0.0 110.037 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.58 131.37 42.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 167.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.4 m -128.21 -160.06 0.99 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.292 1.037 . . . . 0.0 110.02 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -120.83 152.81 37.93 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.634 1.973 . . . . 0.0 108.967 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -52.21 86.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.919 1.688 . . . . 0.0 111.641 166.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -100.75 -54.8 2.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.727 1.211 . . . . 0.0 110.468 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.56 133.96 5.83 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.1 92.22 8.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.428 1.091 . . . . 0.0 109.809 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -72.13 87.92 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.86 143.39 56.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.635 0.774 . . . . 0.0 110.54 -174.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 64.9 -170.27 0.19 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.845 1.258 . . . . 0.0 109.374 -166.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.41 100.75 2.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.84 158.06 26.38 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 122.965 0.506 . . . . 0.0 111.391 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.67 139.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.686 1.195 . . . . 0.0 110.121 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.94 -178.719 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.8 m -150.13 54.76 0.92 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.095 0.958 . . . . 0.0 109.371 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt -85.34 54.98 3.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 0.0 110.219 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -98.46 140.12 33.19 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.22 1.008 . . . . 0.0 109.105 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -167.32 64.75 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -84.54 56.27 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.088 0.955 . . . . 0.0 110.951 -170.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.2 m -137.92 134.24 34.74 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.777 1.631 . . . . 0.0 108.309 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.5 t0 63.2 178.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.286 1.434 . . . . 0.0 110.576 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.5 m 77.39 -40.39 0.34 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.089 1.756 . . . . 0.0 112.236 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.91 -168.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.579 1.951 . . . . 0.0 112.336 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.15 136.96 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.113 0.965 . . . . 0.0 108.849 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -172.73 -43.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.614 1.566 . . . . 0.0 109.826 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.82 130.2 24.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.832 2.053 . . . . 0.0 111.978 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 mmt -145.47 163.31 35.07 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.064 1.745 . . . . 0.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . 0.255 0.3 OUTLIER 72.95 134.38 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.303 2.641 . . . . 0.0 111.843 175.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.77 165.38 18.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.926 0.89 . . . . 0.0 111.999 -163.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -97.55 123.81 41.57 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-O 121.545 0.688 . . . . 0.0 112.092 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.9 ttp -67.9 154.79 40.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 150.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.8 106.94 2.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.39 116.94 28.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.299 1.04 . . . . 0.0 109.547 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.71 93.73 7.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.9 t -92.7 110.01 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.48 0.312 . . . . 0.0 110.646 -166.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -97.96 145.46 26.45 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.204 1.002 . . . . 0.0 110.823 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.52 -166.37 30.17 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 123.751 0.691 . . . . 0.0 111.973 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.84 15.74 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.523 0.729 . . . . 0.0 110.961 169.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.5 -15.44 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.114 1.366 . . . . 0.0 112.29 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -77.13 29.41 0.14 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.369 1.468 . . . . 0.0 113.737 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.82 24.13 0.17 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.153 1.359 . . . . 0.0 112.292 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.97 169.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.227 1.011 . . . . 0.0 108.582 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.87 33.35 2.15 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.663 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.2 t80 -78.48 45.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.031 1.415 . . . . 0.0 110.594 173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -141.13 -45.88 0.39 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.897 2.479 . . . . 0.0 106.526 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -71.26 -44.67 64.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.097 0.959 . . . . 0.0 110.195 169.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.93 -55.62 28.6 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.941 -0.474 . . . . 0.0 111.752 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.21 -34.64 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 122.725 0.41 . . . . 0.0 111.32 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -58.66 -38.57 78.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.404 1.482 . . . . 0.0 112.809 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.45 -57.47 11.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.352 1.433 . . . . 0.0 110.487 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -64.03 -38.98 93.04 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.6 0.636 . . . . 0.0 110.679 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.85 11.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.064 0.545 . . . . 0.0 111.966 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.94 -36.42 77.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.498 0.719 . . . . 0.0 110.861 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -52.41 -43.93 65.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.282 1.033 . . . . 0.0 109.479 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.11 23.07 13.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.05 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.22 63.77 4.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.5 1.048 . . . . 0.0 112.999 173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.41 138.12 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.221 1.409 . . . . 0.0 108.304 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -100.89 165.03 11.55 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.326 1.05 . . . . 0.0 108.463 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.41 -139.34 7.09 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -176.4 148.49 0.75 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.581 0.691 . . . . 0.0 110.669 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.46 78.73 1.14 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 109.502 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -90.22 86.32 6.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.946 0.879 . . . . 0.0 109.244 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.5 97.26 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.967 1.307 . . . . 0.0 109.945 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.6 mt -78.63 102.22 0.95 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 125.059 1.344 . . . . 0.0 107.582 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.79 146.84 79.77 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.501 2.134 . . . . 0.0 111.118 -164.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t70 55.28 53.35 10.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.476 1.11 . . . . 0.0 109.489 -167.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.3 -132.95 1.63 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -127.37 149.69 49.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.743 1.617 . . . . 0.0 109.94 -169.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.96 115.8 29.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 121.594 0.711 . . . . 0.0 109.419 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.97 103.49 16.0 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.34 1.456 . . . . 0.0 107.079 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.58 132.23 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.316 0.646 . . . . 0.0 109.833 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.56 145.83 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.58 119.39 4.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.359 0.527 . . . . 0.0 110.652 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -109.67 107.44 17.49 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.307 1.443 . . . . 0.0 110.865 -166.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.66 174.94 26.33 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-O 121.826 0.681 . . . . 0.0 113.011 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -72.64 173.25 9.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 160.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.97 -30.02 63.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -64.84 -17.86 64.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.426 0.691 . . . . 0.0 112.598 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.44 -2.98 10.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.411 1.085 . . . . 0.0 112.263 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -68.18 -62.32 1.45 Allowed 'General case' 0 C--N 1.345 0.411 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -42.69 -42.84 3.63 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.737 1.615 . . . . 0.0 113.064 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -51.49 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.953 0.501 . . . . 0.0 111.454 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.05 -24.15 63.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.499 1.12 . . . . 0.0 111.639 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.96 -61.79 1.88 Allowed 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 124.862 1.265 . . . . 0.0 108.835 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.23 -25.7 65.33 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.266 1.426 . . . . 0.0 111.766 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -31.98 -54.23 0.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.185 1.394 . . . . 0.0 110.776 159.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mt -71.21 -56.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.87 -48.76 80.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.454 0.302 . . . . 0.0 110.818 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -68.92 -42.34 76.94 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.811 1.245 . . . . 0.0 111.247 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.58 79.1 0.27 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.077 1.322 . . . . 0.0 110.02 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.75 163.37 38.64 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.631 2.887 . . . . 0.0 111.919 -173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.86 162.36 37.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.715 2.943 . . . . 0.0 111.204 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.67 42.23 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.848 0.859 . . . . 0.0 111.039 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -145.92 162.86 36.82 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.778 1.231 . . . . 0.0 109.54 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.1 mp0 -75.02 83.72 2.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.389 1.075 . . . . 0.0 109.192 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.31 83.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.288 1.435 . . . . 0.0 109.914 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -41.0 -60.88 1.08 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.311 1.844 . . . . 0.0 111.37 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -162.62 133.63 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.091 0.244 . . . . 0.0 110.84 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.04 94.24 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 165.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.39 70.05 10.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -75.76 161.3 29.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.391 0.615 . . . . 0.0 111.494 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -143.03 97.55 3.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.63 1.172 . . . . 0.0 108.952 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -55.91 127.33 29.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.673 1.189 . . . . 0.0 109.188 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -134.93 -163.21 1.35 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.53 1.132 . . . . 0.0 109.679 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 151.59 47.17 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.547 0.739 . . . . 0.0 110.04 173.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -58.3 124.7 20.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.969 0.908 . . . . 0.0 112.001 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -73.76 -45.3 52.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.55 176.23 37.21 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -86.95 96.81 10.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.488 1.515 . . . . 0.0 109.505 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -56.06 -55.32 34.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.299 1.04 . . . . 0.0 111.099 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 52.61 61.22 3.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 112.107 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 t70 155.75 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.723 2.809 . . . . 0.0 108.213 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.59 98.1 10.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 168.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -117.45 165.35 13.62 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.454 0.702 . . . . 0.0 109.308 176.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -114.84 144.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.575 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.314 -1.327 . . . . 0.0 108.756 150.512 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.115 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.0 m -144.4 102.73 3.88 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.109 0.963 . . . . 0.0 108.652 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -90.71 60.26 4.45 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.219 1.007 . . . . 0.0 109.656 -171.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -94.05 -173.34 3.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.0 109.828 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 57.83 76.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.302 1.441 . . . . 0.0 110.071 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -116.1 158.79 22.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.568 1.547 . . . . 0.0 109.204 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.9 m -125.98 140.39 52.66 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.378 1.471 . . . . 0.0 109.606 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -162.69 -178.25 6.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.434 1.094 . . . . 0.0 109.154 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p 43.72 51.88 6.48 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.326 1.851 . . . . 0.0 113.02 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -117.44 75.74 1.0 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.47 1.108 . . . . 0.0 108.855 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -162.76 143.7 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.581 1.152 . . . . 0.0 108.643 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -76.68 -56.58 4.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.949 0.499 . . . . 0.0 109.964 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.51 117.83 30.06 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.073 1.349 . . . . 0.0 109.224 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.8 mtt -66.21 -60.15 3.07 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.696 0.398 . . . . 0.0 110.243 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -139.66 146.7 40.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.672 0.789 . . . . 0.0 110.704 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 166.39 16.87 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.882 1.273 . . . . 0.0 111.695 -167.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ptt85 -94.77 124.55 38.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.633 0.773 . . . . 0.0 111.773 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -90.52 151.93 21.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 160.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -135.39 102.64 5.21 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.45 1.1 . . . . 0.0 109.097 -177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.05 106.3 16.76 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.049 0.54 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 98.02 10.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.67 104.23 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -76.16 153.28 36.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.71 -155.51 16.23 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 123.735 0.683 . . . . 0.0 112.549 162.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.71 28.2 0.79 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.158 0.983 . . . . 0.0 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.87 -9.62 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.177 0.991 . . . . 0.0 113.064 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.66 164.93 18.15 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 162.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.69 3.77 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.05 142.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.35 52.73 4.77 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.434 0.54 . . . . 0.0 113.089 -165.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -87.6 51.08 2.13 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.466 0.706 . . . . 0.0 110.437 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -52.61 0.93 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.404 1.481 . . . . 0.0 107.238 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -47.72 -52.61 17.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.696 1.199 . . . . 0.0 110.711 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.88 -54.63 40.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.131 0.972 . . . . 0.0 111.436 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.2 -23.68 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.453 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -50.21 64.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.542 169.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.9 mm -52.14 -53.3 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 119.814 1.188 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -70.7 -31.21 68.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.59 -64.18 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 167.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.6 -41.0 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.312 1.445 . . . . 0.0 112.309 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -49.1 78.39 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 111.279 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -87.05 14.57 7.26 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.83 57.75 17.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.179 0.895 . . . . 0.0 111.829 176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.1 mm -119.18 140.7 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.981 1.313 . . . . 0.0 109.196 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -109.95 165.2 11.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.069 1.347 . . . . 0.0 108.595 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.69 -134.14 5.5 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 118.477 0.581 . . . . 0.0 112.169 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.99 147.8 1.68 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 122.995 0.518 . . . . 0.0 111.646 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.32 84.49 2.63 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.954 1.302 . . . . 0.0 108.75 167.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.38 86.85 5.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.791 0.805 . . . . 0.0 109.544 -169.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -89.72 81.21 6.44 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 126.251 1.821 . . . . 0.0 109.869 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.4 mt -59.85 110.99 3.24 Favored Pre-proline 0 N--CA 1.454 -0.265 0 C-N-CA 125.363 1.465 . . . . 0.0 107.978 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.06 46.36 2.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.958 2.438 . . . . 0.0 112.945 -162.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -153.43 45.92 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.879 1.672 . . . . 0.0 107.676 167.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.07 -136.84 3.87 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.8 m -120.64 173.04 7.43 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.269 1.428 . . . . 0.0 110.266 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.62 122.39 45.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 122.965 0.506 . . . . 0.0 111.744 -173.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -95.64 110.04 22.21 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.201 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -87.18 140.08 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.29 135.19 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 165.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.77 117.23 6.99 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.015 0.926 . . . . 0.0 110.101 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.69 111.4 24.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.129 0.972 . . . . 0.0 110.67 -171.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.67 29.99 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -54.78 163.97 0.87 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 110.104 170.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.47 -44.36 64.9 Favored 'General case' 0 CA--C 1.527 0.063 0 O-C-N 122.116 -0.365 . . . . 0.0 110.629 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -47.74 -43.44 27.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.678 1.191 . . . . 0.0 111.256 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.76 0.36 52.3 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.005 1.322 . . . . 0.0 112.828 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.6 tp -68.8 -60.76 2.16 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.582 1.083 . . . . 0.0 109.461 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 56.3 p -40.9 -47.89 3.04 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.424 1.489 . . . . 0.0 112.32 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.35 -41.46 65.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -73.13 -53.44 11.02 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.89 0.476 . . . . 0.0 109.75 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.8 -52.46 60.2 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.53 -45.0 73.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.234 1.414 . . . . 0.0 111.542 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.95 -53.88 3.67 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.534 1.534 . . . . 0.0 110.481 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.1 mt -63.35 -65.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.25 0.22 . . . . 0.0 110.827 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -55.63 -41.26 73.28 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.93 -37.56 88.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.77 0.828 . . . . 0.0 111.805 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.33 76.61 0.24 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.436 1.494 . . . . 0.0 110.064 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.6 168.04 23.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.349 3.366 . . . . 0.0 112.129 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 169.83 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.656 2.904 . . . . 0.0 111.418 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.68 29.03 0.82 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.0 0.92 . . . . 0.0 111.335 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.85 168.23 16.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.944 1.298 . . . . 0.0 109.635 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.7 84.06 1.61 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.875 0.87 . . . . 0.0 109.881 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.49 98.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.796 0.838 . . . . 0.0 110.293 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -49.78 -55.18 15.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.549 1.539 . . . . 0.0 110.677 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -178.06 135.24 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.086 1.354 . . . . 0.0 110.981 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.1 90.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 121.601 -0.687 . . . . 0.0 109.385 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.05 77.87 6.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -78.46 171.08 15.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.36 0.6 . . . . 0.0 112.166 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -143.39 126.14 16.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.158 1.383 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.03 129.1 34.08 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.3 m -135.7 -162.57 1.28 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.281 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.59 135.74 48.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.798 1.239 . . . . 0.0 109.496 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -57.98 135.76 56.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.315 0.646 . . . . 0.0 112.505 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -79.32 -47.19 16.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.205 0.602 . . . . 0.0 109.432 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.19 -174.28 36.19 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.21 96.56 10.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.537 1.135 . . . . 0.0 110.291 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -58.81 134.32 56.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 167.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -76.73 71.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.736 0.814 . . . . 0.0 110.468 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.06 164.04 0.26 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.422 1.889 . . . . 0.0 111.326 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -82.67 109.97 17.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 100' ' ' THR . 28.8 tt0 -111.57 178.5 4.31 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' GLU . 1.1 p -124.01 138.53 54.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.448 0.699 . . . . 0.0 109.839 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.303 167.42 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 112.262 -0.335 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 33.0 p -153.5 62.76 0.74 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.199 1.0 . . . . 0.0 109.123 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -82.99 63.86 7.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.837 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 114.06 21.18 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.657 1.183 . . . . 0.0 108.464 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -132.47 121.45 23.39 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -178.89 124.62 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.115 1.366 . . . . 0.0 107.768 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 t -139.18 149.06 43.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -164.15 149.31 10.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.332 1.053 . . . . 0.0 109.111 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.3 p -130.62 158.99 38.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.24 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -140.82 176.24 8.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.239 1.415 . . . . 0.0 108.903 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.67 142.79 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.523 1.129 . . . . 0.0 108.961 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -84.45 -66.12 0.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.765 0.826 . . . . 0.0 109.823 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.42 138.76 54.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.855 1.262 . . . . 0.0 109.078 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mmt -76.47 -55.25 5.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.193 0.597 . . . . 0.0 110.317 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -114.17 135.56 53.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.158 0.983 . . . . 0.0 110.841 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -177.06 4.34 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.321 1.048 . . . . 0.0 111.497 -168.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -106.1 135.63 47.21 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.5 ttp -77.7 157.6 30.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 157.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -144.05 88.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.324 1.449 . . . . 0.0 107.253 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.92 102.78 13.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.772 0.829 . . . . 0.0 109.96 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 97.96 9.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 84' ' ' VAL . 18.8 t -99.32 119.78 47.79 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.753 0.421 . . . . 0.0 110.0 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -103.36 148.25 26.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.622 1.569 . . . . 0.0 110.387 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.55 -159.57 23.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.09 0.852 . . . . 0.0 112.003 169.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 tp -87.78 21.85 2.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.536 0.735 . . . . 0.0 111.014 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.55 -24.4 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.282 1.033 . . . . 0.0 111.808 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.72 132.41 49.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 110.632 173.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.69 -54.33 4.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.601 0.62 . . . . 0.0 111.694 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -72.41 77.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.277 1.431 . . . . 0.0 109.963 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.17 -116.97 5.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.4 t80 62.58 -68.77 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.251 2.22 . . . . 0.0 113.504 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -56.78 -35.32 68.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.626 1.17 . . . . 0.0 110.927 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -73.94 -47.48 37.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.922 0.889 . . . . 0.0 110.238 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -53.86 -50.17 66.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.422 1.089 . . . . 0.0 112.447 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.75 -33.75 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.651 0.38 . . . . 0.0 110.506 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -46.84 73.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.888 0.875 . . . . 0.0 109.542 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 mm -51.53 -54.17 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 119.4 1.0 . . . . 0.0 110.717 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -66.27 -42.8 87.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 123.408 0.442 . . . . 0.0 109.963 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.56 -52.37 47.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.81 -43.63 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.416 1.087 . . . . 0.0 109.905 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -54.0 -37.68 64.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.526 0.73 . . . . 0.0 111.002 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -97.4 -1.52 44.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.838 1.655 . . . . 0.0 113.361 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.58 59.91 5.36 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.821 0.737 . . . . 0.0 111.91 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -125.13 138.49 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.859 1.664 . . . . 0.0 108.82 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -92.19 -178.9 5.1 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.909 1.284 . . . . 0.0 108.519 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -143.94 11.79 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 120.04 1.291 . . . . 0.0 112.338 171.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -175.3 147.18 0.87 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.858 0.863 . . . . 0.0 110.328 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.53 82.44 1.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 109.291 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -84.73 80.03 9.4 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.688 1.232 . . . . 0.0 108.636 -170.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 18.8 t-20 -85.17 75.61 10.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.626 2.77 . . . . 0.0 110.042 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -61.42 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.063 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.3 -167.42 0.38 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.98 2.453 . . . . 0.0 110.537 -170.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -100.0 50.77 0.91 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.973 1.309 . . . . 0.0 109.876 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.31 -73.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.875 0 O-C-N 122.052 -0.405 . . . . 0.0 112.439 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 m -96.43 112.21 24.03 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.654 0.782 . . . . 0.0 110.899 -168.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -103.24 132.35 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.064 0 C-N-CA 124.942 1.297 . . . . 0.0 110.059 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -92.44 122.0 34.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.16 145.37 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.445 1.098 . . . . 0.0 109.22 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.35 147.89 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.709 1.204 . . . . 0.0 107.856 167.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.94 115.55 6.75 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.083 0.953 . . . . 0.0 109.379 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -112.64 112.33 23.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -160.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.78 -168.97 35.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.53 167.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.64 160.83 24.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.652 1.581 . . . . 0.0 109.197 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.06 -19.97 53.25 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.13 -47.63 76.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.61 59.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.637 0.775 . . . . 0.0 112.166 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.8 -61.61 1.87 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.066 0.848 . . . . 0.0 108.878 174.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.7 p -40.54 -44.39 2.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.406 1.482 . . . . 0.0 113.001 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.11 -45.49 88.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.845 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.12 -23.25 60.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.103 1.361 . . . . 0.0 111.549 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -56.7 3.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.663 1.185 . . . . 0.0 109.745 -178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -58.67 -37.14 75.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.573 1.149 . . . . 0.0 111.372 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -28.81 -52.99 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 127.068 2.147 . . . . 0.0 112.075 167.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -71.04 -69.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -167.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -51.71 -43.96 63.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -62.65 -56.83 14.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.713 0.805 . . . . 0.0 110.26 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.79 81.8 0.31 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.545 1.545 . . . . 0.0 109.599 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 160.95 47.65 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.592 2.861 . . . . 0.0 111.201 -174.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -68.3 157.53 61.42 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.608 2.205 . . . . 0.0 109.559 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.75 36.98 0.34 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.235 0.614 . . . . 0.0 111.485 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.42 166.35 21.49 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.686 1.594 . . . . 0.0 109.29 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -80.55 72.86 7.48 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.13 0.572 . . . . 0.0 109.978 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -61.44 114.58 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.259 1.024 . . . . 0.0 108.475 168.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.88 -49.04 6.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 110.847 -161.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -162.42 71.09 0.31 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.467 0.651 . . . . 0.0 111.873 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 HG22 ' A' ' 20' ' ' VAL . 7.1 p -69.5 89.12 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.036 0.935 . . . . 0.0 111.214 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.07 81.58 2.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 107.963 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -78.52 164.52 24.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.31 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 m -145.59 139.96 27.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.27 1.028 . . . . 0.0 109.502 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 135.64 33.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.899 1.28 . . . . 0.0 108.352 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 m -135.62 176.82 8.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.514 0.726 . . . . 0.0 111.168 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -89.32 137.58 32.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -64.88 138.77 58.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.237 1.015 . . . . 0.0 111.596 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -79.28 -51.18 9.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.818 0.847 . . . . 0.0 109.249 174.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.15 -178.2 30.99 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.62 103.95 8.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.098 0.959 . . . . 0.0 109.463 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -78.52 70.21 4.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -51.7 127.46 20.67 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.701 1.2 . . . . 0.0 112.347 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.59 174.95 0.24 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.907 1.683 . . . . 0.0 110.85 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.56 93.36 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -112.94 158.69 19.91 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.842 0.353 . . . . 0.0 110.393 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -113.61 149.34 34.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.98 0.912 . . . . 0.0 110.362 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.405 ' HB2' ' H ' ' A' ' 48' ' ' ASN . 20.8 m-30 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.003 -1.475 . . . . 0.0 108.624 148.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.8 t -158.0 62.09 0.46 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.127 0.971 . . . . 0.0 108.778 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt -82.27 68.12 8.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.699 0.8 . . . . 0.0 109.89 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -76.93 110.2 11.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.883 0.873 . . . . 0.0 109.143 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -121.33 161.95 21.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.258 1.423 . . . . 0.0 109.411 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 74.04 145.93 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.545 1.938 . . . . 0.0 112.387 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 p -84.74 -172.03 3.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.135 0.974 . . . . 0.0 111.15 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -72.74 72.34 1.05 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.385 1.074 . . . . 0.0 108.697 168.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m 66.47 -77.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.435 1.894 . . . . 0.0 110.437 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -173.53 102.85 0.12 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.513 1.525 . . . . 0.0 107.538 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.6 m -102.58 144.73 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.455 1.102 . . . . 0.0 109.672 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.61 -52.8 0.81 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.418 1.087 . . . . 0.0 109.424 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.58 102.91 7.21 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.357 1.063 . . . . 0.0 109.908 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.09 -36.79 75.73 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.217 1.007 . . . . 0.0 111.62 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.85 -172.12 3.59 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.853 1.261 . . . . 0.0 110.376 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 159.24 34.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.1 0.96 . . . . 0.0 110.83 173.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -91.62 106.36 18.42 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.724 0.81 . . . . 0.0 110.59 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 ptm -84.68 94.69 8.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -89.81 89.91 7.96 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.83 105.28 17.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.499 0.666 . . . . 0.0 111.225 -171.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.29 102.99 13.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.462 1.105 . . . . 0.0 108.979 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.62 108.99 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -103.84 139.63 38.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.58 0.752 . . . . 0.0 111.089 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.92 -152.96 24.98 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.896 0.748 . . . . 0.0 111.837 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tp -82.26 20.7 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 0.0 111.028 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.75 35.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.371 1.469 . . . . 0.0 112.036 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -96.23 102.3 14.07 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.63 0.772 . . . . 0.0 110.362 -173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.92 48.71 61.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.409 1.004 . . . . 0.0 112.3 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.45 93.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.761 0.824 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.32 -69.17 1.39 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.216 1.388 . . . . 0.0 112.093 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -28.44 -66.74 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.396 3.078 . . . . 0.0 115.103 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -60.69 -30.53 69.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.044 0.538 . . . . 0.0 111.867 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -78.48 -41.41 32.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.086 0.954 . . . . 0.0 109.992 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.9 -48.98 72.33 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.328 -0.858 . . . . 0.0 111.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.92 -28.12 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.928 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -59.87 -59.86 4.75 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 118.564 -0.732 . . . . 0.0 110.022 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.3 mm -46.39 -55.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.208 0.603 . . . . 0.0 111.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -70.9 -42.56 69.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.796 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.02 -50.0 59.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.739 0.699 . . . . 0.0 112.441 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.97 -36.8 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.657 1.583 . . . . 0.0 110.975 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -44.42 89.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.847 0.459 . . . . 0.0 111.917 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.91 -17.02 27.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.971 0.908 . . . . 0.0 113.383 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.87 66.32 1.27 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.74 139.63 45.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 125.713 1.605 . . . . 0.0 108.458 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -111.69 160.06 17.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.035 1.334 . . . . 0.0 108.555 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.78 -133.17 4.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -173.22 141.1 0.91 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.008 1.323 . . . . 0.0 109.878 172.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.79 82.48 2.6 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.613 1.165 . . . . 0.0 108.43 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -92.22 89.54 6.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.091 0.472 . . . . 0.0 110.761 -163.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.17 72.56 6.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.913 1.685 . . . . 0.0 111.566 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.99 118.44 55.42 Favored Pre-proline 0 C--N 1.342 0.259 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.308 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.71 76.93 2.32 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.831 3.021 . . . . 0.0 111.853 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -163.68 28.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.84 -43.06 3.04 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.706 -0.622 . . . . 0.0 112.809 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -95.66 86.63 4.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 110.789 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.26 125.97 40.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 123.828 0.851 . . . . 0.0 109.523 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.58 135.36 34.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.31 94.57 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.8 t -67.53 122.03 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.39 154.03 39.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -127.28 113.61 16.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.646 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.57 -140.67 0.09 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.495 1.521 . . . . 0.0 113.197 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -177.38 -92.58 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.317 3.047 . . . . 0.0 107.1 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -164.47 -63.23 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 122.972 0.509 . . . . 0.0 110.914 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.1 -53.9 6.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.32 67.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.149 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 69' ' ' LEU . 24.1 tp -53.58 -72.34 0.06 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -55.65 -47.52 76.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.821 0.848 . . . . 0.0 112.413 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -54.25 -41.0 68.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.082 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.78 -46.3 17.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.26 0.482 . . . . 0.0 110.725 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 65' ' ' LEU . 1.5 mm? -52.07 -61.93 1.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.884 -0.51 . . . . 0.0 110.239 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -55.01 -43.78 73.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 111.685 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -56.13 3.09 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.645 1.178 . . . . 0.0 110.438 167.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mt -66.24 -53.8 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.125 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -49.68 65.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.204 0.456 . . . . 0.0 110.526 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -100.16 55.02 0.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.12 0.968 . . . . 0.0 109.631 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.49 75.85 0.22 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.18 129.8 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.066 2.511 . . . . 0.0 109.595 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.56 179.37 6.55 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.165 2.577 . . . . 0.0 109.984 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.11 36.55 0.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.547 0.739 . . . . 0.0 111.974 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.94 162.05 38.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.08 0.952 . . . . 0.0 110.004 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -76.74 87.97 3.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.651 0.78 . . . . 0.0 110.287 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.69 78.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.799 1.24 . . . . 0.0 110.449 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -41.8 -59.36 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.995 2.118 . . . . 0.0 112.305 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -162.66 89.74 0.68 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-O 121.629 0.728 . . . . 0.0 112.589 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.85 92.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.89 0.876 . . . . 0.0 110.9 173.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -98.31 78.74 2.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.891 1.277 . . . . 0.0 108.292 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -72.86 164.97 25.81 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.5 m -134.21 119.22 18.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.451 1.101 . . . . 0.0 109.952 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -80.09 124.38 28.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 m -136.91 176.49 8.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.797 1.239 . . . . 0.0 110.662 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.56 153.59 17.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.376 1.47 . . . . 0.0 110.116 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -45.62 104.22 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.053 1.741 . . . . 0.0 112.167 167.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -92.83 -55.03 3.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.827 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.2 146.36 13.19 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.05 107.25 19.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.509 1.123 . . . . 0.0 110.653 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -68.09 169.61 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 160.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.47 49.51 0.69 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.399 0.68 . . . . 0.0 110.676 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 170.14 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.064 2.145 . . . . 0.0 108.972 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -83.89 91.45 7.58 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.67 162.92 17.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.768 0.713 . . . . 0.0 110.233 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.54 138.47 34.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.231 0.612 . . . . 0.0 110.429 -173.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.7 t80 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.264 -1.35 . . . . 0.0 109.56 174.009 . . . . . . . . 0 0 . 1 stop_ save_